MotifMap M00257

M00257: RREB-1 CCCCAAACMMCCCV


Genome coordinateStrandNormalized LOD scoreZ-scoreBLSBBLSFDRNearest geneDistance (bp)Description
chr22:35288983-35288996+0.8994.5352.952.1600.000NM_003753-33760 eukaryotic translation initiation factor 3, subunit 7
chr3:170666914-170666927-0.9374.8542.752.0010.000NM_004991197254 myelodysplasia syndrome 1 (MDS1), mRNA.
chr12:53032099-53032112-0.9615.0492.811.8290.000NM_02037012426 G protein-coupled receptor 84 (GPR84), mRNA.
chr1:56780486-56780499-0.9695.1162.471.6800.000NM_00371337359 phosphatidic acid phosphatase type 2B (PPAP2B),
chr3:197120528-197120541+0.9755.1631.771.3860.000NM_005781-251 activated Cdc42-associated kinase 1 (ACK1), mRNA.
chr19:51078914-51078927+0.9755.1642.041.3110.000NM_0156492302 interferon regulatory factor 2 binding protein 1
chr11:47449954-47449967-1.0005.3741.881.2940.000NM_00102559617198-
chr22:23766575-23766588+1.0005.3741.601.0150.000NM_001001663-101261 hypothetical LOC255349 (bA9F11.1), mRNA.
chrX:119380167-119380180-0.9865.2601.601.0100.000NM_012069272 ATPase, (Na+)/K+ transporting, beta 4 polypeptide
chr12:5460236-5460249-0.9615.0492.211.3180.133NM_002527-13191 neurotrophin 3 (NTF3), mRNA.
chr20:57613050-57613063-0.9615.0491.681.3080.133NM_080672152 phosphatase and actin regulator 3 (PHACTR3),
chr1:40867828-40867841-0.9865.2601.070.6480.143NM_01474736083 regulating synaptic membrane exocytosis 3 (RIMS3),
chr12:47679342-47679355+0.9615.0491.781.3480.167NM_01508613-
chr14:100363063-100363076-0.9865.2601.680.7350.167NM_003836100157 delta-like 1 homolog (Drosophila) (DLK1), mRNA.
chr3:49178571-49178584-0.9615.0492.521.3880.182NM_022903218 hypothetical protein FLJ12800 (FLJ12800), mRNA.
chr6:149115265-149115278-0.9655.0852.161.3780.182NM_0057155208 uronyl-2-sulfotransferase (UST), mRNA.
chr20:22548640-22548653-0.9865.2601.160.4780.182NM_153675-34538 forkhead box A2 (FOXA2), transcript variant 2, mRNA.
chr2:58601480-58601493-0.9865.2601.240.5040.190NM_018062-279462 Fanconi anemia, complementation group L (FANCL), mRNA.
chr7:5640464-5640477-0.9865.2601.630.7790.200NM_00308841584 fascin homolog 1, actin-bundling protein
chr10:133729884-133729897-0.9865.2601.130.3590.207NM_004052-84459 BCL2/adenovirus E1B 19kDa interacting protein 3
chr17:37474812-37474825-0.9865.2601.080.3560.207NM_001013624-40579-
chr1:72523546-72523559-0.9865.2601.220.3480.207NM_173808-2681 neuronal growth regulator 1 (NEGR1), mRNA.
chr11:46256641-46256654+0.9865.2601.290.3350.207NM_052854937 cAMP responsive element binding protein 3-like 1
chr8:72797395-72797408+0.9865.2601.340.5910.211NM_005098121890 musculin (activated B-cell factor-1) (MSC), mRNA.
chr11:17754501-17754514+0.9865.2601.670.8620.222NM_00497640511 potassium voltage-gated channel, Shaw-related
chr13:73606298-73606311-0.9615.0491.841.2460.235NM_007249-231 Kruppel-like factor 12 (KLF12), transcript variant 1,
chr1:201843252-201843265-0.9865.2601.630.6170.235NM_001001396-19199 ATPase, Ca++ transporting, plasma membrane 4 (ATP2B4),
chr1:110496038-110496051-0.9865.2601.040.6010.235NM_0010108981507-
chr14:87673199-87673212-0.9865.2601.360.3730.240NM_003608132050 G protein-coupled receptor 65 (GPR65), mRNA.
chr12:123064675-123064688-0.9615.0491.741.0300.245NM_15243741152 hypothetical protein DKFZp761B128 (DKFZp761B128),
chr9:108269511-108269524+0.9615.0491.891.0200.245NM_021224-395588 zinc finger protein 462 (ZNF462), mRNA.
chr3:46893193-46893206-0.9615.0492.211.0190.245NM_000316-947 parathyroid hormone receptor 1 (PTHR1), mRNA.
chr16:66245185-66245198-0.9615.0492.171.0120.245NM_0010824867034-
chr19:34708135-34708148+0.9615.0491.641.0020.245NM_006627-80806 processing of precursor 4, ribonuclease P/MRP subunit
chr16:2761078-2761091-0.9655.0802.591.4290.250NM_0071086220 transcription elongation factor B (SIII), polypeptide
chr1:109827534-109827547+0.9755.1632.721.0030.250NM_153340-450 ataxin 7-like 1 (ATXN7L2), mRNA.
chr16:24133149-24133162-0.9865.2601.860.8870.250NM_006539-41128 calcium channel, voltage-dependent, gamma subunit 3
chr10:76847411-76847424-0.9865.2601.830.8790.250NM_032772-15980 zinc finger protein 503 (ZNF503), mRNA.
chr12:101884441-101884454+0.9965.3381.000.3800.250NM_0043168947 achaete-scute complex-like 1 (Drosophila) (ASCL1),
chr10:49895647-49895660-0.9655.0851.160.4980.261NM_00103174697910-
chr12:64643459-64643472-0.9615.0491.570.4980.261NM_003484139052-
chr1:45039230-45039243-0.9615.0491.210.4970.261NM_004073707 polo-like kinase 3 (Drosophila) (PLK3), mRNA.
chr16:72163659-72163672-0.9685.1081.140.4960.261NM_006885-523884 AT-binding transcription factor 1 (ATBF1), mRNA.
chr22:37933379-37933392+0.9615.0491.060.4940.261NM_03301633486 platelet-derived growth factor beta polypeptide
chr6:44230631-44230644+0.9615.0491.070.4890.261NM_007058-3795 calpain 11 (CAPN11), mRNA.
chr15:62539969-62539982-0.9615.0491.360.4870.261NM_015042-38603-
chr1:203554859-203554872-0.9615.0491.530.4860.261NM_0309522647 likely ortholog of rat SNF1/AMP-activated protein
chr9:89447209-89447222-0.9615.0491.080.4860.261NM_001912-83485 cathepsin L (CTSL), transcript variant 1, mRNA.
chr9:87547860-87547873+0.9695.1161.220.4860.261NM_015239-1151 ATP/GTP binding protein 1 (AGTPBP1), mRNA.
chr2:206264382-206264395-0.9695.1201.110.4860.261NM_2012799013 neuropilin 2 (NRP2), transcript variant 3, mRNA.
chr20:3705904-3705917-0.9655.0851.060.4850.261NM_0154174198 chromosome 20 open reading frame 28 (C20orf28), mRNA.
chr1:34238603-34238616+0.9695.1201.340.4840.261NM_001008728136485-
chr2:64919498-64919511+0.9615.0491.240.4840.261NM_003038-150500 solute carrier family 1 (glutamate/neutral amino acid
chr10:724504-724517+0.9615.0491.180.4840.261NM_0149741102 KIAA0934 (KIAA0934), mRNA.
chr17:68799428-68799441+0.9615.0491.350.4830.261NM_01212120310 CDC42 effector protein (Rho GTPase binding) 4
chr6:7568189-7568202-0.9615.0491.030.4770.261NM_15255132858 chromosome 6 open reading frame 151 (C6orf151), mRNA.
chr12:6512717-6512730+0.9615.0491.840.4760.261NM_002046-1101 glyceraldehyde-3-phosphate dehydrogenase (GAPD), mRNA.
chr9:122014235-122014248+0.9615.0491.350.4760.261NM_001011649368023-
chr11:78129046-78129059+0.9615.0491.180.4750.261NM_00109881671787-
chr10:106124435-106124448-0.9695.1201.100.4750.261NM_00100872321023-
chr1:31959344-31959357+0.9615.0491.340.4670.261NM_001856-16989 collagen, type XVI, alpha 1 (COL16A1), mRNA.
chr5:64458145-64458158-0.9825.2251.110.4180.261NM_197941355315 similar to ADAMTS-10 precursor (A disintegrin and
chr6:139970356-139970369+0.9755.1631.930.8960.267NM_006079-232878 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr12:6646398-6646411-0.9865.2601.050.2860.267NM_016162-3833 inhibitor of growth family, member 4 (ING4),
chrX:37429910-37429923+0.9615.0491.520.4620.268NM_021083-42 Kell blood group precursor (McLeod phenotype) (XK),
chr20:10228837-10228850-0.9655.0851.100.4620.268NM_13081181460 synaptosomal-associated protein, 25kDa (SNAP25),
chr9:121453181-121453194-0.9655.0801.060.4620.268NM_014618-281621 deleted in bladder cancer 1 (DBC1), mRNA.
chr11:100812218-100812231-0.9695.1201.280.4610.268NM_004621147651 transient receptor potential cation channel, subfamily
chr1:10778353-10778366-0.9615.0491.060.4600.268NM_001079843941-
chr20:3640975-3640988-0.9695.1201.200.4570.268NM_023068-5200 sialoadhesin (SN), mRNA.
chr6:101973203-101973216-0.9615.0491.000.4550.268NM_17576819628 glutamate receptor, ionotropic, kainate 2 (GRIK2),
chr20:61672445-61672458+0.9615.0491.170.4530.268NM_033405-2894 peroxisomal proliferator-activated receptor A
chr12:64643454-64643467-0.9615.0491.480.4530.268NM_003484139047-
chr10:13697803-13697816-0.9615.0491.460.4530.268NM_00367528958 PRP18 pre-mRNA processing factor 18 homolog (yeast)
chr14:24169868-24169881-0.9655.0851.470.4520.268NM_0041313404 granzyme B (granzyme 2, cytotoxic
chr10:120918521-120918534+0.9615.0491.120.4510.268NM_213649-3327 sideroflexin 4 (SFXN4), transcript variant 1, mRNA.
chr5:81718910-81718923-0.9615.0491.130.4470.268NM_00101797182088-
chr2:219779514-219779527+0.9695.1161.510.4430.268NM_138802-168 hypothetical protein BC018415 (LOC130617), mRNA.
chr14:72252302-72252315+0.9615.0491.240.4410.268NM_012074178260 D4, zinc and double PHD fingers, family 3 (DPF3),
chr1:227192773-227192786-0.9615.0491.020.2990.269NM_021205255381 ras homolog gene family, member U (RHOU), mRNA.
chr14:92599152-92599165+0.9615.0491.150.2970.269NM_01421652828 inositol 1,3,4-triphosphate 5/6 kinase (ITPK1), mRNA.
chr1:35797235-35797248+0.9615.0491.760.2960.269NM_0142841355 neurochondrin (NCDN), mRNA.
chr10:100983046-100983059+0.9615.0491.060.2960.269NM_0218282563 heparanase 2 (HPSE2), mRNA.
chr16:31178922-31178935-0.9615.0491.250.2950.269NM_000632233 integrin, alpha M (complement component receptor 3,
chr2:173806533-173806546+0.9655.0851.080.2910.269NM_031942-121174 cell division cycle associated 7 (CDCA7), transcript
chr14:69596939-69596952-0.9615.0491.250.2880.269NM_18293619732 solute carrier family 8 (sodium-calcium exchanger),
chr13:99429450-99429463+0.9615.0491.260.2830.269NM_007129-2770 Zic family member 2 (odd-paired homolog, Drosophila)
chr10:131950341-131950354-0.9615.0491.090.2830.269NM_006541125788 thioredoxin-like 2 (TXNL2), mRNA.
chr1:196150476-196150489+0.9615.0491.180.2820.269NM_0010144342318-
chr2:226603612-226603625-0.9615.0491.180.2790.269NM_020864629866-
chr2:85704431-85704444-0.9695.1201.080.2780.269NM_0065907737 ubiquitin specific protease 39 (USP39), mRNA.
chr1:19104571-19104584+0.9615.0491.200.2780.269NM_170726-2912 aldehyde dehydrogenase 4 family, member A1 (ALDH4A1),
chr8:73883511-73883524+0.9615.0491.020.2770.269NM_003218-200052 telomeric repeat binding factor (NIMA-interacting) 1
chr12:105816396-105816409-0.9615.0491.070.2750.269NM_152261-57339 hypothetical protein MGC17943 (MGC17943), mRNA.
chr1:226627412-226627425+0.9615.0491.120.2750.269NM_14521433728 tripartite motif-containing 11 (TRIM11), mRNA.
chr1:32613457-32613470-0.9615.0491.160.2740.269NM_05284113108 serine/threonine kinase 22C (spermiogenesis
chr20:37184621-37184634+0.9615.0491.340.2730.269NM_021931160307 DEAH (Asp-Glu-Ala-His) box polypeptide 35 (DHX35),
chr19:43558725-43558738-0.9655.0851.430.2700.269NM_0028121764 proteasome (prosome, macropain) 26S subunit,
chr17:35510667-35510680-0.9615.0491.000.2180.272NM_021724-168 nuclear receptor subfamily 1, group D, member 1
chr10:8223648-8223661+0.9615.0491.090.2150.272NM_00205187075 GATA binding protein 3 (GATA3), transcript variant 2,
chr9:34549615-34549628-0.9615.0491.961.2290.273NM_00184230107 ciliary neurotrophic factor receptor (CNTFR),
chr11:61089095-61089108-0.9615.0491.941.2270.273NM_00420015779 synaptotagmin VII (SYT7), mRNA.
chr15:54324071-54324084+0.9615.0491.791.2100.273NM_022841-1296 hypothetical protein FLJ12994 (FLJ12994), mRNA.
chr5:107223145-107223158+0.9615.0492.251.2100.273NM_001962-188650 ephrin-A5 (EFNA5), mRNA.
chr4:140997962-140997975+0.9615.0491.380.3990.273NM_002413191690 microsomal glutathione S-transferase 2 (MGST2), mRNA.
chr12:790300-790313+0.9615.0491.070.3930.273NM_213655-56857 hereditary sensory neuropathy, type II (HSN2), mRNA.
chr5:131631857-131631870+0.9615.0491.380.3920.273NM_00368710671 PDZ and LIM domain 4 (PDLIM4), mRNA.
chrX:67983639-67983652+0.9615.0491.080.3900.273NM_00442918183 ephrin-B1 (EFNB1), mRNA.
chr1:64709656-64709669+0.9615.0491.170.3870.273NM_020925692 KIAA1573 protein (KIAA1573), mRNA.
chr11:189658-189671-0.9615.0491.220.3860.273NM_0532802997 outer dense fiber of sperm tails 3 (ODF3), mRNA.
chr2:164573967-164573980-0.9655.0851.090.3860.273NM_018086-273208 fidgetin (FIGN), mRNA.
chr10:6660867-6660880-0.9615.0491.330.3850.273NM_0062571377 protein kinase C, theta (PRKCQ), mRNA.
chr19:51585714-51585727-0.9615.0491.300.3810.273NM_03204022967 coiled-coil domain containing 8 (CCDC8), mRNA.
chr12:117902936-117902949-0.9615.0491.360.3800.273NM_194286-743 KIAA1853 protein (KIAA1853), mRNA.
chr6:44215082-44215095-0.9655.0851.230.3790.273NM_01842611828-
chr5:160057187-160057200-0.9615.0491.030.3780.273NM_025153154610-
chr11:110088827-110088840+0.9615.0491.540.3780.273NM_020809-166 Rho GTPase activating protein 20 (ARHGAP20), mRNA.
chr17:39190807-39190820+0.9705.1281.050.3670.273NM_025237875 sclerosteosis (SOST), mRNA.
chr15:55861004-55861017-0.9615.0491.080.2630.273NM_01553274911 glutamate receptor, ionotropic, N-methyl
chr18:33179529-33179542-0.9615.0491.030.2560.273NM_020180220412 bruno-like 4, RNA binding protein (Drosophila)
chr6:25016181-25016194+0.9615.0491.050.2540.273NM_015864-30619 chromosome 6 open reading frame 32 (C6orf32), mRNA.
chr14:64415247-64415260+0.9615.0491.050.2490.273NM_145165-35546 churchill domain containing 1 (CHURC1), mRNA.
chr1:200143385-200143398+0.9655.0851.050.2470.273NM_19814918830 chromosome 1 open reading frame 40 (C1orf40), mRNA.
chr22:28928348-28928361-0.9655.0851.170.2450.273NM_00230944400 leukemia inhibitory factor (cholinergic
chr19:36530473-36530486+0.9695.1201.280.2400.273NM_0208561557 zinc finger protein 537 (ZNF537), mRNA.
chrX:149421757-149421770-0.9615.0491.080.2360.273NM_00549157479 chromosome X open reading frame 6 (CXorf6), mRNA.
chr11:115503655-115503668-0.9695.1201.100.3310.274NM_014333-623204 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr18:22337814-22337827-0.9615.0491.020.3300.274NM_198991136492 potassium channel tetramerisation domain containing 1
chr19:47039453-47039466+0.9615.0491.350.3270.274NM_173506895 hypothetical protein MGC42718 (MGC42718), mRNA.
chr5:175268078-175268091-0.9615.0491.030.3270.274NM_00100822037071-
chr2:202300642-202300655-0.9615.0491.280.3220.274NM_033066-28980 membrane protein, palmitoylated 4 (MAGUK p55 subfamily
chr2:28803003-28803016+0.9615.0491.030.3200.274NM_206876-25015 protein phosphatase 1, catalytic subunit, beta isoform
chr16:64756605-64756618+0.9695.1201.180.3200.274NM_001795-201359 cadherin 5, type 2, VE-cadherin (vascular epithelium)
chrX:117513444-117513457+0.9615.0491.170.3120.274NM_144658-356 dedicator of cytokinesis 11 (DOCK11), mRNA.
chr2:88254613-88254626-0.9695.1201.110.3010.274NM_0182713763 hypothetical protein FLJ10916 (FLJ10916), mRNA.
chr11:65806461-65806474-0.9615.0491.260.4330.276NM_1825534289 hypothetical protein MGC50896 (MGC50896), mRNA.
chr1:38047017-38047030-0.9615.0491.000.4290.276NM_198446561 FLJ45459 protein (FLJ45459), mRNA.
chr11:119621399-119621412-0.9705.1281.050.4250.276NM_0143525338 POU domain, class 2, transcription factor 3 (POU2F3),
chr19:51805568-51805581+0.9615.0491.570.4230.276NM_0051849316 calmodulin 3 (phosphorylase kinase, delta) (CALM3),
chr10:102406212-102406225+0.9615.0491.160.4230.276NM_003988-89146 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr20:38880260-38880273+0.9695.1161.110.4220.276NM_005461-128970 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr11:114966968-114966981-0.9615.0491.040.4220.276NM_014333-86517 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr3:172462774-172462787+0.9615.0491.210.4180.276NM_015028197772-
chr12:50896379-50896392-0.9615.0491.090.4140.276NM_005556-16742 keratin 7 (KRT7), mRNA.
chr9:100447692-100447705+0.9615.0491.020.4080.276NM_00545863608 G protein-coupled receptor 51 (GPR51), mRNA.
chr10:95381412-95381425+0.9695.1201.120.4070.276NM_00620419177 phosphodiesterase 6C, cGMP-specific, cone, alpha prime
chr16:26779796-26779809+0.9695.1161.180.4070.276NM_182831-205633 TNT protein (TNT), mRNA.
chrX:133631710-133631723+0.9615.0491.260.4010.276NM_021796-11531 placenta-specific 1 (PLAC1), mRNA.
chr4:2416976-2416989+0.9615.0491.040.3610.276NM_002938-23529 ring finger protein 4 (RNF4), mRNA.
chr10:103513013-103513026+0.9655.0851.070.3590.276NM_00611912804 fibroblast growth factor 8 (androgen-induced) (FGF8),
chr12:7980133-7980146+0.9615.0491.270.3540.276NM_0069315 solute carrier family 2 (facilitated glucose
chr3:112272824-112272837+0.9615.0491.290.3530.276NM_015480-631 poliovirus receptor-related 3 (PVRL3), mRNA.
chr3:14939094-14939107-0.9615.0491.240.3510.276NM_003298-25046 nuclear receptor subfamily 2, group C, member 2
chr6:10522447-10522460+0.9615.0491.060.3500.276NM_0032201009 transcription factor AP-2 alpha (activating enhancer
chr17:45601637-45601650-0.9615.0491.020.3380.276NM_0000233347 sarcoglycan, alpha (50kDa dystrophin-associated
chr14:23051584-23051597+0.9615.0491.760.9660.277NM_00104263542946-
chr12:66342051-66342064-0.9695.1162.950.9590.277NM_00648213372 dual-specificity tyrosine-(Y)-phosphorylation
chr2:219180739-219180752+0.9615.0492.180.9520.277NM_032726-37 phospholipase C, delta 4 (PLCD4), mRNA.
chr16:53003383-53003396-0.9615.0492.280.9470.277NM_024336-125504 iroquois homeobox protein 3 (IRX3), mRNA.
chr12:57597174-57597187+0.9615.0492.370.9400.277NM_1533773355 leucine-rich repeats and immunoglobulin-like domains 3
chr5:176851639-176851652+0.9615.0491.020.1700.277NM_0054515569 PDZ and LIM domain 7 (enigma) (PDLIM7), transcript
chrX:130991260-130991273+0.9755.1631.580.4910.279NM_0010424526043-
chr2:12234868-12234881+0.9755.1631.100.4880.279NM_145693430777 lipin 1 (LPIN1), mRNA.
chr19:60515502-60515515-0.9615.0492.281.4570.286NM_00108548813018-
chr16:1932457-1932470+1.0005.3741.040.5180.286NM_016332838 selenoprotein X, 1 (SEPX1), mRNA.
chr4:186955916-186955929+0.9755.1631.140.3610.291NM_00360314470 Arg/Abl-interacting protein ArgBP2 (ARGBP2),
chr11:63776857-63776870-0.9615.0491.691.0610.293NM_0009321259 phospholipase C, beta 3
chr9:36791173-36791186-0.9695.1162.171.0610.293NM_014791228368 maternal embryonic leucine zipper kinase (MELK), mRNA.
chr19:56886201-56886214+0.9615.0491.371.0590.293NM_00152332832 hyaluronan synthase 1 (HAS1), mRNA.
chr15:63413544-63413557+0.9615.0491.411.0550.293NM_00488443887 putative neuronal cell adhesion molecule (PUNC), mRNA.
chr1:22873081-22873094+0.9615.0492.061.0510.293NM_00049120912 complement component 1, q subcomponent, beta
chr11:1854982-1854995+0.9615.0491.231.0430.293NM_0010132556352-
chr11:133280341-133280354+0.9615.0491.841.0370.293NM_01498751749-
chr17:39467690-39467703+0.9615.0491.941.0350.293NM_032376-19819 hypothetical protein MGC4251 (MGC4251), mRNA.
chrX:110375182-110375195-0.9655.0851.620.5330.294NM_01428925225 calpain 6 (CAPN6), mRNA.
chr11:76543319-76543332+0.9615.0491.220.5310.294NM_00026026455 myosin VIIA (Usher syndrome 1B (autosomal recessive,
chr16:65894521-65894534+0.9615.0491.520.5290.294NM_018296-23627 hypothetical protein FLJ11004 (FLJ11004), mRNA.
chr6:159670155-159670168-0.9615.0491.140.5280.294NM_032532159838-
chr9:35681111-35681124-0.9615.0491.180.5260.294NM_003289-1058 tropomyosin 2 (beta) (TPM2), transcript variant 1,
chr5:141674908-141674921-0.9615.0491.140.5200.294NM_0309649842 sprouty homolog 4 (Drosophila) (SPRY4), mRNA.
chr14:62581425-62581438+0.9615.0491.370.5200.294NM_139318283 potassium voltage-gated channel, subfamily H
chr2:119317321-119317334-0.9615.0491.140.5190.294NM_0014264908 engrailed homolog 1 (EN1), mRNA.
chrX:101035712-101035725-0.9655.0851.300.5180.294NM_032441-3863-
chr3:11574931-11574944+0.9615.0491.220.5140.294NM_014667162106 vestigial like 4 (Drosophila) (VGLL4), mRNA.
chr5:77181209-77181222+0.9695.1201.220.5140.294NM_004607-73268 tubulin-specific chaperone a (TBCA), mRNA.
chr5:92954501-92954514-0.9695.1201.380.5130.294NM_0056549802 nuclear receptor subfamily 2, group F, member 1
chr17:40193920-40193933-0.9615.0491.510.5030.294NM_0023901926 a disintegrin and metalloproteinase domain 11
chr2:85513813-85513826-0.9615.0491.230.5010.294NM_198482-1516 similar to B-cell linker; B cell linker protein
chr17:34300978-34300991-0.9615.0491.080.5000.294NM_00614821184 LIM and SH3 protein 1 (LASP1), mRNA.
chr5:141243070-141243083-0.9755.1631.820.6990.296NM_002587-4942 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr12:44894917-44894930-0.9755.1641.130.5020.300NM_03067454558 solute carrier family 38, member 1 (SLC38A1), mRNA.
chr13:73606303-73606316-0.9615.0492.091.1940.308NM_007249-236 Kruppel-like factor 12 (KLF12), transcript variant 1,
chr3:18166740-18166753+0.9655.0851.811.1910.308NM_002971273604 special AT-rich sequence binding protein 1 (binds to
chr6:42529420-42529433+0.9615.0492.041.1850.308NM_033502-1659 transcriptional regulating factor 1 (TRERF1),
chr12:48508141-48508154-0.9615.0491.701.1800.308NM_020941334-
chr3:46868634-46868647+0.9755.1641.310.7250.308NM_00025811343 myosin, light polypeptide 3, alkali; ventricular,
chr12:6104243-6104256+0.9755.1641.450.7230.308NM_000552-146 von Willebrand factor (VWF), mRNA.
chr11:94949488-94949501-0.9755.1641.820.7210.308NM_144664213114 hypothetical protein MGC33371 (MGC33371), mRNA.
chr17:24727313-24727326-0.9795.1991.390.7030.308NM_020791-14656 serine/threonine protein kinase TAO1 homolog
chr17:1934510-1934523-0.9615.0491.620.9960.310NM_00109820228256-
chr12:56157966-56157979+0.9615.0491.840.9950.310NM_00108015629-
chr17:2540507-2540520-0.9615.0492.230.9880.310NM_01522921170 KIAA0664 protein (KIAA0664), mRNA.
chr5:170979024-170979037-0.9615.0491.510.9800.310NM_003862199852 fibroblast growth factor 18 (FGF18), transcript
chr1:212376256-212376269-0.9615.0491.780.9730.310NM_020197-144843 SET and MYND domain containing 2 (SMYD2), mRNA.
chr13:50925014-50925027+0.9615.0491.460.9730.310NM_001039937262-
chr14:76565155-76565168+0.9615.0491.600.9690.310NM_024496-368 chromosome 14 open reading frame 4 (C14orf4), mRNA.
chr8:114519004-114519017-0.9615.0492.020.9690.310NM_198123-586 CUB and Sushi multiple domains 3 (CSMD3), transcript
chr10:118912265-118912278-0.9795.1991.060.4560.311NM_199131-24463 ventral anterior homeobox 1 (VAX1), mRNA.
chr1:64586965-64586978-0.9755.1631.030.4510.311NM_020925-121999 KIAA1573 protein (KIAA1573), mRNA.
chr1:27204970-27204983+0.9615.0491.570.6750.320NM_0529436944 family with sequence similarity 46, member B (FAM46B),
chr11:16583852-16583865-0.9615.0491.140.6730.320NM_033326-129358 SRY (sex determining region Y)-box 6 (SOX6), mRNA.
chr12:7980128-7980141+0.9615.0491.860.6690.320NM_00693110 solute carrier family 2 (facilitated glucose
chr20:44125864-44125877-0.9755.1631.590.3850.320NM_02096726123 nuclear receptor coactivator 5 (NCOA5), mRNA.
chr7:99913630-99913643-0.9865.2601.080.2410.323NM_0309351208 TSC-22-like (THG-1), mRNA.
chr12:56290746-56290759-0.9615.0491.530.8760.324NM_133483-639 RAC/CDC42 exchange factor (GEFT), transcript variant
chr5:17271387-17271400-0.9615.0491.220.8750.324NM_006317737 brain abundant, membrane attached signal protein 1
chr2:29950606-29950619+0.9615.0492.270.8690.324NM_00430447330 anaplastic lymphoma kinase (Ki-1) (ALK), mRNA.
chr5:88611365-88611378-0.9615.0491.520.8690.324NM_002397-396585 MADS box transcription enhancer factor 2, polypeptide
chr1:163449105-163449118+0.9695.1201.240.5660.324NM_00103350731-
chr8:56964656-56964669-0.9695.1161.310.5560.324NM_0023509830 v-yes-1 Yamaguchi sarcoma viral related oncogene
chr13:78511854-78511867+0.9695.1201.150.5540.324NM_022118366070 chromosome 13 open reading frame 10 (C13orf10), mRNA.
chr20:30648471-30648484+0.9615.0491.180.5490.324NM_0010109769629-
chr14:92464356-92464369-0.9615.0491.040.5490.324NM_0012755258 chromogranin A (parathyroid secretory protein 1)
chr9:36871400-36871413+0.9755.1631.470.5440.324NM_016734153076 paired box gene 5 (B-cell lineage specific activator)
chr14:55513173-55513186+0.9615.0491.340.5440.324NM_021255-141573 pellino homolog 2 (Drosophila) (PELI2), mRNA.
chr10:78383852-78383865+0.9695.1201.390.5430.324NM_001014797683731-
chr1:159434139-159434152-0.9615.0491.350.5420.324NM_0050991329 a disintegrin-like and metalloprotease (reprolysin
chr19:48961688-48961701-0.9695.1161.100.5410.324NM_019108-10706 hypothetical protein FLJ12886 (FLJ12886), mRNA.
chr6:1568971-1568984-0.9795.1991.250.5400.324NM_00145313391 forkhead box C1 (FOXC1), mRNA.
chr20:42056696-42056709+0.9655.0851.100.5360.324NM_00109879848846-
chr14:95322691-95322704+0.9655.0851.600.5340.324NM_001098725-72405-
chr12:119272777-119272790-0.9615.0491.070.5980.325NM_00244218564 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr12:86903339-86903352+0.9695.1201.600.5970.325NM_15258943968 hypothetical protein FLJ35821 (FLJ35821), mRNA.
chr12:56289887-56289900-0.9615.0491.100.5890.325NM_133483-1498 RAC/CDC42 exchange factor (GEFT), transcript variant
chr12:94640119-94640132+0.9655.0851.260.5890.325NM_02122968548 netrin 4 (NTN4), mRNA.
chr4:14995520-14995533-0.9695.1201.490.5840.325NM_03191144910 C1q and tumor necrosis factor related protein 7
chr12:120982929-120982942-0.9615.0491.920.5820.325NM_014938-18114 Mlx interactor (MONDOA), mRNA.
chr20:43973513-43973526-0.9615.0491.130.5810.325NM_006227680 phospholipid transfer protein (PLTP), transcript
chr12:14026229-14026242+0.9615.0491.310.5760.325NM_000834-1910 glutamate receptor, ionotropic, N-methyl D-aspartate
chrX:39896846-39896859+0.9615.0491.150.5760.325NM_020926-55246 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr1:23723424-23723437+0.9615.0491.020.5720.325NM_0040916876 E2F transcription factor 2 (E2F2), mRNA.
chr18:2837981-2837994-0.9615.0491.340.5670.325NM_0320481053 elastin microfibril interfacer 2 (EMILIN2), mRNA.
chr10:125716078-125716091-0.9615.0491.300.6510.328NM_198148-74588 carboxypeptidase X (M14 family), member 2 (CPXM2),
chr9:34549758-34549771-0.9615.0491.150.6500.328NM_00184229964 ciliary neurotrophic factor receptor (CNTFR),
chr12:112398173-112398186+0.9615.0491.960.6460.328NM_022363-3913 LIM homeobox 5 (LHX5), mRNA.
chr8:22046980-22046993+0.9615.0491.040.6410.328NM_018411-3005 hairless homolog (mouse) (HR), transcript variant 2,
chr19:7604264-7604277-0.9615.0491.060.6380.328NM_174895306-
chr12:7980123-7980136+0.9615.0491.540.6360.328NM_00693115 solute carrier family 2 (facilitated glucose
chr4:109890113-109890126+0.9655.0851.390.6340.328NM_03127913545 alanine-glyoxylate aminotransferase 2-like 1
chr2:119628850-119628863-0.9615.0491.260.6340.328NM_1825284085 complement component 1, q subcomponent-like 2 (C1QL2),
chr15:45804127-45804140-0.9615.0491.150.7250.331NM_1536196249 sema domain, transmembrane domain (TM), and
chr12:120211070-120211083-0.9615.0492.020.7160.331NM_1722267818 calcium/calmodulin-dependent protein kinase kinase 2,
chr14:36325736-36325749-0.9615.0491.140.7080.331NM_006194125180 paired box gene 9 (PAX9), mRNA.
chrX:39259654-39259667+0.9615.0491.190.7070.331NM_017745581946 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr1:20630215-20630228+0.9615.0491.050.7050.331NM_01858455100 calcium/calmodulin-dependent protein kinase II
chr7:130065708-130065721+0.9655.0851.650.7030.331NM_1386933692 Kruppel-like factor 14 (KLF14), mRNA.
chr17:6295911-6295924+0.9655.0851.820.6290.331NM_0190137492 hypothetical protein FLJ10156 (FLJ10156), mRNA.
chr6:112081965-112081978-0.9695.1201.280.6220.331NM_147686-47951 chromosome 6 open reading frame 4 (C6orf4), transcript
chr22:28980545-28980558+0.9615.0491.590.6210.331NM_002309-7797 leukemia inhibitory factor (cholinergic
chr3:31911547-31911560+0.9695.1201.050.6190.331NM_01778486695 oxysterol binding protein-like 10 (OSBPL10), mRNA.
chr9:107192275-107192288-0.9655.0851.800.6150.331NM_207647-57771 similar to fibronectin type 3 and SPRY
chr3:73523299-73523312+0.9695.1161.560.6150.331NM_015009233463-
chr12:52723632-52723645+0.9615.0491.170.6140.331NM_153633-10196 homeo box C4 (HOXC4), transcript variant 2, mRNA.
chr2:223626439-223626452-0.9615.0491.270.6140.331NM_0806711368 potassium voltage-gated channel, Isk-related family,
chr15:46732746-46732759-0.9615.0491.390.6100.331NM_000138-7536 fibrillin 1 (Marfan syndrome) (FBN1), mRNA.
chr1:22802473-22802486+0.9615.0491.430.6090.331NM_015991-33132 complement component 1, q subcomponent, alpha
chr3:50513813-50513826+0.9615.0491.570.6070.331NM_0010055052083-
chr17:53113119-53113132-0.9615.0491.850.6030.331NM_016070169279 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr14:65919948-65919961-0.9615.0491.960.6020.331NM_001024218-123830-
chr1:32492230-32492243-0.9615.0491.700.6000.331NM_0053562903 lymphocyte-specific protein tyrosine kinase (LCK),
chr5:88522581-88522594-0.9655.0802.621.4790.333NM_002397-307801 MADS box transcription enhancer factor 2, polypeptide
chr12:56405744-56405757+0.9865.2601.310.9100.333NM_01477016463 centaurin, gamma 1 (CENTG1), mRNA.
chr19:41054954-41054967-1.0005.3741.190.5700.333NM_0051663813 amyloid beta (A4) precursor-like protein 1 (APLP1),
chr11:109693297-109693310+0.9755.1641.180.4330.340NM_002906-20650 radixin (RDX), mRNA.
chr1:27778481-27778494+0.9755.1631.160.5880.343NM_00102988224249-
chr12:46415385-46415398+0.9755.1631.080.5670.343NM_006025-9768 26 serine protease (P11), mRNA.
chr15:86600432-86600445-0.9615.0491.080.9100.358NM_001012338233-
chr15:54324066-54324079+0.9615.0491.791.0780.364NM_022841-1291 hypothetical protein FLJ12994 (FLJ12994), mRNA.
chr1:214294628-214294641+0.9615.0491.831.0760.364NM_206933368733 Usher syndrome 2A (autosomal recessive, mild) (USH2A),
chr16:85825574-85825587+0.9655.0851.570.8240.364NM_024735149290 F-box protein 31 (FBXO31), mRNA.
chr12:64643449-64643462-0.9615.0491.710.8220.364NM_003484139042-
chr3:48534805-48534818+0.9695.1161.630.8210.364NM_016479-18140 scotin (SCOTIN), mRNA.
chr2:32436606-32436619-0.9615.0491.590.8180.364NM_0162521106 baculoviral IAP repeat-containing 6 (apollon) (BIRC6),
chr17:44626469-44626482+0.9615.0491.480.8170.364NM_03149815273 guanine nucleotide binding protein (G protein), gamma
chr2:66521760-66521773-0.9615.0492.020.8170.364NM_0023985824 Meis1, myeloid ecotropic viral integration site 1
chr17:53086102-53086115+0.9615.0491.050.8050.364NM_016070196296 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr4:85555536-85555549+0.9615.0491.160.7650.364NM_00616882875 NK6 transcription factor related, locus 1 (Drosophila)
chr19:50701959-50701972+0.9615.0491.370.7560.364NM_003370-469 vasodilator-stimulated phosphoprotein (VASP), mRNA.
chr7:25186274-25186287-0.9615.0492.120.7540.364NM_13881168 chromosome 7 open reading frame 31 (C7orf31), mRNA.
chr2:198499172-198499185+0.9695.1201.590.7540.364NM_006226-40273 phospholipase C-like 1 (PLCL1), mRNA.
chr3:182917450-182917463+0.9695.1162.280.7530.364NM_0031065134 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr1:226462300-226462313-0.9615.0491.680.7470.364NM_052843-84 obscurin, cytoskeletal calmodulin and
chr7:96478054-96478067+0.9615.0491.440.7450.364NM_0052224928-
chr1:115014921-115014934+0.9615.0491.600.7360.364NM_198459-666 FLJ37099 protein (FLJ37099), mRNA.
chr7:113514723-113514736-0.9655.0851.570.7340.364NM_002711-168423 protein phosphatase 1, regulatory (inhibitor) subunit
chr16:53227114-53227127-0.9615.0492.070.8660.370NM_005853-295398 iroquois homeobox protein 5 (IRX5), mRNA.
chr1:148936164-148936177+0.9615.0491.480.8600.370NM_01817893 GPP34-related protein (GPP34R), mRNA.
chr13:76356299-76356312+0.9615.0492.460.8520.370NM_1384442242 potassium channel tetramerisation domain containing 12
chr15:38985765-38985778-0.9615.0491.440.8510.370NM_02085711945 vacuolar protein sorting protein 18 (VPS18), mRNA.
chr12:11890863-11890876+0.9615.0491.730.8490.370NM_001987196908 ets variant gene 6 (TEL oncogene) (ETV6), mRNA.
chr14:89153175-89153188-0.9615.0491.370.8350.370NM_0010854712072-
chr6:37218272-37218285+0.9695.1201.280.7970.371NM_002648-27592 pim-1 oncogene (PIM1), mRNA.
chrX:68217620-68217633+0.9655.0851.680.7930.371NM_00103239684377-
chr11:32234059-32234072-0.9615.0492.100.7910.371NM_002901164892 reticulocalbin 1, EF-hand calcium binding domain
chr19:12995366-12995379-0.9615.0491.720.7890.371NM_00250127882 nuclear factor I/X (CCAAT-binding transcription
chr2:27393014-27393027+0.9695.1201.890.7820.371NM_0024376459 MpV17 transgene, murine homolog, glomerulosclerosis
chr17:23717952-23717965-0.9655.0851.620.7810.371NM_0010838961162-
chr11:63397271-63397284-0.9695.1161.500.7810.371NM_004954-15280 MAP/microtubule affinity-regulating kinase 2 (MARK2),
chr1:46433022-46433035+0.9615.0491.740.7670.371NM_0177393686 O-linked mannose
chr20:47482811-47482824+0.9755.1641.250.7560.381NM_00497549777 potassium voltage-gated channel, Shab-related
chr6:85438183-85438196-0.9795.1991.690.7420.381NM_00108050892435-
chr12:53097529-53097542-0.9615.0491.581.1230.387NM_0022051788 integrin, alpha 5 (fibronectin receptor, alpha
chr19:40676910-40676923+0.9615.0492.801.5960.400NM_207392-3714 KIPV467 (UNQ467), mRNA.
chr7:99919396-99919409-0.9655.0851.321.1430.400NM_17356410 hypothetical protein FLJ37538 (FLJ37538), mRNA.
chr16:19847894-19847907+0.9755.1631.921.1430.400NM_016235-44242 G protein-coupled receptor, family C, group 5, member
chr2:176718785-176718798+0.9655.0852.761.1400.400NM_014621-5474 homeo box D4 (HOXD4), mRNA.
chr2:70634702-70634715-0.9655.0851.721.1350.400NM_003236-89 transforming growth factor, alpha (TGFA), mRNA.
chr6:33508407-33508420+0.9865.2601.510.9640.400NM_00677212682-
chr6:33797628-33797641+0.9865.2601.870.9380.400NM_032340-10146 chromosome 6 open reading frame 125 (C6orf125), mRNA.
chr2:177617159-177617172+1.0005.3741.470.6000.400NM_194247-168409 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr15:66799145-66799158+0.9755.1631.020.2420.414NM_006305101132 acidic (leucine-rich) nuclear phosphoprotein 32
chr14:67854960-67854973-0.9795.1991.640.9680.444NM_004926474578 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr10:77141046-77141059-0.9585.0231.310.2960.494NM_032024-71379 chromosome 10 open reading frame 11 (C10orf11), mRNA.
chr1:202887353-202887366+0.9565.0101.090.2830.494NM_00633833751 leucine rich repeat neuronal 5 (LRRN5), transcript
chr17:35863950-35863963+0.9565.0071.490.2810.494NM_00155210848 insulin-like growth factor binding protein 4 (IGFBP4),
chr11:112113027-112113040-0.9575.0141.090.2670.494NM_181351-224078 neural cell adhesion molecule 1 (NCAM1), mRNA.
chr6:145215330-145215343-0.9555.0022.391.6810.500NM_007124560864 utrophin (homologous to dystrophin) (UTRN), mRNA.
chr2:119281659-119281672+0.9615.0492.711.6120.500NM_00142640570 engrailed homolog 1 (EN1), mRNA.
chr17:7323145-7323158+0.9615.0492.251.6110.500NM_0208995096 zinc finger and BTB domain containing 4 (ZBTB4), mRNA.
chr10:105350670-105350683+0.9795.1991.981.2070.500NM_004210106732 neuralized-like (Drosophila) (NEURL), mRNA.
chrX:69634828-69634841-1.0005.3741.260.7070.500NM_02073046042-
chr19:39679411-39679424-0.9514.9711.180.2470.502NM_00108043614791-
chr2:100086404-100086417-0.9514.9711.100.2400.502NM_0010251082073-
chr9:27641939-27641952-0.9514.9711.140.2370.502NM_145005-78097 chromosome 9 open reading frame 72 (C9orf72),
chr17:45186483-45186496+0.9514.9711.010.3990.504NM_03080210035 C/EBP-induced protein (LOC81558), mRNA.
chr11:133352450-133352463+0.9595.0381.460.3880.504NM_014987-20360-
chrX:149789291-149789304+0.9514.9711.320.3790.504NM_03146228546 CD99 antigen-like 2 (CD99L2), mRNA.
chr2:144070081-144070094+0.9595.0381.060.3720.504NM_018460466748 Rho GTPase activating protein 15 (ARHGAP15), mRNA.
chr19:40476917-40476930-0.9565.0071.060.3710.504NM_0806002139 myelin associated glycoprotein (MAG), transcript
chr5:141673691-141673704+0.9585.0231.180.4640.505NM_03096411059 sprouty homolog 4 (Drosophila) (SPRY4), mRNA.
chr12:50872289-50872302-0.9544.9941.390.4620.505NM_182507-238 hypothetical protein LOC144501 (LOC144501), mRNA.
chr7:113759985-113759998-0.9595.0381.020.4590.505NM_014491-82203 forkhead box P2 (FOXP2), transcript variant 1, mRNA.
chr20:35407629-35407642-0.9555.0021.320.4570.505NM_198291-242 v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene
chr1:33401785-33401798+0.9565.0071.120.4560.505NM_01820718069 hypothetical protein FLJ10759 (FLJ10759), mRNA.
chr5:139038496-139038509-0.9565.0101.540.4560.505NM_01646329894 CXXC finger 5 (CXXC5), mRNA.
chr14:61017468-61017481+0.9544.9881.440.4510.505NM_006255159300 protein kinase C, eta (PRKCH), mRNA.
chr5:167654970-167654983-0.9565.0071.060.4430.505NM_0152383400 KIBRA protein (KIBRA), mRNA.
chr12:103380883-103380896-0.9595.0381.010.4400.505NM_0184136075 carbohydrate (chondroitin 4) sulfotransferase 11
chr9:135294495-135294508+0.9595.0381.050.4370.505NM_13902717654 a disintegrin-like and metalloprotease (reprolysin
chr11:21120821-21120834-0.9585.0231.550.4330.507NM_006157473209 NEL-like 1 (chicken) (NELL1), mRNA.
chr15:58984343-58984356-0.9585.0231.270.4310.507NM_134260-277319 RAR-related orphan receptor A (RORA), transcript
chr2:119056375-119056388+0.9595.0381.180.4280.507NM_001426265854 engrailed homolog 1 (EN1), mRNA.
chr20:54588800-54588813-0.9555.0021.190.4270.507NM_00101364647191-
chr16:30667496-30667509+0.9575.0141.380.4210.507NM_000294358 phosphorylase kinase, gamma 2 (testis) (PHKG2), mRNA.
chr15:87733735-87733748+0.9595.0381.330.4090.507NM_002693-54705 polymerase (DNA directed), gamma (POLG), mRNA.
chr1:17607826-17607839-0.9605.0461.160.4070.507NM_01871530981 RCC1-like (TD-60), mRNA.
chr1:10775018-10775031-0.9514.9711.080.3220.513NM_0010798434276-
chr12:66270027-66270040+0.9585.0231.100.3200.513NM_003583-58652 dual-specificity tyrosine-(Y)-phosphorylation
chr7:28146671-28146684+0.9544.9881.310.3150.513NM_17506140291 juxtaposed with another zinc finger gene 1 (JAZF1),
chr2:173928638-173928651+0.9514.9711.000.3140.513NM_145810931 cell division cycle associated 7 (CDCA7), transcript
chr3:136793755-136793768+0.9555.0021.110.3100.513NM_002718-373402 protein phosphatase 2 (formerly 2A), regulatory
chr16:6657108-6657121-0.9565.0071.170.3090.513NM_018723648075 ataxin 2-binding protein 1 (A2BP1), transcript variant
chr11:119000960-119000973-0.9514.9711.130.3080.513NM_203285103685 poliovirus receptor-related 1 (herpesvirus entry
chr19:55046773-55046786-0.9514.9711.140.3070.513NM_017432645 prostate tumor overexpressed gene 1 (PTOV1), mRNA.
chr9:72276022-72276035-0.9514.9711.380.3070.513NM_001206-56629 basic transcription element binding protein 1 (BTEB1),
chr10:24456246-24456259-0.9514.9711.060.3040.513NM_001098501-81380-
chr16:23448757-23448770+0.9555.0021.010.3000.513NM_015044-19448 golgi associated, gamma adaptin ear containing, ARF
chr16:65988907-65988920+0.9555.0021.760.5280.517NM_016140-3985 brain specific protein (CGI-38), mRNA.
chr16:48382005-48382018+0.9565.0071.080.5270.517NM_01506936414 zinc finger protein 423 (ZNF423), mRNA.
chr5:148578511-148578524+0.9514.9711.130.5180.517NM_152406-53040-
chr8:65279384-65279397+0.9565.0071.210.5170.517NM_152414-375884 basic helix-loop-helix domain containing, class B, 5
chr17:40026096-40026109-0.9565.0071.430.5160.517NM_00146635745 frizzled homolog 2 (Drosophila) (FZD2), mRNA.
chr1:20664024-20664037+0.9565.0071.020.5050.517NM_01858421291 calcium/calmodulin-dependent protein kinase II
chr1:175077180-175077193+0.9544.9881.210.4930.517NM_004319323467 astrotactin (ASTN), transcript variant 1, mRNA.
chr11:75921957-75921970-0.9565.0071.390.4910.517NM_02019388340 chromosome 11 open reading frame 30 (C11orf30), mRNA.
chr7:26494606-26494619-0.9555.0021.000.4900.517NM_013322196666 sorting nexin 10 (SNX10), mRNA.
chr19:47073143-47073156-0.9544.9881.240.4890.517NM_021601213 CD79A antigen (immunoglobulin-associated alpha)
chr1:63556742-63556755-0.9555.0021.370.4870.517NM_012183-4476 forkhead box D3 (FOXD3), mRNA.
chr7:91248359-91248372+0.9555.0021.490.4710.517NM_00698099593 transcription termination factor, mitochondrial
chrX:54868711-54868724+0.9585.0231.100.3630.519NM_20122216593 melanoma antigen, family D, 2 (MAGED2), transcript
chr1:64386174-64386187-0.9514.9711.050.3600.519NM_152489-55804 hypothetical protein MGC35130 (MGC35130), mRNA.
chrX:110115149-110115162+0.9544.9881.350.3560.519NM_002578-111007 p21 (CDKN1A)-activated kinase 3 (PAK3), mRNA.
chr1:54521049-54521062+0.9544.9881.210.3530.519NM_001031672-82715-
chr5:81679165-81679178+0.9555.0021.040.3500.519NM_00101797142343-
chr12:107685354-107685367+0.9544.9881.050.3490.519NM_014325-35930 coronin, actin binding protein, 1C (CORO1C), mRNA.
chr1:144439385-144439398-0.9544.9881.100.3460.519NM_002614402 PDZ domain containing 1 (PDZK1), mRNA.
chr19:11297053-11297066-0.9514.9711.170.3400.519NM_00428314268 RAB3D, member RAS oncogene family (RAB3D), mRNA.
chr15:76870684-76870697+0.9555.0021.080.3390.519NM_01427220144 a disintegrin-like and metalloprotease (reprolysin
chr1:20591439-20591452+0.9565.0071.060.3380.519NM_01858493876 calcium/calmodulin-dependent protein kinase II
chr19:45889107-45889120-0.9575.0141.410.3370.519NM_004756-711 numb homolog (Drosophila)-like (NUMBL), mRNA.
chr6:132823446-132823459+0.9605.0421.040.3340.519NM_00356952413 syntaxin 7 (STX7), mRNA.
chr10:122339242-122339255-0.9544.9881.640.5940.524NM_001030059132886-
chr4:186670979-186670992-0.9565.0071.130.5810.524NM_01447622660 PDZ and LIM domain 3 (PDLIM3), mRNA.
chr14:96196133-96196146-0.9555.0021.220.5780.524NM_003384-137204 vaccinia related kinase 1 (VRK1), mRNA.
chr11:60360879-60360892+0.9565.0071.060.5570.526NM_024098-5026 hypothetical protein MGC2574 (MGC2574), mRNA.
chr20:13059756-13059769+0.9585.0231.580.5530.526NM_080826-90562-
chr20:50691843-50691856-0.9514.9711.120.5510.526NM_173485-330341 chromosome 20 open reading frame 17 (C20orf17), mRNA.
chr11:112811263-112811276-0.9575.0142.000.5480.526NM_00079539828 dopamine receptor D2 (DRD2), transcript variant 1,
chr1:188709643-188709656+0.9565.0071.810.5400.526NM_1990513739 DBCCR1-like (DBCCR1L), mRNA.
chr18:33598611-33598624+0.9514.9712.100.5400.526NM_020180-198670 bruno-like 4, RNA binding protein (Drosophila)
chr17:61328570-61328583-0.9575.0141.590.5390.526NM_001037325-75507-
chr17:35162927-35162940-0.9595.0381.010.5370.526NM_00103000214911-
chrX:120124588-120124601-0.9565.0071.320.5350.526NM_012084115545 glutamate dehydrogenase 2 (GLUD2), mRNA.
chr19:10830046-10830059-0.9595.0381.180.6320.541NM_199141-13107 coactivator-associated arginine methyltransferase 1
chr11:7555505-7555518-0.9605.0461.230.6220.541NM_00362163976-
chr20:3727914-3727927-0.9514.9711.730.6170.541NM_0218733613 cell division cycle 25B (CDC25B), transcript variant
chr1:25673715-25673728-0.9595.0381.180.6160.541NM_01820243809 hypothetical protein FLJ10747 (FLJ10747), mRNA.
chr15:97050716-97050729-0.9585.0231.270.6160.541NM_00087540532 insulin-like growth factor 1 receptor (IGF1R), mRNA.
chr15:75849128-75849141+0.9514.9711.000.6140.541NM_032808-137364 leucine rich repeat neuronal 6A (LRRN6A), mRNA.
chr1:25230085-25230098+0.9585.0231.430.6060.541NM_001031680-65997-
chr2:69834936-69834949-0.9585.0231.180.6970.553NM_00115312251 annexin A4 (ANXA4), mRNA.
chr5:74703894-74703907+0.9514.9672.130.6810.553NM_00085935139 3-hydroxy-3-methylglutaryl-Coenzyme A reductase
chr10:75080966-75080979+0.9514.9711.350.6800.553NM_024875-173 synaptopodin 2-like (SYNPO2L), mRNA.
chr12:52132723-52132736-0.9514.9711.730.6790.553NM_001098620662-
chr2:33989662-33989675-0.9585.0231.090.6780.553NM_015475-311796 DKFZP564F0522 protein (DKFZP564F0522), mRNA.
chr18:21176234-21176247+0.9555.0031.450.6750.553NM_0154619880 zinc finger protein 521 (ZNF521), mRNA.
chr7:29339902-29339915+0.9555.0021.250.6740.553NM_004067139356 chimerin (chimaerin) 2 (CHN2), mRNA.
chr1:43860561-43860574-0.9514.9712.110.6590.557NM_014663-27723 jumonji domain containing 2A (JMJD2A), mRNA.
chr6:42822233-42822246-0.9565.0071.490.6580.557NM_003192-371 tubulin-specific chaperone c (TBCC), mRNA.
chr22:29100435-29100448+0.9585.0231.060.6440.557NM_00101798112867-
chr17:52839434-52839447-0.9544.9881.440.6340.557NM_170721150161 musashi homolog 2 (Drosophila) (MSI2), transcript
chr3:55561334-55561347-0.9514.9711.350.7330.579NM_003392-64963 wingless-type MMTV integration site family, member 5A
chr17:45402371-45402384+0.9514.9711.810.7320.579NM_138281908 distal-less homeobox 4 (DLX4), transcript variant 1,
chr3:11045851-11045864-0.9555.0022.060.7280.579NM_00304236495 solute carrier family 6 (neurotransmitter transporter,
chr6:70563130-70563143+0.9544.9881.750.7070.579NM_018368479 chromosome 6 open reading frame 209 (C6orf209), mRNA.
chr11:27699062-27699075+0.9514.9711.630.7020.579NM_170732-216 brain-derived neurotrophic factor (BDNF), transcript
chrX:53094966-53094979-0.9575.0141.740.7590.629NM_018969-165 G-protein coupled receptor 173 (GPR173), mRNA.
chrX:67836982-67836995+0.9585.0231.470.8920.633NM_01472552846 START domain containing 8 (STARD8), mRNA.
chr5:115270259-115270272-0.9514.9712.260.8830.633NM_173800-55811 laeverin (FLJ90650), mRNA.
chr6:42303864-42303877+0.9514.9712.320.8790.633NM_018141-10283 mitochondrial ribosomal protein S10 (MRPS10), nuclear
chr19:56525187-56525200+0.9585.0231.710.8720.633NM_00101476324721-
chr11:16939310-16939323+0.9595.0381.600.8690.633NM_17505853225 pleckstrin homology domain containing, family A member
chr17:53201468-53201481+0.9555.0032.010.9560.642NM_01607080930 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr1:204068266-204068279-0.9264.7591.430.5330.647NM_15249117602 hypothetical protein FLJ32569 (FLJ32569), mRNA.
chr6:37259068-37259081-0.9304.7951.520.5330.647NM_00264813204 pim-1 oncogene (PIM1), mRNA.
chr11:115076918-115076931-0.9254.7492.010.5330.647NM_014333-196467 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr17:46422288-46422301+0.9234.7341.210.5320.647NM_005749-125876 transducer of ERBB2, 1 (TOB1), mRNA.
chr6:20511911-20511924+0.9264.7591.100.5310.647NM_0019491634 E2F transcription factor 3 (E2F3), mRNA.
chrX:38550391-38550404+0.9264.7591.770.5310.647NM_0212422474 MID1 interacting protein 1 (gastrulation specific
chrX:153262823-153262836-0.9264.7591.840.5300.647NM_0001171942 emerin (Emery-Dreifuss muscular dystrophy) (EMD),
chr1:55345129-55345142-0.9274.7651.210.5300.647NM_17493667421 proprotein convertase subtilisin/kexin type 9 (PCSK9),
chr1:174932118-174932131-0.9264.7591.510.5300.647NM_020318233288 pappalysin 2 (PAPPA2), transcript variant 1, mRNA.
chr20:38715305-38715318+0.9264.7591.220.5300.647NM_00546135985 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr11:86287843-86287856+0.9214.7171.310.5280.647NM_01219356238 frizzled homolog 4 (Drosophila) (FZD4), mRNA.
chr22:35835562-35835575+0.9264.7591.670.5270.647NM_153609-5923 transmembrane protease, serine 6 (TMPRSS6), mRNA.
chr16:4318975-4318988-0.9264.7591.150.5270.647NM_032575-3151 GLIS family zinc finger 2 (GLIS2), mRNA.
chr14:56341123-56341136+0.9274.7701.030.5270.647NM_172337975 orthodenticle homolog 2 (Drosophila) (OTX2),
chr14:79332291-79332304-0.9274.7691.650.5270.647NM_001007023415305-
chr11:114574804-114574817+0.9244.7391.180.5250.647NM_001098517305647-
chr5:87421253-87421266+0.9224.7301.440.5250.647NM_153354179168 hypothetical protein MGC33214 (MGC33214), mRNA.
chr6:99386389-99386402-0.9264.7591.320.5250.647NM_005604-2812 POU domain, class 3, transcription factor 2 (POU3F2),
chr1:158449188-158449201-0.9264.7591.030.5230.647NM_0037687537 phosphoprotein enriched in astrocytes 15 (PEA15),
chr2:64410317-64410330+0.9254.7551.240.5230.647NM_014181-124749 HSPC159 protein (HSPC159), mRNA.
chrX:51658256-51658269-0.9274.7691.130.5230.647NM_0069864918 melanoma antigen, family D, 1 (MAGED1), transcript
chrX:136336278-136336291+0.9264.7591.550.5220.647NM_003413-139634 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr4:4255527-4255540+0.9214.7201.330.5210.647NM_17799823995 otopetrin 1 (OTOP1), mRNA.
chr1:159412714-159412727+0.9234.7341.700.5200.647NM_0037791224 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase,
chr2:32436612-32436625-0.9264.7591.630.5200.647NM_0162521112 baculoviral IAP repeat-containing 6 (apollon) (BIRC6),
chr19:47623452-47623465+0.9304.7911.560.5190.647NM_005357-34 lipase, hormone-sensitive (LIPE), mRNA.
chr5:176896216-176896229-0.9304.7901.550.5190.647NM_016222-19643 DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (DDX41),
chr2:107269751-107269764-0.9254.7471.200.5190.647NM_032528-399769 beta-galactoside alpha-2,6-sialyltransferase II
chr3:49145563-49145576+0.9304.7951.020.5180.647NM_00229240 laminin, beta 2 (laminin S) (LAMB2), mRNA.
chr11:65311029-65311042+0.9264.7591.270.5170.647NM_00456124 ovo-like 1(Drosophila) (OVOL1), mRNA.
chr6:1027769-1027782+0.9304.7911.240.5170.647NM_033260-229806 forkhead box Q1 (FOXQ1), mRNA.
chr19:11426005-11426018-0.9264.7591.410.5160.647NM_00274318836 protein kinase C substrate 80K-H (PRKCSH), transcript
chr1:36388977-36388990-0.9254.7491.120.5150.647NM_014408-1323 trafficking protein particle complex 3 (TRAPPC3),
chr12:49875996-49876009+0.9254.7551.640.5150.647NM_00270221748-
chr16:11255277-11255290+0.9264.7591.100.5140.647NM_0037452263 suppressor of cytokine signaling 1 (SOCS1), mRNA.
chr17:35485080-35485093-0.9264.7591.750.5130.647NM_00325012494 thyroid hormone receptor, alpha (erythroblastic
chr1:206393993-206394006-0.9264.7591.120.5130.647NM_02517990295 plexin A2 (PLXNA2), mRNA.
chr4:82501570-82501583-0.9274.7651.550.5120.647NM_152545110515 RasGEF domain family, member 1B (RASGEF1B), mRNA.
chr7:102903010-102903023+0.9284.7731.510.5120.647NM_198999-29176 prestin (motor protein) (PRES), transcript variant a,
chr10:93991053-93991066-0.9264.7591.420.5110.647NM_017824-49747 ring finger protein 153 (RNF153), mRNA.
chr4:186670984-186670997-0.9304.7951.130.5100.647NM_01447622655 PDZ and LIM domain 3 (PDLIM3), mRNA.
chr13:73617096-73617109+0.9304.7951.730.5080.647NM_007249-11029 Kruppel-like factor 12 (KLF12), transcript variant 1,
chr17:35752012-35752025+0.9264.7591.260.5060.647NM_001024809244-
chr11:69294885-69294898+0.9304.7951.180.5060.647NM_0020074467 fibroblast growth factor 4 (heparin secretory
chrX:30556170-30556183+0.9254.7531.290.5050.647NM_000167-25191 glycerol kinase (GK), transcript variant 2, mRNA.
chr5:149150240-149150253+0.9274.7651.740.5050.647NM_13326360283 peroxisome proliferative activated receptor, gamma,
chr1:110547185-110547198+0.9304.7911.380.5040.647NM_153763-8303 potassium voltage-gated channel, Shaw-related
chr20:46847283-46847296+0.9284.7771.630.5030.647NM_02082030544 phosphatidylinositol 3,4,5-trisphosphate-dependent RAC
chrX:149286190-149286203-0.9264.7591.210.5000.647NM_005491-78088 chromosome X open reading frame 6 (CXorf6), mRNA.
chr17:32577870-32577883+0.9565.0101.570.8650.648NM_198837152935 acetyl-Coenzyme A carboxylase alpha (ACACA),
chr17:53314661-53314674-0.9514.9711.740.8430.648NM_01794921088 CUE domain containing 1 (CUEDC1), mRNA.
chr3:50255040-50255053+0.9514.9712.110.8410.648NM_0020706489 guanine nucleotide binding protein (G protein), alpha
chr12:56157109-56157122-0.9214.7201.130.4980.649NM_001080156886-
chr4:89662530-89662543+0.9254.7551.300.4980.649NM_0010426161448-
chr2:218978516-218978529-0.9224.7301.360.4970.649NM_1826425558 CTD (carboxy-terminal domain, RNA polymerase II,
chr17:53325098-53325111+0.9264.7591.050.4970.649NM_01794910651 CUE domain containing 1 (CUEDC1), mRNA.
chr12:106552864-106552877-0.9254.7491.350.4970.649NM_152322225 BTB (POZ) domain containing 11 (BTBD11), mRNA.
chr12:55309811-55309824+0.9264.7591.220.4970.649NM_0134496619 bromodomain adjacent to zinc finger domain, 2A
chr11:133120984-133120997+0.9264.7591.260.4960.649NM_17492799618 spergen-1 (SPAS1), mRNA.
chr9:128728662-128728675-0.9254.7551.050.4940.649NM_01463611888-
chr14:53724306-53724319+0.9264.7591.180.4930.649NM_005192-209070 cyclin-dependent kinase inhibitor 3 (CDK2-associated
chr1:1215951-1215964-0.9304.7951.370.4920.649NM_0029788612 sodium channel, nonvoltage-gated 1, delta (SCNN1D),
chr1:15609818-15609831+0.9264.7591.150.4920.649NM_024329890 EF hand domain containing 2 (EFHD2), mRNA.
chr1:151850238-151850251+0.9304.7911.040.4920.649NM_0803881900 S100 calcium binding protein A16 (S100A16), mRNA.
chr3:124951630-124951643+0.9274.7651.100.4920.649NM_053032-129410 myosin, light polypeptide kinase (MYLK), transcript
chr7:68914624-68914637+0.9214.7221.000.4920.649NM_015570212469 autism susceptibility candidate 2 (AUTS2), mRNA.
chr3:43224405-43224418+0.9264.7591.820.4900.649NM_017719-78595 SNF-1 related kinase (SNRK), mRNA.
chr17:56896189-56896202-0.9304.7952.910.4900.649NM_0184887700 T-box 4 (TBX4), mRNA.
chr12:48346116-48346129+0.9224.7301.940.4890.649NM_00103169835622-
chrX:133631715-133631728+0.9264.7591.070.4880.649NM_021796-11536 placenta-specific 1 (PLAC1), mRNA.
chr5:132239792-132239805+0.9304.7911.230.4870.649NM_0529712635 liver-expressed antimicrobial peptide 2 (LEAP-2),
chrX:132376060-132376073+0.9264.7591.150.4870.649NM_001448811 glypican 4 (GPC4), mRNA.
chr12:47508676-47508689-0.9254.7491.050.4860.649NM_0007259997 calcium channel, voltage-dependent, beta 3 subunit
chr1:58083560-58083573-0.9274.7651.060.4850.649NM_001093732211207-
chr12:56289882-56289895-0.9264.7591.100.4830.649NM_133483-1503 RAC/CDC42 exchange factor (GEFT), transcript variant
chr11:85197954-85197967+0.9254.7551.470.4830.649NM_173556-45738 hypothetical protein MGC34732 (MGC34732), mRNA.
chr17:34492781-34492794-0.9304.7911.550.4830.649NM_02040568517 plexin domain containing 1 (PLXDC1), mRNA.
chr19:56885970-56885983-0.9264.7591.050.4810.649NM_00152333063 hyaluronan synthase 1 (HAS1), mRNA.
chr5:89088886-89088899-0.9304.7911.470.4800.649NM_004365652473 centrin, EF-hand protein, 3 (CDC31 homolog, yeast)
chr19:11429038-11429051+0.9264.7591.040.4790.649NM_00274321869 protein kinase C substrate 80K-H (PRKCSH), transcript
chr16:65496602-65496615-0.9304.7901.780.4790.649NM_00406213665 cadherin 16, KSP-cadherin (CDH16), mRNA.
chr15:72216049-72216062-0.9304.7951.120.4790.649NM_0208516151 KIAA1465 protein (KIAA1465), mRNA.
chr1:203549546-203549559-0.9264.7591.600.4790.649NM_0309527960 likely ortholog of rat SNF1/AMP-activated protein
chr5:89088887-89088900-0.9284.7741.470.4790.649NM_004365652472 centrin, EF-hand protein, 3 (CDC31 homolog, yeast)
chr19:51128897-51128910-0.9214.7201.300.4760.649NM_001029861-19021-
chr17:25028418-25028431-0.9264.7591.270.4760.649NM_032854-55798 coronin, actin binding protein 6 (FLJ14871), mRNA.
chrX:128743459-128743472+0.9304.7951.390.4750.649NM_0189901918 chromosome X open reading frame 9 (CXorf9), mRNA.
chr11:64945247-64945260+0.9304.7951.390.4750.649NM_03190434730 FKSG44 gene (FKSG44), mRNA.
chr21:27139646-27139659+0.9264.7591.000.4740.649NM_006988-47 a disintegrin-like and metalloprotease (reprolysin
chrX:70384992-70385005-0.9264.7591.120.4730.649NM_2015995679 zinc finger protein 261 (ZNF261), transcript variant
chr5:170781489-170781502-0.9264.7591.120.4720.649NM_0038622317 fibroblast growth factor 18 (FGF18), transcript
chr7:96491015-96491028+0.9264.7591.370.4710.649NM_0052211064 distal-less homeo box 5 (DLX5), mRNA.
chr9:14843607-14843620+0.9264.7571.090.4710.649NM_14496656627 chromosome 9 open reading frame 154 (C9orf154), mRNA.
chr8:100806375-100806388+0.9294.7831.060.4710.649NM_004374168696 cytochrome c oxidase subunit VIc (COX6C), mRNA.
chr7:69675382-69675395-0.9264.7591.770.4710.649NM_022479-560243 Williams-Beuren syndrome chromosome region 17
chr3:141506336-141506349+0.9304.7951.040.4690.649NM_022131369539 calsyntenin 2 (CLSTN2), mRNA.
chr9:117022244-117022257+0.9304.7912.080.4690.649NM_01741878426 deleted in esophageal cancer 1 (DEC1), mRNA.
chr1:45048792-45048805+0.9304.7951.280.4680.649NM_001013632-3248-
chr6:46296695-46296708+0.9234.7341.020.4670.649NM_021572-50019 ectonucleotide pyrophosphatase/phosphodiesterase 5
chr11:62148990-62149003+0.9514.9711.390.7980.651NM_012200-2966 beta-1,3-glucuronyltransferase 3
chr16:66325521-66325534+0.9514.9711.470.7970.651NM_030819-14801 hypothetical protein MGC11335 (MGC11335), mRNA.
chr8:32738144-32738157-0.9565.0071.610.7960.651NM_013959114173 neuregulin 1 (NRG1), transcript variant SMDF, mRNA.
chr7:11263054-11263067-0.9555.0021.420.7700.651NM_001007157283113-
chr3:18439942-18439955+0.9544.9881.750.8150.655NM_002971402 special AT-rich sequence binding protein 1 (binds to
chr2:46697304-46697317+0.9304.7951.630.4660.661NM_014171-408 postsynaptic protein CRIPT (CRIPT), mRNA.
chr2:32436617-32436630-0.9304.7951.630.4660.661NM_0162521117 baculoviral IAP repeat-containing 6 (apollon) (BIRC6),
chrX:122869490-122869503-0.9304.7901.390.4620.661NM_00116747861 baculoviral IAP repeat-containing 4 (BIRC4), mRNA.
chr12:104629009-104629022-0.9254.7531.090.4620.661NM_014840428932 AMP-activated protein kinase family member 5 (ARK5),
chrX:39764109-39764122+0.9264.7591.550.4620.661NM_01774577491 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr18:36418725-36418738-0.9254.7491.150.4620.661NM_002647-1370372 phosphoinositide-3-kinase, class 3 (PIK3C3), mRNA.
chr3:195233431-195233444+0.9264.7591.290.4610.661NM_005524-103097 hairy and enhancer of split 1, (Drosophila) (HES1),
chr8:110730304-110730317-0.9304.7951.570.4600.661NM_0177864 hypothetical protein FLJ20366 (FLJ20366), mRNA.
chr16:88518308-88518321-0.9244.7461.230.4590.661NM_0060861162 tubulin, beta, 4 (TUBB4), mRNA.
chr14:102263376-102263389+0.9264.7591.280.4590.661NM_003300-50093 TNF receptor-associated factor 3 (TRAF3), transcript
chrX:50467358-50467371+0.9264.7591.790.4580.661NM_020717106426-
chr2:66655056-66655069-0.9264.7591.130.4580.661NM_002398139120 Meis1, myeloid ecotropic viral integration site 1
chr3:50134098-50134111-0.9284.7771.230.4570.661NM_00577832826 RNA binding motif protein 5 (RBM5), mRNA.
chr12:52714084-52714097+0.9234.7381.150.4560.661NM_0189531085 homeo box C5 (HOXC5), mRNA.
chr1:23998802-23998815+0.9304.7951.520.4550.661NM_000403819 galactose-4-epimerase, UDP- (GALE), mRNA.
chr17:2899356-2899369-0.9274.7661.180.4520.661NM_01456614295 olfactory receptor, family 1, subfamily D, member 5
chr5:37890045-37890058-0.9294.7811.370.4500.661NM_000514-14506 glial cell derived neurotrophic factor (GDNF),
chr11:65326873-65326886+0.9304.7911.300.4490.661NM_00456115868 ovo-like 1(Drosophila) (OVOL1), mRNA.
chr1:32020303-32020316+0.9284.7771.050.4480.661NM_001703-18068 brain-specific angiogenesis inhibitor 2 (BAI2), mRNA.
chr1:176155758-176155771-0.9214.7211.070.4470.661NM_03312749915 regucalcin gene promotor region related protein
chr11:44504943-44504956-0.9284.7771.280.4450.661NM_001024844-38674-
chr17:4572745-4572758-0.9234.7341.120.4440.661NM_001001683-8627 similar to HSPC296 (MGC88387), mRNA.
chr12:51583924-51583937+0.9304.7911.170.4430.661NM_0022731203 keratin 8 (KRT8), mRNA.
chr20:42815726-42815739+0.9254.7491.110.4430.661NM_0223587924 potassium channel, subfamily K, member 15 (KCNK15),
chr17:44947128-44947141-0.9214.7211.340.4420.661NM_00250719562 nerve growth factor receptor (TNFR superfamily, member
chr9:84343654-84343667+0.9274.7701.330.4420.661NM_001098807-476830-
chr17:35473692-35473705-0.9264.7591.040.4410.661NM_0032501106 thyroid hormone receptor, alpha (erythroblastic
chr3:174597341-174597354-0.9264.7591.250.4410.661NM_014932-1497 neuroligin 1 (NLGN1), mRNA.
chr7:116907503-116907516-0.9234.7341.470.4410.661NM_000492350 cystic fibrosis transmembrane conductance regulator,
chr1:59019902-59019915+0.9234.7371.080.4400.661NM_0022282471 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN),
chrX:18852368-18852381+0.9274.7651.150.4400.661NM_00029259729 phosphorylase kinase, alpha 2 (liver) (PHKA2), mRNA.
chr15:29453383-29453396-0.9254.7551.250.4400.661NM_01599547108 Kruppel-like factor 13 (KLF13), mRNA.
chr1:7282304-7282317+0.9214.7171.200.4400.661NM_004781-471512 vesicle-associated membrane protein 3 (cellubrevin)
chrX:136478512-136478525+0.9264.7591.290.4400.661NM_0034132600 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr11:19069198-19069211+0.9304.7911.280.4390.661NM_001001483-25970 zinc finger, DHHC domain containing 13 (ZDHHC13),
chr1:163516229-163516242+0.9274.7651.050.4390.661NM_177399-67093 LIM homeobox transcription factor 1, alpha (LMX1A),
chr22:41717350-41717363+0.9304.7911.250.4390.661NM_007229-44359 protein kinase C and casein kinase substrate in
chr5:134488529-134488542-0.9304.7951.560.4390.661NM_002653-90666 paired-like homeodomain transcription factor 1
chr7:149733724-149733737-0.9294.7821.050.4370.661NM_17368026485 hypothetical protein MGC33584 (MGC33584), mRNA.
chr9:127319484-127319497-0.9304.7951.180.4370.661NM_001006617189850-
chr8:118932381-118932394+0.9294.7831.000.4370.661NM_000127260858 exostoses (multiple) 1 (EXT1), mRNA.
chr1:179295123-179295136+0.9224.7301.110.4360.661NM_00153125461 major histocompatibility complex, class I-related
chr10:108663709-108663722+0.9274.7701.050.4360.661NM_001013031250573-
chr18:51241194-51241207+0.9254.7531.620.4340.661NM_003199165664 transcription factor 4 (TCF4), mRNA.
chr17:35035166-35035179+0.9214.7201.480.3980.663NM_032192-1439 protein phosphatase 1, regulatory (inhibitor) subunit
chr3:5043164-5043177+0.9264.7591.540.3970.663NM_00367047056 basic helix-loop-helix domain containing, class B, 2
chr9:134334322-134334335-0.9264.7591.000.3970.663NM_20741758990 FLJ46082 protein (FLJ46082), mRNA.
chr1:37724546-37724559+0.9264.7591.030.3940.663NM_02507911906 hypothetical protein FLJ23231 (FLJ23231), mRNA.
chr1:24935119-24935132-0.9304.7951.210.3940.663NM_013943-9216 chloride intracellular channel 4 (CLIC4), mRNA.
chr5:64458146-64458159-0.9234.7381.110.3940.663NM_197941355314 similar to ADAMTS-10 precursor (A disintegrin and
chr12:111739638-111739651+0.9264.7591.140.3930.663NM_01495425613 rabphilin 3A homolog (mouse) (RPH3A), mRNA.
chr11:74655389-74655402+0.9304.7951.230.3930.663NM_00404185132 arrestin, beta 1 (ARRB1), transcript variant 1, mRNA.
chr6:99795962-99795975-0.9304.7911.100.3930.663NM_032511108290 chromosome 6 open reading frame 168 (C6orf168), mRNA.
chr3:76566754-76566767+0.9274.7651.010.3930.663NM_002942-605130-
chr14:90088002-90088015-0.9304.7901.370.3920.663NM_006888154976 calmodulin 1 (phosphorylase kinase, delta) (CALM1),
chr6:25045463-25045476-0.9304.7911.030.3920.663NM_015864-59901 chromosome 6 open reading frame 32 (C6orf32), mRNA.
chr7:129163792-129163805+0.9264.7591.190.3900.663NM_001040110106737-
chr2:7024089-7024102-0.9294.7831.210.3900.663NM_01474649215 ring finger protein 144 (RNF144), mRNA.
chr5:134855137-134855150+0.9264.7591.090.3880.663NM_001099221-39149-
chr4:48395575-48395588+0.9304.7951.250.3880.663NM_01503081498-
chr3:183231081-183231094-0.9304.7911.630.3870.663NM_003106318765 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr16:13569477-13569490+0.9224.7301.120.3870.663NM_005236-351947 excision repair cross-complementing rodent repair
chr16:66520432-66520445-0.9214.7171.260.3860.663NM_0019072834 chymotrypsin-like (CTRL), mRNA.
chr1:154984058-154984071-0.9264.7591.160.3850.663NM_0044944102 hepatoma-derived growth factor (high-mobility group
chr11:64216704-64216717+0.9264.7591.310.3850.663NM_01508030532 neurexin 2 (NRXN2), transcript variant alpha-1, mRNA.
chr16:19777469-19777482+0.9264.7591.350.3840.663NM_01623526183 G protein-coupled receptor, family C, group 5, member
chr19:13902120-13902133-0.9304.7911.120.3830.663NM_0248258169 hypothetical protein FLJ23447 (FLJ23447), mRNA.
chr2:32436601-32436614-0.9264.7591.010.3830.663NM_0162521101 baculoviral IAP repeat-containing 6 (apollon) (BIRC6),
chr19:13902121-13902134-0.9284.7741.120.3820.663NM_0248258168 hypothetical protein FLJ23447 (FLJ23447), mRNA.
chr1:206414248-206414261-0.9214.7171.260.3820.663NM_02517970040 plexin A2 (PLXNA2), mRNA.
chr17:44909532-44909545+0.9274.7651.150.3810.663NM_002507-18034 nerve growth factor receptor (TNFR superfamily, member
chr1:7076903-7076916+0.9264.7591.280.3800.663NM_015215309032-
chr11:6379551-6379564+0.9304.7911.020.3790.663NM_00100759311420-
chr9:126191673-126191686+0.9254.7491.050.3790.663NM_00279925869 proteasome (prosome, macropain) subunit, beta type, 7
chr14:73759242-73759255-0.9264.7591.100.3790.663NM_182894-16586 ceh-10 homeo domain containing homolog (C. elegans)
chr9:34333904-34333917+0.9304.7951.200.3780.663NM_14717314500 nudix (nucleoside diphosphate linked moiety X)-type
chr15:64095290-64095303-0.9214.7171.030.3760.663NM_004663146540 RAB11A, member RAS oncogene family (RAB11A), mRNA.
chr17:43158010-43158023+0.9274.7701.120.3750.663NM_013351-7499 T-box 21 (TBX21), mRNA.
chr5:133435294-133435307+0.9264.7591.270.3750.663NM_003202-42907 transcription factor 7 (T-cell specific, HMG-box)
chr5:93064117-93064130-0.9254.7531.330.3750.663NM_15321638948 hypothetical protein FLJ25680 (FLJ25680), mRNA.
chr9:14239953-14239966+0.9264.7571.210.3750.663NM_00559663992 nuclear factor I/B (NFIB), mRNA.
chr1:206435624-206435637-0.9224.7301.430.3730.663NM_02517948664 plexin A2 (PLXNA2), mRNA.
chr6:34319930-34319943-0.9224.7301.260.3720.663NM_0010087034952-
chr4:38543461-38543474-0.9274.7691.390.3720.663NM_138389-2271 hypothetical protein BC001096 (LOC92689), mRNA.
chr11:117442076-117442089+0.9254.7491.110.3720.663NM_001083947-10761-
chr20:30508922-30508935+0.9264.7591.050.3720.663NM_08061625927 chromosome 20 open reading frame 112 (C20orf112),
chr17:69779880-69779893-0.9264.7591.130.3710.663NM_023036-2027 dynein, axonemal, intermediate polypeptide 2 (DNAI2),
chr9:123994809-123994822+0.9224.7301.110.3710.663NM_014222-32890 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8,
chr1:148126689-148126702+0.9264.7591.220.3700.663NM_175065-599 histone 2, H2ab (HIST2H2AB), mRNA.
chr19:48675567-48675580-0.9304.7951.400.3690.663NM_014400-13896 GPI-anchored metastasis-associated protein homolog
chr1:118104857-118104870+0.9214.7171.340.3690.663NM_017709154830 family with sequence similarity 46, member C (FAM46C),
chr8:55886436-55886449+0.9254.7491.030.3690.663NM_006269195356 retinitis pigmentosa 1 (autosomal dominant) (RP1),
chr18:8830338-8830351+0.9254.7471.070.3680.663NM_015210123069 KIAA0802 (KIAA0802), mRNA.
chr12:2038702-2038715-0.9214.7211.070.3680.663NM_0007196077 calcium channel, voltage-dependent, L type, alpha 1C
chr2:220314452-220314465-0.9214.7211.030.3670.663NM_005070113604 solute carrier family 4, anion exchanger, member 3
chr6:112262739-112262752+1.0005.3741.730.7550.667NM_00203738581 FYN oncogene related to SRC, FGR, YES (FYN),
chr1:27735954-27735967+0.9264.7591.520.4330.675NM_006990-46698 WAS protein family, member 2 (WASF2), mRNA.
chr10:116227074-116227087-0.9304.7951.170.4330.675NM_00672049601 actin binding LIM protein 1 (ABLIM1), transcript
chr19:52353183-52353196-0.9264.7591.370.4310.675NM_00550027299 SUMO-1 activating enzyme subunit 1 (SAE1), mRNA.
chr1:161162674-161162687+0.9304.7951.250.4310.675NM_178550-57445 hypothetical protein MGC48998 (MGC48998), mRNA.
chr5:72612297-72612310-0.9264.7591.150.4310.675NM_153217112567 hypothetical protein MGC13034 (MGC13034), mRNA.
chr10:114648808-114648821-0.9264.7591.060.4310.675NM_030756-51293 transcription factor 7-like 2 (T-cell specific,
chr20:44055468-44055481-0.9264.7571.210.4300.675NM_004994-15386 matrix metalloproteinase 9 (gelatinase B, 92kDa
chr15:38281662-38281675-0.9234.7341.170.4300.675NM_020168-37606 p21(CDKN1A)-activated kinase 6 (PAK6), mRNA.
chr4:77724956-77724969-0.9304.7911.330.4290.675NM_020859149779 Shroom-related protein (ShrmL), mRNA.
chr17:66360172-66360185+0.9234.7341.140.4280.675NM_000891683001 potassium inwardly-rectifying channel, subfamily J,
chr3:70225470-70225483-0.9234.7341.120.4280.675NM_198158157127 microphthalmia-associated transcription factor (MITF),
chr19:9907757-9907770+0.9274.7651.190.4270.675NM_058164313 olfactomedin 2 (OLFM2), mRNA.
chr21:33428848-33428861+0.9274.7651.010.4260.675NM_13898364505 oligodendrocyte transcription factor 1 (OLIG1), mRNA.
chr11:124529798-124529811-0.9214.7201.300.4220.675NM_022062-9871 PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.
chr3:152286981-152286994+0.9264.7591.470.4220.675NM_053002-285 TRALPUSH (TRALPUSH), mRNA.
chr14:98788617-98788630+0.9274.7701.010.4220.675NM_02289818958 B-cell CLL/lymphoma 11B (zinc finger protein)
chr17:29189922-29189935+0.9254.7491.410.4220.675NM_001094318016 amiloride-sensitive cation channel 1, neuronal
chr19:50970212-50970225+0.9274.7651.050.4210.675NM_0010815635489-
chr15:87793132-87793145+0.9264.7591.260.4210.675NM_01632147671 Rhesus blood group, C glycoprotein (RHCG), mRNA.
chr6:9613610-9613623+0.9214.7211.180.4210.675NM_153003555298 orofacial cleft 1 candidate 1 (OFCC1), mRNA.
chr11:94529628-94529641+0.9264.7591.320.4190.675NM_01503667063-
chrX:63322049-63322062+0.9264.7591.590.4190.675NM_15242420300 hypothetical protein FLJ39827 (FLJ39827), mRNA.
chr11:65819824-65819837-0.9264.7591.000.4180.675NM_1532664007 hypothetical protein MGC33486 (MGC33486), mRNA.
chr17:34594769-34594782-0.9264.7591.320.4180.675NM_00072312658 calcium channel, voltage-dependent, beta 1 subunit
chr4:152925881-152925894-0.9234.7341.160.4170.675NM_004564-24285 PET112-like (yeast) (PET112L), mRNA.
chr2:218128365-218128378-0.9304.7901.310.4160.675NM_022648388641 tensin (TNS), mRNA.
chr18:33300378-33300391-0.9264.7591.000.4150.675NM_02018099563 bruno-like 4, RNA binding protein (Drosophila)
chr1:200458166-200458179-0.9304.7901.160.4140.675NM_0010174048360-
chr19:62109081-62109094+0.9214.7201.060.4130.675NM_015363-65194 zinc finger, imprinted 2 (ZIM2), mRNA.
chr10:118478398-118478411+0.9214.7141.170.4120.675NM_02501513677-
chr3:48437035-48437048+0.9234.7381.080.4100.675NM_0026734711 plexin B1 (PLXNB1), mRNA.
chr1:149048933-149048946+0.9254.7511.050.4100.675NM_000396-1497 cathepsin K (pycnodysostosis) (CTSK), mRNA.
chrX:17464656-17464669-0.9254.7551.440.4100.675NM_198270161292 Nance-Horan syndrome (congenital cataracts and dental
chr22:31490962-31490975+0.9264.7591.310.4080.675NM_000362-35740 tissue inhibitor of metalloproteinase 3 (Sorsby fundus
chr9:16695135-16695148+0.9264.7591.570.4060.675NM_017637165651 basonuclin 2 (BNC2), mRNA.
chr17:43317444-43317457-0.9264.7591.220.4050.675NM_003110-10971 Sp2 transcription factor (SP2), mRNA.
chr5:159112496-159112509+0.9304.7951.090.4050.675NM_000679-163722 adrenergic, alpha-1B-, receptor (ADRA1B), mRNA.
chr17:39682415-39682428+0.9264.7591.080.4040.675NM_00034218578 solute carrier family 4, anion exchanger, member 1
chr9:100179337-100179350-0.9214.7201.250.4010.675NM_018421-121601-
chr8:72153881-72153894+0.9264.7591.410.4010.675NM_172059277394 eyes absent homolog 1 (Drosophila) (EYA1), transcript
chr17:53113114-53113127-0.9264.7591.450.5650.676NM_016070169284 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr11:34029484-34029497+0.9264.7591.500.5640.676NM_005898-222 membrane component, chromosome 11, surface marker 1
chr5:121429374-121429387-0.9274.7691.450.5630.676NM_00231712479 lysyl oxidase (LOX), mRNA.
chr19:47449800-47449813-0.9304.7951.120.5620.676NM_0064941313 Ets2 repressor factor (ERF), mRNA.
chr11:113813687-113813700-0.9254.7531.410.5620.676NM_015523-1600 small fragment nuclease (DKFZP566E144), mRNA.
chr16:63827397-63827410+0.9264.7571.940.5620.676NM_001797-113977 cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11),
chr3:10296050-10296063-0.9304.7901.400.5610.676NM_01636211359 ghrelin precursor (GHRL), mRNA.
chr2:74066686-74066699+0.9214.7201.730.5600.676NM_08091859325 deoxyguanosine kinase (DGUOK), nuclear gene encoding
chr9:123461005-123461018-0.9254.7551.420.5590.676NM_138709-83780 DAB2 interacting protein (DAB2IP), mRNA.
chr9:81467787-81467800-0.9264.7591.140.5590.676NM_00700591189 transducin-like enhancer of split 4 (E(sp1) homolog,
chr12:52699224-52699237+0.9264.7591.530.5570.676NM_1536932415 homeo box C6 (HOXC6), transcript variant 2, mRNA.
chr7:103719248-103719261-0.9254.7551.660.5570.676NM_199000-36992 lipoma HMGIC fusion partner-like 3 (LHFPL3), mRNA.
chrX:129750718-129750731-0.9264.7591.110.5570.676NM_006375114171 cytosolic ovarian carcinoma antigen 1 (COVA1),
chr14:20974868-20974881-0.9264.7591.880.5540.676NM_020920376-
chr3:15573413-15573426+0.9254.7471.040.5530.676NM_005677-35151 collagen-like tail subunit (single strand of
chr8:140871432-140871445-0.9254.7471.410.5530.676NM_016601-86951 potassium channel, subfamily K, member 9 (KCNK9),
chr20:17448446-17448459+0.9254.7511.530.5520.676NM_00119511528 beaded filament structural protein 1, filensin
chr1:38683563-38683576+0.9294.7821.460.5520.676NM_002699-398526 POU domain, class 3, transcription factor 1 (POU3F1),
chr19:1223728-1223741-0.9234.7341.200.5510.676NM_152480-2469 chromosome 19 open reading frame 23 (C19orf23), mRNA.
chr11:113442117-113442130-0.9304.7951.210.5500.676NM_0010180115719-
chr8:128989264-128989277-0.9254.7491.240.5500.676NM_002467171866 v-myc myelocytomatosis viral oncogene homolog (avian)
chr11:65243569-65243582-0.9304.7951.500.5490.676NM_0321931416 AYP1 protein (AYP1), mRNA.
chr18:13454780-13454793+0.9264.7591.330.5460.676NM_001003674-146786 chromosome 18 open reading frame 1 (C18orf1),
chr2:42133835-42133848+0.9264.7591.320.5440.676NM_1383704678-
chr20:3712853-3712866-0.9264.7591.540.5430.676NM_0018102484 centromere protein B, 80kDa (CENPB), mRNA.
chr10:21855051-21855064+0.9264.7591.200.5430.676NM_207371-434 FLJ45187 protein (FLJ45187), mRNA.
chrX:128938653-128938666-0.9294.7831.450.5430.676NM_021946-5597 BCL6 co-repressor-like 1 (BCORL1), mRNA.
chr10:115793568-115793581-0.9304.7951.170.5430.676NM_000684-128 adrenergic, beta-1-, receptor (ADRB1), mRNA.
chr16:85157193-85157206+0.9224.7301.210.5420.676NM_005251-1150 forkhead box C2 (MFH-1, mesenchyme forkhead 1)
chr2:25400972-25400985+0.9264.7591.020.5420.676NM_02255217306 DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A),
chr22:39408535-39408548-0.9304.7951.480.5420.676NM_0052973507 G protein-coupled receptor 24 (GPR24), mRNA.
chr17:35886005-35886018-0.9264.7591.070.5410.676NM_03286525336 C-terminal tensin-like (CTEN), mRNA.
chr1:205108608-205108621+0.9294.7831.400.5400.676NM_0187242931 interleukin 20 (IL20), mRNA.
chr6:43835738-43835751+0.9214.7201.610.5390.676NM_001025366-10093-
chr2:46884025-46884038-0.9264.7591.400.5390.676NM_144949104272 suppressor of cytokine signaling 5 (SOCS5), transcript
chr1:35810607-35810620-0.9234.7341.300.5380.676NM_178548-851 adaptor-related protein complex 2, epsilon subunit
chr11:66253128-66253141-0.9264.7591.970.5380.676NM_006946-7682 spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA.
chr17:53523194-53523207-0.9264.7591.220.5380.676NM_0806777496 dynein light chain 2 (Dlc2), mRNA.
chr14:55513178-55513191+0.9304.7951.340.5370.676NM_021255-141568 pellino homolog 2 (Drosophila) (PELI2), mRNA.
chrX:68287379-68287392-0.9304.7951.880.5360.676NM_00103239614618-
chr15:24570056-24570069+0.9264.7591.290.5340.676NM_021912-36 gamma-aminobutyric acid (GABA) A receptor, beta 3
chr5:14627120-14627133-0.9304.7901.210.5340.676NM_019018-7712 hypothetical protein FLJ11127 (FLJ11127), mRNA.
chr3:169542366-169542379-0.9254.7491.250.5340.676NM_014498-246003 golgi phosphoprotein 4 (GOLPH4), mRNA.
chr9:85773576-85773589-0.9224.7241.430.6330.679NM_03126311326 heterogeneous nuclear ribonucleoprotein K (HNRPK),
chr12:123064670-123064683-0.9304.7951.820.6330.679NM_15243741147 hypothetical protein DKFZp761B128 (DKFZp761B128),
chr5:159148567-159148580-0.9254.7471.410.6320.679NM_000679-127651 adrenergic, alpha-1B-, receptor (ADRA1B), mRNA.
chr10:75303536-75303549-0.9264.7591.360.6300.679NM_001222808 calcium/calmodulin-dependent protein kinase (CaM
chr2:60184244-60184257-0.9214.7212.260.6260.679NM_018014449893 B-cell CLL/lymphoma 11A (zinc finger protein)
chr6:37818216-37818229+0.9274.7651.210.6250.679NM_153487-44472 MAM domain containing glycosylphosphatidylinositol
chrX:79950618-79950631-0.9244.7461.750.6230.679NM_1532521271 bromo domain-containing protein disrupted in leukemia
chr2:85296392-85296405-0.9264.7591.980.6220.679NM_03128382247 transcription factor 7-like 1 (T-cell specific,
chr6:154975073-154975086-0.9254.7551.240.6220.679NM_173515-101628 membrane associated guanylate kinase interacting
chr1:148861673-148861686+0.9264.7591.480.6210.679NM_2070456560 endosulfine alpha (ENSA), transcript variant 5, mRNA.
chr3:160047833-160047846-0.9274.7691.540.6200.679NM_02273645327 hypothetical protein FLJ14153 (FLJ14153), mRNA.
chr17:60771942-60771955+0.9304.7951.450.6190.679NM_003835208031 regulator of G-protein signalling 9 (RGS9), mRNA.
chr12:5651116-5651129+0.9254.7471.120.6190.679NM_002527177689 neurotrophin 3 (NTF3), mRNA.
chrX:11269994-11270007+0.9264.7591.280.6190.679NM_18268148640 amelogenin (amelogenesis imperfecta 1, X-linked)
chr10:94479956-94479969-0.9264.7591.570.6160.679NM_00272940395 hematopoietically expressed homeobox (HHEX), mRNA.
chr1:33110733-33110746+0.9294.7821.700.6150.679NM_153756-1799 fibronectin type III domain containing 5 (FNDC5),
chr1:89776609-89776622+0.9304.7951.860.6140.679NM_015350-20151 T-cell activation leucine repeat-rich protein
chr2:160180240-160180253+0.9264.7591.630.6140.679NM_0134501065 bromodomain adjacent to zinc finger domain, 2B
chr18:33365598-33365611-0.9304.7951.430.6140.679NM_02018034343 bruno-like 4, RNA binding protein (Drosophila)
chr16:26068654-26068667+0.9254.7551.700.6140.679NM_006040457906 heparan sulfate (glucosamine) 3-O-sulfotransferase 4
chr20:46677626-46677639-0.9264.7591.220.6130.679NM_020820200201 phosphatidylinositol 3,4,5-trisphosphate-dependent RAC
chr6:137861069-137861082+0.9264.7591.920.6120.679NM_175747-3845 oligodendrocyte transcription factor 3 (OLIG3), mRNA.
chr1:150688990-150689003-0.9304.7951.310.6110.679NM_016190-35638 chromosome 1 open reading frame 10 (C1orf10), mRNA.
chr10:99538911-99538924-0.9264.7591.250.6100.679NM_003015-17151 secreted frizzled-related protein 5 (SFRP5), mRNA.
chr6:109117408-109117421+0.9274.7651.980.6100.679NM_001455128746 forkhead box O3A (FOXO3A), transcript variant 1, mRNA.
chr12:51898985-51898998+0.9284.7771.200.6090.679NM_0010427281432-
chr17:34081434-34081447+0.9264.7591.630.6090.679NM_005937-33865 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr11:17628913-17628926-0.9294.7831.440.6090.679NM_002478-68673 myogenic factor 3 (MYOD1), mRNA.
chr1:24553048-24553061+0.9254.7531.450.6080.679NM_19817431031 transcription factor CP2-like 4 (TFCP2L4), transcript
chr1:153208913-153208926-0.9264.7591.510.6060.679NM_183001713 SHC (Src homology 2 domain containing) transforming
chr10:23530156-23530169-0.9304.7951.420.6050.679NM_1781618790 pancreas specific transcription factor, 1a (PTF1A),
chr12:44296247-44296260-0.9254.7491.320.6050.679NM_152641-113540-
chr6:40283422-40283435+0.9264.7571.310.6010.679NM_001001705148301 FLJ41649 protein (FLJ41649), mRNA.
chr7:154282204-154282217+0.9264.7571.390.6010.679NM_007349143411 PAX transcription activation domain interacting
chrX:129044741-129044754+0.9264.7591.220.6000.679NM_00142127406 E74-like factor 4 (ets domain transcription factor)
chr17:67915209-67915222+0.9234.7341.520.6000.679NM_000346286553 SRY (sex determining region Y)-box 9 (campomelic
chr2:45136721-45136734+0.9264.7591.200.2660.680NM_016932-46695 sine oculis homeobox homolog 2 (Drosophila) (SIX2),
chr7:39092218-39092231+0.9234.7381.100.2600.680NM_00725279385 POU domain, class 6, transcription factor 2 (POU6F2),
chr15:75710762-75710775+0.9304.7951.060.2590.680NM_0328081002 leucine rich repeat neuronal 6A (LRRN6A), mRNA.
chr10:104426103-104426116+0.9264.7591.000.2570.680NM_03091231961 tripartite motif-containing 8 (TRIM8), mRNA.
chr7:91248368-91248381+0.9304.7951.090.2570.680NM_00698099584 transcription termination factor, mitochondrial
chr1:203685857-203685870-0.9264.7591.010.2560.680NM_001001552-28053 LEM domain containing 1 (LEMD1), mRNA.
chr16:25188296-25188309-0.9274.7691.070.2560.680NM_001012981-11953-
chr1:27195827-27195840-0.9304.7951.160.2550.680NM_0010136423145-
chr19:51060683-51060696-0.9284.7771.010.2550.680NM_0044971425 forkhead box A3 (FOXA3), mRNA.
chr5:30975631-30975644+0.9224.7301.110.2530.680NM_004932-253822 cadherin 6, type 2, K-cadherin (fetal kidney) (CDH6),
chr10:111861301-111861314+0.9304.7951.130.2510.680NM_130439-95952 MAX interactor 1 (MXI1), transcript variant 2, mRNA.
chrX:39394087-39394100-0.9304.7951.020.2510.680NM_017745447513 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr2:53662966-53662979-0.9214.7211.060.2510.680NM_001008708-185367-
chr5:158336016-158336029+0.9264.7591.030.2460.680NM_024007123331 early B-cell factor (EBF), mRNA.
chr2:165309138-165309151+0.9294.7811.120.2420.680NM_01490097036 COBL-like 1 (COBLL1), mRNA.
chr15:100031050-100031063+0.9284.7771.000.2410.680NM_078474-20933 BBP-like protein 2 (BLP2), transcript variant 1, mRNA.
chr20:590309-590322-0.9254.7491.110.2400.680NM_080725-8419 chromosome 20 open reading frame 139 (C20orf139),
chr2:85984818-85984831-0.9234.7341.160.2390.680NM_003896-15150 sialyltransferase 9 (CMP-NeuAc:lactosylceramide
chr15:81009515-81009528+0.9264.7591.220.2380.680NM_001021.R2-3252-
chr17:22809052-22809065+0.9214.7211.150.2360.680NM_014238-14011-
chr3:59925364-59925377+0.9264.7571.030.2360.680NM_198463-914609 FLJ42117 protein (FLJ42117), mRNA.
chr5:149900707-149900720-0.9214.7211.090.2350.680NM_00154320184 N-deacetylase/N-sulfotransferase (heparan
chr7:25525360-25525373+0.9304.7951.100.2340.680NM_022150-290730 chromosome 7 open reading frame 9 (C7orf9), mRNA.
chr14:98899210-98899223+0.9334.8181.100.4990.681NM_138576-91635 B-cell CLL/lymphoma 11B (zinc finger protein)
chr8:40171243-40171256-0.9354.8311.250.4990.681NM_02013041197 chromosome 8 open reading frame 4 (C8orf4), mRNA.
chr8:118784709-118784722+0.9324.8111.150.4970.681NM_080651182598 thyroid hormone receptor associated protein 6
chr5:65258223-65258236+0.9404.8741.160.4940.681NM_018695183 erbb2 interacting protein (ERBB2IP), mRNA.
chr11:119555435-119555448+0.9354.8341.330.4920.681NM_178507-31422 NS5ATP13TP2 protein (NS5ATP13TP2), mRNA.
chr17:4351310-4351323+0.9324.8131.380.4920.681NM_01452054083 MYB binding protein (P160) 1a (MYBBP1A), mRNA.
chr7:142263887-142263900+0.9404.8741.180.4910.681NM_0044451073 EphB6 (EPHB6), mRNA.
chrX:76594221-76594234+0.9354.8311.600.4910.681NM_003868-1982 fibroblast growth factor 16 (FGF16), mRNA.
chr1:159321241-159321254-0.9354.8311.710.4900.681NM_0309164725 poliovirus receptor-related 4 (PVRL4), mRNA.
chr2:23083889-23083902-0.9344.8271.140.4900.681NM_017552919549-
chr15:72447885-72447898+0.9404.8741.140.4880.681NM_000781-751 cytochrome P450, family 11, subfamily A, polypeptide 1
chr4:122329559-122329572+0.9374.8541.390.4870.681NM_024873-24633 TNFAIP3 interacting protein 3 (TNIP3), mRNA.
chr17:16884131-16884144+0.9354.8341.050.4860.681NM_015134-2601 myosin phosphatase-Rho interacting protein (M-RIP),
chr13:32390169-32390182-0.9404.8741.430.4850.681NM_004795-98302 klotho (KL), transcript variant 1, mRNA.
chr2:74607836-74607849+0.9324.8091.250.4830.681NM_133637-1010 DEAQ box polypeptide 1 (RNA-dependent ATPase) (DQX1),
chr17:5966395-5966408+0.9354.8311.200.4810.681NM_01525351837-
chr10:83626962-83626975+0.9404.8741.520.4800.681NM_0010108481985-
chr20:19822972-19822985+0.9354.8341.020.4750.681NM_0189934862 Ras and Rab interactor 2 (RIN2), mRNA.
chr9:117152877-117152890-0.9404.8781.330.4750.681NM_017418209059 deleted in esophageal cancer 1 (DEC1), mRNA.
chr12:118710547-118710560+0.9384.8621.430.4730.681NM_00717488928 citron (rho-interacting, serine/threonine kinase 21)
chr2:66760138-66760151-0.9354.8381.290.4720.681NM_002398244202 Meis1, myeloid ecotropic viral integration site 1
chr8:28335562-28335575-0.9344.8261.170.4710.681NM_018660-35666 zinc finger protein 395 (ZNF395), mRNA.
chr11:79318411-79318424-0.9344.8271.060.4700.681NM_001098816-1117578-
chr1:24935114-24935127-0.9404.8741.430.4690.681NM_013943-9221 chloride intracellular channel 4 (CLIC4), mRNA.
chr1:10720996-10721009+0.9354.8381.300.4690.681NM_00107984358298-
chr22:36811112-36811125-0.9324.8131.110.4670.681NM_013356-1996 solute carrier 16 (monocarboxylic acid transporters),
chr17:43159997-43160010-0.9494.9521.130.3890.681NM_013351-5512 T-box 21 (TBX21), mRNA.
chr12:106313031-106313044+0.9444.9101.090.3860.681NM_00101807276804-
chr16:68516094-68516107+0.9424.8961.540.3850.681NM_199424-208 WW domain containing E3 ubiquitin protein ligase 2
chr18:33361609-33361622-0.9464.9231.110.3830.681NM_02018038332 bruno-like 4, RNA binding protein (Drosophila)
chr1:47263084-47263097-0.9434.9041.030.3690.681NM_1780331357 cytochrome P450, family 4, subfamily X, polypeptide 1
chr3:64807567-64807580+0.9254.7551.730.5980.683NM_182920-159162 a disintegrin-like and metalloprotease (reprolysin
chr13:58730536-58730549+0.9224.7302.020.5960.683NM_030932754808 diaphanous homolog 3 (Drosophila) (DIAPH3), mRNA.
chr6:125807638-125807651+0.9264.7591.180.5930.683NM_016063-142657 chromosome 6 open reading frame 74 (C6orf74), mRNA.
chr12:104702960-104702973+0.9304.7911.740.5930.683NM_014840354981 AMP-activated protein kinase family member 5 (ARK5),
chr17:44343254-44343267-0.9254.7491.370.5920.683NM_0230792588 hypothetical protein FLJ13855 (FLJ13855), mRNA.
chr11:91681967-91681980+0.9304.7911.250.5920.683NM_001008781-42843-
chr7:150283867-150283880+0.9264.7591.140.5910.683NM_172057-19 potassium voltage-gated channel, subfamily H
chr14:69037008-69037021-0.9304.7901.380.5900.683NM_018375101404 solute carrier family 39 (zinc transporter), member 9
chr6:105946359-105946372-0.9224.7301.030.5900.683NM_00272611303 prolyl endopeptidase (PREP), mRNA.
chrX:70681858-70681871+0.9304.7951.830.5890.683NM_18167312300 O-linked N-acetylglucosamine (GlcNAc) transferase
chr2:2312083-2312096-0.9264.7592.290.5850.683NM_0150251969-
chr12:52698211-52698224-0.9264.7591.460.5840.683NM_1536931402 homeo box C6 (HOXC6), transcript variant 2, mRNA.
chr1:68459573-68459586+0.9304.7911.340.5840.683NM_00100229211268 putative NFkB activating protein 373 (FLJ23091),
chrX:19054596-19054609-0.9274.7691.370.5840.683NM_005756-3998 G protein-coupled receptor 64 (GPR64), mRNA.
chr1:232440987-232441000+0.9304.7951.650.5840.683NM_001012985-134965-
chr17:1012002-1012015+0.9274.7651.320.5830.683NM_02196217879 active BCR-related gene (ABR), transcript variant 1,
chr2:42649840-42649853-0.9264.7591.050.5830.683NM_020744765 metastasis associated family, member 3 (MTA3), mRNA.
chr3:50513818-50513831+0.9264.7591.270.5820.683NM_0010055052078-
chr1:100591494-100591507+0.9304.7951.420.5820.683NM_033312983 CDC14 cell division cycle 14 homolog A (S. cerevisiae)
chr11:71497653-71497666+0.9264.7591.730.5800.683NM_0140423817 DKFZP564M082 protein (DKFZP564M082), mRNA.
chr5:140843757-140843770-0.9264.7591.300.5790.683NM_032406-1068 protocadherin gamma subfamily C, 4 (PCDHGC4),
chr3:50233546-50233559+0.9304.7951.220.5790.683NM_002070-15005 guanine nucleotide binding protein (G protein), alpha
chr7:129379814-129379827-0.9264.7591.220.5790.683NM_003344211 ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast)
chr22:34641224-34641237-0.9214.7211.270.5780.683NM_001082577-74648-
chr10:93117081-93117094+0.9264.7591.610.5780.683NM_173497-42900 HECT domain containing 2 (HECTD2), transcript variant
chr16:71516414-71516427-0.9254.7551.810.5770.683NM_006885123361 AT-binding transcription factor 1 (ATBF1), mRNA.
chr2:104030076-104030089+0.9264.7591.300.5770.683NM_006236-808225 POU domain, class 3, transcription factor 3 (POU3F3),
chr18:10393798-10393811+0.9264.7591.660.5750.683NM_153000-50727 adenomatosis polyposis coli down-regulated 1 (APCDD1),
chr11:45729397-45729410+0.9264.7571.570.5740.683NM_018389-54415 solute carrier family 35, member C1 (SLC35C1), mRNA.
chr20:50693181-50693194+0.9304.7951.420.5730.683NM_173485-329003 chromosome 20 open reading frame 17 (C20orf17), mRNA.
chr10:256789-256802-0.9294.7831.310.5730.683NM_00662486246 zinc finger, MYND domain containing 11 (ZMYND11),
chr17:3813710-3813723-0.9264.7591.580.5720.683NM_005173775 ATPase, Ca++ transporting, ubiquitous (ATP2A3),
chr1:24508610-24508623+0.9254.7551.030.5720.683NM_198173-9758 transcription factor CP2-like 4 (TFCP2L4), transcript
chr11:17686369-17686382+0.9304.7911.300.5720.683NM_002478-11217 myogenic factor 3 (MYOD1), mRNA.
chr16:30866500-30866513-0.9264.7591.090.5700.683NM_152288-1316 hypothetical protein MGC13024 (MGC13024), mRNA.
chr9:16265310-16265323+0.9254.7551.140.5690.683NM_017637595476 basonuclin 2 (BNC2), mRNA.
chr1:54249788-54249801+0.9304.7911.380.5680.683NM_0010109786603-
chr3:158264349-158264362+0.9214.7201.020.3330.683NM_02030796827 cyclin L1 (CCNL1), mRNA.
chr13:71339200-71339213-0.9264.7591.180.3310.683NM_004392131 dachshund homolog 1 (Drosophila) (DACH1), transcript
chr3:42234943-42234956-0.9214.7171.000.3300.683NM_00072946456 cholecystokinin (CCK), mRNA.
chr5:141059277-141059290-0.9294.7821.090.3300.683NM_022481-17293 ARF-GAP, RHO-GAP, ankyrin repeat and plekstrin
chr11:113452554-113452567+0.9264.7591.380.3300.683NM_00101801116156-
chrX:50560394-50560407-0.9254.7491.320.3290.683NM_02071713390-
chr12:84754157-84754170-0.9264.7591.300.3290.683NM_005447292 peptidylglycine alpha-amidating monooxygenase
chr8:25933512-25933525+0.9294.7831.440.3290.683NM_02265924797 early B-cell factor 2 (EBF2), mRNA.
chr11:73148626-73148639+0.9304.7911.320.3280.683NM_0028691223 RAB6A, member RAS oncogene family (RAB6A), transcript
chr11:1548742-1548755+0.9264.7591.010.3280.683NM_004420984 dual specificity phosphatase 8 (DUSP8), mRNA.
chr20:51023465-51023478-0.9244.7391.160.3280.683NM_1734851281 chromosome 20 open reading frame 17 (C20orf17), mRNA.
chr10:124893672-124893685-0.9264.7591.530.3260.683NM_005519-3856-
chr13:72718375-72718388-0.9304.7951.150.3260.683NM_001730187332 Kruppel-like factor 5 (intestinal) (KLF5), mRNA.
chr1:148150968-148150981+0.9284.7741.060.3250.683NM_0148495086 synaptic vesicle glycoprotein 2A (SV2A), mRNA.
chr3:41176448-41176461+0.9214.7171.240.3250.683NM_001098210-39398-
chr1:113049508-113049521+0.9284.7771.260.3240.683NM_0010426791693-
chr3:62145735-62145748-0.9264.7591.290.3240.683NM_020685-134601 chromosome 3 open reading frame 14 (C3orf14), mRNA.
chr2:17690052-17690065+0.9264.7591.000.3230.683NM_003385104864 visinin-like 1 (VSNL1), mRNA.
chr11:121684228-121684241-0.9234.7341.060.3230.683NM_001001786-192095 BRCC2 mRNA (BRCC2), mRNA.
chr3:182655963-182655976-0.9264.7591.340.3230.683NM_003106-256353 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr12:120365282-120365295+0.9304.7951.190.3210.683NM_19427143097 ring finger protein 34 (RNF34), transcript variant 1,
chr2:72343185-72343198-0.9304.7951.060.3210.683NM_019885-114714 cytochrome P450, family 26, subfamily B, polypeptide 1
chr17:34280746-34280759-0.9214.7171.340.3180.683NM_006148952 LIM and SH3 protein 1 (LASP1), mRNA.
chr15:76173890-76173903-0.9304.7951.050.3170.683NM_015079-16978 KIAA1055 protein (KIAA1055), mRNA.
chr19:6701133-6701146-0.9304.7901.130.3160.683NM_00424010526 thyroid hormone receptor interactor 10 (TRIP10), mRNA.
chr1:19013857-19013870+0.9244.7391.020.3160.683NM_15223244885 taste receptor, type 1, member 2 (TAS1R2), mRNA.
chr6:152146017-152146030+0.9274.7701.250.3160.683NM_000125-24262 estrogen receptor 1 (ESR1), mRNA.
chr2:177219197-177219210-0.9234.7341.310.3160.683NM_006554376914 metaxin 2 (MTX2), mRNA.
chr10:78060569-78060582+0.9254.7541.100.3130.683NM_032024848144 chromosome 10 open reading frame 11 (C10orf11), mRNA.
chr1:22953272-22953285+0.9274.7701.040.3120.683NM_01744943454 EphB2 (EPHB2), transcript variant 1, mRNA.
chr11:112156402-112156415+0.9284.7771.500.3120.683NM_181351-180703 neural cell adhesion molecule 1 (NCAM1), mRNA.
chr1:15586442-15586455-0.9254.7491.090.3110.683NM_024329-22486 EF hand domain containing 2 (EFHD2), mRNA.
chr22:39677757-39677770-0.9304.7951.050.3100.683NM_014248526 ring-box 1 (RBX1), mRNA.
chr11:91823206-91823219-0.9214.7171.130.3100.683NM_00100878198396-
chr17:43153549-43153562+0.9264.7591.170.3080.683NM_013351-11960 T-box 21 (TBX21), mRNA.
chr1:112163541-112163554+0.9234.7341.550.3060.683NM_198926-63599 hypothetical protein LOC55924 (LOC55924), transcript
chr2:16685651-16685664-0.9264.7591.080.3050.683NM_03079724926 family with sequence similarity 49, member A (FAM49A),
chr19:55027110-55027123-0.9214.7201.270.3040.683NM_03097313852 ARC/mediator transcriptional coactivator subunit
chr20:34357490-34357503-0.9264.7591.580.3040.683NM_014902-127 discs, large (Drosophila) homolog-associated protein 4
chr1:33401780-33401793+0.9304.7951.440.3040.683NM_01820718074 hypothetical protein FLJ10759 (FLJ10759), mRNA.
chr13:99845268-99845281-0.9214.7211.120.3040.683NM_032813279836 hypothetical protein FLJ14624 (FLJ14624), mRNA.
chr12:53097776-53097789-0.9304.7951.090.3030.683NM_0022051541 integrin, alpha 5 (fibronectin receptor, alpha
chrX:147884725-147884738-0.9264.7591.470.3030.683NM_002025494994 fragile X mental retardation 2 (FMR2), mRNA.
chr9:131048714-131048727+0.9264.7591.070.3020.683NM_203434-68353 immediate early response 5-like (IER5L), mRNA.
chr1:19314071-19314084-0.9304.7901.010.3010.683NM_02076595262 retinoblastoma-associated factor 600 (RBAF600), mRNA.
chr6:44427465-44427478-0.9304.7951.360.3000.683NM_1450269101 spermatogenesis associated, serine-rich 1 (SPATS1),
chr17:35733532-35733545-0.9274.7691.420.3660.685NM_00096414660 retinoic acid receptor, alpha (RARA), mRNA.
chr19:45478000-45478013-0.9254.7491.060.3660.685NM_0016265105 v-akt murine thymoma viral oncogene homolog 2 (AKT2),
chr16:4497051-4497064-0.9304.7951.130.3630.685NM_00213430704 heme oxygenase (decycling) 2 (HMOX2), mRNA.
chr3:32859261-32859274+0.9264.7591.210.3620.685NM_00103911124847-
chr3:53170906-53170919+0.9264.7591.070.3610.685NM_212539743 protein kinase C, delta (PRKCD), transcript variant 2,
chr3:124584577-124584590+0.9264.7591.050.3610.685NM_18335765505 adenylate cyclase 5 (ADCY5), mRNA.
chr2:133144852-133144865-0.9214.7201.030.3610.685NM_14458699 hypothetical protein MGC29643 (MGC29643), mRNA.
chr16:51682236-51682249+0.9304.7951.420.3610.685NM_02513435890 chromodomain helicase DNA binding protein 9 (CHD9),
chr6:34166074-34166087-0.9294.7831.060.3600.685NM_00084143347 glutamate receptor, metabotropic 4 (GRM4), mRNA.
chr4:103485278-103485291+0.9244.7421.220.3590.685NM_02215493 solute carrier family 39 (zinc transporter), member 8
chr6:157061406-157061419+0.9264.7591.210.3580.685NM_017519-79272 AT rich interactive domain 1B (SWI1-like) (ARID1B),
chr10:49886508-49886521-0.9274.7691.360.3570.685NM_001006939-94225-
chr5:133127280-133127293+0.9254.7491.230.3570.685NM_015082-151158-
chr3:124184629-124184642+0.9294.7871.030.3560.685NM_00103170244637-
chr12:11781254-11781267-0.9274.7651.090.3560.685NM_00198787299 ets variant gene 6 (TEL oncogene) (ETV6), mRNA.
chr16:26364680-26364693+0.9254.7531.130.3560.685NM_182831-620749 TNT protein (TNT), mRNA.
chr12:119133607-119133620+0.9304.7951.290.3540.685NM_053275-10210 ribosomal protein, large, P0 (RPLP0), transcript
chr16:59968595-59968608+0.9294.7831.030.3540.685NM_001796658942 cadherin 8, type 2 (CDH8), mRNA.
chr22:24759622-24759635+0.9254.7531.070.3520.685NM_021115-135758 seizure related 6 homolog (mouse)-like (SEZ6L), mRNA.
chr1:109619160-109619173+0.9304.7951.040.3500.685NM_0010052908134 differential display and activated by p53 (DDA3),
chr1:61712625-61712638+0.9264.7591.070.3500.685NM_032027251058 beta-amyloid binding protein precursor (BBP), mRNA.
chr1:158604523-158604536-0.9304.7951.200.3490.685NM_0055981125 nescient helix loop helix 1 (NHLH1), mRNA.
chr10:120204549-120204562+0.9294.7831.130.3490.685NM_022063-112741 chromosome 10 open reading frame 84 (C10orf84), mRNA.
chr17:53164164-53164177-0.9234.7341.090.3490.685NM_016070118234 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr16:5494028-5494041-0.9274.7651.040.3490.685NM_201598-406246 hypothetical protein SB153 (SB153), transcript variant
chr16:48388969-48388982-0.9304.7901.080.3480.685NM_01506929450 zinc finger protein 423 (ZNF423), mRNA.
chr1:6448460-6448473+0.9264.7591.090.3470.685NM_003790382 tumor necrosis factor receptor superfamily, member 25
chr1:199882749-199882762-0.9234.7341.120.3470.685NM_020443-1224 neuron navigator 1 (NAV1), mRNA.
chr1:235272054-235272067+0.9284.7771.040.3460.685NM_001035-171 ryanodine receptor 2 (cardiac) (RYR2), mRNA.
chr11:20741954-20741967-0.9234.7341.070.3460.685NM_00615794342 NEL-like 1 (chicken) (NELL1), mRNA.
chr1:36389182-36389195+0.9214.7171.130.3450.685NM_014408-1528 trafficking protein particle complex 3 (TRAPPC3),
chr2:206431079-206431092+0.9284.7741.420.3430.685NM_201279175710 neuropilin 2 (NRP2), transcript variant 3, mRNA.
chr12:79626369-79626382+0.9304.7951.100.3420.685NM_002469892 myogenic factor 6 (herculin) (MYF6), mRNA.
chrX:135281931-135281944+0.9274.7701.180.3410.685NM_15383471243 G protein-coupled receptor 112 (GPR112), mRNA.
chr11:46225155-46225168+0.9264.7591.120.3410.685NM_052854-30549 cAMP responsive element binding protein 3-like 1
chr20:38917170-38917183+0.9304.7951.340.3410.685NM_005461-165880 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr1:47651193-47651206+0.9264.7591.370.3400.685NM_012186-3038 forkhead box E3 (FOXE3), mRNA.
chr8:82464892-82464905-0.9304.7901.200.3400.685NM_00267757382 peripheral myelin protein 2 (PMP2), mRNA.
chr9:130521960-130521973-0.9264.7591.030.3390.685NM_0327994269 zinc finger, DHHC domain containing 12 (ZDHHC12),
chr11:73148625-73148638+0.9284.7741.320.3390.685NM_0028691224 RAB6A, member RAS oncogene family (RAB6A), transcript
chrX:76644443-76644456-0.9304.7951.150.3380.685NM_00386848240 fibroblast growth factor 16 (FGF16), mRNA.
chr1:153369706-153369719-0.9304.7911.180.3370.685NM_1826852833 ephrin-A1 (EFNA1), transcript variant 2, mRNA.
chr21:35181421-35181434-0.9274.7651.130.3370.685NM_0010018901436 runt-related transcription factor 1 (acute myeloid
chr2:220684447-220684460-0.9304.7901.090.3370.685NM_005070483599 solute carrier family 4, anion exchanger, member 3
chr10:124600103-124600116+0.9234.7341.230.3360.685NM_022034-4422 CUB and zona pellucida-like domains 1 (CUZD1), mRNA.
chrX:100376744-100376757+0.9224.7301.030.3350.685NM_00193915255 dystrophin related protein 2 (DRP2), mRNA.
chr1:55781374-55781387+0.9274.7661.020.2990.685NM_015306-328024-
chr2:237803807-237803820+0.9254.7471.280.2970.685NM_198189145084 COP9 constitutive photomorphogenic homolog subunit 8
chr9:129971362-129971375+0.9304.7951.070.2960.685NM_0241129102 chromosome 9 open reading frame 16 (C9orf16), mRNA.
chr1:158596745-158596758+0.9304.7951.240.2950.685NM_005598-6653 nescient helix loop helix 1 (NHLH1), mRNA.
chr17:39205110-39205123+0.9304.7911.040.2940.685NM_0040906762 dual specificity phosphatase 3 (vaccinia virus
chr3:38735113-38735126+0.9214.7211.310.2940.685NM_001099404-68946-
chr1:18352802-18352815-0.9304.7951.060.2930.685NM_03288046075 hypothetical protein MGC15730 (MGC15730), mRNA.
chr19:44603653-44603666-0.9244.7461.020.2920.685NM_0228358163 likely ortholog of mouse common-site lymphoma/leukemia
chr12:55809481-55809494-0.9264.7591.050.2910.685NM_0023321032 low density lipoprotein-related protein 1
chr7:28417704-28417717-0.9264.7591.070.2910.685NM_182898-865 cAMP responsive element binding protein 5 (CREB5),
chr14:101033776-101033789+0.9264.7591.050.2900.685NM_001362-63565 deiodinase, iodothyronine, type III (DIO3), mRNA.
chr11:2235072-2235085-0.9264.7591.010.2880.685NM_00517013686 achaete-scute complex-like 2 (Drosophila) (ASCL2),
chr1:158599125-158599138-0.9224.7301.000.2830.685NM_005598-4273 nescient helix loop helix 1 (NHLH1), mRNA.
chr17:44036777-44036790+0.9264.7592.250.2820.685NM_018952556 homeo box B6 (HOXB6), transcript variant 2, mRNA.
chr8:103031518-103031531+0.9224.7301.250.2790.685NM_032041-158903 neurocalcin delta (NCALD), mRNA.
chr2:222813294-222813307+0.9224.7291.200.2790.685NM_153038-57716 hypothetical protein FLJ32447 (FLJ32447), mRNA.
chr3:40761486-40761499-0.9264.7591.060.2780.685NM_001098414220206-
chr15:94348364-94348377+0.9264.7591.030.2780.685NM_021005-326486 nuclear receptor subfamily 2, group F, member 2
chr12:55790306-55790319+0.9304.7951.020.2750.685NM_0031531122 signal transducer and activator of transcription 6,
chr4:140405877-140405890-0.9284.7771.080.2750.685NM_03262315065 ovary-specific acidic protein (OSAP), mRNA.
chr11:16958721-16958734-0.9274.7691.040.2750.685NM_17505833814 pleckstrin homology domain containing, family A member
chr11:45833282-45833295+0.9264.7591.160.2730.685NM_0211177777 cryptochrome 2 (photolyase-like) (CRY2), mRNA.
chr8:119161077-119161090+0.9264.7591.020.2730.685NM_00012732162 exostoses (multiple) 1 (EXT1), mRNA.
chr3:38646429-38646442-0.9214.7201.260.2720.685NM_00109940519738-
chr11:16786887-16786900+0.9284.7771.030.2700.685NM_01426770217 small acidic protein (SMAP), mRNA.
chr3:13009970-13009983-0.9264.7591.030.2690.685NM_014869-26010 IQ motif and Sec7 domain 1 (IQSEC1), mRNA.
chr9:129368995-129369008+0.9264.7591.260.2670.685NM_0228332181 chromosome 9 open reading frame 88 (C9orf88), mRNA.
chr10:102320886-102320899-0.9494.9521.030.2640.685NM_01790235355 hypoxia-inducible factor 1, alpha subunit inhibitor
chr8:142501440-142501453-0.9494.9521.170.2510.685NM_032611351 protein tyrosine phosphatase type IVA, member 3
chr1:14684065-14684078+0.9444.9101.060.2420.685NM_015209-113635-
chr3:172879299-172879312+0.9404.8741.070.4660.686NM_00266259267 phospholipase D1, phophatidylcholine-specific (PLD1),
chr1:183185872-183185885+0.9404.8741.230.4640.686NM_05296624433 chromosome 1 open reading frame 24 (C1orf24), mRNA.
chr11:124802882-124802895+0.9374.8511.060.4640.686NM_00510368451 fasciculation and elongation protein zeta 1 (zygin I)
chr10:34101722-34101735-0.9344.8271.350.4630.686NM_003873-437883 neuropilin 1 (NRP1), mRNA.
chr3:42557284-42557297-0.9344.8271.070.4600.686NM_00462438263 vasoactive intestinal peptide receptor 1 (VIPR1),
chr12:112497261-112497274+0.9354.8341.050.4580.686NM_022363-103001 LIM homeobox 5 (LHX5), mRNA.
chrX:118097409-118097422-0.9344.8271.550.4570.686NM_02072171161-
chr15:64169541-64169554+0.9404.8741.070.4560.686NM_032445163588 MEGF11 protein (MEGF11), mRNA.
chr16:77878906-77878919+0.9344.8271.050.4550.686NM_001031804313206-
chr1:5969080-5969093+0.9354.8311.250.4550.686NM_0151026038 nephronophthisis 4 (NPHP4), mRNA.
chr2:149606696-149606709-0.9344.8261.010.4500.686NM_1779643569 hypothetical protein LOC130576 (LOC130576), mRNA.
chr9:34560188-34560201+0.9374.8541.290.4430.686NM_00184219534 ciliary neurotrophic factor receptor (CNTFR),
chrX:102471661-102471674-0.9324.8111.530.4410.686NM_152278-60 hypothetical protein MGC23947 (MGC23947), mRNA.
chr1:54528080-54528093-0.9404.8741.000.4410.686NM_001031672-89746-
chr9:121682640-121682653+0.9394.8701.120.4370.686NM_014618-511080 deleted in bladder cancer 1 (DBC1), mRNA.
chr11:16748043-16748056+0.9404.8741.060.4360.686NM_01426731373 small acidic protein (SMAP), mRNA.
chr17:45603045-45603058-0.9324.8101.060.4350.686NM_0000234755 sarcoglycan, alpha (50kDa dystrophin-associated
chr4:134294211-134294224-0.9404.8741.270.4350.686NM_0329614391 protocadherin 10 (PCDH10), transcript variant 1, mRNA.
chr11:74719070-74719083+0.9344.8261.660.3980.686NM_00404121451 arrestin, beta 1 (ARRB1), transcript variant 1, mRNA.
chrX:109133544-109133557-0.9314.7981.500.3980.686NM_032227626 hypothetical protein FLJ22679 (FLJ22679), mRNA.
chr22:32159869-32159882-0.9354.8311.270.3980.686NM_133633-427186 synapsin III (SYN3), transcript variant IIIc, mRNA.
chr20:59381149-59381162+0.9404.8741.130.3940.686NM_001794120295 cadherin 4, type 1, R-cadherin (retinal) (CDH4), mRNA.
chr1:45048015-45048028+0.9404.8741.630.3900.686NM_001013632-2471-
chr4:144839823-144839836+0.9324.8131.380.3900.686NM_003601185857 SWI/SNF related, matrix associated, actin dependent
chr4:140032987-140033000+0.9344.8271.070.3900.686NM_012118-123306 CCR4 carbon catabolite repression 4-like (S.
chr7:139584804-139584817+0.9404.8741.040.3880.686NM_030647-61594-
chr2:218433542-218433555+0.9344.8271.070.3860.686NM_02264883464 tensin (TNS), mRNA.
chr20:3682594-3682607+0.9404.8741.040.3850.686NM_00103914013858-
chr6:137882588-137882601-0.9404.8741.080.3850.686NM_175747-25364 oligodendrocyte transcription factor 3 (OLIG3), mRNA.
chr5:175232698-175232711+0.9354.8381.460.3800.686NM_0010082201691-
chr4:112062888-112062901-0.9394.8671.250.3800.686NM_153427-284931 paired-like homeodomain transcription factor 2
chr10:86930330-86930343+0.9324.8131.020.3780.686NM_018999852040 KIAA1128 (KIAA1128), mRNA.
chr9:132344312-132344325+0.9404.8741.320.3740.686NM_05401234497 argininosuccinate synthetase (ASS), transcript variant
chrX:140330869-140330882+0.9394.8671.220.3730.686NM_022661-166557 SPANX family, member C (SPANXC), mRNA.
chr12:48765714-48765727-0.9404.8741.090.3690.686NM_139071564 SWI/SNF related, matrix associated, actin dependent
chr14:61591554-61591567-0.9344.8271.290.3690.686NM_03191459360 synaptotagmin XIV-like (SYT14L), mRNA.
chr15:92210109-92210122-0.9374.8541.150.3670.686NM_018349-432290 multiple C2-domains with two transmembrane regions 2
chrX:100549294-100549307+0.9444.9101.050.2880.687NM_000169363 galactosidase, alpha (GLA), mRNA.
chr2:233073850-233073863-0.9444.9061.070.4870.689NM_004826-13075 endothelin converting enzyme-like 1 (ECEL1), mRNA.
chr8:30533625-30533638+0.9444.9101.220.4870.689NM_002095101655 general transcription factor IIE, polypeptide 2, beta
chrX:146596152-146596165-0.9414.8811.160.4830.689NM_002024-204949 fragile X mental retardation 1 (FMR1), mRNA.
chr15:59253749-59253762+0.9434.9041.220.4790.689NM_13426155045 RAR-related orphan receptor A (RORA), transcript
chr20:52562956-52562969-0.9474.9321.200.4780.689NM_01843137383 docking protein 5 (DOK5), transcript variant 1, mRNA.
chr15:62938792-62938805-0.9434.9041.060.4770.689NM_02520117704 PH domain-containing protein (pp9099), mRNA.
chr14:23675870-23675883+0.9464.9241.050.4750.689NM_176783752 proteasome (prosome, macropain) activator subunit 1
chr22:34687737-34687750+0.9424.8961.180.4750.689NM_00108257866794-
chr12:24215124-24215137+0.9494.9521.050.4730.689NM_006940-221220 SRY (sex determining region Y)-box 5 (SOX5),
chr9:128639819-128639832-0.9484.9461.360.4710.689NM_001099270-22846-
chr9:122517665-122517678-0.9304.7951.060.2300.690NM_001080497-1232-
chr13:47980241-47980254+0.9304.7951.090.2300.690NM_00126825076 chromosome condensation 1-like (CHC1L), mRNA.
chr18:53251918-53251931-0.9264.7591.090.2260.690NM_004852-1897 one cut domain, family member 2 (ONECUT2), mRNA.
chr2:122079164-122079177+0.9264.7591.040.2250.690NM_01528244358 cytoplasmic linker associated protein 1 (CLASP1),
chr3:182917459-182917472+0.9264.7591.180.2250.690NM_0031065143 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr17:39749628-39749641+0.9254.7531.300.2110.690NM_0160168030 CGI-69 protein (CGI-69), mRNA.
chr5:138765467-138765480+0.9224.7301.000.2010.690NM_016459-11963 proapoptotic caspase adaptor protein (PACAP), mRNA.
chr2:109137231-109137244-0.9264.7571.030.2000.690NM_00109928924902-
chr12:66674083-66674096+0.9264.7571.470.1880.690NM_000619165705 interferon, gamma (IFNG), mRNA.
chr8:21994154-21994167-0.9304.7911.120.1850.690NM_022749-8406 retinoic acid induced 16 (RAI16), mRNA.
chr17:9554181-9554194-0.9304.7911.000.1840.690NM_15321064606-
chr7:27119182-27119195+0.9304.7951.000.1700.690NM_153632959 homeo box A3 (HOXA3), transcript variant 3, mRNA.
chr2:204927721-204927734+0.9214.7211.110.1690.690NM_152526-190940 amyotrophic lateral sclerosis 2 (juvenile) chromosome
chrX:136478518-136478531+0.9264.7591.150.1690.690NM_0034132606 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr12:52714085-52714098+0.9424.8891.150.4610.692NM_0189531086 homeo box C5 (HOXC5), mRNA.
chr15:24776810-24776823+0.9434.9041.390.4510.692NM_033223-22353 gamma-aminobutyric acid (GABA) A receptor, gamma 3
chr17:24531147-24531160+0.9414.8871.530.4500.692NM_078471386 myosin XVIIIA (MYO18A), transcript variant 1, mRNA.
chr6:2503935-2503948+0.9484.9461.280.4420.692NM_15255476362 chromosome 6 open reading frame 195 (C6orf195), mRNA.
chr12:94972309-94972322-0.9484.9461.370.4400.692NM_000895-18813 leukotriene A4 hydrolase (LTA4H), mRNA.
chr1:204717994-204718007+0.9464.9241.270.4360.692NM_0140027675 inhibitor of kappa light polypeptide gene enhancer in
chr8:144873330-144873343+0.9424.8891.020.2330.693NM_1390212935 extracellular signal-regulated kinase 8 (ERK8), mRNA.
chr5:152446577-152446590+0.9444.9081.020.2320.693NM_000827-403822 glutamate receptor, ionotropic, AMPA 1 (GRIA1), mRNA.
chr3:134037171-134037184-0.9434.9041.030.2130.693NM_153240-113205 nephronophthisis 3 (adolescent) (NPHP3), mRNA.
chr3:127711391-127711404+0.9464.9241.070.1860.693NM_1446397893 hypothetical protein FLJ31300 (FLJ31300), mRNA.
chr3:24254783-24254796-0.9494.9521.010.1820.693NM_000461256534 thyroid hormone receptor, beta (erythroblastic
chr19:50084048-50084061+0.9264.7591.000.1270.693NM_006114-2186 translocase of outer mitochondrial membrane 40 homolog
chr1:45774800-45774813+0.9304.7951.000.1490.694NM_006066-14185 aldo-keto reductase family 1, member A1 (aldehyde
chr9:33808373-33808386-0.9264.7591.170.1470.694NM_0178111291 ubiquitin-conjugating enzyme E2R 2 (UBE2R2), mRNA.
chr9:70208502-70208515-0.9444.9081.080.1290.695NM_02196546967 phosphoglucomutase 5 (PGM5), mRNA.
chr3:48437036-48437049+0.9504.9581.080.4330.696NM_0026734710 plexin B1 (PLXNB1), mRNA.
chr7:36873029-36873042-0.9444.9081.100.4310.696NM_001039459118161-
chr6:34127176-34127189+0.9494.9521.510.4260.696NM_00084182245 glutamate receptor, metabotropic 4 (GRM4), mRNA.
chr12:118215806-118215819-0.9464.9231.180.4230.696NM_178499-40994 hypothetical protein MGC39827 (MGC39827), mRNA.
chr11:17807744-17807757+0.9434.9041.150.4120.696NM_00497693754 potassium voltage-gated channel, Shaw-related
chr11:85831324-85831337-0.9444.9101.280.4050.696NM_02182767998 hypothetical protein FLJ23514 (FLJ23514), mRNA.
chr5:149126940-149126953-0.9444.9081.140.4030.696NM_13326336983 peroxisome proliferative activated receptor, gamma,
chr18:46864877-46864890-0.9514.9711.980.9280.698NM_00535954366 SMAD, mothers against DPP homolog 4 (Drosophila)
chr17:53523107-53523120-0.9544.9881.410.9180.698NM_0806777409 dynein light chain 2 (Dlc2), mRNA.
chr3:195904745-195904758-0.9514.9711.730.9000.698NM_15369016934 family with sequence similarity 43, member A (FAM43A),
chrX:118445230-118445243+0.9404.8741.210.4330.698NM_14530528279 similar to solute carrier family 25 , member 16
chr1:38391393-38391406+0.9344.8271.500.4280.698NM_002699-106356 POU domain, class 3, transcription factor 1 (POU3F1),
chr17:71644304-71644317+0.9384.8621.110.4270.698NM_0014543857 forkhead box J1 (FOXJ1), mRNA.
chr12:99512716-99512729-0.9344.8271.260.4250.698NM_17494221196 growth arrest-specific 2 like 3 (GAS2L3), mRNA.
chr2:202540792-202540805+0.9354.8311.230.4240.698NM_003507-66663 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr2:216347090-216347103+0.9344.8271.240.4230.698NM_018000239501 hypothetical protein FLJ10116 (FLJ10116), mRNA.
chr1:22288093-22288106-0.9324.8131.230.4210.698NM_00179136486 cell division cycle 42 (GTP binding protein, 25kDa)
chr13:94860673-94860686-0.9324.8091.110.4210.698NM_182848-23086 claudin 10 (CLDN10), transcript variant 1, mRNA.
chr2:220187836-220187849-0.9404.8741.440.4200.698NM_201574-12595 solute carrier family 4, anion exchanger, member 3
chr16:22874457-22874470+0.9314.7991.280.4180.698NM_006043141196 heparan sulfate (glucosamine) 3-O-sulfotransferase 2
chr19:50540100-50540113+0.9354.8381.050.4140.698NM_1774174362 kinesin light chain 2-like (KLC2L), transcript variant
chr5:66037943-66037956+0.9344.8271.140.4140.698NM_198828110111 similar to microtubule associated testis specific
chr9:128924218-128924231+0.9324.8131.090.4130.698NM_012098647 angiopoietin-like 2 (ANGPTL2), mRNA.
chr10:73172442-73172455-0.9374.8491.210.4130.698NM_02215330901-
chr1:29317118-29317131-0.9344.8271.960.4120.698NM_0010036825876 cDNA DKFZp434C184 gene (DKFZp434C184), mRNA.
chr5:177728880-177728893+0.9344.8261.120.4090.698NM_153373-136488 hypothetical protein MGC15875 (MGC15875), mRNA.
chr3:138970262-138970275-0.9394.8701.080.4080.698NM_0041894093 SRY (sex determining region Y)-box 14 (SOX14), mRNA.
chr1:54479715-54479728+0.9354.8311.060.4030.698NM_001031672-41381-
chr2:186313351-186313364+0.9374.8511.010.4030.698NM_207482-64555 FLJ44048 protein (FLJ44048), mRNA.
chr3:72390634-72390647-0.9394.8701.520.4010.698NM_012234187830 RING1 and YY1 binding protein (RYBP), mRNA.
chr9:127960178-127960191-0.9374.8511.270.4000.698NM_001011703-168671-
chr3:45777472-45777485-0.9444.9081.150.5310.700NM_02020835494 solute carrier family 6 (neurotransmitter
chr3:13437955-13437968-0.9434.8981.310.5280.700NM_024923-1146 nucleoporin 210 (NUP210), mRNA.
chr8:70717248-70717261+0.9444.9081.250.5180.700NM_015170175921 sulfatase 1 (SULF1), mRNA.
chr12:97277536-97277549+0.9444.9101.080.5170.700NM_001032283-155904-
chr2:180443088-180443101+0.9464.9241.040.5160.700NM_152520-8776 zinc finger protein 533 (ZNF533), mRNA.
chr12:104576470-104576483-0.9444.9101.500.5140.700NM_018171-422332 DIP13 beta (DIP13B), mRNA.
chr17:29962352-29962365-0.9444.9081.110.5080.700NM_20731330571 hypothetical protein LOC124842 (LOC124842), mRNA.
chr11:78471201-78471214-0.9444.9081.210.5080.700NM_001098816-270368-
chr17:44481980-44481993+0.9444.9101.530.5050.700NM_00654652307 IGF-II mRNA-binding protein 1 (IMP-1), mRNA.
chr1:44074803-44074816+0.9404.8741.230.2660.700NM_057091-96676 artemin (ARTN), transcript variant 2, mRNA.
chr17:4589243-4589256+0.9324.8091.190.2620.700NM_022059620 chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA.
chr5:76259579-76259592-0.9354.8311.010.2620.700NM_001882-24757 corticotropin releasing hormone binding protein
chr11:72092302-72092315-0.9384.8591.000.2530.700NM_0152429542 centaurin, delta 2 (CENTD2), transcript variant 2,
chr16:24473568-24473581-0.9384.8591.480.2520.700NM_01870315259 retinoblastoma binding protein 6 (RBBP6), transcript
chr1:63870415-63870428+0.9404.8741.300.2520.700NM_00263338980 phosphoglucomutase 1 (PGM1), mRNA.
chr1:30979423-30979436+0.9354.8311.030.2460.700NM_002379-9949 matrilin 1, cartilage matrix protein (MATN1), mRNA.
chr9:130017988-130018001+0.9404.8741.050.2460.700NM_012127-11505 CDKN1A interacting zinc finger protein 1 (CIZ1), mRNA.
chr19:13111095-13111108+0.9404.8741.110.2350.700NM_00376510892 syntaxin 10 (STX10), mRNA.
chr11:34029477-34029490+0.9404.8741.000.2340.700NM_005898-229 membrane component, chromosome 11, surface marker 1
chr5:117465206-117465219+0.9384.8621.030.2340.700NM_173666886933 hypothetical protein FLJ33977 (FLJ33977), mRNA.
chr16:8503179-8503192+0.9384.8621.090.2940.701NM_024109-119749 hypothetical protein MGC2654 (MGC2654), mRNA.
chr4:24461568-24461581-0.9404.8741.170.2890.701NM_00310255485 superoxide dismutase 3, extracellular (SOD3), mRNA.
chr17:69045322-69045335-0.9374.8511.150.2810.701NM_019064-99514 sidekick homolog 2 (chicken) (SDK2), mRNA.
chr10:124533402-124533415+0.9374.8511.050.2780.701NM_02203462279 CUB and zona pellucida-like domains 1 (CUZD1), mRNA.
chr5:41808060-41808073-0.9344.8271.120.2780.701NM_00043698488 3-oxoacid CoA transferase 1 (OXCT1), nuclear gene
chr7:137077523-137077536+0.9404.8741.360.2770.701NM_004717104626 diacylglycerol kinase, iota (DGKI), mRNA.
chr12:51559861-51559874+0.9354.8381.090.2740.701NM_00227325266 keratin 8 (KRT8), mRNA.
chr2:153153703-153153716-0.9444.9101.210.5940.702NM_017892128518-
chr2:158422729-158422742+0.9484.9461.350.5900.702NM_001105-19693 activin A receptor, type I (ACVR1), mRNA.
chr19:12974181-12974194+0.9424.8891.260.5840.702NM_0025016697 nuclear factor I/X (CCAAT-binding transcription
chr11:128159925-128159938+0.9484.9461.050.5810.702NM_00022057648 potassium inwardly-rectifying channel, subfamily J,
chr17:46024652-46024665-0.9484.9461.190.5770.702NM_19839631304 calcium channel, voltage-dependent, alpha 1G subunit
chrX:39517120-39517133+0.9354.8381.360.5310.704NM_017745324480 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr5:52812891-52812904-0.9334.8181.040.5300.704NM_013409639 follistatin (FST), transcript variant FST344, mRNA.
chr17:37448943-37448956+0.9404.8741.110.5280.704NM_001013624-14710-
chr5:36642797-36642810-0.9344.8261.450.5250.704NM_004172449 solute carrier family 1 (glial high affinity glutamate
chr5:136869424-136869437+0.9344.8271.330.5240.704NM_004598-6507 sparc/osteonectin, cwcv and kazal-like domains
chr4:143987177-143987190+0.9404.8741.060.5240.704NM_032557-338271 ubiquitin specific protease 38 (USP38), mRNA.
chrX:48210251-48210264+0.9354.8341.300.5220.704NM_0335183258 solute carrier family 38, member 5 (SLC38A5), mRNA.
chr10:65266668-65266681-0.9394.8671.040.5180.704NM_001001330315639 chromosome 10 open reading frame 74 (C10orf74), mRNA.
chr18:6583726-6583739-0.9354.8311.310.5170.704NM_173464-178825 l(3)mbt-like 4 (Drosophila) (L3MBTL4), mRNA.
chr7:96447138-96447151+0.9384.8631.410.5150.704NM_005222-25988-
chr2:43426201-43426214+0.9374.8541.560.5140.704NM_006887-118952 zinc finger protein 36, C3H type-like 2 (ZFP36L2),
chr1:25856712-25856725-0.9344.8271.280.5120.704NM_02037940266 mannosidase, alpha, class 1C, member 1 (MAN1C1), mRNA.
chr1:39648409-39648422-0.9384.8621.110.5090.704NM_015038746-
chr9:125558828-125558841-0.9354.8311.340.5090.704NM_020946173410-
chr5:158062181-158062194+0.9394.8671.760.5090.704NM_024007397166 early B-cell factor (EBF), mRNA.
chr5:167012164-167012177+0.9384.8621.150.5090.704NM_001080428-102255-
chr8:82041909-82041922-0.9334.8181.820.5070.704NM_001033723-92338-
chr19:1803715-1803728+0.9354.8381.220.5060.704NM_020695-4263 transcription elongation factor B polypeptide 3
chr17:43425596-43425609+0.9344.8271.120.5050.704NM_17609622268 CDK5 regulatory subunit associated protein 3
chr5:131688552-131688565-0.9374.8541.110.5050.704NM_00305930608 solute carrier family 22 (organic cation transporter),
chr2:45400195-45400208-0.9384.8631.220.5040.704NM_018079291712 hypothetical protein FLJ10379 (FLJ10379), mRNA.
chr5:164995698-164995711-0.9374.8511.300.5040.704NM_001080428-2118721-
chr7:99919819-99919832-0.9354.8311.510.5020.704NM_173564433 hypothetical protein FLJ37538 (FLJ37538), mRNA.
chr14:101061829-101061842+0.9354.8381.340.5020.704NM_001362-35512 deiodinase, iodothyronine, type III (DIO3), mRNA.
chr3:187504734-187504747-0.9394.8701.630.5010.704NM_00108074457983-
chr10:72953139-72953152+0.9374.8541.110.3660.704NM_022124126542 cadherin-like 23 (CDH23), transcript variant 1, mRNA.
chrX:11194637-11194650-0.9404.8741.260.3650.704NM_013423-621 Rho GTPase activating protein 6 (ARHGAP6), transcript
chr1:76548310-76548323+0.9334.8181.010.3650.704NM_152996235418 sialyltransferase 7
chr11:61100751-61100764-0.9354.8381.050.3640.704NM_0042004123 synaptotagmin VII (SYT7), mRNA.
chr3:62620770-62620783-0.9404.8741.190.3640.704NM_003716215324 Ca2+-dependent secretion activator (CADPS), transcript
chr3:50513341-50513354+0.9354.8311.020.3630.704NM_0010055052555-
chr2:67918693-67918706+0.9434.9041.030.3620.704NM_006333224941 nuclear DNA-binding protein (C1D), transcript variant
chr10:29607318-29607331+0.9344.8271.620.3620.704NM_032517-10578 lysozyme-like 1 (LYZL1), mRNA.
chr13:42914669-42914682+0.9354.8311.690.3600.704NM_017993224986 hypothetical protein FLJ10094 (FLJ10094), mRNA.
chr1:175375779-175375792+0.9324.8131.250.3590.704NM_00431924868 astrotactin (ASTN), transcript variant 1, mRNA.
chr3:124300102-124300115-0.9404.8741.040.3580.704NM_00681031547 for protein disulfide isomerase-related (PDIR), mRNA.
chr18:42545987-42546000-0.9404.8741.100.3580.704NM_01330545050 sialyltransferase 8E (alpha-2,
chr5:38134726-38134739-0.9464.9231.230.3580.704NM_152403-159464 hypothetical protein FLJ39155 (FLJ39155), transcript
chr20:44003047-44003060-0.9444.9081.530.3530.704NM_0221046423 chromosome 20 open reading frame 67 (C20orf67), mRNA.
chr17:60965758-60965771+0.9404.8741.190.3530.704NM_00465522469 axin 2 (conductin, axil) (AXIN2), mRNA.
chr18:73956178-73956191-0.9424.8961.100.3500.704NM_001480865557 galanin receptor 1 (GALR1), mRNA.
chr7:127584769-127584782+0.9404.8741.110.3490.704NM_000230-83698 leptin (obesity homolog, mouse) (LEP), mRNA.
chr1:176076783-176076796+0.9444.9101.190.3490.704NM_033127128890 regucalcin gene promotor region related protein
chr10:119032234-119032247+0.9344.8271.340.3480.704NM_00305441628 solute carrier family 18 (vesicular monoamine), member
chr5:123945867-123945880+0.9314.7991.110.3410.704NM_020747162837-
chr4:85192250-85192263+0.9444.9081.110.3380.704NM_006168446161 NK6 transcription factor related, locus 1 (Drosophila)
chr15:94254621-94254634+0.9354.8381.070.3360.704NM_021005-420229 nuclear receptor subfamily 2, group F, member 2
chr2:104403843-104403856+0.9444.9101.170.3360.704NM_006236-434458 POU domain, class 3, transcription factor 3 (POU3F3),
chr7:132160707-132160720+0.9394.8671.300.3350.704NM_181775-176720 hypothetical protein DKFZp434G0625 (DKFZp434G0625),
chr11:72020569-72020582+0.9264.7591.550.6660.705NM_00259942491 phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.
chr11:19693096-19693109-0.9254.7551.510.6650.705NM_1829641708 neuron navigator 2 (NAV2), transcript variant 1, mRNA.
chr2:187478007-187478020+0.9304.7911.700.6650.705NM_182521-55865 zinc finger, SWIM domain containing 2 (ZSWIM2), mRNA.
chr1:34415040-34415053+0.9264.7591.850.6640.705NM_032884-718 hypothetical protein MGC15882 (MGC15882), mRNA.
chr7:41631564-41631577+0.9264.7591.850.6640.705NM_00219277667 inhibin, beta A (activin A, activin AB alpha
chr6:170437547-170437560+0.9264.7591.180.6630.705NM_0056184075 delta-like 1 (Drosophila) (DLL1), mRNA.
chr10:17311145-17311158+0.9294.7821.540.6600.705NM_003380-59 vimentin (VIM), mRNA.
chr6:42529425-42529438+0.9264.7591.590.6590.705NM_033502-1664 transcriptional regulating factor 1 (TRERF1),
chr11:66899231-66899244-0.9264.7591.100.6580.705NM_013246-1449 cardiotrophin-like cytokine (CLC), mRNA.
chr12:54996118-54996131+0.9224.7291.580.6570.705NM_014255269 transmembrane protein 4 (TMEM4), mRNA.
chr3:185515350-185515363-0.9264.7591.330.6550.705NM_182917-338 eukaryotic translation initiation factor 4 gamma, 1
chr11:2687031-2687044+0.9264.7591.800.6550.705NM_000076176506 cyclin-dependent kinase inhibitor 1C (p57, Kip2)
chr19:60680002-60680015-0.9264.7591.460.6540.705NM_033113591-
chrX:47381049-47381062+0.9304.7951.630.6530.705NM_002621-6401 properdin P factor, complement (PFC), mRNA.
chr6:14701532-14701545+0.9264.7591.690.6510.705NM_004233475788 CD83 antigen (activated B lymphocytes, immunoglobulin
chr18:36236811-36236824-0.9294.7831.320.6510.705NM_002647-1552286 phosphoinositide-3-kinase, class 3 (PIK3C3), mRNA.
chr15:23234282-23234295+0.9254.7491.940.6500.705NM_130839939 ubiquitin protein ligase E3A (human papilloma virus
chr3:49890456-49890469-0.9264.7591.590.6490.705NM_024046-8083 hypothetical protein MGC8407 (MGC8407), mRNA.
chr10:98711450-98711463-0.9234.7332.030.6490.705NM_015652-19481 chromosome 10 open reading frame 12 (C10orf12), mRNA.
chr11:131940695-131940708+0.9214.7141.410.6480.705NM_002545377552 opioid binding protein/cell adhesion molecule-like
chr9:116013009-116013022-0.9274.7651.530.6470.705NM_03288855057 collagen, type XXVII, alpha 1 (COL27A1), mRNA.
chr11:17931194-17931207+0.9264.7591.640.6430.705NM_01213960019 deafness locus associated putative guanine nucleotide
chr5:141212920-141212933+0.9264.7591.210.6420.705NM_03242025208 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr2:113756357-113756370-0.9254.7551.630.6390.705NM_013992-3389 paired box gene 8 (PAX8), transcript variant PAX8E,
chr12:6907878-6907891+0.9264.7591.210.6380.705NM_001940237 dentatorubral-pallidoluysian atrophy (atrophin-1)
chr14:22864804-22864817+0.9304.7951.610.6380.705NM_0046435667 poly(A) binding protein, nuclear 1 (PABPN1), mRNA.
chr7:27167675-27167688-0.9264.7591.670.6370.705NM_1527393999 homeo box A9 (HOXA9), transcript variant 1, mRNA.
chr19:60820374-60820387-0.9264.7591.840.6370.705NM_2033747379 similar to zinc finger protein (LOC147808), mRNA.
chr10:48111667-48111680-0.9294.7831.290.6370.705NM_004962-52495 growth differentiation factor 10 (GDF10), mRNA.
chr6:30758363-30758376+0.9264.7591.260.6360.705NM_1334713600-
chr12:55933862-55933875+0.9254.7471.200.6350.705NM_145064-2626 SH3 and cysteine rich domain 3 (STAC3), mRNA.
chr20:48094125-48094138-0.9264.7591.310.6350.705NM_00598561291 snail homolog 1 (Drosophila) (SNAI1), mRNA.
chr1:153967250-153967263-0.9274.7651.440.6350.705NM_139118-41835 YY1 associated protein (YAP), transcript variant 2,
chr2:54749353-54749366-0.9254.7471.990.6350.705NM_178313110418 spectrin, beta, non-erythrocytic 1 (SPTBN1),
chr20:772813-772826-0.9284.7771.310.6340.705NM_031424-372 chromosome 20 open reading frame 55 (C20orf55),
chr3:13734312-13734325-0.9304.7901.520.6340.705NM_004625162307 wingless-type MMTV integration site family, member 7A
chr1:206598496-206598509+0.9254.7491.580.6340.705NM_025179-114208 plexin A2 (PLXNA2), mRNA.
chr19:50950887-50950900-0.9464.9231.150.3310.705NM_17587513265 sine oculis homeobox homolog 5 (Drosophila) (SIX5),
chr8:61103130-61103143+0.9464.9241.160.3290.705NM_004056253378 carbonic anhydrase VIII (CA8), mRNA.
chr5:148726792-148726805+0.9424.8961.050.3260.705NM_0240289090 hypothetical protein MGC3265 (MGC3265), mRNA.
chrX:48804316-48804329-0.9444.9081.070.3200.705NM_033626956 JM11 protein (JM11), mRNA.
chr3:46865487-46865500+0.9444.9101.210.3150.705NM_00025814490 myosin, light polypeptide 3, alkali; ventricular,
chr1:112677550-112677563+0.9424.8961.240.3150.705NM_018704-62733 hypothetical protein DKFZp547A023 (DKFZp547A023),
chr3:46977439-46977452-0.9444.9081.150.3080.705NM_14471615804 hypothetical protein MGC23918 (MGC23918), mRNA.
chr11:74665766-74665779+0.9444.9101.410.3030.705NM_00404174755 arrestin, beta 1 (ARRB1), transcript variant 1, mRNA.
chr17:44177218-44177231-0.9404.8741.000.2260.705NM_006361-16108 homeo box B13 (HOXB13), mRNA.
chr17:74848562-74848575+0.9324.8131.090.2230.705NM_001082575141596-
chr7:25530939-25530952-0.9404.8741.080.2010.705NM_022150-296309 chromosome 7 open reading frame 9 (C7orf9), mRNA.
chr4:152599106-152599119-0.9354.8311.030.1990.706NM_183375181431 epidermis-specific serine protease-like protein
chr11:29994923-29994936-0.9404.8741.080.1820.706NM_002233141 potassium voltage-gated channel, shaker-related
chr7:29025939-29025952+0.9414.8811.680.5660.710NM_014817-61385-
chr7:27194394-27194407-0.9494.9521.690.5650.710NM_005523-3034 homeo box A11 (HOXA11), mRNA.
chr14:60892690-60892703-0.9484.9401.430.5630.710NM_00625534522 protein kinase C, eta (PRKCH), mRNA.
chr1:110102209-110102222+0.9484.9401.630.5600.710NM_0245265878 EPS8-like 3 (EPS8L3), transcript variant 3, mRNA.
chr2:227373001-227373014-0.9444.9101.120.5550.710NM_005544-282 insulin receptor substrate 1 (IRS1), mRNA.
chr5:53201136-53201149+0.9464.9231.320.5480.710NM_002495308994 NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa
chr19:40301675-40301688+0.9444.9061.620.5350.710NM_0219103136 FXYD domain containing ion transport regulator 3
chr16:66475660-66475673-0.9444.9061.540.6320.711NM_198443-522 MRCC2446 (UNQ2446), mRNA.
chr1:41690889-41690902-0.9444.9081.550.6320.711NM_00195631995 endothelin 2 (EDN2), mRNA.
chr3:126576422-126576435+0.9464.9241.210.6310.711NM_021964466 zinc finger protein 148 (pHZ-52) (ZNF148), mRNA.
chrX:21744460-21744473+0.9424.8961.060.6060.711NM_015884-23115 membrane-bound transcription factor protease, site 2
chr5:73960761-73960774+0.9464.9241.430.6040.711NM_00363311512 ectodermal-neural cortex (with BTB-like domain)
chr10:93042774-93042787+0.9464.9231.050.6020.711NM_03237372525 ring finger protein (C3HC4 type) 159 (RNF159), mRNA.
chr17:46023029-46023042-0.9354.8341.040.3330.714NM_19839629681 calcium channel, voltage-dependent, alpha 1G subunit
chr12:112798208-112798221-0.9404.8741.020.3330.714NM_01619690291 RNA binding motif protein 19 (RBM19), mRNA.
chr17:3902244-3902257+0.9394.8671.030.3260.714NM_174958-87759 ATPase, Ca++ transporting, ubiquitous (ATP2A3),
chr6:155199174-155199187-0.9384.8631.110.3230.714NM_014892103070 RNA binding motif protein 16 (RBM16), mRNA.
chr3:55025860-55025873+0.9344.8271.090.3230.714NM_020678-88748 HT017 protein (HT017), mRNA.
chr3:170440825-170440838+0.9404.8741.120.3200.714NM_005241-94038 ecotropic viral integration site 1 (EVI1), mRNA.
chr1:203583929-203583942-0.9354.8341.230.3180.714NM_0182038733 hypothetical protein FLJ10748 (FLJ10748), mRNA.
chr7:139220957-139220970+0.9404.8741.000.3160.714NM_03098445636 thromboxane A synthase 1 (platelet, cytochrome P450,
chr21:35499531-35499544+0.9404.8741.070.3130.714NM_001754-156066 runt-related transcription factor 1 (acute myeloid
chr11:64706040-64706053+0.9344.8271.300.3120.714NM_005186221 calpain 1, (mu/I) large subunit (CAPN1), mRNA.
chr2:99565963-99565976+0.9384.8621.150.3090.714NM_016316-93051 REV1-like (yeast) (REV1L), mRNA.
chrX:53312798-53312811-0.9354.8381.140.3050.714NM_01507514723-
chr2:124507790-124507803+0.9384.8631.000.3050.714NM_1307738556 contactin associated protein-like 5 (CNTNAP5),
chr13:38242794-38242807+0.9354.8381.060.3030.714NM_20736183721 Fras1 related extracellular matrix protein 2 (FREM2),
chr6:43345700-43345713-0.9575.0141.761.0250.719NM_03253826600-
chr14:20933246-20933259+0.9565.0071.961.0160.719NM_007192-10981 suppressor of Ty 16 homolog (S. cerevisiae) (SUPT16H),
chr14:35365383-35365396-0.9555.0022.341.0100.719NM_032352135 breast cancer metastasis-suppressor 1-like (BRMS1L),
chr9:4327918-4327931+0.9274.7651.800.6990.720NM_001042413-37883-
chrX:47305760-47305773-0.9304.7951.830.6980.720NM_001654338 v-raf murine sarcoma 3611 viral oncogene homolog 1
chr6:40662205-40662218+0.9304.7911.810.6980.720NM_020737899-
chr1:20630220-20630233+0.9264.7591.050.6960.720NM_01858455095 calcium/calmodulin-dependent protein kinase II
chr15:72143280-72143293+0.9224.7291.050.6950.720NM_00103864018664-
chr6:36026519-36026532-0.9304.7901.850.6930.720NM_003137-29585 SFRS protein kinase 1 (SRPK1), mRNA.
chr20:22512962-22512975+0.9264.7591.110.6910.720NM_021784139 forkhead box A2 (FOXA2), transcript variant 1, mRNA.
chr22:24963716-24963729+0.9304.7951.830.6890.720NM_02111568336 seizure related 6 homolog (mouse)-like (SEZ6L), mRNA.
chr7:25560749-25560762-0.9274.7691.610.6890.720NM_022150-326119 chromosome 7 open reading frame 9 (C7orf9), mRNA.
chr2:86795987-86796000+0.9274.7651.180.6870.720NM_022780-5117 hypothetical protein FLJ13910 (FLJ13910), mRNA.
chr15:73380919-73380932-0.9224.7291.050.6870.720NM_017828-34408 COMM domain containing 4 (COMMD4), mRNA.
chr1:200140924-200140937-0.9254.7551.640.6850.720NM_19814916369 chromosome 1 open reading frame 40 (C1orf40), mRNA.
chr17:53522619-53522632-0.9224.7301.240.6830.720NM_0806776921 dynein light chain 2 (Dlc2), mRNA.
chr1:181519894-181519907-0.9304.7951.540.6810.720NM_17070620738 nicotinamide nucleotide adenylyltransferase 2
chr12:119900820-119900833-0.9264.7571.340.6800.720NM_000545-12 transcription factor 1, hepatic; LF-B1, hepatic
chr1:44739309-44739322-0.9264.7592.400.6780.720NM_01815095862 hypothetical protein FLJ10597 (FLJ10597), mRNA.
chr8:22606667-22606680-0.9254.7551.220.6760.720NM_00443093 early growth response 3 (EGR3), mRNA.
chr20:10615406-10615419+0.9304.7911.430.6760.720NM_000214-12816 jagged 1 (Alagille syndrome) (JAG1), mRNA.
chr14:73885339-73885352+0.9264.7591.560.6750.720NM_018228520 chromosome 14 open reading frame 115 (C14orf115),
chr11:66940076-66940089-0.9264.7591.470.6730.720NM_020811451-
chr12:8857926-8857939-0.9214.7171.570.6730.720NM_144670-8458 hypothetical protein FLJ25179 (FLJ25179), mRNA.
chr17:33861741-33861754-0.9264.7591.390.6730.720NM_014598100310-
chr15:94704755-94704768-0.9264.7591.920.6730.720NM_02100529905 nuclear receptor subfamily 2, group F, member 2
chrX:67845521-67845534-0.9264.7591.130.6700.720NM_01472561385 START domain containing 8 (STARD8), mRNA.
chrX:147884717-147884730-0.9264.7592.200.6700.720NM_002025494986 fragile X mental retardation 2 (FMR2), mRNA.
chr13:105971574-105971587-0.9264.7591.300.6700.720NM_00409313764 ephrin-B2 (EFNB2), mRNA.
chr9:81467781-81467794-0.9264.7591.950.6700.720NM_00700591183 transducin-like enhancer of split 4 (E(sp1) homolog,
chr5:141235933-141235946+0.9264.7591.670.6690.720NM_0324202195 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr12:123064681-123064694-0.9264.7591.400.6690.720NM_15243741158 hypothetical protein DKFZp761B128 (DKFZp761B128),
chr12:52179445-52179458+0.9264.7591.380.6670.720NM_00630193 mitogen-activated protein kinase kinase kinase 12
chr13:27262614-27262627+0.9264.7591.500.7290.726NM_145657-2066 GS homeobox 1 (GSH1), mRNA.
chr9:85465396-85465409+0.9264.7592.000.7270.726NM_00100155137710 chromosome 9 open reading frame 103 (C9orf103), mRNA.
chrX:130250404-130250417+0.9264.7591.820.7270.726NM_001555532 immunoglobulin superfamily, member 1 (IGSF1),
chr15:67240782-67240795-0.9214.7211.360.7230.726NM_015554855 glucuronyl C5-epimerase (GLCE), mRNA.
chr12:56932767-56932780-0.9294.7831.610.7230.726NM_033276311155-
chr14:22386683-22386696-0.9264.7591.310.7190.726NM_00499511150 matrix metalloproteinase 14 (membrane-inserted)
chr7:128259512-128259525+0.9294.7821.350.7190.726NM_0014581893 filamin C, gamma (actin binding protein 280) (FLNC),
chr6:139783675-139783688-0.9224.7301.540.7150.726NM_006079-46197 Cbp/p300-interacting transactivator, with Glu/Asp-rich
chr7:150304593-150304606+0.9304.7951.570.7130.726NM_0002381354 potassium voltage-gated channel, subfamily H
chr10:71050537-71050550+0.9304.7951.400.7120.726NM_145306-9372 chromosome 10 open reading frame 35 (C10orf35), mRNA.
chr15:100122707-100122720+0.9224.7291.050.7110.726NM_152334-40539 FLJ25005 protein (FLJ25005), mRNA.
chr5:83053250-83053263-0.9214.7171.720.7090.726NM_001884-796 hyaluronan and proteoglycan link protein 1 (HAPLN1),
chr10:93988637-93988650-0.9294.7831.790.7080.726NM_017824-52163 ring finger protein 153 (RNF153), mRNA.
chr21:32025432-32025445+0.9214.7171.580.7070.726NM_020706701 splicing factor, arginine/serine-rich 15 (SFRS15),
chr11:73037480-73037493+0.9264.7591.790.7050.726NM_0212002709 pleckstrin homology domain containing, family B
chr17:33974507-33974520-0.9264.7591.690.7030.726NM_02524841202 SNAP25-interacting protein (SNIP), mRNA.
chr17:13375578-13375591+0.9264.7591.990.7030.726NM_00604270391 heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
chr2:197881451-197881464+0.9304.7911.330.7000.726NM_153697-110444 hypothetical protein DKFZp434D2328 (LOC91526), mRNA.
chr11:70852421-70852434-0.9404.8741.200.5650.739NM_01816110656 NAD synthetase 1 (NADSYN1), mRNA.
chr15:70329202-70329215+0.9384.8621.600.5610.739NM_182471-18464 pyruvate kinase, muscle (PKM2), transcript variant 3,
chr11:110677324-110677337-0.9394.8671.070.5580.739NM_207429-1575 FLJ45803 protein (FLJ45803), mRNA.
chr4:68897939-68897952+0.9404.8741.410.5580.739NM_001031732480-
chr5:139148375-139148388+0.9314.8031.380.5570.739NM_032289-7115 pleckstrin and Sec7 domain containing 2 (PSD2), mRNA.
chr2:176711527-176711540-0.9404.8741.640.5520.739NM_0195588904 homeo box D8 (HOXD8), mRNA.
chr7:69804165-69804178-0.9404.8741.350.5510.739NM_022479-431460 Williams-Beuren syndrome chromosome region 17
chr14:23592375-23592388+0.9404.8741.470.5490.739NM_1383601429 hypothetical protein BC008134 (LOC90668), mRNA.
chrX:68648214-68648227-0.9404.8741.440.5440.739NM_0156866511 transmembrane protein 28 (TMEM28), mRNA.
chr1:17871886-17871899-0.9374.8471.140.5420.739NM_030812-82445 actin like protein (LOC81569), mRNA.
chr1:199949461-199949474-0.9394.8701.500.5410.739NM_02044365488 neuron navigator 1 (NAV1), mRNA.
chr5:161208388-161208401-0.9324.8091.780.5410.739NM_0008061505 gamma-aminobutyric acid (GABA) A receptor, alpha 1
chr19:47189142-47189155+0.9354.8381.790.5370.739NM_1522961080 ATPase, Na+/K+ transporting, alpha 3 polypeptide
chr10:69662126-69662139-0.9404.8741.520.5360.739NM_145178-265 atonal homolog 7 (Drosophila) (ATOH7), mRNA.
chr9:130206868-130206881-0.9404.8741.760.5350.739NM_016174-15970 cerebral endothelial cell adhesion molecule 1
chr3:57015671-57015684+0.9354.8381.620.5340.739NM_181727-53738 spermatogenesis associated 12 (SPATA12), mRNA.
chr11:94645214-94645227-0.9484.9461.850.6970.753NM_144665-41320 sestrin 3 (SESN3), mRNA.
chr9:35787172-35787185-0.9474.9311.430.6630.756NM_0039954866 natriuretic peptide receptor B/guanylate cyclase B
chr1:151853951-151853964+0.9424.8961.520.6600.756NM_0206721463 S100 calcium binding protein A14 (S100A14), mRNA.
chr12:120211076-120211089-0.9264.7591.750.7640.759NM_1722267812 calcium/calmodulin-dependent protein kinase kinase 2,
chr1:53936331-53936344+0.9304.7911.390.7640.759NM_14719336134 GLIS family zinc finger 1 (GLIS1), mRNA.
chr1:158461027-158461040-0.9304.7951.650.7600.759NM_00376819376 phosphoprotein enriched in astrocytes 15 (PEA15),
chrX:111995897-111995910-0.9214.7171.870.7600.759NM_133265-25198 angiomotin (AMOT), mRNA.
chr7:101130444-101130457-0.9264.7591.240.7580.759NM_138403-71326 myosin light chain 2, precursor lymphocyte-specific
chr2:104882387-104882400-0.9234.7341.870.7580.759NM_00623644086 POU domain, class 3, transcription factor 3 (POU3F3),
chrX:139300939-139300952-0.9264.7591.640.7570.759NM_005634113952 SRY (sex determining region Y)-box 3 (SOX3), mRNA.
chr9:108821034-108821047+0.9264.7591.730.7500.759NM_021224155935 zinc finger protein 462 (ZNF462), mRNA.
chr1:36140298-36140311-0.9304.7952.180.7490.759NM_01219919001 eukaryotic translation initiation factor 2C, 1
chr9:134849518-134849531-0.9304.7911.450.7490.759NM_0041885699 growth factor independent 1B (potential regulator of
chr3:62332463-62332476+0.9234.7341.740.7470.759NM_0180081598 zinc finger protein 312 (ZNF312), mRNA.
chr20:57308833-57308846+0.9304.7911.350.7470.759NM_20703439 endothelin 3 (EDN3), transcript variant 4, mRNA.
chr10:123892986-123892999-0.9244.7391.700.7450.759NM_006997-20009 transforming, acidic coiled-coil containing protein 2
chr2:7691912-7691925-0.9264.7591.480.7440.759NM_014746717038 ring finger protein 144 (RNF144), mRNA.
chr7:100156242-100156255+0.9264.7591.260.7430.759NM_000799-17 erythropoietin (EPO), mRNA.
chrX:128766529-128766542+0.9264.7592.400.7420.759NM_01899024988 chromosome X open reading frame 9 (CXorf9), mRNA.
chr1:115014926-115014939+0.9304.7911.700.7370.759NM_198459-671 FLJ37099 protein (FLJ37099), mRNA.
chr17:34132075-34132088+0.9294.7871.880.7370.759NM_00593716776 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr22:49255464-49255477+0.9294.7831.670.7970.761NM_0029724856 SET binding factor 1 (SBF1), transcript variant 1,
chr7:90811273-90811286+0.9264.7572.000.7970.761NM_00350579654 frizzled homolog 1 (Drosophila) (FZD1), mRNA.
chr5:137116352-137116365+0.9304.7952.310.7960.761NM_0068051586 heterogeneous nuclear ribonucleoprotein A0 (HNRPA0),
chr9:18910444-18910457+0.9304.7951.690.7960.761NM_00104027294398-
chr2:171216578-171216591+0.9264.7592.600.7940.761NM_001003845-63429 Sp5 transcription factor (SP5), mRNA.
chr1:109893161-109893174-0.9264.7571.340.7920.761NM_006496437 guanine nucleotide binding protein (G protein), alpha
chr2:42102309-42102322+0.9264.7591.510.7920.761NM_138370-26848-
chr3:49364340-49364353-0.9304.7951.830.7910.761NM_0005816455 glutathione peroxidase 1 (GPX1), transcript variant 1,
chr3:182901962-182901975-0.9264.7591.610.7910.761NM_003106-10354 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr1:158092193-158092206-0.9304.7951.490.7890.761NM_0010136616878-
chr12:52060291-52060304+0.9234.7381.260.7890.761NM_138473145 Sp1 transcription factor (SP1), mRNA.
chr1:11421801-11421814+0.9244.7461.470.7890.761NM_020780-39981-
chr1:217719070-217719083+0.9274.7651.840.7870.761NM_138794305324 lysophospholipase-like 1 (LYPLAL1), mRNA.
chr17:7547726-7547739-0.9264.7591.870.7860.761NM_001406-1419 ephrin-B3 (EFNB3), mRNA.
chr6:50788778-50788791-0.9274.7692.300.7830.761NM_172238-338 transcription factor AP-2 beta (activating enhancer
chrX:48635814-48635827+0.9264.7591.660.7820.761NM_001032381-4225-
chr14:77976855-77976868-0.9304.7952.100.7820.761NM_00479637109 neurexin 3 (NRXN3), transcript variant alpha, mRNA.
chr6:25016175-25016188+0.9264.7591.580.7800.761NM_015864-30613 chromosome 6 open reading frame 32 (C6orf32), mRNA.
chr14:84463578-84463591+0.9264.7592.000.7790.761NM_013231-602563 fibronectin leucine rich transmembrane protein 2
chr12:108599538-108599551+0.9304.7911.960.7780.761NM_032829-57317 hypothetical protein FLJ14721 (FLJ14721), mRNA.
chr14:59166703-59166716-0.9264.7591.320.7780.761NM_206852570 reticulon 1 (RTN1), transcript variant 3, mRNA.
chr20:49080400-49080413-0.9264.7592.150.7770.761NM_172318-7318 potassium voltage-gated channel, subfamily G, member 1
chr12:3182571-3182584+0.9264.7591.520.7760.761NM_006675125853 transmembrane 4 superfamily member tetraspan NET-5
chr11:19356735-19356748-0.9264.7592.380.7760.761NM_024680-137652 FLJ23311 protein (FLJ23311), mRNA.
chr2:220084726-220084739-0.9264.7591.150.7720.761NM_018674-2470 amiloride-sensitive cation channel 4, pituitary
chr8:38414583-38414596+0.9224.7301.710.7720.761NM_02310530926 fibroblast growth factor receptor 1 (fms-related
chr12:92490525-92490538+0.9264.7591.350.7720.761NM_0038772896 suppressor of cytokine signaling 2 (SOCS2), mRNA.
chr20:35417052-35417065+0.9264.7591.830.7720.761NM_1982919181 v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene
chr1:153514917-153514930-0.9264.7591.490.7700.761NM_0208971019 hyperpolarization activated cyclic nucleotide-gated
chr19:59534498-59534511-0.9214.7211.320.7690.761NM_0122767735 leukocyte immunoglobulin-like receptor, subfamily A
chr8:29248648-29248661+0.9214.7211.810.7690.761NM_05715813593 dual specificity phosphatase 4 (DUSP4), transcript
chr1:22971141-22971154+0.9304.7952.130.7680.761NM_01744961323 EphB2 (EPHB2), transcript variant 1, mRNA.
chr16:78220206-78220219+0.9294.7831.520.7680.761NM_005360-28094 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr2:15867017-15867030-0.9404.8741.630.5970.767NM_005378-131017 v-myc myelocytomatosis viral related oncogene,
chr1:180220400-180220413-0.9374.8511.120.5960.767NM_00100999277070-
chr10:125123411-125123424+0.9384.8631.680.5950.767NM_004725219651 BUB3 budding uninhibited by benzimidazoles 3 homolog
chr3:101249931-101249944-0.9324.8091.670.5850.767NM_18290966108 downregulated in ovarian cancer 1 (DOC1), transcript
chr1:154188017-154188030-0.9404.8741.120.5790.767NM_18188510013 G protein-coupled receptor 100 (GPR100), mRNA.
chr1:44259473-44259486+0.9354.8381.470.5780.767NM_201649-3889 solute carrier family 6 (neurotransmitter transporter,
chr5:142072690-142072703+0.9394.8671.500.5720.767NM_033137-26878 fibroblast growth factor 1 (acidic) (FGF1), transcript
chr1:6081881-6081894+0.9354.8381.060.5720.767NM_17213073014 potassium voltage-gated channel, shaker-related
chr9:100872709-100872722+0.9404.8741.180.5670.767NM_004612-34424 transforming growth factor, beta receptor I (activin A
chrX:100765085-100765098-0.9434.8981.950.7310.769NM_177948178 armadillo repeat containing, X-linked 3 (ARMCX3),
chr7:18093653-18093666+0.9444.9101.520.7110.769NM_175886-59642 phosphoribosyl pyrophosphate synthetase 1-like 1
chr17:38600564-38600577+0.9354.8341.490.6320.769NM_00589923892 membrane component, chromosome 17, surface marker 2
chr19:50141023-50141036+0.9354.8381.580.6290.769NM_00048340 apolipoprotein C-II (APOC2), mRNA.
chrX:48450558-48450571+0.9384.8621.270.6210.769NM_00317310583 suppressor of variegation 3-9 homolog 1 (Drosophila)
chr1:158461022-158461035-0.9404.8741.690.6190.769NM_00376819371 phosphoprotein enriched in astrocytes 15 (PEA15),
chr19:44266671-44266684-0.9404.8741.620.6180.769NM_001004318-14 FLJ16165 protein (FLJ16165), mRNA.
chr1:94850954-94850967-0.9324.8131.590.6100.769NM_001993-71051 coagulation factor III (thromboplastin, tissue factor)
chr1:78183007-78183020+0.9354.8311.180.6080.769NM_00390234358 far upstream element (FUSE) binding protein 1 (FUBP1),
chr20:29716003-29716016-0.9404.8741.230.6050.769NM_03260926751 cytochrome c oxidase subunit IV isoform 2 (lung)
chr1:69807480-69807493-0.9544.9881.971.2220.786NM_020794-190866 densin-180 (KIAA1365), mRNA.
chr6:123359807-123359820-0.9514.9712.261.2030.786NM_001010852626-
chr2:72229335-72229348-0.9514.9711.631.2000.786NM_019885-864 cytochrome P450, family 26, subfamily B, polypeptide 1
chr22:41362841-41362854+0.9124.6441.060.3990.789NM_00732610121 diaphorase (NADH) (cytochrome b-5 reductase) (DIA1),
chr16:71539106-71539119-0.9204.7131.130.3990.789NM_006885100669 AT-binding transcription factor 1 (ATBF1), mRNA.
chr11:67047509-67047522-0.9144.6581.110.3980.789NM_031204-34 calcium binding protein 2 (CABP2), transcript variant
chr3:98962829-98962842-0.9194.7051.170.3980.789NM_032146-3356 ADP-ribosylation factor-like 6 (ARL6), transcript
chr18:58960364-58960377-0.9124.6421.280.3980.789NM_000633177229 B-cell CLL/lymphoma 2 (BCL2), nuclear gene encoding
chr10:52815432-52815445+0.9174.6881.080.3960.789NM_006258311292 protein kinase, cGMP-dependent, type I (PRKG1), mRNA.
chr6:21407557-21407570+0.9164.6781.060.3960.789NM_003107-294294 SRY (sex determining region Y)-box 4 (SOX4), mRNA.
chr16:5073596-5073609-0.9184.6941.100.3950.789NM_01910911875 asparagine-linked glycosylation 1 homolog (yeast,
chr20:55278892-55278905+0.9194.6981.340.3950.789NM_001719-4184 bone morphogenetic protein 7 (osteogenic protein 1)
chr11:88436200-88436213+0.9174.6861.380.3950.789NM_000842-15362 glutamate receptor, metabotropic 5 (GRM5), mRNA.
chr12:47467292-47467305+0.9164.6781.480.3940.789NM_0209831795 adenylate cyclase 6 (ADCY6), transcript variant 2,
chr17:46298155-46298168+0.9204.7131.200.3940.789NM_005749-1743 transducer of ERBB2, 1 (TOB1), mRNA.
chr6:41855276-41855289-0.9124.6421.210.3920.789NM_006653332 fibroblast growth factor receptor substrate 3 (FRS3),
chr4:169923825-169923838+0.9164.6771.730.3920.789NM_032783244172 carbonic reductase 4 (CBR4), mRNA.
chr10:78842112-78842125+0.9204.7131.260.3920.789NM_001014797225471-
chrX:47325732-47325745+0.9144.6621.000.3900.789NM_003254-802 tissue inhibitor of metalloproteinase 1 (erythroid
chr11:16761173-16761186+0.9134.6521.410.3900.789NM_01426744503 small acidic protein (SMAP), mRNA.
chr7:31066251-31066264-0.9144.6601.210.3890.789NM_0011187684 adenylate cyclase activating polypeptide 1 (pituitary)
chr1:229364177-229364190-0.9134.6501.300.3880.789NM_001004342-1020 TRIM9-like protein TNL (TNL), mRNA.
chr19:1391278-1391291-0.9194.6981.040.3860.789NM_0010182015 ribosomal protein S15 (RPS15), mRNA.
chr12:51111807-51111820-0.9154.6651.340.3860.789NM_0046932570 cytokeratin type II (K6HF), mRNA.
chr17:72062353-72062366+0.9204.7131.030.3860.789NM_00107762014686-
chrX:130037081-130037094-0.9194.6981.110.3860.789NM_14496717284 hypothetical protein FLJ30058 (FLJ30058), mRNA.
chr9:33912476-33912489+0.9194.6981.770.3850.789NM_017811105394 ubiquitin-conjugating enzyme E2R 2 (UBE2R2), mRNA.
chrX:106792985-106792998+0.9144.6621.050.3840.789NM_00276434670 phosphoribosyl pyrophosphate synthetase 1 (PRPS1),
chr12:69137168-69137181-0.9134.6561.130.3840.789NM_01450590939 potassium large conductance calcium-activated channel,
chr9:81104829-81104842+0.9204.7131.200.3830.789NM_007005-271769 transducin-like enhancer of split 4 (E(sp1) homolog,
chr6:138333266-138333279-0.9174.6861.790.3820.789NM_006290103092 tumor necrosis factor, alpha-induced protein 3
chr3:65914785-65914798+0.9114.6341.410.3820.789NM_00103305784764-
chr4:77142995-77143008-0.9124.6421.140.3810.789NM_0024164670 chemokine (C-X-C motif) ligand 9 (CXCL9), mRNA.
chr9:35388833-35388846-0.9134.6561.700.3810.789NM_014806-91191-
chr6:15198399-15198412-0.9204.7131.300.3810.789NM_004973-156007 Jumonji, AT rich interactive domain 2 (JARID2), mRNA.
chr6:41996695-41996708+0.9144.6581.210.3800.789NM_004053-148 bystin-like (BYSL), mRNA.
chr16:68445838-68445851-0.9154.6691.510.3800.789NM_199424-70464 WW domain containing E3 ubiquitin protein ligase 2
chr1:188713957-188713970-0.9144.6621.020.3800.789NM_199051-575 DBCCR1-like (DBCCR1L), mRNA.
chr7:54583751-54583764+0.9134.6521.100.3790.789NM_1825466338 hypothetical protein MGC33530 (MGC33530), mRNA.
chr1:227093830-227093843-0.9134.6561.110.3790.789NM_021205156438 ras homolog gene family, member U (RHOU), mRNA.
chr5:158989643-158989656+0.9184.6901.030.3780.789NM_000679-286575 adrenergic, alpha-1B-, receptor (ADRA1B), mRNA.
chrX:135585781-135585794-0.9144.6621.070.3770.789NM_00007427879 tumor necrosis factor (ligand) superfamily, member 5
chr9:125931426-125931439-0.9164.6731.400.3770.789NM_004789117816 LIM homeobox 2 (LHX2), mRNA.
chrX:68451541-68451554-0.9144.6601.040.3770.789NM_022368-149476 praja 1 (PJA1), mRNA.
chr19:51805573-51805586+0.9144.6621.570.3760.789NM_0051849321 calmodulin 3 (phosphorylase kinase, delta) (CALM3),
chr10:103583058-103583071-0.9194.6981.230.3760.789NM_1731946543 Kv channel interacting protein 2 (KCNIP2), transcript
chr12:51389897-51389910-0.9134.6561.060.3750.789NM_175078-6383 keratin 1B (KRT1B), mRNA.
chr3:58130582-58130595-0.9204.7131.020.3750.789NM_00494444856 deoxyribonuclease I-like 3 (DNASE1L3), mRNA.
chrX:48962005-48962018-0.9194.6981.000.3740.789NM_00518314772 calcium channel, voltage-dependent, alpha 1F subunit
chr6:146174846-146174859-0.9114.6341.050.3730.789NM_0321452768 F-box protein 30 (FBXO30), mRNA.
chr12:3034478-3034491-0.9204.7121.030.3730.789NM_006675-22240 transmembrane 4 superfamily member tetraspan NET-5
chr1:113134953-113134966+0.9134.6561.380.3710.789NM_18275970341 TAFA3 protein (TAFA3), transcript variant 1, mRNA.
chr19:12621678-12621691+0.9164.6781.210.3700.789NM_001099737-16850-
chr1:145523468-145523481+0.9154.6701.360.3700.789NM_00432643762 B-cell CLL/lymphoma 9 (BCL9), mRNA.
chr5:175232697-175232710+0.9144.6601.350.3700.789NM_0010082201690-
chr17:63891971-63891984-0.9194.6981.430.3690.789NM_01798373239 WD40 repeat protein Interacting with phosphoInositides
chr8:21458677-21458690+0.9124.6421.110.3690.789NM_001495243615 GDNF family receptor alpha 2 (GFRA2), mRNA.
chr20:37235870-37235883-0.9134.6561.360.3670.789NM_021931211556 DEAH (Asp-Glu-Ala-His) box polypeptide 35 (DHX35),
chr19:1803714-1803727+0.9144.6601.220.4990.790NM_020695-4262 transcription elongation factor B polypeptide 3
chr10:69762056-69762069-0.9134.6501.250.4960.790NM_021644271 heterogeneous nuclear ribonucleoprotein H3 (2H9)
chr17:76057047-76057060-0.9134.6521.320.4960.790NM_0025227952 neuronal pentraxin I (NPTX1), mRNA.
chr22:27780597-27780610-0.9174.6861.050.4950.790NM_0153707310 hypothetical protein HS747E2A (HS747E2A), mRNA.
chr10:72828283-72828296-0.9194.6981.510.4950.790NM_0221241686 cadherin-like 23 (CDH23), transcript variant 1, mRNA.
chr1:218538786-218538799-0.9194.6981.530.4930.790NM_012414-26411 rab3 GTPase-activating protein, non-catalytic subunit
chr14:101061828-101061841+0.9144.6601.340.4930.790NM_001362-35513 deiodinase, iodothyronine, type III (DIO3), mRNA.
chr5:78503491-78503504+0.9154.6691.510.4920.790NM_00171360152 betaine-homocysteine methyltransferase (BHMT), mRNA.
chr1:203253384-203253397-0.9134.6521.340.4920.790NM_005076-25479 contactin 2 (axonal) (CNTN2), mRNA.
chr15:72494757-72494770+0.9194.6981.360.4910.790NM_00361218572 sema domain, immunoglobulin domain (Ig), and GPI
chr1:41008762-41008775+0.9114.6341.620.4910.790NM_004700-13409 potassium voltage-gated channel, KQT-like subfamily,
chr11:29259843-29259856-0.9194.6981.400.4910.790NM_002233735221 potassium voltage-gated channel, shaker-related
chr2:217298398-217298411-0.9134.6521.310.4900.790NM_000599-29882 insulin-like growth factor binding protein 5 (IGFBP5),
chr6:41474100-41474113+0.9134.6521.230.4890.790NM_00482862694 natural cytotoxicity triggering receptor 2 (NCR2),
chr8:25838968-25838981+0.9154.6701.830.4890.790NM_022659119341 early B-cell factor 2 (EBF2), mRNA.
chr17:33891805-33891818+0.9164.6741.620.4870.790NM_025248123904 SNAP25-interacting protein (SNIP), mRNA.
chr3:187407073-187407086+0.9144.6621.430.4870.790NM_004454-97502 ets variant gene 5 (ets-related molecule) (ETV5),
chr1:212230399-212230412-0.9144.6621.410.4860.790NM_0027632016 prospero-related homeobox 1 (PROX1), mRNA.
chr2:71692883-71692896-0.9184.6941.560.4860.790NM_003494158715 dysferlin, limb girdle muscular dystrophy 2B
chr10:76878221-76878234-0.9154.6691.170.4840.790NM_032772-46790 zinc finger protein 503 (ZNF503), mRNA.
chr10:6660862-6660875-0.9194.6981.330.4840.790NM_0062571382 protein kinase C, theta (PRKCQ), mRNA.
chrX:53094973-53094986-0.9144.6621.220.4830.790NM_018969-158 G-protein coupled receptor 173 (GPR173), mRNA.
chr10:72648043-72648056-0.9194.6981.230.4820.790NM_1707445788 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr3:189351789-189351802+0.9164.6731.480.4800.790NM_005578-61526 LIM domain containing preferred translocation partner
chr3:141506341-141506354+0.9204.7131.040.4790.790NM_022131369544 calsyntenin 2 (CLSTN2), mRNA.
chr17:51574025-51574038-0.9194.6981.830.4790.790NM_153228-11710 hypothetical protein FLJ38335 (FLJ38335), mRNA.
chr15:73275321-73275334+0.9194.6981.690.4780.790NM_015492-5853 DKFZP434H132 protein (DKFZP434H132), mRNA.
chr19:40958834-40958847+0.9144.6621.110.4770.790NM_052948618 sorting nexin 26 (SNX26), mRNA.
chr22:37859765-37859778+0.9124.6421.120.4760.790NM_17570918719 chromobox homolog 7 (CBX7), mRNA.
chr9:18971240-18971253+0.9134.6521.170.4760.790NM_15370751944 chromosome 9 open reading frame 138 (C9orf138), mRNA.
chr1:35963709-35963722+0.9204.7131.160.4740.790NM_152374-6332 hypothetical protein FLJ38984 (FLJ38984), mRNA.
chr6:16913583-16913596-0.9194.6981.100.4740.790NM_000332-43883 ataxin 1 (ATXN1), mRNA.
chr21:33837494-33837507+0.9124.6411.270.4730.790NM_138927374 SON DNA binding protein (SON), transcript variant f,
chr20:29997002-29997015+0.9194.6981.070.4730.790NM_0308156542 chromosome 20 open reading frame 126 (C20orf126),
chr13:50710752-50710765-0.9134.6561.380.4730.790NM_14501916344 hypothetical protein FLJ30707 (FLJ30707), mRNA.
chr10:122831218-122831231-0.9154.6691.170.4720.790NM_018117230633 WD repeat domain 11 (WDR11), mRNA.
chr1:159311372-159311385+0.9194.6981.920.4710.790NM_181720-4988 hypothetical protein LOC257106 (LOC257106), mRNA.
chr15:64568534-64568547-0.9184.6901.050.4710.790NM_0060498666 small nuclear RNA activating complex, polypeptide 5,
chr1:94300647-94300660+0.9194.6981.110.4700.790NM_00035058646 ATP-binding cassette, sub-family A (ABC1), member 4
chr9:14843608-14843621+0.9184.6961.090.4690.790NM_14496656626 chromosome 9 open reading frame 154 (C9orf154), mRNA.
chr19:47451339-47451352-0.9184.6901.370.4680.790NM_006494-226 Ets2 repressor factor (ERF), mRNA.
chr12:7175259-7175272-0.9194.6981.460.4670.790NM_0147181125 calsyntenin 3 (CLSTN3), mRNA.
chr3:51374821-51374834-0.9134.6501.440.4670.790NM_006010-22822 arginine-rich, mutated in early stage tumors (ARMET),
chr11:71318215-71318228-0.9404.8741.470.6630.791NM_194453584 ring finger protein 121 (RNF121), transcript variant
chr18:34882872-34882885-0.9404.8742.110.6580.791NM_020180-1482931 bruno-like 4, RNA binding protein (Drosophila)
chr5:157413686-157413699+0.9404.8742.160.6570.791NM_014666-194940 enthoprotin (ENTH), mRNA.
chr18:20948107-20948120-0.9404.8742.120.6530.791NM_015461238007 zinc finger protein 521 (ZNF521), mRNA.
chr6:79598665-79598678+0.9384.8621.270.6530.791NM_001010844-35143-
chr2:218897369-218897382+0.9324.8131.170.6500.791NM_0225721307 myofibrillogenesis regulator 1 (MR-1), mRNA.
chrX:102518844-102518857-0.9344.8271.520.6490.791NM_014380179 nerve growth factor receptor (TNFRSF16) associated
chr10:905978-905991+0.9374.8491.550.6490.791NM_01515515724-
chr2:8735449-8735462+0.9404.8741.630.6440.791NM_002166-4015 inhibitor of DNA binding 2, dominant negative
chr8:60104332-60104345+0.9354.8381.950.6400.791NM_01472989989 thymus high mobility group box protein TOX (TOX),
chr12:111075136-111075149-0.9354.8312.050.6390.791NM_00670027472 FLN29 gene product (FLN29), mRNA.
chr12:55819369-55819382+0.9404.8741.540.6380.791NM_00233210920 low density lipoprotein-related protein 1
chr17:23876903-23876916+0.9354.8341.170.6360.791NM_0035931917 forkhead box N1 (FOXN1), mRNA.
chr13:19629339-19629352-0.9354.8341.300.6360.791NM_0219543844 gap junction protein, alpha 3, 46kDa (connexin 46)
chr22:16070218-16070231+0.9354.8341.210.6340.791NM_017424561 cat eye syndrome chromosome region, candidate 1
chr1:35804444-35804457-0.9144.6621.430.4660.792NM_178548-7014 adaptor-related protein complex 2, epsilon subunit
chr5:151006019-151006032+0.9204.7131.210.4660.792NM_00311840691 secreted protein, acidic, cysteine-rich (osteonectin)
chr1:238921437-238921450+0.9114.6331.350.4650.792NM_022469-79352 gremlin 2 homolog, cysteine knot superfamily (Xenopus
chr10:50639319-50639332+0.9154.6701.120.4640.792NM_0182451056 oxoglutarate dehydrogenase-like (OGDHL), mRNA.
chr6:16908380-16908393-0.9184.6901.370.4640.792NM_000332-38680 ataxin 1 (ATXN1), mRNA.
chr3:62005760-62005773-0.9134.6561.070.4640.792NM_020685-274576 chromosome 3 open reading frame 14 (C3orf14), mRNA.
chr6:109613627-109613640+0.9154.6651.200.4630.792NM_17383056527 chromosome 6 open reading frame 182 (C6orf182), mRNA.
chr8:75899215-75899228+0.9194.6981.470.4620.792NM_015886-12 protease inhibitor 15 (PI15), mRNA.
chr19:53834230-53834243+0.9134.6541.090.4610.792NM_001352-1830 D site of albumin promoter (albumin D-box) binding
chr1:143801437-143801450-0.9124.6421.340.4610.792NM_004892-6227 SEC22 vesicle trafficking protein-like 1 (S.
chrX:53095169-53095182+0.9114.6381.330.4610.792NM_01896938 G-protein coupled receptor 173 (GPR173), mRNA.
chr12:64592163-64592176+0.9134.6521.290.4600.792NM_00348487756-
chr17:51478764-51478777-0.9134.6501.570.4590.792NM_153228-106971 hypothetical protein FLJ38335 (FLJ38335), mRNA.
chr22:26356633-26356646+0.9144.6621.370.4590.792NM_002430170853 meningioma (disrupted in balanced translocation) 1
chr14:99812466-99812479-0.9114.6341.300.4580.792NM_00103935530147-
chr7:127600826-127600839+0.9134.6501.120.4560.792NM_000230-67641 leptin (obesity homolog, mouse) (LEP), mRNA.
chr15:87739538-87739551+0.9124.6421.170.4550.792NM_002693-60508 polymerase (DNA directed), gamma (POLG), mRNA.
chr11:32162828-32162841+0.9204.7131.070.4510.792NM_00290193661 reticulocalbin 1, EF-hand calcium binding domain
chr2:62277574-62277587+0.9144.6621.340.4510.792NM_006577908 UDP-GlcNAc:betaGal
chr3:74085495-74085508-0.9154.6691.010.4510.792NM_015009-328733-
chr3:185561257-185561270-0.9144.6601.140.4500.792NM_004366704 chloride channel 2 (CLCN2), mRNA.
chr22:44829832-44829845-0.9144.6601.190.4500.792NM_018280-1144 hypothetical protein FLJ10945 (FLJ10945), mRNA.
chr17:32250058-32250071-0.9194.6981.520.4490.792NM_005568-118454 LIM homeobox 1 (LHX1), mRNA.
chr22:28361845-28361858-0.9204.7131.220.4480.792NM_18183332380 neurofibromin 2 (bilateral acoustic neuroma) (NF2),
chr7:114353795-114353808+0.9204.7131.180.4480.792NM_1990724450 I-mfa domain-containing protein (HIC), mRNA.
chr10:103871261-103871274+0.9134.6501.310.4430.792NM_003893-6569 LIM domain binding 1 (LDB1), mRNA.
chr11:61950497-61950510+0.9134.6561.210.4430.792NM_0033577498 secretoglobin, family 1A, member 1 (uteroglobin)
chr22:29849153-29849166+0.9114.6341.120.4420.792NM_014422292 phosphatidylinositol (4,5) bisphosphate 5-phosphatase,
chr17:34144610-34144623+0.9164.6781.190.4420.792NM_00714413474 ring finger protein 110 (RNF110), mRNA.
chr9:70992812-70992825-0.9134.6501.110.4420.792NM_20162914003 tight junction protein 2 (zona occludens 2) (TJP2),
chr10:8159848-8159861+0.9114.6331.070.4420.792NM_00205123275 GATA binding protein 3 (GATA3), transcript variant 2,
chr17:76926848-76926861-0.9134.6501.090.4410.792NM_178520-7779 hypothetical protein FLJ38792 (FLJ38792), mRNA.
chr9:115319488-115319501-0.9194.6981.520.4400.792NM_13079516060 regulator of G-protein signalling 3 (RGS3), transcript
chr20:45081228-45081241+0.9144.6621.100.4400.792NM_17211239590 eyes absent homolog 2 (Drosophila) (EYA2), transcript
chr9:113605571-113605584-0.9124.6421.040.4390.792NM_173521-19971 chromosome 9 open reading frame 84 (C9orf84), mRNA.
chr22:41720859-41720872+0.9184.6901.380.4390.792NM_007229-47868 protein kinase C and casein kinase substrate in
chr3:53040346-53040359+0.9194.6981.500.4390.792NM_00100515913975 Scm-like with four mbt domains 1 (SFMBT1), transcript
chr1:202261260-202261273+0.9204.7121.350.4390.792NM_18257915751 hypothetical protein FLJ40343 (FLJ40343), mRNA.
chr1:6993658-6993671+0.9164.6761.050.4390.792NM_015215225787-
chr2:220020554-220020567+0.9204.7131.280.4350.792NM_00192729311 desmin (DES), mRNA.
chr16:52103058-52103071+0.9194.6981.120.4340.792NM_022476-8387 fused toes homolog (mouse) (FTS), mRNA.
chr13:76083992-76084005+0.9134.6521.320.4340.792NM_138444274549 potassium channel tetramerisation domain containing 12
chr1:22935404-22935417-0.9134.6501.000.4330.795NM_01744925586 EphB2 (EPHB2), transcript variant 1, mRNA.
chr20:35967866-35967879-0.9144.6621.300.4320.795NM_0806073053 chromosome 20 open reading frame 102 (C20orf102),
chr7:22569435-22569448+0.9144.6621.020.4310.795NM_000600-163810 interleukin 6 (interferon, beta 2) (IL6), mRNA.
chr12:113740085-113740098+0.9184.6941.050.4310.795NM_016569-133733 T-box 3 (ulnar mammary syndrome) (TBX3), transcript
chr15:73796553-73796566-0.9134.6501.460.4300.795NM_001897-4309 chondroitin sulfate proteoglycan 4
chr2:55044129-55044142+0.9134.6561.170.4290.795NM_00700846845 reticulon 4 (RTN4), transcript variant 3, mRNA.
chr9:37019380-37019393+0.9144.6621.540.4280.795NM_0167345096 paired box gene 5 (B-cell lineage specific activator)
chr2:224451477-224451490+0.9184.6941.480.4270.795NM_001039569-40914-
chr11:47987070-47987083-0.9124.6421.010.4270.795NM_00109850328484-
chr11:16960748-16960761+0.9174.6881.010.4270.795NM_17505831787 pleckstrin homology domain containing, family A member
chr3:3816574-3816587+0.9114.6381.210.4270.795NM_020873553 leucine rich repeat neuronal 1 (LRRN1), mRNA.
chr14:23876606-23876619-0.9194.6981.280.4260.795NM_0068712476 receptor-interacting serine-threonine kinase 3
chr15:73451334-73451347+0.9194.6981.520.4260.795NM_006715-3340 mannosidase, alpha, class 2C, member 1 (MAN2C1), mRNA.
chr7:137285847-137285860-0.9174.6881.030.4250.795NM_19407151539 cAMP responsive element binding protein 3-like 2
chr2:218834347-218834360-0.9124.6421.080.4240.795NM_170699464 G protein-coupled bile acid receptor 1 (GPBAR1), mRNA.
chr14:100402732-100402745-0.9194.6981.290.4240.795NM_003836139826 delta-like 1 homolog (Drosophila) (DLK1), mRNA.
chr1:199262201-199262214-0.9124.6401.000.4230.795NM_017596-2750-
chr7:27582954-27582967-0.9124.6441.340.4230.795NM_15274086173 3-hydroxyisobutyrate dehydrogenase (HIBADH), mRNA.
chr7:44071736-44071749+0.9144.6601.250.4220.795NM_000290-48 phosphoglycerate mutase 2 (muscle) (PGAM2), mRNA.
chr3:50233541-50233554+0.9144.6601.220.4210.795NM_002070-15010 guanine nucleotide binding protein (G protein), alpha
chr14:44312868-44312881-0.9174.6881.110.4210.795NM_001017923-123289-
chr11:19555840-19555853-0.9134.6561.530.4210.795NM_145117-135548 neuron navigator 2 (NAV2), transcript variant 2, mRNA.
chr5:113724852-113724865+0.9144.6601.360.4210.795NM_021614-963 potassium intermediate/small conductance
chr4:44048171-44048184+0.9184.6921.040.4200.795NM_19835397410 potassium channel tetramerisation domain containing 8
chr8:116636474-116636487+0.9134.6521.370.4200.795NM_014112113928 trichorhinophalangeal syndrome I (TRPS1), mRNA.
chr12:126691908-126691921-0.9134.6521.350.4200.795NM_1456481182586 solute carrier family 15, member 4 (SLC15A4), mRNA.
chr4:68897946-68897959+0.9144.6621.220.4180.795NM_001031732473-
chr3:141384095-141384108-0.9174.6881.060.4180.795NM_022131247298 calsyntenin 2 (CLSTN2), mRNA.
chr1:76542660-76542673+0.9184.6901.370.4180.795NM_152996229768 sialyltransferase 7
chr20:19211439-19211452-0.9184.6941.020.4170.795NM_02068970249 solute carrier family 24 (sodium/potassium/calcium
chr15:68191107-68191120-0.9194.6981.530.4160.795NM_005078-14895 transducin-like enhancer of split 3 (E(sp1) homolog,
chr17:33942968-33942981-0.9204.7131.150.4150.795NM_02524872741 SNAP25-interacting protein (SNIP), mRNA.
chr20:33523211-33523224-0.9174.6881.160.4140.795NM_00718616747 centrosomal protein 2 (CEP2), mRNA.
chr12:107102267-107102280-0.9154.6651.050.4140.795NM_01465354726-
chr16:48254800-48254813+0.9194.6981.170.4140.795NM_015069163619 zinc finger protein 423 (ZNF423), mRNA.
chr1:36822580-36822593+0.9144.6621.450.4130.795NM_172313-101484 colony stimulating factor 3 receptor (granulocyte)
chr1:22472628-22472641-0.9194.7051.120.4120.795NM_030761-130431 wingless-type MMTV integration site family, member 4
chr1:45083507-45083520-0.9174.6881.270.4110.795NM_003738-2304 patched homolog 2 (Drosophila) (PTCH2), mRNA.
chr6:128819800-128819813+0.9124.6421.610.4110.795NM_00284463616 protein tyrosine phosphatase, receptor type, K
chr17:4436116-4436129-0.9204.7131.060.4090.795NM_1985012173 FLJ42461 protein (FLJ42461), mRNA.
chr4:155305921-155305934+0.9204.7131.400.4090.795NM_017639225978 dachsous 2 (Drosophila) (DCHS2), transcript variant 1,
chr12:51754411-51754424+0.9154.6651.210.4080.795NM_0328404994 hypothetical protein FLJ14800 (FLJ14800), mRNA.
chr1:151478336-151478349-0.9204.7131.020.4080.795NM_000427-20367 loricrin (LOR), mRNA.
chr12:3911128-3911141+0.9194.6981.370.4080.795NM_020367-58265 poly (ADP-ribose) polymerase family, member 11
chr2:217014819-217014832-0.9134.6561.060.4070.795NM_01414028096 SWI/SNF related, matrix associated, actin dependent
chr14:49544156-49544169-0.9204.7131.550.4070.795NM_001012706-168-
chr3:10512772-10512785-0.9184.6901.220.4070.795NM_001683-46226 ATPase, Ca++ transporting, plasma membrane 2 (ATP2B2),
chr16:2758309-2758322-0.9124.6421.210.4060.795NM_0071088989 transcription elongation factor B (SIII), polypeptide
chr11:33384375-33384388+0.9154.6651.160.4060.795NM_012194-135978-
chr9:113735920-113735933+0.9194.6981.100.4060.795NM_00335836993 UDP-glucose ceramide glucosyltransferase (UGCG), mRNA.
chr14:88944311-88944324+0.9124.6421.200.4060.795NM_0051978896 checkpoint suppressor 1 (CHES1), mRNA.
chr11:124138984-124138997-0.9204.7131.030.4050.795NM_138961-1551 endothelial cell adhesion molecule (ESAM), mRNA.
chr1:47429383-47429396+0.9144.6621.180.4050.795NM_005764-1025 membrane-associated protein 17 (MAP17), mRNA.
chr8:61579593-61579606-0.9154.6651.170.4040.795NM_002865-12420 RAB2, member RAS oncogene family (RAB2), mRNA.
chr20:48094325-48094338+0.9114.6341.070.4030.795NM_00598561491 snail homolog 1 (Drosophila) (SNAI1), mRNA.
chr17:17634357-17634370-0.9124.6421.190.4030.795NM_00100529146693 sterol regulatory element binding transcription factor
chrX:64661349-64661362+0.9184.6901.360.4000.795NM_03120610043 hypothetical protein FLJ12525 (FLJ12525), mRNA.
chr3:42234937-42234950-0.9204.7131.240.4000.795NM_00072946462 cholecystokinin (CCK), mRNA.
chr13:96915440-96915453+0.9224.7291.600.8330.798NM_02103331063 RAP2A, member of RAS oncogene family (RAP2A), mRNA.
chr7:150576141-150576154+0.9264.7591.330.8250.798NM_001003801541 SWI/SNF related, matrix associated, actin dependent
chr17:9363840-9363853+0.9264.7591.430.8250.798NM_00485356160 syntaxin 8 (STX8), mRNA.
chr15:56217597-56217610+0.9304.7951.910.8240.798NM_020980-74 aquaporin 9 (AQP9), mRNA.
chr13:27262608-27262621+0.9264.7591.500.8230.798NM_145657-2072 GS homeobox 1 (GSH1), mRNA.
chr10:103316417-103316430+0.9264.7591.460.8220.798NM_01327421546 polymerase (DNA directed), lambda (POLL), mRNA.
chr12:51898636-51898649+0.9304.7911.960.8190.798NM_0010427281781-
chr12:119017440-119017453+0.9264.7591.480.8190.798NM_00686121542 RAB35, member RAS oncogene family (RAB35), mRNA.
chr5:131627307-131627320+0.9274.7701.470.8170.798NM_0036876121 PDZ and LIM domain 4 (PDLIM4), mRNA.
chr15:87999724-87999737+0.9274.7652.120.8140.798NM_198525-7146 similar to kinesin family member 21A; N-5 kinesin
chrX:131179809-131179822+0.9264.7591.610.8120.798NM_02118361 RAP2C, member of RAS oncogene family (RAP2C), mRNA.
chr22:31473014-31473027-0.9304.7901.380.8110.798NM_000362-53688 tissue inhibitor of metalloproteinase 3 (Sorsby fundus
chr11:61326342-61326355+0.9234.7341.710.8060.798NM_014206-9681 chromosome 11 open reading frame 10 (C11orf10), mRNA.
chr22:37597923-37597936-0.9264.7591.770.8060.798NM_014292281 chromobox homolog 6 (CBX6), mRNA.
chrX:68414863-68414876-0.9264.7591.560.8060.798NM_022368-112798 praja 1 (PJA1), mRNA.
chr4:109334422-109334435-0.9254.7551.810.8060.798NM_016269-25395 lymphoid enhancer-binding factor 1 (LEF1), mRNA.
chr10:102575952-102575965+0.9264.7591.240.8050.798NM_00027880594 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr5:38140366-38140379+0.9304.7911.890.8040.798NM_152403-153824 hypothetical protein FLJ39155 (FLJ39155), transcript
chr5:176243616-176243629+0.9274.7651.360.8030.798NM_00211515305 hexokinase 3 (white cell) (HK3), nuclear gene encoding
chr5:151284066-151284079-0.9304.7951.650.8030.798NM_000171530 glycine receptor, alpha 1 (startle
chr2:202545875-202545888+0.9264.7591.970.8020.798NM_003507-61580 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr3:50333697-50333710-0.9264.7591.620.8000.798NM_033158206 hyaluronoglucosaminidase 2 (HYAL2), transcript variant
chr3:170868692-170868705-0.9264.7591.710.8000.798NM_004991-4524 myelodysplasia syndrome 1 (MDS1), mRNA.
chr7:41694754-41694767+0.8844.4082.851.7810.800NM_00219214477 inhibin, beta A (activin A, activin AB alpha
chr17:40605811-40605824+0.9344.8272.090.7330.801NM_14460811864 hypothetical protein MGC39389 (FLJ32384), mRNA.
chr1:45579667-45579680-0.9384.8621.460.7290.801NM_012222-938 mutY homolog (E. coli) (MUTYH), mRNA.
chr7:34065650-34065663+0.9354.8381.580.7250.801NM_133468154702 BMP-binding endothelial regulator precursor protein
chr19:14154359-14154372-0.9394.8701.530.7100.801NM_00100870123638-
chr17:31077485-31077498-0.9404.8741.560.7100.801NM_033315-5286 RAS-like, family 10, member B (RASL10B), mRNA.
chr12:52103798-52103811+0.9404.8742.100.7050.801NM_020547-10 anti-Mullerian hormone receptor, type II (AMHR2),
chr3:36738172-36738185+0.9384.8621.350.7030.801NM_03340318184-
chr1:27796775-27796788-0.9334.8181.050.7020.801NM_0010298825955-
chr5:59550300-59550313-0.9384.8631.240.7020.801NM_018369481413 DEP domain containing 1B (DEPDC1B), mRNA.
chr11:11518502-11518515-0.9384.8621.070.7000.801NM_19851681626 UDP-N-acetyl-alpha-D-galactosamine:polypeptide
chrX:151823155-151823168-0.9184.6901.340.5320.801NM_007150-10398 zinc finger protein 185 (LIM domain) (ZNF185), mRNA.
chr10:74935023-74935036+0.9164.6781.630.5310.801NM_021132-9263 protein phosphatase 3 (formerly 2B), catalytic
chr7:107667144-107667157-0.9184.6961.290.5310.801NM_001037133-82826-
chr22:34494039-34494052+0.9174.6881.230.5300.801NM_03064250274 apolipoprotein L, 5 (APOL5), mRNA.
chr10:79655460-79655473+0.9134.6521.630.5290.801NM_033022191980 ribosomal protein S24 (RPS24), transcript variant 1,
chr1:39229913-39229926-0.9174.6851.760.5280.801NM_024595509 hypothetical protein FLJ12666 (FLJ12666), mRNA.
chr19:47189141-47189154+0.9144.6601.790.5260.801NM_1522961081 ATPase, Na+/K+ transporting, alpha 3 polypeptide
chr2:222156670-222156683+0.9184.6921.320.5260.801NM_004438-11416 EphA4 (EPHA4), mRNA.
chr5:124344105-124344118-0.9194.6981.760.5260.801NM_020747-235401-
chr1:34415045-34415058+0.9144.6601.880.5240.801NM_032884-713 hypothetical protein MGC15882 (MGC15882), mRNA.
chr1:32573701-32573714+0.9144.6601.050.5240.801NM_023009709 MARCKS-like protein (MLP), mRNA.
chr1:40198635-40198648+0.9144.6601.570.5220.801NM_0327935338 hypothetical protein FLJ14490 (FLJ14490), mRNA.
chr4:90423982-90423995-0.9204.7131.060.5220.801NM_19828124202 hypothetical protein LOC285513 (LOC285513), mRNA.
chr6:126159168-126159181+0.9144.6621.260.5210.801NM_18178215268 nuclear receptor coactivator 7 (NCOA7), mRNA.
chr11:17886501-17886514+0.9194.6981.250.5200.801NM_012139104712 deafness locus associated putative guanine nucleotide
chr1:59078576-59078589+0.9124.6441.400.5190.801NM_002228-56203 v-jun sarcoma virus 17 oncogene homolog (avian) (JUN),
chr22:22426459-22426472+0.9194.6981.370.5170.801NM_013378133 pre-B lymphocyte gene 3 (VPREB3), mRNA.
chr12:53011674-53011687-0.9154.6691.050.5160.801NM_0160576596 coatomer protein complex, subunit zeta 1 (COPZ1),
chr20:45036758-45036771-0.9134.6561.160.5160.801NM_172113-3423 eyes absent homolog 2 (Drosophila) (EYA2), transcript
chr19:43719255-43719268+0.9194.6981.360.5160.801NM_00104260081228-
chr10:73748353-73748366-0.9184.6941.280.5130.801NM_00100276236522 DnaJ (Hsp40) homolog, subfamily B, member 12
chr2:216944248-216944261+0.9194.6981.360.5130.801NM_020814747-
chr19:43393605-43393618+0.9144.6581.200.5130.801NM_00464713023 D4, zinc and double PHD fingers family 1 (DPF1), mRNA.
chr20:20711608-20711621+0.9204.7131.150.5130.801NM_020343-70342-
chr3:182910837-182910850+0.9204.7131.160.5130.801NM_003106-1479 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr5:56656002-56656015+0.9184.6941.570.5120.801NM_022913150401 vasculin (DKFZp761C169), mRNA.
chr9:123885489-123885502+0.9204.7131.030.5110.801NM_19425210217 chromosome 9 open reading frame 20 (C9orf20), mRNA.
chr11:60943930-60943943+0.9154.6701.710.5090.801NM_0248119919 pre-mRNA cleavage factor I, 59 kDa subunit (FLJ12529),
chr16:30650113-30650126-0.9134.6561.190.5090.801NM_000294-17025 phosphorylase kinase, gamma 2 (testis) (PHKG2), mRNA.
chrX:44237262-44237275-0.9174.6881.120.5090.801NM_17379449898 FUN14 domain containing 1 (FUNDC1), mRNA.
chr8:131814774-131814787-0.9204.7091.380.5090.801NM_001115309080 adenylate cyclase 8 (brain) (ADCY8), mRNA.
chr7:129795371-129795384-0.9144.6601.470.5080.801NM_001868-12120 carboxypeptidase A1 (pancreatic) (CPA1), mRNA.
chr17:17816568-17816581+0.9144.6601.750.5060.801NM_001033551-59-
chr10:70277139-70277152-0.9114.6331.070.5050.801NM_15270919852-
chr3:125893496-125893509+0.9184.6901.180.5040.801NM_000373-38307 uridine monophosphate synthetase (orotate
chr10:29525348-29525361+0.9134.6501.150.5040.801NM_032517-92548 lysozyme-like 1 (LYZL1), mRNA.
chr5:167660020-167660033+0.9144.6621.200.5030.801NM_0152388450 KIBRA protein (KIBRA), mRNA.
chr19:59070290-59070303-0.9134.6561.200.5020.801NM_0010208185797-
chr9:115902276-115902289-0.9204.7131.180.5010.801NM_138424-1118 kinesin family member 12 (KIF12), mRNA.
chr12:54647301-54647314-0.9124.6421.730.5000.801NM_052827575 cyclin-dependent kinase 2 (CDK2), transcript variant
chr1:23115297-23115310+0.9194.6981.300.5000.801NM_015013-103136 amine oxidase (flavin containing) domain 2 (AOF2),
chr3:197097623-197097636+0.9134.6501.050.3330.801NM_0010109389206-
chrX:39990119-39990132-0.9134.6521.030.3330.801NM_020926-148519 BCL6 co-repressor (BCOR), transcript variant 2, mRNA.
chr11:66380542-66380555+0.9144.6621.100.3320.801NM_024036-907 leucine rich repeat and fibronectin type III domain
chr10:112158113-112158126-0.9194.7051.050.3320.801NM_004419-89402 dual specificity phosphatase 5 (DUSP5), mRNA.
chr1:44262541-44262554-0.9134.6501.090.3310.801NM_201649-6957 solute carrier family 6 (neurotransmitter transporter,
chr9:108549345-108549358+0.9134.6561.110.3310.801NM_021224-115754 zinc finger protein 462 (ZNF462), mRNA.
chr5:149528076-149528089+0.9194.6981.600.3300.801NM_0018041639 caudal type homeo box transcription factor 1 (CDX1),
chr3:137463268-137463281-0.9134.6521.200.3300.801NM_00053211511 propionyl Coenzyme A carboxylase, beta polypeptide
chr1:220632689-220632702+0.9164.6761.010.3300.801NM_024746155378 hypothetical protein FLJ13840 (FLJ13840), mRNA.
chr8:126589007-126589020+0.9194.6981.160.3300.801NM_02519577362 tribbles homolog 1 (Drosophila) (TRIB1), mRNA.
chr10:100196362-100196375+0.9114.6331.150.3290.801NM_000195332 Hermansky-Pudlak syndrome 1 (HPS1), transcript variant
chr9:129344624-129344637+0.9174.6861.060.3290.801NM_02283326552 chromosome 9 open reading frame 88 (C9orf88), mRNA.
chr8:19658367-19658380+0.9184.6901.020.3280.801NM_018142-60731 hypothetical protein FLJ10569 (FLJ10569), mRNA.
chr10:50276210-50276223+0.9144.6601.160.3280.801NM_001080520-6297-
chr19:11297046-11297059-0.9144.6601.000.3270.801NM_00428314275 RAB3D, member RAS oncogene family (RAB3D), mRNA.
chr9:27737129-27737142+0.9174.6861.360.3250.801NM_145005-173287 chromosome 9 open reading frame 72 (C9orf72),
chr3:71434738-71434751+0.9204.7131.070.3250.801NM_032682281092 forkhead box P1 (FOXP1), mRNA.
chr8:25933507-25933520+0.9134.6561.440.3240.801NM_02265924802 early B-cell factor 2 (EBF2), mRNA.
chr10:7053504-7053517-0.9154.6651.000.3230.801NM_006257-391260 protein kinase C, theta (PRKCQ), mRNA.
chr2:172911559-172911572+0.9154.6691.060.3220.801NM_000210-88901 integrin, alpha 6 (ITGA6), mRNA.
chr1:30608577-30608590+0.9204.7131.250.3220.801NM_002379360897 matrilin 1, cartilage matrix protein (MATN1), mRNA.
chr18:48678739-48678752-0.9194.6981.270.3220.801NM_005215558270 deleted in colorectal carcinoma (DCC), mRNA.
chr16:29943591-29943604-0.9114.6331.280.3210.801NM_0314786096 hypothetical protein DKFZp434I2117 (DKFZP434I2117),
chr11:46332141-46332154+0.9124.6421.320.3210.801NM_0036466709 diacylglycerol kinase, zeta 104kDa (DGKZ), transcript
chr2:45265598-45265611+0.9164.6731.980.3210.801NM_016932-175572 sine oculis homeobox homolog 2 (Drosophila) (SIX2),
chr2:121292632-121292645+0.9134.6521.080.3210.801NM_00527026405 GLI-Kruppel family member GLI2 (GLI2), transcript
chr20:29971312-29971325+0.9184.6901.570.3200.801NM_03081532232 chromosome 20 open reading frame 126 (C20orf126),
chr7:27225717-27225730-0.9204.7131.070.3180.801NM_000522-19467 homeo box A13 (HOXA13), mRNA.
chr9:14062603-14062616-0.9174.6861.110.3180.801NM_005596241342 nuclear factor I/B (NFIB), mRNA.
chr11:544358-544371-0.9154.6651.180.3170.801NM_1735736421 hypothetical protein MGC35138 (MGC35138), mRNA.
chr2:69720141-69720154+0.9174.6851.210.3170.801NM_0149114340 AP2 associated kinase 1 (AAK1), mRNA.
chr12:3471318-3471331-0.9144.6621.050.3170.801NM_019854732 HMT1 hnRNP methyltransferase-like 4 (S. cerevisiae)
chr5:131631943-131631956-0.9114.6381.040.3150.801NM_00368710757 PDZ and LIM domain 4 (PDLIM4), mRNA.
chr8:80859278-80859291-0.9154.6681.370.3150.801NM_012258-16625 hairy/enhancer-of-split related with YRPW motif 1
chrX:147884732-147884745-0.9144.6621.130.3140.801NM_002025495001 fragile X mental retardation 2 (FMR2), mRNA.
chr3:25109055-25109068+0.9134.6501.080.3140.801NM_000965-335603 retinoic acid receptor, beta (RARB), transcript
chr3:182306179-182306192-0.9154.6701.110.3140.801NM_145261-115955 homolog of yeast TIM14 (TIM14), transcript variant 1,
chr12:56309895-56309908-0.9124.6421.250.3110.801NM_0014783357
chr22:35594285-35594298-0.9154.6651.170.3110.801NM_0134167394 neutrophil cytosolic factor 4, 40kDa (NCF4),
chr3:61455893-61455906+0.9134.6561.350.3100.801NM_002841-66292 protein tyrosine phosphatase, receptor type, G
chr2:40051647-40051660+0.9194.6981.200.3090.801NM_025264-191766 THUMP domain containing 2 (THUMPD2), mRNA.
chr17:4592678-4592691-0.9124.6441.420.3080.801NM_0322652692 zinc finger, MYND domain containing 15 (ZMYND15),
chr19:55884372-55884385-0.9174.6851.050.3080.801NM_01614827635 SH3 and multiple ankyrin repeat domains 1 (SHANK1),
chr1:26612039-26612052+0.9114.6341.150.3070.801NM_0246742283 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr1:233114560-233114573+0.9204.7131.090.3060.801NM_014765244194 translocase of outer mitochondrial membrane 20 homolog
chr2:72008717-72008730+0.9134.6561.100.3060.801NM_019885219754 cytochrome P450, family 26, subfamily B, polypeptide 1
chr3:43070352-43070365-0.9194.6981.140.3050.801NM_03280652217 hypothetical protein FLJ14566 (FLJ14566), mRNA.
chr10:72566256-72566269+0.9114.6341.070.3050.801NM_170744-75999 unc-5 homolog B (C. elegans) (UNC5B), mRNA.
chr15:64989631-64989644+0.9174.6861.090.3040.801NM_005902-155518 SMAD, mothers against DPP homolog 3 (Drosophila)
chr10:73195473-73195486+0.9124.6401.450.3030.801NM_0221537870-
chr1:23036853-23036866+0.9194.6981.000.3010.801NM_017449127035 EphB2 (EPHB2), transcript variant 1, mRNA.
chr10:103035904-103035917-0.9144.6621.110.3000.801NM_006562-57197 transcription factor similar to D. melanogaster
chr6:55530431-55530444-0.9324.8131.350.6990.804NM_00104240621540-
chr1:109811716-109811729+0.9344.8271.480.6910.804NM_0010407091193-
chr2:19639642-19639655-0.9394.8701.660.6870.804NM_145260-217789 odd-skipped homolog (Drosophila) (ODD), mRNA.
chr14:23655913-23655926-0.9384.8621.220.6840.804NM_1813572152 WD repeat domain 23 (WDR23), transcript variant 2,
chr1:33120791-33120804-0.9354.8341.710.6810.804NM_002143-3794 hippocalcin (HPCA), mRNA.
chr17:24977336-24977349-0.9354.8341.330.6800.804NM_032854-4716 coronin, actin binding protein 6 (FLJ14871), mRNA.
chr7:140732553-140732566-0.9384.8631.680.6700.804NM_018238-169069 hypothetical protein FLJ10842 (FLJ10842), mRNA.
chr20:1195784-1195797+0.9264.7592.070.8650.805NM_014723924 syntaphilin (SNPH), mRNA.
chr17:45616950-45616963+0.9304.7911.930.8640.805NM_00008817049 collagen, type I, alpha 1 (COL1A1), mRNA.
chr3:123716078-123716091+0.9264.7591.790.8640.805NM_002264396 karyopherin alpha 1 (importin alpha 5) (KPNA1), mRNA.
chr18:20972478-20972491-0.9264.7591.960.8610.805NM_015461213636 zinc finger protein 521 (ZNF521), mRNA.
chr2:152663326-152663339+0.9264.7591.730.8590.805NM_001005746139-
chr9:97308099-97308112-0.9264.7591.640.8590.805NM_0010836071203-
chr1:158545064-158545077-0.9284.7772.320.8570.805NM_002857-23509 peroxisomal biogenesis factor 19 (PEX19), mRNA.
chr5:17271382-17271395-0.9264.7591.220.8570.805NM_006317732 brain abundant, membrane attached signal protein 1
chr20:15978595-15978608-0.9264.7591.900.8550.805NM_024704523483 chromosome 20 open reading frame 23 (C20orf23), mRNA.
chr5:177478272-177478285+0.9234.7371.860.8540.805NM_0151115210-
chr6:99194048-99194061+0.9264.7592.020.8540.805NM_005604-195153 POU domain, class 3, transcription factor 2 (POU3F2),
chr5:32747067-32747080+0.9264.7591.920.8530.805NM_000908-255 natriuretic peptide receptor C/guanylate cyclase C
chr1:212364680-212364693-0.9304.7952.440.8510.805NM_002763136297 prospero-related homeobox 1 (PROX1), mRNA.
chr5:51143789-51143802+0.9304.7952.000.8510.805NM_002202429174 ISL1 transcription factor, LIM/homeodomain, (islet-1)
chrX:67969642-67969655-0.9264.7592.020.8480.805NM_0044294186 ephrin-B1 (EFNB1), mRNA.
chr14:23907684-23907697-0.9264.7591.530.8450.805NM_004554690 nuclear factor of activated T-cells, cytoplasmic,
chr14:20639051-20639064+0.9214.7201.840.8410.805NM_016423-2412 zinc finger protein 219 (ZNF219), mRNA.
chr22:37024238-37024251+0.9214.7171.440.8400.805NM_15222119121 casein kinase 1, epsilon (CSNK1E), transcript variant
chr11:119103554-119103567+0.9294.7821.670.8380.805NM_2032851091 poliovirus receptor-related 1 (herpesvirus entry
chr2:66779408-66779421+0.9284.7771.630.8350.805NM_002398263472 Meis1, myeloid ecotropic viral integration site 1
chr22:37979470-37979483+0.9264.7591.550.8340.805NM_002608-8534 platelet-derived growth factor beta polypeptide
chr9:16857694-16857707+0.9264.7591.960.8340.805NM_0176373092 basonuclin 2 (BNC2), mRNA.
chr1:204048688-204048701+0.9084.6081.400.3990.807NM_17385496 solute carrier family 41, member 1 (SLC41A1), mRNA.
chr8:102029021-102029034+0.9044.5731.210.3990.807NM_1456904426 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
chr1:10501792-10501805+0.9014.5551.260.3990.807NM_00456544302 peroxisomal biogenesis factor 14 (PEX14), mRNA.
chr2:66779410-66779423+0.9014.5551.060.3990.807NM_002398263474 Meis1, myeloid ecotropic viral integration site 1
chr6:20474937-20474950-0.9084.6141.420.3980.807NM_001949-35340 E2F transcription factor 3 (E2F3), mRNA.
chr7:36651043-36651056-0.9024.5631.300.3980.807NM_00163779507 acyloxyacyl hydrolase (neutrophil) (AOAH), mRNA.
chr11:75550065-75550078-0.9014.5551.110.3980.807NM_00462645157 wingless-type MMTV integration site family, member 11
chr7:16940185-16940198-0.9044.5731.130.3980.807NM_176813-52047 breast cancer membrane protein 11 (BCMP11), mRNA.
chr15:38941710-38941723+0.9094.6201.200.3970.807NM_13363912021 ras homolog gene family, member V (RHOV), mRNA.
chr19:2001776-2001789+0.9084.6061.180.3970.807NM_017572467 MAP kinase interacting serine/threonine kinase 2
chr14:79747674-79747687-0.9094.6201.790.3970.807NM_001007023-78-
chr12:51916719-51916732+0.9094.6201.050.3960.807NM_000966-4416 retinoic acid receptor, gamma (RARG), mRNA.
chr5:52811913-52811926+0.9064.5931.130.3950.807NM_006350-339 follistatin (FST), transcript variant FST317, mRNA.
chr17:59129381-59129394-0.9064.5971.110.3940.807NM_0305761870 hypothetical protein MGC10986 (MGC10986), mRNA.
chr12:56502181-56502194+0.9044.5801.730.3930.807NM_006576-6062 advillin (AVIL), mRNA.
chr11:115986968-115986981-0.9074.6011.250.3930.807NM_032725161946 hypothetical protein MGC13125 (MGC13125), mRNA.
chr8:11632059-11632072+0.9074.6011.350.3920.807NM_145043-32507 nei like 2 (E. coli) (NEIL2), mRNA.
chr20:36219062-36219075+0.9054.5851.290.3920.807NM_0046138052 transglutaminase 2 (C polypeptide,
chr8:125804222-125804235-0.9044.5811.590.3920.807NM_0147515689 metastasis suppressor 1 (MTSS1), mRNA.
chr5:168409421-168409434-0.9064.5921.070.3920.807NM_003062251133 slit homolog 3 (Drosophila) (SLIT3), mRNA.
chrX:39207592-39207605-0.9044.5801.170.3920.807NM_017745634008 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr1:151782680-151782693+0.9104.6281.580.3910.807NM_002962-1815 S100 calcium binding protein A5 (S100A5), mRNA.
chr18:28712699-28712712-0.9094.6161.540.3910.807NM_020805-105727-
chr19:12806243-12806256+0.9014.5551.310.3900.807NM_031429987 retbindin (RTBDN), mRNA.
chr16:30667495-30667508+0.9104.6241.380.3900.807NM_000294357 phosphorylase kinase, gamma 2 (testis) (PHKG2), mRNA.
chr7:27208440-27208453-0.9044.5771.220.3900.807NM_000522-2190 homeo box A13 (HOXA13), mRNA.
chr8:8999555-8999568-0.9094.6221.020.3900.807NM_02460746075 protein phosphatase 1, regulatory (inhibitor) subunit
chr11:113512637-113512650-0.9094.6171.310.3900.807NM_00101801176239-
chr11:130770528-130770541+0.9044.5761.450.3900.807NM_00104820925047-
chr7:105414952-105414965-0.9024.5591.080.3890.807NM_15275024131 hypothetical protein FLJ23834 (FLJ23834), mRNA.
chr11:128091477-128091490-0.9014.5531.350.3890.807NM_00201722378 Friend leukemia virus integration 1 (FLI1), mRNA.
chr6:82211544-82211557+0.9094.6201.110.3890.807NM_017633307603 family with sequence similarity 46, member A (FAM46A),
chr1:155332075-155332088-0.9034.5721.210.3880.807NM_0010043414149 FLJ16478 protein (FLJ16478), mRNA.
chr19:60350278-60350291+0.9084.6061.090.3870.807NM_0032832108 troponin T1, skeletal, slow (TNNT1), mRNA.
chr5:156704733-156704746+0.9014.5531.430.3870.807NM_001001343524 MGC27121 gene (MGC27121), mRNA.
chr19:40994810-40994823-0.9014.5551.390.3850.807NM_0212321231 proline dehydrogenase (oxidase) 2 (PRODH2), mRNA.
chr9:125844025-125844038-0.9044.5801.350.3850.807NM_00478930415 LIM homeobox 2 (LHX2), mRNA.
chr1:200800097-200800110-0.9044.5811.080.3840.807NM_032104101703 protein phosphatase 1, regulatory (inhibitor) subunit
chr11:43559913-43559926+0.9064.5931.740.3840.807NM_016142-98706 hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12),
chr9:2087745-2087758-0.9044.5771.410.3840.807NM_13904582503 SWI/SNF related, matrix associated, actin dependent
chr10:71910143-71910156-0.9084.6141.050.3830.807NM_0144311660 paladin (PALD), mRNA.
chr6:35267053-35267066+0.9084.6091.070.3820.807NM_152753-23015 signal peptide, CUB domain, EGF-like 3 (SCUBE3), mRNA.
chr12:530685-530698+0.9044.5801.230.3820.807NM_17359390981 beta
chr6:88530393-88530406-0.9044.5811.060.3820.807NM_018064-61748 chromosome 6 open reading frame 166 (C6orf166), mRNA.
chr20:9767595-9767608+0.9064.5971.210.3820.807NM_177990-73 p21(CDKN1A)-activated kinase 7 (PAK7), transcript
chrX:100386981-100386994-0.9054.5851.310.3810.807NM_00193925492 dystrophin related protein 2 (DRP2), mRNA.
chr22:40283385-40283398-0.9054.5851.630.3790.807NM_014460-3475 RNA-binding protein pippin (PIPPIN), mRNA.
chrX:24078039-24078052-0.9064.5931.120.3790.807NM_003410-1590 zinc finger protein, X-linked (ZFX), mRNA.
chr15:76861091-76861104-0.9014.5531.020.3790.807NM_01427229737 a disintegrin-like and metalloprotease (reprolysin
chr1:152571844-152571857-0.9064.5941.450.3780.807NM_0204525044 ATPase, Class I, type 8B, member 2 (ATP8B2), mRNA.
chr8:25961593-25961606+0.9084.6091.300.3770.807NM_022659-3284 early B-cell factor 2 (EBF2), mRNA.
chr5:141205618-141205631+0.9054.5851.110.3760.807NM_03242032510 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr1:61418435-61418448+0.9044.5801.210.3760.807NM_00559597652 nuclear factor I/A (NFIA), mRNA.
chr9:133304287-133304300-0.9064.5901.200.3750.807NM_0133189089-
chr11:68898602-68898615-0.9034.5721.050.3750.807NM_13876880504 myeloma overexpressed gene (in a subset of t(11;14)
chr12:97701617-97701630-0.9044.5731.170.3750.807NM_181869138508 apoptotic protease activating factor (APAF1),
chr12:115049083-115049096+0.9084.6131.060.3750.807NM_015335150443 thyroid hormone receptor associated protein 2
chr12:70156174-70156187+0.9044.5731.010.3740.807NM_00366736194 G protein-coupled receptor 49 (GPR49), mRNA.
chrX:68451540-68451553-0.9044.5801.040.3740.807NM_022368-149475 praja 1 (PJA1), mRNA.
chr4:77561845-77561858+0.9064.5971.140.3730.807NM_020859-13332 Shroom-related protein (ShrmL), mRNA.
chr11:64707318-64707331+0.9084.6061.250.3730.807NM_0051861499 calpain 1, (mu/I) large subunit (CAPN1), mRNA.
chr4:148206872-148206885+0.9084.6091.220.3730.807NM_031956-120388 NYD-SP14 protein (NYD-SP14), mRNA.
chr4:58175958-58175971-0.9094.6201.140.3730.807NM_001553-504662 insulin-like growth factor binding protein 7 (IGFBP7),
chr11:95730772-95730785-0.9104.6261.200.3720.807NM_032427-14780 mastermind-like 2 (Drosophila) (MAML2), mRNA.
chr20:33521034-33521047-0.9094.6201.210.3720.807NM_00718614570 centrosomal protein 2 (CEP2), mRNA.
chr3:128572970-128572983+0.9084.6081.000.3720.807NM_001007534178406-
chr3:4784073-4784086-0.9084.6141.030.3720.807NM_003670-212035 basic helix-loop-helix domain containing, class B, 2
chr11:117154908-117154921+0.9064.5971.120.3720.807NM_02069318278 Down syndrome cell adhesion molecule like 1 (DSCAML1),
chr14:68298109-68298122+0.9044.5731.000.3720.807NM_00492631429 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr21:28545534-28545547-0.9024.5591.090.3720.807NM_013240634030 chromosome 21 open reading frame 127 (C21orf127),
chr10:126124274-126124287-0.9064.5901.040.3710.807NM_022126-16028 phospholysine phosphohistidine inorganic pyrophosphate
chr16:81348448-81348461+0.9044.5731.280.3710.807NM_001257130469 cadherin 13, H-cadherin (heart) (CDH13), mRNA.
chr14:24589106-24589119-0.9084.6061.730.3690.807NM_014178-171 syntaxin binding protein 6 (amisyn) (STXBP6), mRNA.
chr9:130047357-130047370-0.9084.6141.060.3680.807NM_00448630732 golgi autoantigen, golgin subfamily a, 2 (GOLGA2),
chr12:88016748-88016761+0.9084.6081.030.3670.807NM_001946253679 dual specificity phosphatase 6 (DUSP6), transcript
chr1:200940388-200940401+0.9194.6981.000.2650.807NM_1774025780 synaptotagmin II (SYT2), mRNA.
chr12:56209474-56209487+0.9174.6851.690.2640.807NM_0528976648 methyl-CpG binding domain protein 6 (MBD6), mRNA.
chr2:37405191-37405204-0.9204.7131.290.2640.807NM_005813-7465 protein kinase C, nu (PRKCN), mRNA.
chr1:235110181-235110194-0.9114.6341.100.2640.807NM_00025484940 5-methyltetrahydrofolate-homocysteine
chr10:97810224-97810237-0.9184.6901.060.2630.807NM_01908417180 cyclin J (CCNJ), mRNA.
chr12:51559860-51559873+0.9144.6601.090.2620.807NM_00227325267 keratin 8 (KRT8), mRNA.
chr15:67748394-67748407-0.9194.6981.030.2620.807NM_213725216281 ribosomal protein, large, P1 (RPLP1), transcript
chr10:50183413-50183426+0.9124.6421.110.2600.807NM_1994596320 chromosome 10 open reading frame 71 (C10orf71), mRNA.
chr3:24254781-24254794-0.9114.6341.010.2590.807NM_000461256536 thyroid hormone receptor, beta (erythroblastic
chr12:6892700-6892713-0.9144.6621.110.2580.807NM_001975-1075 enolase 2 (gamma, neuronal) (ENO2), mRNA.
chr12:55677294-55677307+0.9134.6501.110.2580.807NM_0072642772 adrenomedullin receptor (ADMR), mRNA.
chr10:102773133-102773146-0.9194.6981.170.2580.807NM_0248957736 PDZ domain containing 7 (PDZK7), mRNA.
chr9:115871766-115871779-0.9184.6901.180.2580.807NM_0016338770 alpha-1-microglobulin/bikunin precursor (AMBP), mRNA.
chr16:65033806-65033819-0.9194.6981.050.2570.807NM_00179575842 cadherin 5, type 2, VE-cadherin (vascular epithelium)
chr11:119052692-119052705-0.9194.7051.580.2570.807NM_20328551953 poliovirus receptor-related 1 (herpesvirus entry
chr10:113320528-113320541+0.9154.6681.200.2530.807NM_000681493717 adrenergic, alpha-2A-, receptor (ADRA2A), mRNA.
chr11:35765952-35765965+0.9174.6861.310.2520.807NM_017583125123 tripartite motif-containing 44 (TRIM44), mRNA.
chr1:232435052-232435065+0.9204.7131.110.2520.807NM_001012985-140900-
chr19:38693713-38693726+0.9134.6521.310.2510.807NM_00028510928 peptidase D (PEPD), mRNA.
chr19:39398199-39398212-0.9134.6561.010.2500.807NM_014686-38997 KIAA0355 (KIAA0355), mRNA.
chr19:48830587-48830600-0.9204.7131.400.2490.807NM_1452965244 immunoglobulin superfamily, member 4C (IGSF4C), mRNA.
chr14:37137886-37137899+0.9144.6621.200.2490.807NM_004496-3646 forkhead box A1 (FOXA1), mRNA.
chr3:71361961-71361974-0.9144.6601.110.2490.807NM_032682353869 forkhead box P1 (FOXP1), mRNA.
chr6:35553365-35553378+0.9144.6621.460.2470.807NM_0071049309 ribosomal protein L10a (RPL10A), mRNA.
chr11:10601885-10601898+0.9114.6341.110.2460.807NM_00109857928539-
chr10:100218815-100218828-0.9174.6861.080.2460.807NM_182639-22121 Hermansky-Pudlak syndrome 1 (HPS1), transcript variant
chr12:50272108-50272121+0.9144.6621.800.2430.807NM_014191921 sodium channel, voltage gated, type VIII, alpha
chr2:27342200-27342213+0.9134.6521.150.2400.807NM_003459-2736 solute carrier family 30 (zinc transporter), member 3
chr2:183612856-183612869-0.9194.6981.010.2390.807NM_205842-1382 NCK-associated protein 1 (NCKAP1), transcript variant
chr15:87062508-87062521-0.9184.6901.040.2370.807NM_00220179565 interferon stimulated gene 20kDa (ISG20), mRNA.
chr22:42150391-42150404-0.9444.9101.850.8570.810NM_00104437012527-
chr3:197559912-197559925+0.9464.9241.760.8370.810NM_138461-10257 hypothetical protein BC013113 (LOC116211), mRNA.
chr12:48023671-48023684-0.9144.6621.580.2990.810NM_024902-3537 hypothetical protein FLJ13236 (FLJ13236), mRNA.
chr17:40453709-40453722+0.9144.6621.390.2980.810NM_02481940203 hypothetical protein FLJ22955 (FLJ22955), mRNA.
chr12:116938438-116938451-0.9184.6921.010.2980.810NM_007370-355 replication factor C (activator 1) 5, 36.5kDa (RFC5),
chr15:31866705-31866718+0.9154.6651.370.2980.810NM_012125-230915 cholinergic receptor, muscarinic 5 (CHRM5), mRNA.
chr15:74443401-74443414+0.9134.6561.130.2980.810NM_14580527299 ISL2 transcription factor, LIM/homeodomain, (islet-2)
chr9:35783743-35783756-0.9194.6981.030.2960.810NM_0039951437 natriuretic peptide receptor B/guanylate cyclase B
chr16:85244189-85244202-0.9184.6901.150.2950.810NM_00525074673 forkhead box L1 (FOXL1), mRNA.
chr7:110067334-110067347+0.9154.6691.050.2940.810NM_001099658-450864-
chr1:23265357-23265370-0.9134.6501.270.2930.810NM_01501346924 amine oxidase (flavin containing) domain 2 (AOF2),
chr7:99834953-99834966+0.9204.7121.020.2910.810NM_17827326049 paired immunoglobin-like type 2 receptor alpha
chr5:76973962-76973975-0.9184.6901.120.2910.810NM_032109-3684 orthopedia homolog (Drosophila) (OTP), mRNA.
chr12:112560468-112560481-0.9144.6621.000.2910.810NM_022363-166208 LIM homeobox 5 (LHX5), mRNA.
chr1:36347285-36347298+0.9144.6601.190.2900.810NM_005202-8848 collagen, type VIII, alpha 2 (COL8A2), mRNA.
chr5:134825864-134825877+0.9164.6731.120.2890.810NM_001099221-9876-
chr20:48865503-48865516-0.9114.6361.240.2870.810NM_19879920729 breast carcinoma amplified sequence 4 (BCAS4),
chr7:96483467-96483480+0.9134.6561.230.2860.810NM_0052218612 distal-less homeo box 5 (DLX5), mRNA.
chr5:133360143-133360156+0.9204.7131.200.2850.810NM_0033748189 voltage-dependent anion channel 1 (VDAC1), mRNA.
chr12:119291636-119291649+0.9144.6601.020.2850.810NM_002442-295 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr5:171778251-171778264-0.9194.6981.120.2850.810NM_00101799535881-
chr20:57334602-57334615-0.9134.6521.190.2850.810NM_20703425808 endothelin 3 (EDN3), transcript variant 4, mRNA.
chr3:46315818-46315831+0.9154.6681.150.2840.810NM_000648-54446 chemokine (C-C motif) receptor 2 (CCR2), transcript
chr17:43128992-43129005-0.9134.6561.090.2830.810NM_0147261463-
chr7:92301927-92301940-0.9144.6621.010.2810.810NM_001259-779 cyclin-dependent kinase 6 (CDK6), mRNA.
chr6:72979251-72979264+0.9124.6421.300.2810.810NM_014989325980 regulating synaptic membrane exocytosis 1 (RIMS1),
chr10:20146522-20146535-0.9144.6601.250.2810.810NM_0328121244 plexin domain containing 2 (PLXDC2), mRNA.
chr12:52980824-52980837+0.9194.6981.020.2800.810NM_006163-5013 nuclear factor (erythroid-derived 2), 45kDa (NFE2),
chr6:107352874-107352887+0.9194.6981.030.2800.810NM_016487-103136 chromosome 6 open reading frame 203 (C6orf203), mRNA.
chr22:48563393-48563406-0.9194.6981.140.2800.810NM_01457741063 bromodomain containing 1 (BRD1), mRNA.
chr11:125122932-125122945-0.9134.6561.050.2780.810NM_1382941634 expressed in prostate and testis (PATE), mRNA.
chr9:132261288-132261301+0.9204.7131.180.2780.810NM_000050-48527 argininosuccinate synthetase (ASS), transcript variant
chr1:155131039-155131052-0.9194.6981.050.2740.810NM_001080471992-
chr9:91526382-91526395-0.9194.6981.070.2740.810NM_006705116734 growth arrest and DNA-damage-inducible, gamma
chr11:12739298-12739311+0.9164.6781.190.2730.810NM_02196186853 TEA domain family member 1 (SV40 transcriptional
chr1:148173793-148173806+0.9144.6601.210.2720.810NM_1818731074 cisplatin resistance associated (CRA), mRNA.
chr17:11073011-11073024-0.9144.6601.070.2710.810NM_207386-12660 FLJ45455 protein (FLJ45455), mRNA.
chr2:69074635-69074648+0.9194.6981.310.2670.810NM_018153-19258 anthrax toxin receptor 1 (ANTXR1), transcript variant
chr15:65085477-65085490+0.9164.6761.470.2670.810NM_005902-59672 SMAD, mothers against DPP homolog 3 (Drosophila)
chrX:16765192-16765205+0.9044.5731.250.2660.810NM_00289333186 retinoblastoma binding protein 7 (RBBP7), mRNA.
chr17:76753994-76754007+0.9094.6161.000.2640.810NM_001080395-32254-
chr19:40336773-40336786+0.9044.5801.020.2630.810NM_014164-594 FXYD domain containing ion transport regulator 5
chr5:139537759-139537772+0.9044.5811.640.2620.810NM_0324123022 putative nuclear protein ORF1-FL49 (ORF1-FL49), mRNA.
chr3:50653252-50653265-0.9104.6291.120.2610.810NM_00463523747 mitogen-activated protein kinase-activated protein
chr2:173806534-173806547+0.9044.5811.080.2600.810NM_031942-121173 cell division cycle associated 7 (CDCA7), transcript
chr3:197643346-197643359-0.9084.6141.020.2590.810NM_015562396-
chr2:86275757-86275770+0.9014.5551.280.2580.810NM_006839351 inner membrane protein, mitochondrial (mitofilin)
chr12:56209472-56209485+0.9024.5631.690.2560.810NM_0528976646 methyl-CpG binding domain protein 6 (MBD6), mRNA.
chr11:30425410-30425423+0.9034.5651.440.2560.810NM_152316124285 hypothetical protein FLJ38968 (FLJ38968), mRNA.
chr19:45888733-45888746+0.9094.6161.010.2550.810NM_004756-337 numb homolog (Drosophila)-like (NUMBL), mRNA.
chrX:128918471-128918484+0.9024.5631.000.2550.810NM_021946-25779 BCL6 co-repressor-like 1 (BCORL1), mRNA.
chr12:48955883-48955896-0.9094.6201.060.2550.810NM_0163577656 epithelial protein lost in neoplasm beta (EPLIN),
chr20:4292739-4292752-0.9034.5721.050.2550.810NM_000678-115080 adrenergic, alpha-1D-, receptor (ADRA1D), mRNA.
chr8:22624139-22624152-0.9054.5841.260.2530.810NM_004430-17379 early growth response 3 (EGR3), mRNA.
chr18:66280494-66280507-0.9074.6011.180.2530.810NM_004232173477 suppressor of cytokine signaling 6 (SOCS6), mRNA.
chr10:102839657-102839670-0.9044.5801.060.2520.810NM_03092928169 Kazal-type serine protease inhibitor domain 1
chr4:111390502-111390515-0.9104.6261.060.2520.810NM_024090-51282 ELOVL family member 6, elongation of long chain fatty
chr5:160906901-160906914-0.9084.6141.220.2510.810NM_000813807 gamma-aminobutyric acid (GABA) A receptor, beta 2
chr17:41178561-41178574-0.9044.5801.110.2500.810NM_004382-38788 corticotropin releasing hormone receptor 1 (CRHR1),
chr2:218461026-218461039-0.9094.6201.360.2490.810NM_02264855980 tensin (TNS), mRNA.
chr7:155644574-155644587+0.9064.5941.030.2480.810NM_000193-346846 sonic hedgehog homolog (Drosophila) (SHH), mRNA.
chr20:1258797-1258810-0.9044.5771.060.2470.810NM_080489-959 syndecan binding protein (syntenin) 2 (SDCBP2),
chr22:39545034-39545047+0.9044.5731.140.2470.810NM_006358304 solute carrier family 25 (mitochondrial carrier;
chr9:33368466-33368479-0.9044.5771.090.2460.810NM_00117024051 aquaporin 7 (AQP7), mRNA.
chr3:158698375-158698388-0.9084.6141.020.2440.810NM_0246211662 hypothetical protein FLJ12604 (FLJ12604), mRNA.
chr9:127252428-127252441+0.9014.5551.150.2440.810NM_015635188596 DKFZP434C212 protein (DKFZP434C212), mRNA.
chr22:26716718-26716731-0.9054.5851.020.2430.810NM_012399-71463 phosphatidylinositol transfer protein, beta (PITPNB),
chr12:122283307-122283320+0.9104.6241.340.2410.810NM_152269-9 hypothetical protein FLJ38663 (FLJ38663), mRNA.
chr21:43146685-43146698+0.9084.6081.010.2410.810NM_03366126062 WD repeat domain 4 (WDR4), transcript variant 2, mRNA.
chr14:22824570-22824583-0.9084.6081.270.2400.810NM_020834503 KIAA1443 (KIAA1443), mRNA.
chr18:44180246-44180259+0.9044.5731.370.2400.810NM_014772-139079 KIAA0427 (KIAA0427), mRNA.
chr1:21694731-21694744-0.9054.5851.180.2390.810NM_000478-13614 alkaline phosphatase, liver/bone/kidney (ALPL), mRNA.
chr10:114636807-114636820+0.9044.5801.080.2390.810NM_030756-63294 transcription factor 7-like 2 (T-cell specific,
chr3:68142964-68142977-0.9024.5631.060.2390.810NM_2136096920 TAFA1 protein (TAFA1), mRNA.
chr15:65229715-65229728+0.9064.5931.340.2380.810NM_00590284566 SMAD, mothers against DPP homolog 3 (Drosophila)
chr1:22969442-22969455-0.9024.5591.330.2380.810NM_01744959624 EphB2 (EPHB2), transcript variant 1, mRNA.
chr20:46876143-46876156+0.9014.5531.050.2370.810NM_0208201684 phosphatidylinositol 3,4,5-trisphosphate-dependent RAC
chr6:26165272-26165285-0.9024.5631.020.2350.810NM_005319-594 histone 1, H1c (HIST1H1C), mRNA.
chr2:109137230-109137243-0.9184.6961.030.1970.810NM_00109928924901-
chr19:38920891-38920904-0.9114.6331.020.1950.810NM_02246753717 carbohydrate (N-acetylgalactosamine 4-0)
chr17:7998636-7998649+0.9124.6401.170.1930.810NM_002616-2209 period homolog 1 (Drosophila) (PER1), mRNA.
chr11:117532612-117532625+0.9194.6981.030.1920.810NM_174934-3867 sodium channel, voltage-gated, type IV, beta (SCN4B),
chr13:30483733-30483746+0.9184.6961.230.1800.810NM_15232578999 hypothetical protein MGC40178 (MGC40178), mRNA.
chr14:22609243-22609256-0.9144.6621.250.1790.810NM_144985-14368 cadherin-like 24 (CDH24), mRNA.
chr2:30297502-30297515+0.9174.6851.360.3660.811NM_030915-10299 likely ortholog of mouse limb-bud and heart gene
chr1:24510606-24510619+0.9204.7131.280.3660.811NM_198173-7762 transcription factor CP2-like 4 (TFCP2L4), transcript
chr14:72182192-72182205+0.9204.7131.150.3660.811NM_012074248370 D4, zinc and double PHD fingers, family 3 (DPF3),
chr3:50524056-50524069-0.9194.6981.080.3650.811NM_006030-8160 calcium channel, voltage-dependent, alpha 2/delta
chr9:109440071-109440084+0.9144.6601.070.3650.811NM_004235-148495 Kruppel-like factor 4 (gut) (KLF4), mRNA.
chr5:123574817-123574830+0.9124.6421.030.3640.811NM_020747533887-
chr1:153375106-153375119-0.9134.6501.340.3630.811NM_018845256 stromal cell protein (LOC55974), mRNA.
chr8:125359822-125359835+0.9204.7061.270.3630.811NM_19429194299 hypothetical protein BC017881 (LOC157378), mRNA.
chr11:72043835-72043848+0.9194.6981.030.3620.811NM_00259919225 phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.
chr19:14063455-14063468-0.9194.6981.020.3610.811NM_138352-1223 atherin (LOC90378), mRNA.
chr16:12381245-12381258-0.9134.6561.120.3610.811NM_001080530327789-
chr1:204177398-204177411+0.9114.6331.150.3590.811NM_0529341813 solute carrier family 26, member 9 (SLC26A9),
chr3:23950775-23950788+0.9174.6881.320.3580.811NM_005126-10935 nuclear receptor subfamily 1, group D, member 2
chr17:40677309-40677322+0.9184.6901.310.3580.811NM_15234317953 hypothetical protein FLJ25414 (FLJ25414), mRNA.
chr17:39781341-39781354-0.9124.6421.370.3570.811NM_0020873424 granulin (GRN), mRNA.
chr5:67865938-67865951+0.9204.7131.510.3560.811NM_181504243787 phosphoinositide-3-kinase, regulatory subunit,
chr4:77822457-77822470+0.9134.6561.050.3540.811NM_001029870215569-
chr14:68201960-68201973+0.9124.6421.320.3540.811NM_004926127578 zinc finger protein 36, C3H type-like 1 (ZFP36L1),
chr3:120103985-120103998+0.9204.7131.730.3540.811NM_001015887132381-
chr5:76973046-76973059-0.9124.6481.050.3530.811NM_032109-2768 orthopedia homolog (Drosophila) (OTP), mRNA.
chr1:99455982-99455995+0.9184.6941.280.3530.811NM_014839-46406 plasticity related gene 1 (LPPR4), mRNA.
chr3:108280306-108280319-0.9124.6441.080.3530.811NM_032600-298472 testes development-related NYD-SP17 (NYD-SP17), mRNA.
chr10:102539870-102539883-0.9164.6781.070.3510.811NM_00027844512 paired box gene 2 (PAX2), transcript variant b, mRNA.
chr7:42289719-42289732-0.9134.6561.260.3510.811NM_000168-46582 GLI-Kruppel family member GLI3 (Greig
chr8:128571876-128571889+0.9164.6761.040.3510.811NM_002467-245522 v-myc myelocytomatosis viral oncogene homolog (avian)
chrX:70288361-70288374+0.9124.6421.160.3490.811NM_0189777025 neuroligin 3 (NLGN3), mRNA.
chr14:60154204-60154217-0.9184.6941.360.3490.811NM_00598231729 sine oculis homeobox homolog 1 (Drosophila) (SIX1),
chr1:61450353-61450366-0.9194.7051.160.3490.811NM_005595129570 nuclear factor I/A (NFIA), mRNA.
chr1:46430968-46430981+0.9114.6331.190.3480.811NM_0177395740 O-linked mannose
chr14:74496237-74496250+0.9124.6421.190.3480.811NM_002632-4193 placental growth factor, vascular endothelial growth
chr7:142301195-142301208+0.9134.6521.020.3470.811NM_018646-7596 transient receptor potential cation channel, subfamily
chr5:39107482-39107495+0.9154.6651.230.3470.811NM_1527562776-
chr6:1070234-1070247+0.9194.6981.310.3470.811NM_033260-187341 forkhead box Q1 (FOXQ1), mRNA.
chr1:32907101-32907114-0.9184.6941.210.3460.811NM_00561017790 retinoblastoma binding protein 4 (RBBP4), mRNA.
chr7:99905516-99905529-0.9144.6601.180.3450.811NM_001004323-5686 hypothetical gene supported by BC031966 (MGC43036),
chr12:92027993-92028006+0.9194.6981.140.3440.811NM_003566-180755 early endosome antigen 1, 162kD (EEA1), mRNA.
chr3:51690712-51690725-0.9194.6981.870.3420.811NM_01592610482 testis expressed sequence 264 (TEX264), mRNA.
chr5:131390163-131390176-0.9194.6981.160.3420.811NM_015256-14915 acyl-CoA synthetase long-chain family member 6
chr11:131677231-131677244-0.9114.6331.190.3420.811NM_016522391409 neurotrimin (HNT), mRNA.
chr1:64048478-64048491-0.9154.6691.400.3410.811NM_00501236300 receptor tyrosine kinase-like orphan receptor 1
chr14:78371044-78371057+0.9124.6421.370.3390.811NM_004796431298 neurexin 3 (NRXN3), transcript variant alpha, mRNA.
chr12:4254418-4254431+0.9144.6621.080.3380.811NM_0017591319 cyclin D2 (CCND2), mRNA.
chr1:199348391-199348404-0.9144.6601.070.3380.811NM_000069-74 calcium channel, voltage-dependent, L type, alpha 1S
chr17:36998169-36998182+0.9114.6341.150.3360.811NM_000526-1496 keratin 14 (epidermolysis bullosa simplex,
chrX:64661498-64661511+0.9194.6981.030.3350.811NM_0312069894 hypothetical protein FLJ12525 (FLJ12525), mRNA.
chr6:84769578-84769591-0.9204.7121.200.3350.811NM_138409-30461 chromosome 6 open reading frame 117 (C6orf117), mRNA.
chr5:114887612-114887625+0.9134.6521.410.3350.811NM_02017720878 fem-1 homolog c (C.elegans) (FEM1C), mRNA.
chr1:173884207-173884220+0.9134.6501.110.3350.811NM_003285-241653 tenascin R (restrictin, janusin) (TNR), mRNA.
chr22:36244279-36244292+0.9204.7131.150.3340.811NM_014550877 caspase recruitment domain family, member 10 (CARD10),
chr14:22824747-22824760+0.9154.6701.180.3340.811NM_020834326 KIAA1443 (KIAA1443), mRNA.
chr11:12104942-12104955-0.9084.6081.120.3330.812NM_01463216328 flavoprotein oxidoreductase MICAL2 (MICAL2), mRNA.
chr3:86203191-86203204+0.9054.5891.390.3330.812NM_153184344969 immunoglobulin superfamily, member 4D (IGSF4D), mRNA.
chr5:155327150-155327163+0.9044.5811.730.3330.812NM_172244-359095 sarcoglycan, delta (35kDa dystrophin-associated
chr10:20146521-20146534-0.9044.5801.250.3330.812NM_0328121243 plexin domain containing 2 (PLXDC2), mRNA.
chr12:93590668-93590681+0.9024.5591.020.3320.812NM_020698-22213 KIAA1145 protein (KIAA1145), mRNA.
chr3:71522422-71522435-0.9084.6061.040.3320.812NM_032682193408 forkhead box P1 (FOXP1), mRNA.
chr12:54458046-54458059-0.9094.6201.000.3310.812NM_00581134812 growth differentiation factor 11 (GDF11), mRNA.
chr1:46915844-46915857-0.9054.5851.390.3310.812NM_022745-9158 ATP synthase mitochondrial F1 complex assembly factor
chr17:38107953-38107966-0.9094.6201.090.3310.812NM_00363219895 contactin associated protein 1 (CNTNAP1), mRNA.
chr17:2083689-2083702+0.9084.6061.760.3310.812NM_01757570130 chromosome 17 open reading frame 31 (C17orf31), mRNA.
chr7:26543959-26543972-0.9094.6201.020.3300.812NM_013322246019 sorting nexin 10 (SNX10), mRNA.
chr20:2683291-2683304+0.9044.5801.080.3290.812NM_01960945991 carboxypeptidase X (M14 family) (CPXM), mRNA.
chr7:96455280-96455293-0.9024.5591.640.3280.812NM_005222-17846-
chr17:56812098-56812111-0.9044.5811.060.3260.812NM_005994-19841 T-box 2 (TBX2), mRNA.
chr2:95420386-95420399+0.9054.5851.010.3250.812NM_016044-11689 fumarylacetoacetate hydrolase domain containing 2A
chr20:57305315-57305328-0.9054.5851.130.3240.812NM_000114-3479 endothelin 3 (EDN3), transcript variant 1, mRNA.
chr8:135589995-135590008+0.9044.5731.150.3240.812NM_001029939187981-
chr15:34579653-34579666+0.9084.6061.160.3230.812NM_032499-94634 hypothetical protein HH114 (HH114), mRNA.
chr19:56885962-56885975-0.9044.5731.200.3220.812NM_00152333071 hyaluronan synthase 1 (HAS1), mRNA.
chr7:139818111-139818124+0.9044.5811.020.3220.812NM_0134467660 makorin, ring finger protein, 1 (MKRN1), mRNA.
chr10:126823726-126823739-0.9044.5801.120.3220.812NM_00132915367 C-terminal binding protein 2 (CTBP2), transcript
chr20:62046766-62046779-0.9074.6011.250.3210.812NM_01785911446 uridine-cytidine kinase 1-like 1 (UCKL1), mRNA.
chr20:33653422-33653435+0.9064.5971.000.3210.812NM_003116-13701 sperm associated antigen 4 (SPAG4), mRNA.
chr19:47039448-47039461+0.9014.5551.350.3200.812NM_173506900 hypothetical protein MGC42718 (MGC42718), mRNA.
chr20:2314311-2314324-0.9044.5801.150.3200.812NM_1989944857 transglutaminase 6 (TGM6), mRNA.
chr5:139780934-139780947-0.9084.6091.110.3200.812NM_02069019421 MASK-4E-BP3 alternate reading frame gene (MASK-BP3),
chr18:70524366-70524379-0.9104.6261.180.3190.812NM_01775752559 zinc finger protein 407 (ZNF407), mRNA.
chr1:153292091-153292104+0.9094.6161.170.3180.812NM_2071971805 a disintegrin and metalloproteinase domain 15
chr1:93816560-93816573+0.9014.5551.320.3180.812NM_003567103413 breast cancer anti-estrogen resistance 3 (BCAR3),
chrX:100362745-100362758-0.9084.6141.120.3160.812NM_0019391256 dystrophin related protein 2 (DRP2), mRNA.
chr2:54509315-54509328+0.9084.6081.000.3160.812NM_003128-27543 spectrin, beta, non-erythrocytic 1 (SPTBN1),
chr17:44249448-44249461+0.9094.6201.040.3150.812NM_005831-13823 nuclear domain 10 protein (NDP52), mRNA.
chr14:23051568-23051581+0.9064.5971.310.3150.812NM_00104263542930-
chr8:64780856-64780869-0.9084.6081.590.3150.812NM_152758537281 YTH domain family 3 (YTHDF3), mRNA.
chr6:41862242-41862255+0.9064.5901.320.3140.812NM_0133975864 chromosome 6 open reading frame 49 (C6orf49), mRNA.
chr20:2971694-2971707+0.9094.6201.010.3130.812NM_001501-474 gonadotropin-releasing hormone 2 (GNRH2), transcript
chrX:31551910-31551923+0.9094.6201.060.3130.812NM_004014-115574 dystrophin (muscular dystrophy, Duchenne and Becker
chr9:128317686-128317699+0.9044.5801.050.3120.812NM_002316-98833 LIM homeobox transcription factor 1, beta (LMX1B),
chr12:51776541-51776554-0.9094.6201.290.3110.812NM_002178-1062 insulin-like growth factor binding protein 6 (IGFBP6),
chr14:68796266-68796279-0.9094.6201.190.3110.812NM_020692-302-
chr6:35313225-35313238+0.9054.5851.290.3100.812NM_003427-22163 zinc finger protein 76 (expressed in testis) (ZNF76),
chr18:46865143-46865156-0.9094.6201.270.3100.812NM_00535954632 SMAD, mothers against DPP homolog 4 (Drosophila)
chr8:30548984-30548997-0.9084.6091.310.3100.812NM_00209586296 general transcription factor IIE, polypeptide 2, beta
chr3:158609633-158609646-0.9084.6091.120.3100.812NM_002852-27568 pentaxin-related gene, rapidly induced by IL-1 beta
chr2:71684670-71684683-0.9094.6201.210.3100.812NM_003494150502 dysferlin, limb girdle muscular dystrophy 2B
chr10:80573384-80573397-0.9024.5631.160.3100.812NM_020338-18392 retinoic acid induced 17 (RAI17), mRNA.
chr17:57909831-57909844+0.9044.5761.020.3090.812NM_006852-205 tousled-like kinase 2 (TLK2), mRNA.
chr1:6434803-6434816+0.9094.6221.120.3080.812NM_00379014039 tumor necrosis factor receptor superfamily, member 25
chr1:10920325-10920338-0.9044.5761.150.3080.812NM_17350726520 hypothetical protein FLJ37118 (FLJ37118), mRNA.
chr2:45322190-45322203+0.9044.5731.050.3070.812NM_016932-232164 sine oculis homeobox homolog 2 (Drosophila) (SIX2),
chr15:67999779-67999792+0.9014.5531.280.3070.812NM_005078176433 transducin-like enhancer of split 3 (E(sp1) homolog,
chr9:2041013-2041026-0.9064.5941.660.3070.812NM_13904535771 SWI/SNF related, matrix associated, actin dependent
chr6:40332909-40332922-0.9044.5811.170.3060.812NM_00100170598814 FLJ41649 protein (FLJ41649), mRNA.
chr17:35729694-35729707-0.9014.5561.060.3050.812NM_00096410822 retinoic acid receptor, alpha (RARA), mRNA.
chr12:4961887-4961900+0.9094.6221.060.3050.812NM_002234-61359 potassium voltage-gated channel, shaker-related
chr8:96728688-96728701-0.9094.6201.080.3050.812NM_177965-378075 hypothetical protein LOC157657 (LOC157657), mRNA.
chr11:35207906-35207919-0.9094.6201.070.3040.812NM_00100139291013 CD44 antigen (homing function and Indian blood group
chr15:73075651-73075664-0.9014.5551.260.3030.812NM_138967797 secretory carrier membrane protein 5 (SCAMP5), mRNA.
chr16:80819930-80819943-0.9044.5771.080.3030.812NM_005792-58600 M-phase phosphoprotein 6 (MPHOSPH6), mRNA.
chr11:116167699-116167712+0.9094.6201.010.3020.812NM_05296895 apolipoprotein A-V (APOA5), mRNA.
chr17:36356615-36356628-0.9044.5801.350.3020.812NM_015515-9253 keratin 23 (histone deacetylase inducible) (KRT23),
chr14:49544161-49544174-0.9014.5551.450.3020.812NM_001012706-173-
chr9:38049232-38049245+0.9054.5851.030.3020.812NM_0030289978 SHB (Src homology 2 domain containing) adaptor protein
chr1:69807859-69807872-0.9064.5931.070.3020.812NM_020794-190487 densin-180 (KIAA1365), mRNA.
chr3:46865492-46865505+0.9094.6201.210.3010.812NM_00025814485 myosin, light polypeptide 3, alkali; ventricular,
chr19:55884374-55884387-0.9024.5631.050.3010.812NM_01614827633 SH3 and multiple ankyrin repeat domains 1 (SHANK1),
chrX:48270405-48270418-0.9014.5551.140.3000.812NM_0065795304 emopamil binding protein (sterol isomerase) (EBP),
chr9:115975243-115975256-0.9014.5511.140.3000.812NM_03288817291 collagen, type XXVII, alpha 1 (COL27A1), mRNA.
chr2:72118607-72118620+0.9204.7131.130.2320.812NM_019885109864 cytochrome P450, family 26, subfamily B, polypeptide 1
chr1:18604746-18604759+0.9204.7131.070.2300.812NM_152375-75165 hypothetical protein FLJ38753 (FLJ38753), mRNA.
chr6:143307247-143307260+0.9194.6981.060.2300.812NM_006734784 human immunodeficiency virus type I enhancer binding
chr4:85506167-85506180+0.9134.6521.030.2300.812NM_006168132244 NK6 transcription factor related, locus 1 (Drosophila)
chr12:92485161-92485174+0.9184.6921.040.2290.812NM_003877-2468 suppressor of cytokine signaling 2 (SOCS2), mRNA.
chr6:37771874-37771887-0.9114.6341.150.2290.812NM_1534871870 MAM domain containing glycosylphosphatidylinositol
chr3:126240027-126240040+0.9194.6981.310.2280.812NM_02073317465-
chr1:204798921-204798934+0.9114.6331.000.2250.812NM_1826651906 Ras association (RalGDS/AF-6) domain family 5
chr2:67087049-67087062-0.9124.6401.050.2250.812NM_019002-390797 ETAA16 protein (ETAA16), mRNA.
chr17:68945788-68945801-0.9194.7051.000.2240.812NM_01906420 sidekick homolog 2 (chicken) (SDK2), mRNA.
chr4:26628738-26628751-0.9134.6501.230.2240.812NM_020860157376 stromal interaction molecule 2 (STIM2), mRNA.
chr8:98456672-98456685-0.9134.6521.170.2220.812NM_033512-97320 TSPY-like 5 (TSPYL5), mRNA.
chr22:41983835-41983848+0.9194.6981.080.2200.812NM_015140-70784 KIAA0153 protein (KIAA0153), mRNA.
chr22:36359639-36359652+0.9174.6851.050.2190.812NM_018957-5891 SH3-domain binding protein 1 (SH3BP1), mRNA.
chr9:99397041-99397054-0.9134.6501.010.2160.812NM_002486-38385 nuclear cap binding protein subunit 1, 80kDa (NCBP1),
chr19:45132578-45132591-0.9124.6421.070.2100.812NM_003890-205 Fc fragment of IgG binding protein (FCGBP), mRNA.
chr12:5592281-5592294-0.9134.6501.200.2080.812NM_002527118854 neurotrophin 3 (NTF3), mRNA.
chrX:133422219-133422232-0.9204.7061.030.2050.812NM_000194396 hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan
chr1:208970600-208970613-0.9144.6601.200.2050.812NM_018194401780 hedgehog acyltransferase (HHAT), mRNA.
chr12:49875989-49876002+0.9144.6621.150.2030.812NM_00270221755-
chr6:106365375-106365388-0.9174.6851.000.2020.812NM_001198-275413 PR domain containing 1, with ZNF domain (PRDM1),
chr2:225251799-225251812-0.9034.5651.170.1970.814NM_003590-93441 cullin 3 (CUL3), mRNA.
chr3:49913038-49913051-0.9044.5801.040.1960.814NM_0024473272 macrophage stimulating 1 receptor (c-met-related
chr6:35386009-35386022-0.9094.6201.050.1960.814NM_02204712536 differentially expressed in FDCP 6 homolog (mouse)
chr19:54816711-54816724-0.9074.6011.100.1930.814NM_00627018501 related RAS viral (r-ras) oncogene homolog (RRAS),
chr15:84049304-84049317-0.9044.5731.000.1920.814NM_14476728132 A kinase (PRKA) anchor protein 13 (AKAP13), transcript
chr1:200143386-200143399+0.9044.5811.050.1890.814NM_19814918831 chromosome 1 open reading frame 40 (C1orf40), mRNA.
chr2:27128068-27128081-0.9044.5811.290.1840.814NM_021831173 hypothetical protein FLJ21839 (FLJ21839), mRNA.
chr2:128010677-128010690-0.9094.6161.110.1830.814NM_001080527929-
chr5:87535902-87535915+0.9104.6291.060.1820.814NM_15335464519 hypothetical protein MGC33214 (MGC33214), mRNA.
chr6:44338424-44338437-0.9094.6201.490.1730.814NM_0045563079 nuclear factor of kappa light polypeptide gene
chr2:173846478-173846491+0.9094.6201.000.1710.814NM_031942-81229 cell division cycle associated 7 (CDCA7), transcript
chr10:11449389-11449402+0.9054.5851.010.1710.814NM_001080491164891-
chr10:67532493-67532506-0.9134.6561.110.1460.815NM_178011-823205 leucine rich repeat transmembrane neuronal 3 (LRRTM3),
chr3:49818718-49818731-0.9144.6621.270.1450.815NM_2033703127 similar to RIKEN cDNA 6530418L21 (LOC389119), mRNA.
chr1:200556268-200556281+0.9134.6561.120.1440.815NM_01417621439 HSPC150 protein similar to ubiquitin-conjugating
chr17:53022310-53022323+0.9094.6201.120.2320.816NM_016070260088 mitochondrial ribosomal protein S23 (MRPS23), nuclear
chr7:130965024-130965037-0.9054.5851.220.2310.816NM_005397-73108 podocalyxin-like (PODXL), mRNA.
chr1:154390186-154390199-0.9044.5761.160.2300.816NM_022367274 sema domain, immunoglobulin domain (Ig), transmembrane
chrX:16974001-16974014-0.9094.6201.170.2300.816NM_00472699366 RALBP1 associated Eps domain containing 2 (REPS2),
chr2:46931622-46931635+0.9094.6161.000.2290.816NM_13927964831 multiple coagulation factor deficiency 2 (MCFD2),
chr1:31964509-31964522+0.9014.5551.170.2280.816NM_001856-22154 collagen, type XVI, alpha 1 (COL16A1), mRNA.
chr3:55930390-55930403-0.9024.5591.100.2270.816NM_003392-434019 wingless-type MMTV integration site family, member 5A
chr12:31431475-31431488+0.9094.6201.010.2260.816NM_021238-61135 chromosome 12 open reading frame 14 (C12orf14), mRNA.
chr7:89568048-89568061-0.9044.5731.040.2260.816NM_012449-53477 six transmembrane epithelial antigen of the prostate
chr7:142804579-142804592-0.9094.6161.060.2220.816NM_00523211528 EphA1 (EPHA1), mRNA.
chr3:190283813-190283826-0.9054.5861.200.2210.816NM_198485-88544 FLJ41238 protein (FLJ41238), mRNA.
chr22:26331862-26331875+0.9094.6201.120.2200.816NM_002430195624 meningioma (disrupted in balanced translocation) 1
chr16:48162022-48162035+0.9044.5731.110.2190.816NM_144602196813 hypothetical protein MGC32905 (MGC33367), mRNA.
chrX:40324743-40324756+0.9034.5711.220.2190.816NM_005765-317 ATPase, H+ transporting, lysosomal accessory protein 2
chr12:104982689-104982702+0.9094.6201.150.2180.816NM_01484075252 AMP-activated protein kinase family member 5 (ARK5),
chr9:133091605-133091618-0.9064.5901.100.2140.816NM_03338750122 chromosome 9 open reading frame 59 (C9orf59), mRNA.
chr19:38484021-38484034+0.9014.5511.070.2130.816NM_0043641139 CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA),
chr3:49614518-49614531-0.9014.5511.060.2110.816NM_00345847692 bassoon (presynaptic cytomatrix protein) (BSN), mRNA.
chr10:102873467-102873480+0.9054.5851.220.2100.816NM_005521-6685 T-cell leukemia, homeobox 1 (TLX1), mRNA.
chr3:56822888-56822901+0.9014.5551.200.2100.816NM_019555-11895 Rho guanine nucleotide exchange factor (GEF) 3
chr1:200564611-200564624-0.9084.6061.000.2050.816NM_01417613096 HSPC150 protein similar to ubiquitin-conjugating
chr18:42290759-42290772-0.9054.5841.330.2030.816NM_152470122674 chromosome 18 open reading frame 23 (C18orf23), mRNA.
chr10:123089883-123089896+0.9084.6061.070.2020.816NM_022970258079 fibroblast growth factor receptor 2
chr1:34415046-34415059+0.9044.5801.150.2010.816NM_032884-712 hypothetical protein MGC15882 (MGC15882), mRNA.
chr15:68176734-68176747-0.9044.5811.110.2950.817NM_005078-522 transducin-like enhancer of split 3 (E(sp1) homolog,
chr3:136513029-136513042+0.9094.6201.100.2950.817NM_004441516179 EphB1 (EPHB1), mRNA.
chr2:219572029-219572042+0.9054.5851.260.2940.817NM_057094-5658 crystallin, beta A2 (CRYBA2), transcript variant 3,
chr11:125851771-125851784-0.9104.6241.560.2930.817NM_006278120565 sialyltransferase 4C (beta-galactoside
chr11:119038947-119038960-0.9084.6061.230.2890.817NM_20328565698 poliovirus receptor-related 1 (herpesvirus entry
chr4:183874263-183874276+0.9054.5891.210.2890.817NM_001012732201361-
chr11:57197260-57197273-0.9044.5731.360.2880.817NM_0154575310 zinc finger, DHHC domain containing 5 (ZDHHC5), mRNA.
chr2:66548512-66548525-0.9044.5771.180.2880.817NM_00239832576 Meis1, myeloid ecotropic viral integration site 1
chr1:36347286-36347299+0.9044.5801.190.2860.817NM_005202-8849 collagen, type VIII, alpha 2 (COL8A2), mRNA.
chr1:60235346-60235359-0.9084.6081.020.2850.817NM_000775-70335 cytochrome P450, family 2, subfamily J, polypeptide 2
chr10:79067466-79067479+0.9044.5731.170.2850.817NM_001014797117-
chr6:39463332-39463345-0.9014.5511.160.2840.817NM_032115-65038 potassium channel, subfamily K, member 16 (KCNK16),
chr1:59632110-59632123+0.9054.5841.050.2840.817NM_01829196882 hypothetical protein FLJ10986 (FLJ10986), mRNA.
chr14:19966863-19966876-0.9024.5591.400.2820.817NM_007110-15443 telomerase-associated protein 1 (TEP1), mRNA.
chr14:54303115-54303128-0.9044.5761.220.2810.817NM_000161136177 GTP cyclohydrolase 1 (dopa-responsive dystonia)
chr20:29791926-29791939-0.9084.6091.530.2800.817NM_0121121461 TPX2, microtubule-associated protein homolog (Xenopus
chr12:119291637-119291650+0.9034.5721.020.2780.817NM_002442-296 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr11:8331011-8331024+0.9014.5511.030.2780.817NM_002315-89029 LIM domain only 1 (rhombotin 1) (LMO1), mRNA.
chr4:152811000-152811013-0.9104.6291.070.2780.817NM_00456490596 PET112-like (yeast) (PET112L), mRNA.
chr7:44703656-44703669+0.9054.5851.120.2770.817NM_031449-51299-
chr2:200879337-200879350-0.9064.5971.030.2770.817NM_015535396 DNA polymerase-transactivated protein 6 (DNAPTP6),
chr20:17792443-17792456+0.9044.5801.090.2760.817NM_014426104711 sorting nexin 5 (SNX5), transcript variant 2, mRNA.
chr6:35554155-35554168+0.9014.5531.150.2750.817NM_00710410099 ribosomal protein L10a (RPL10A), mRNA.
chrX:19732889-19732902+0.9064.5971.140.2750.817NM_001024666-5099-
chr17:23860167-23860180-0.9044.5801.350.2740.817NM_003593-14819 forkhead box N1 (FOXN1), mRNA.
chr5:168336608-168336621-0.9084.6061.010.2740.817NM_003062323946 slit homolog 3 (Drosophila) (SLIT3), mRNA.
chr18:43222842-43222855+0.9014.5531.380.2710.817NM_016097-266099 immediate early response 3 interacting protein 1
chr2:241406719-241406732+0.9084.6081.020.2700.817NM_0043211578 kinesin family member 1A (KIF1A), mRNA.
chr11:111449466-111449479-0.9044.5731.080.2690.817NM_018195-612 hypothetical protein FLJ10726 (FLJ10726), mRNA.
chr9:116728921-116728934-0.9094.6201.020.2680.817NM_0012443670 tumor necrosis factor (ligand) superfamily, member 8
chr11:118347926-118347939-0.9064.5971.080.2670.817NM_181721399 forkhead box R1 (FOXR1), mRNA.
chr1:208970599-208970612-0.9044.5801.010.1600.817NM_018194401779 hedgehog acyltransferase (HHAT), mRNA.
chrX:149612036-149612049-0.9064.5921.050.1560.817NM_003828-391 myotubularin related protein 1 (MTMR1), transcript
chr11:124032037-124032050+0.9054.5851.630.1550.817NM_017425-16813 sperm autoantigenic protein 17 (SPA17), mRNA.
chr18:41296057-41296070+0.9064.5941.450.1490.817NM_007163-152607 solute carrier family 14 (urea transporter), member 2
chr22:41095422-41095435-0.9064.5921.230.1460.817NM_14591262923 NFAT activation molecule 1 (NFAM1), mRNA.
chr9:112010467-112010480+0.9044.5801.150.1410.817NM_001012993-732-
chr10:98422356-98422369+0.9464.9241.770.7980.819NM_15230947913 phosphoinositide-3-kinase adaptor protein 1 (PIK3AP1),
chrX:39674873-39674886+0.9414.8871.670.7810.819NM_017745166727 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chr1:859013-859026-0.8944.4931.090.3990.819NM_1524868129 sterile alpha motif domain containing 11 (SAMD11),
chr1:154700387-154700400-0.8964.5071.490.3990.819NM_006365-34579 transcriptional activator of the c-fos promoter
chr14:69567011-69567024-0.8954.5011.060.3980.819NM_18293649660 solute carrier family 8 (sodium-calcium exchanger),
chr17:8492657-8492670-0.9004.5451.060.3970.819NM_005964-17896 myosin, heavy polypeptide 10, non-muscle (MYH10),
chr2:204646257-204646270+0.8984.5281.140.3970.819NM_012092136609 inducible T-cell co-stimulator (ICOS), mRNA.
chr10:112847933-112847946-0.8934.4841.170.3970.819NM_00068121122 adrenergic, alpha-2A-, receptor (ADRA2A), mRNA.
chr1:151906881-151906894+0.8954.4991.360.3960.819NM_0045153222 interleukin enhancer binding factor 2, 45kDa (ILF2),
chr4:109219004-109219017-0.8964.5121.360.3960.819NM_00532788715 L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain
chr7:73030989-73031002+0.8994.5351.510.3950.819NM_000501-49274 elastin (supravalvular aortic stenosis,
chr5:72665480-72665493-0.8964.5111.150.3950.819NM_004472114628 forkhead box D1 (FOXD1), mRNA.
chr4:152933689-152933702-0.8964.5111.510.3950.819NM_004564-32093 PET112-like (yeast) (PET112L), mRNA.
chr3:136288602-136288615-0.8914.4671.340.3950.819NM_004441291752 EphB1 (EPHB1), mRNA.
chr5:139010660-139010673-0.8954.5011.760.3940.819NM_0164632058 CXXC finger 5 (CXXC5), mRNA.
chr12:111597030-111597043-0.8944.4931.360.3940.819NM_014954-116995 rabphilin 3A homolog (mouse) (RPH3A), mRNA.
chr7:26496709-26496722-0.8914.4671.340.3940.819NM_013322198769 sorting nexin 10 (SNX10), mRNA.
chrX:129019456-129019469+0.8954.5011.450.3920.819NM_00142152691 E74-like factor 4 (ets domain transcription factor)
chr1:61677418-61677431+0.9004.5451.630.3920.819NM_032027286265 beta-amyloid binding protein precursor (BBP), mRNA.
chr12:52703608-52703621-0.8974.5231.100.3910.819NM_004503-4753 homeo box C6 (HOXC6), transcript variant 1, mRNA.
chr1:27056452-27056465+0.8934.4841.300.3910.819NM_006142-5668 stratifin (SFN), mRNA.
chr9:119205916-119205929+0.8994.5391.560.3910.819NM_01401011222 astrotactin 2 (ASTN2), transcript variant 1, mRNA.
chr12:39373006-39373019-0.8984.5251.250.3910.819NM_175038481 contactin 1 (CNTN1), transcript variant 2, mRNA.
chr4:134294212-134294225-0.8934.4841.270.3910.819NM_0329614392 protocadherin 10 (PCDH10), transcript variant 1, mRNA.
chr12:6955403-6955416-0.8994.5331.210.3900.819NM_0063315248 C2f protein (C2F), mRNA.
chr20:2014997-2015010+0.8964.5071.000.3900.819NM_080836-16422 serine/threonine kinase 35 (STK35), mRNA.
chr20:6812874-6812887-0.9004.5411.370.3900.819NM_001200116229 bone morphogenetic protein 2 (BMP2), mRNA.
chr5:114890815-114890828-0.8924.4751.270.3890.819NM_02017717675 fem-1 homolog c (C.elegans) (FEM1C), mRNA.
chrX:17542477-17542490-0.8954.5011.570.3890.819NM_001037535-122936-
chr1:220606132-220606145+0.8934.4881.080.3890.819NM_024746181935 hypothetical protein FLJ13840 (FLJ13840), mRNA.
chr12:54398275-54398288+0.8934.4851.150.3880.819NM_002905-2113 retinol dehydrogenase 5 (11-cis and 9-cis) (RDH5),
chr2:64688276-64688289-0.8974.5231.060.3880.819NM_01475546274-
chr2:202540800-202540813+0.8974.5231.060.3880.819NM_003507-66655 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr2:104389085-104389098+0.9004.5451.230.3880.819NM_006236-449216 POU domain, class 3, transcription factor 3 (POU3F3),
chr1:16345462-16345475+0.8984.5281.950.3870.819NM_0044319689 EphA2 (EPHA2), mRNA.
chr13:51440261-51440274+0.8964.5081.260.3870.819NM_00005343370 ATPase, Cu++ transporting, beta polypeptide (Wilson
chr8:26426034-26426047+0.8924.4751.480.3870.819NM_0072571308-
chr2:8532941-8532954+0.8974.5201.430.3870.819NM_002166-206523 inhibitor of DNA binding 2, dominant negative
chrX:16748003-16748016-0.8964.5151.260.3860.819NM_01836033622 chromosome X open reading frame 15 (CXorf15), mRNA.
chr1:54726629-54726642-0.8944.4931.410.3860.819NM_147161-59760 thioesterase, adipose associated (THEA), transcript
chr19:14347143-14347156-0.8924.4761.100.3860.819NM_001025160-5970-
chrX:44912606-44912619-0.8994.5371.080.3860.819NM_02468932484 chromosome X open reading frame 36 (CXorf36), mRNA.
chr2:216278423-216278436+0.8994.5371.290.3860.819NM_054034-269387 fibronectin 1 (FN1), transcript variant 7, mRNA.
chr14:35810934-35810947+0.8994.5371.220.3860.819NM_01658648662 MAP3K12 binding inhibitory protein 1 (MBIP), mRNA.
chr2:16515901-16515914-0.8974.5231.780.3860.819NM_030797194676 family with sequence similarity 49, member A (FAM49A),
chr10:76183509-76183522+0.8954.5011.230.3860.819NM_012330-72776 MYST histone acetyltransferase (monocytic leukemia) 4
chr20:30498190-30498203-0.8964.5151.250.3850.819NM_08061636659 chromosome 20 open reading frame 112 (C20orf112),
chr3:114256038-114256051+0.8914.4671.240.3850.819NM_015412-34793 DKFZP434F2021 protein (DKFZP434F2021), mRNA.
chr14:35810933-35810946+0.8974.5161.220.3850.819NM_01658648663 MAP3K12 binding inhibitory protein 1 (MBIP), mRNA.
chr17:40380613-40380626+0.8964.5091.290.3840.819NM_001080443-5-
chrX:106890356-106890369-0.8964.5111.150.3830.819NM_19805715317 delta sleep inducing peptide, immunoreactor (DSIPI),
chr15:97499345-97499358-0.8914.4671.470.3830.819NM_14572836636 desmuslin (DMN), transcript variant A, mRNA.
chr9:36138925-36138938-0.8994.5371.080.3820.819NM_02234312283 chromosome 9 open reading frame 19 (C9orf19), mRNA.
chr16:30811626-30811639+0.8974.5171.510.3820.819NM_0047651274 B-cell CLL/lymphoma 7C (BCL7C), mRNA.
chr11:133581586-133581599+0.8954.4991.580.3820.819NM_01526118050 KIAA0056 protein (KIAA0056), mRNA.
chr15:62540212-62540225-0.8994.5371.020.3800.819NM_015042-38360-
chr10:80746316-80746329-0.8924.4801.260.3800.819NM_005729-30810 peptidylprolyl isomerase F (cyclophilin F) (PPIF),
chrX:49645150-49645163-0.8994.5371.180.3800.819NM_000084-73705 chloride channel 5 (nephrolithiasis 2, X-linked, Dent
chr12:14952287-14952300+0.9004.5441.220.3780.819NM_000900-22192 matrix Gla protein (MGP), mRNA.
chr19:47199730-47199743+0.8924.4761.000.3780.819NM_152296-9508 ATPase, Na+/K+ transporting, alpha 3 polypeptide
chr8:124021519-124021532-0.8944.4951.070.3780.819NM_024295102203 derlin-1 (DER1), mRNA.
chr1:96351257-96351270+0.8964.5121.110.3780.819NM_021190-608609 polypyrimidine tract binding protein 2 (PTBP2), mRNA.
chr12:105502493-105502506+0.8974.5201.630.3770.819NM_2135941430 regulatory factor X, 4 (influences HLA class II
chr2:102154135-102154148-0.8954.4991.260.3770.819NM_003854-15630 interleukin 1 receptor-like 2 (IL1RL2), mRNA.
chr2:234539909-234539922-0.8974.5231.510.3770.819NM_02408049227 transient receptor potential cation channel, subfamily
chr8:131438335-131438348+0.8954.5001.320.3770.819NM_01848245064 development and differentiation enhancing factor 1
chrX:138672687-138672700+0.8964.5071.050.3760.819NM_001099855-54640-
chr15:62540213-62540226-0.8934.4841.020.3760.819NM_015042-38359-
chr12:4890538-4890551+0.8924.4801.190.3760.819NM_0002171304 potassium voltage-gated channel, shaker-related
chr5:141551586-141551599+0.8954.5031.140.3760.819NM_03057183178 Nedd4 family interacting protein 1 (NDFIP1), mRNA.
chr12:52147573-52147586-0.8954.5002.090.3750.819NM_00109862015512-
chr15:62435163-62435176+0.8964.5091.170.3750.819NM_022048332 casein kinase 1, gamma 1 (CSNK1G1), mRNA.
chrX:72986409-72986422-0.8914.4721.120.3750.819NM_001099278-25089-
chr15:58695661-58695674-0.8964.5111.010.3740.819NM_00294311363 RAR-related orphan receptor A (RORA), transcript
chr2:190111007-190111020-0.8984.5311.110.3740.819NM_01458542851 solute carrier family 40 (iron-regulated transporter),
chr15:62435162-62435175+0.8934.4851.170.3740.819NM_022048333 casein kinase 1, gamma 1 (CSNK1G1), mRNA.
chr5:129020881-129020894+0.9004.5411.230.3740.819NM_133638196979 a disintegrin-like and metalloprotease (reprolysin
chr11:75550525-75550538+0.8954.5011.170.3740.819NM_00462644697 wingless-type MMTV integration site family, member 11
chr6:45453589-45453602-0.8994.5351.400.3730.819NM_003599-36 suppressor of Ty 3 homolog (S. cerevisiae) (SUPT3H),
chr19:52611641-52611654+0.8934.4851.080.3730.819NM_0010098132956-
chr3:113005007-113005020+0.8954.5011.120.3730.819NM_145753-80393 pleckstrin homology-like domain, family B, member 2
chr10:77133040-77133053-0.8994.5371.060.3730.819NM_032024-79385 chromosome 10 open reading frame 11 (C10orf11), mRNA.
chr14:79165646-79165659-0.8934.4841.190.3730.819NM_138970350311 neurexin 3 (NRXN3), transcript variant beta, mRNA.
chr6:19846266-19846279+0.8934.4891.450.3730.819NM_001546-99230 inhibitor of DNA binding 4, dominant negative
chr1:200517215-200517228+0.8914.4671.040.3720.819NM_01417660492 HSPC150 protein similar to ubiquitin-conjugating
chr3:157759938-157759951+0.8974.5161.200.3720.819NM_007107-4309 signal sequence receptor, gamma (translocon-associated
chr2:178337256-178337269+0.8924.4801.550.3720.819NM_001077196124456-
chr4:183369468-183369481-0.8974.5201.050.3720.819NM_001080477-112563-
chr1:34395627-34395640+0.8954.5031.030.3710.819NM_0528968403 CUB and Sushi multiple domains 2 (CSMD2), mRNA.
chr4:72534091-72534104+0.9004.5411.050.3710.819NM_003759110566 solute carrier family 4, sodium bicarbonate
chr17:9084703-9084716-0.9004.5451.080.3710.819NM_004822219219 netrin 1 (NTN1), mRNA.
chr17:8132942-8132955-0.8964.5081.910.3700.819NM_016492328 RAN guanine nucleotide release factor (RANGNRF), mRNA.
chr3:45965258-45965271-0.8954.5031.020.3700.819NM_0065645381 chemokine (C-X-C motif) receptor 6 (CXCR6), mRNA.
chr1:98552982-98552995-0.8994.5391.290.3700.819NM_015976-346719 sorting nexin 7 (SNX7), transcript variant 1, mRNA.
chr16:4872297-4872310-0.8934.4841.880.3690.819NM_01693630319 ubinuclein 1 (UBN1), mRNA.
chrX:102770770-102770783-0.8994.5351.470.3690.819NM_004780322 transcription elongation factor A (SII)-like 1
chr10:105263145-105263158-0.8914.4711.050.3690.819NM_00421019207 neuralized-like (Drosophila) (NEURL), mRNA.
chr3:183231080-183231093-0.8974.5201.630.3690.819NM_003106318764 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr17:37249139-37249152+0.8984.5311.140.3680.819NM_1524671670 kelch-like 10 (Drosophila) (KLHL10), mRNA.
chr15:41764074-41764087+0.8994.5371.140.3680.819NM_001015001-8202-
chr19:5903544-5903557+0.8964.5151.050.3680.819NM_00732225559 RAN binding protein 3 (RANBP3), transcript variant
chr5:179961508-179961521-0.8924.4751.070.3680.819NM_052863-10415 secretoglobin, family 3A, member 1 (SCGB3A1), mRNA.
chr6:32122999-32123012+0.8914.4671.050.3680.819NM_032470-1116 tenascin XB (TNXB), transcript variant XB-S, mRNA.
chr19:5287152-5287165+0.8944.4931.310.3680.819NM_1308554662 protein tyrosine phosphatase, receptor type, S
chr20:41902784-41902797-0.8994.5371.000.3670.819NM_001098797-74022-
chr1:232305610-232305623+0.8954.5051.250.3670.819NM_173508198408 solute carrier family 35, member F3 (SLC35F3), mRNA.
chr7:42046749-42046762+0.9004.5411.140.3670.819NM_000168196388 GLI-Kruppel family member GLI3 (Greig
chr18:41167073-41167086-0.9004.5441.090.3670.819NM_007163-281591 solute carrier family 14 (urea transporter), member 2
chr19:35715428-35715441-0.9004.5411.280.3670.819NM_014717160360-
chr1:212376257-212376270-0.9284.7741.780.9630.820NM_020197-144842 SET and MYND domain containing 2 (SMYD2), mRNA.
chr15:58832108-58832121+0.9264.7592.560.9600.820NM_134260-125084 RAR-related orphan receptor A (RORA), transcript
chrX:48263983-48263996+0.9304.7951.780.9580.820NM_006579-1118 emopamil binding protein (sterol isomerase) (EBP),
chr1:216396565-216396578-0.9254.7551.870.9580.820NM_016052-128587 CGI-115 protein (CGI-115), mRNA.
chr20:49847649-49847662+0.9264.7591.990.9490.820NM_0204364772 sal-like 4 (Drosophila) (SALL4), mRNA.
chr1:61388946-61388959+0.9264.7571.550.9460.820NM_00559568163 nuclear factor I/A (NFIA), mRNA.
chr16:30583273-30583286+0.9264.7591.520.9360.820NM_02403113631 hypothetical protein MGC3121 (MGC3121), mRNA.
chr12:50492235-50492248-0.9304.7952.220.9360.820NM_00101369010240-
chr6:41579711-41579724-0.9264.7592.180.9340.820NM_001012426-42331-
chr17:7269664-7269677-0.9044.5731.060.4330.821NM_175734105 hypothetical protein LOC201243 (LOC201243), mRNA.
chrX:132354910-132354923-0.9064.5941.390.4330.821NM_00144821961 glypican 4 (GPC4), mRNA.
chr11:119906303-119906316-0.9054.5851.120.4330.821NM_014619-129835 glutamate receptor, ionotropic, kainate 4 (GRIK4),
chr4:141240758-141240771+0.9084.6141.430.4330.821NM_01871753925 mastermind-like 3 (Drosophila) (MAML3), mRNA.
chr17:2246908-2246921-0.9094.6221.570.4320.821NM_0203104100 MAX binding protein (MNT), mRNA.
chr17:4788381-4788394+0.9044.5811.460.4300.821NM_0155284106 ring finger protein 167 (RNF167), mRNA.
chr14:35997833-35997846+0.9034.5651.170.4290.821NM_00331760821 thyroid transcription factor 1 (TITF1), mRNA.
chrX:69560796-69560809-0.9094.6201.520.4280.821NM_0177111180 glycerophosphodiester phosphodiesterase domain
chr5:79165501-79165514-0.9104.6261.180.4280.821NM_153610144186 cardiomyopathy associated 5 (CMYA5), mRNA.
chr7:104441448-104441461-0.9044.5811.030.4270.821NM_182931-325 myeloid/lymphoid or mixed-lineage leukemia 5
chr9:100179332-100179345-0.9014.5551.350.4260.821NM_018421-121596-
chr17:32023099-32023112-0.9094.6201.270.4250.821NM_024308860 hypothetical protein MGC4172 (MGC4172), mRNA.
chr16:66992307-66992320-0.9104.6261.050.4250.821NM_01866747598 sphingomyelin phosphodiesterase 3, neutral membrane
chr12:20731826-20731839+0.9054.5851.020.4250.821NM_017435-7740 solute carrier organic anion transporter family,
chrX:67978279-67978292+0.9094.6161.260.4250.821NM_00442912823 ephrin-B1 (EFNB1), mRNA.
chr15:75561174-75561187+0.9094.6161.060.4240.821NM_01820060976 high-mobility group 20A (HMG20A), mRNA.
chr10:104418476-104418489-0.9104.6281.030.4230.821NM_03091224334 tripartite motif-containing 8 (TRIM8), mRNA.
chr17:39098244-39098257-0.9044.5801.130.4230.821NM_001040002-3456-
chr1:181541055-181541068-0.9084.6141.610.4230.821NM_170706-423 nicotinamide nucleotide adenylyltransferase 2
chr10:73516874-73516887+0.9014.5531.630.4230.821NM_0147671899 sparc/osteonectin, cwcv and kazal-like domains
chr10:115793545-115793558-0.9044.5811.100.4230.821NM_000684-151 adrenergic, beta-1-, receptor (ADRB1), mRNA.
chrX:48959580-48959593+0.9054.5891.020.4220.821NM_003179-15975 synaptophysin (SYP), mRNA.
chr20:43973796-43973809+0.9094.6161.050.4220.821NM_006227397 phospholipid transfer protein (PLTP), transcript
chrX:148020725-148020738-0.9094.6201.230.4220.821NM_000202373973 iduronate 2-sulfatase (Hunter syndrome) (IDS),
chr20:37120348-37120361-0.9094.6201.100.4220.821NM_02193196034 DEAH (Asp-Glu-Ala-His) box polypeptide 35 (DHX35),
chr8:77774007-77774020+0.9094.6201.380.4200.821NM_02472118037 zinc finger homeodomain 4 (ZFHX4), mRNA.
chr18:33324645-33324658-0.9024.5591.000.4200.821NM_02018075296 bruno-like 4, RNA binding protein (Drosophila)
chr3:52540236-52540249-0.9054.5851.060.4180.821NM_0229083874 hypothetical protein FLJ12442 (FLJ12442), mRNA.
chr1:42933174-42933187-0.9094.6201.120.4180.821NM_00455912621 nuclease sensitive element binding protein 1 (NSEP1),
chrX:39129559-39129572+0.9014.5551.190.4180.821NM_021242581642 MID1 interacting protein 1 (gastrulation specific
chr2:197813790-197813803+0.9094.6161.090.4170.821NM_153697-42783 hypothetical protein DKFZp434D2328 (LOC91526), mRNA.
chr11:114325949-114325962-0.9084.6061.660.4160.821NM_001077639-354255-
chr3:14460931-14460944-0.9084.6091.210.4130.821NM_00304341921 solute carrier family 6 (neurotransmitter transporter,
chr3:185561256-185561269-0.9044.5801.260.4120.821NM_004366705 chloride channel 2 (CLCN2), mRNA.
chr7:44071737-44071750+0.9044.5801.080.4120.821NM_000290-49 phosphoglycerate mutase 2 (muscle) (PGAM2), mRNA.
chr3:72729957-72729970+0.9084.6141.240.4120.821NM_012234-151493 RING1 and YY1 binding protein (RYBP), mRNA.
chr12:129208949-129208962+0.9064.5971.050.4120.821NM_007197-3936 frizzled homolog 10 (Drosophila) (FZD10), mRNA.
chr3:51677011-51677024-0.9064.5971.280.4100.821NM_015926-3219 testis expressed sequence 264 (TEX264), mRNA.
chr12:55807945-55807958+0.9084.6141.260.4090.821NM_002332-504 low density lipoprotein-related protein 1
chr16:17371722-17371735-0.9084.6141.140.4090.821NM_022166100517 xylosyltransferase I (XYLT1), mRNA.
chr22:40108833-40108846-0.9034.5651.060.4070.821NM_0032161024 thyrotrophic embryonic factor (TEF), mRNA.
chr16:2593523-2593536-0.9084.6141.540.4070.821NM_03126865652 3-phosphoinositide dependent protein kinase-1 (PDPK1),
chr14:75616468-75616481-0.9054.5841.300.4070.821NM_017926-71444 chromosome 14 open reading frame 118 (C14orf118),
chr8:13015174-13015187-0.9014.5491.390.4070.821NM_00609420006 deleted in liver cancer 1 (DLC1), transcript variant
chr11:71397895-71397908-0.9054.5851.380.4060.821NM_17304210238 interleukin 18 binding protein (IL18BP), transcript
chr3:126330954-126330967+0.9084.6141.430.4060.821NM_020733-73462-
chr14:94472326-94472339+0.9054.5851.210.4060.821NM_173849-166074 goosecoid (GSC), mRNA.
chr1:38282039-38282052+0.9044.5811.180.4050.821NM_0026992998 POU domain, class 3, transcription factor 1 (POU3F1),
chr15:40103261-40103274+0.9064.5921.250.4050.821NM_001080490-13524-
chr14:98885760-98885773-0.9044.5731.110.4050.821NM_138576-78185 B-cell CLL/lymphoma 11B (zinc finger protein)
chr1:29321432-29321445+0.9024.5631.080.4050.821NM_0010036821562 cDNA DKFZp434C184 gene (DKFZp434C184), mRNA.
chr11:27699117-27699130+0.9084.6141.570.4040.821NM_170732-271 brain-derived neurotrophic factor (BDNF), transcript
chr3:187246969-187246982+0.9054.5891.070.4040.821NM_00445462602 ets variant gene 5 (ets-related molecule) (ETV5),
chr3:116069871-116069884+0.9064.5941.050.4040.821NM_015642278946 zinc finger and BTB domain containing 20 (ZBTB20),
chr12:3490758-3490771-0.9064.5971.160.4030.821NM_01985420172 HMT1 hnRNP methyltransferase-like 4 (S. cerevisiae)
chr1:212376263-212376276-0.9094.6201.060.4020.821NM_020197-144836 SET and MYND domain containing 2 (SMYD2), mRNA.
chr6:110119446-110119459-0.9084.6081.450.4020.821NM_145025-333 chromosome 6 open reading frame 199 (C6orf199), mRNA.
chr11:31746980-31746993-0.9084.6081.760.4010.821NM_00028042454 paired box gene 6 (aniridia, keratitis) (PAX6), mRNA.
chr3:134583669-134583682+0.9014.5551.160.4010.821NM_003571-17711 beaded filament structural protein 2, phakinin
chr2:205010673-205010686+0.9064.5901.040.4010.821NM_152526-107988 amyotrophic lateral sclerosis 2 (juvenile) chromosome
chr11:6379318-6379331+0.9054.5851.550.4000.821NM_00100759311187-
chrX:70513329-70513342-0.9014.5552.190.4000.821NM_13892310590 TAF1 RNA polymerase II, TATA box binding protein
chr5:38842927-38842940+0.9044.5731.140.4000.821NM_003999-38866 oncostatin M receptor (OSMR), mRNA.
chrX:29703266-29703279-0.9044.5811.330.3660.823NM_002364-440235 melanoma antigen, family B, 2 (MAGEB2), mRNA.
chr8:72989780-72989793-0.9014.5511.210.3650.823NM_005098-70495 musculin (activated B-cell factor-1) (MSC), mRNA.
chr22:29970073-29970086+0.9054.5851.120.3640.823NM_001031801-4175-
chr2:27301621-27301634-0.9044.5731.320.3640.823NM_0043417959 carbamoyl-phosphate synthetase 2, aspartate
chr10:80778754-80778767-0.9054.5851.600.3640.823NM_0057291628 peptidylprolyl isomerase F (cyclophilin F) (PPIF),
chr1:178394506-178394519-0.9084.6091.040.3630.823NM_0028264015 quiescin Q6 (QSCN6), transcript variant 1, mRNA.
chr8:126334842-126334855-0.9044.5731.160.3630.823NM_014846-161599 KIAA0196 gene product (KIAA0196), mRNA.
chr10:123209448-123209461-0.9024.5601.410.3630.823NM_022970138514 fibroblast growth factor receptor 2
chrX:130007392-130007405-0.9054.5851.350.3610.823NM_144967-12405 hypothetical protein FLJ30058 (FLJ30058), mRNA.
chr2:46059878-46059891+0.9024.5601.450.3610.823NM_001430-318089 endothelial PAS domain protein 1 (EPAS1), mRNA.
chr11:35015140-35015153+0.9044.5731.150.3600.823NM_000610-101753 CD44 antigen (homing function and Indian blood group
chr1:178518049-178518062-0.9084.6061.180.3600.823NM_03334352084 LIM homeobox 4 (LHX4), mRNA.
chr1:211569800-211569813+0.9084.6061.180.3600.823NM_012424278680 ribosomal protein S6 kinase, 52kDa, polypeptide 1
chr14:100437865-100437878+0.9024.5631.050.3600.823NM_003836174959 delta-like 1 homolog (Drosophila) (DLK1), mRNA.
chr17:2109205-2109218+0.9064.5941.700.3590.823NM_01757544614 chromosome 17 open reading frame 31 (C17orf31), mRNA.
chr10:121060198-121060211-0.9084.6141.080.3590.823NM_005308103111 G protein-coupled receptor kinase 5 (GRK5), mRNA.
chr14:23868399-23868412-0.9104.6261.280.3580.823NM_1392475305 adenylate cyclase 4 (ADCY4), mRNA.
chr2:159739183-159739196-0.9094.6201.200.3580.823NM_152528112126 WD repeat and SAM domain containing 1 (WDSAM1), mRNA.
chr17:34156587-34156600+0.9094.6201.560.3560.823NM_0071441497 ring finger protein 110 (RNF110), mRNA.
chr7:114200250-114200263-0.9044.5771.270.3560.823NM_199072-149095 I-mfa domain-containing protein (HIC), mRNA.
chr3:188475540-188475553+0.9064.5971.190.3550.823NM_00187916906 mannan-binding lectin serine protease 1 (C4/C2
chr17:2025372-2025385-0.9094.6201.280.3550.823NM_001098202119118-
chrX:46320711-46320724+0.9084.6141.250.3550.823NM_0198862675 carbohydrate (N-acetylglucosamine 6-O)
chr15:76051333-76051346+0.9014.5531.150.3550.823NM_015079105579 KIAA1055 protein (KIAA1055), mRNA.
chr1:154624842-154624855+0.9064.5971.350.3530.823NM_02040719315 Rhesus blood group, B glycoprotein (RHBG), mRNA.
chrX:131003323-131003336+0.9084.6141.080.3530.823NM_00104245218106-
chr10:114857969-114857982+0.9104.6281.300.3530.823NM_030756157868 transcription factor 7-like 2 (T-cell specific,
chr1:118047910-118047923+0.9084.6141.080.3520.823NM_01770997883 family with sequence similarity 46, member C (FAM46C),
chr21:37080782-37080795+0.9044.5771.310.3510.823NM_00506987021 single-minded homolog 2 (Drosophila) (SIM2),
chr12:15799891-15799904+0.9044.5771.320.3500.823NM_00444733710 epidermal growth factor receptor pathway substrate 8
chr7:21777979-21777992+0.9084.6141.160.3500.823NM_018719174052 transcription factor RAM2 (RAM2), mRNA.
chr8:95255715-95255728+0.9084.6091.100.3500.823NM_00406334271 cadherin 17, LI cadherin (liver-intestine) (CDH17),
chr5:76972268-76972281+0.9064.5941.080.3490.823NM_032109-1990 orthopedia homolog (Drosophila) (OTP), mRNA.
chr9:136242975-136242988+0.9104.6261.070.3490.823NM_002957-115156 retinoid X receptor, alpha (RXRA), mRNA.
chr9:36929377-36929390+0.9074.6001.270.3490.823NM_01673495099 paired box gene 5 (B-cell lineage specific activator)
chr1:154898421-154898434+0.9094.6161.080.3480.823NM_00661715392 nestin (NES), mRNA.
chr6:151097486-151097499-0.9024.5591.000.3480.823NM_015440-130798 formyltetrahydrofolate synthetase domain containing 1
chr1:153080413-153080426+0.9044.5731.020.3480.823NM_17078218549 potassium intermediate/small conductance
chr1:112520303-112520316+0.9044.5731.020.3480.823NM_172198-187003 potassium voltage-gated channel, Shal-related
chr8:40878556-40878569+0.9094.6201.280.3460.823NM_024645-4056 hypothetical protein FLJ13842 (FLJ13842), mRNA.
chr5:76259583-76259596-0.9094.6201.090.3440.823NM_001882-24753 corticotropin releasing hormone binding protein
chr19:12983173-12983186+0.9024.5631.320.3440.823NM_00250115689 nuclear factor I/X (CCAAT-binding transcription
chr7:103416400-103416413+0.9084.6141.680.3430.823NM_005045798 reelin (RELN), transcript variant 1, mRNA.
chr7:99905515-99905528-0.9044.5801.180.3420.823NM_001004323-5685 hypothetical gene supported by BC031966 (MGC43036),
chr19:48675571-48675584-0.9044.5801.400.3420.823NM_014400-13900 GPI-anchored metastasis-associated protein homolog
chr5:131840617-131840630+0.9024.5591.130.3410.823NM_00219813709 interferon regulatory factor 1 (IRF1), mRNA.
chr11:46099376-46099389-0.9054.5841.090.3410.823NM_016621185 BRAF35/HDAC2 complex (80 kDa) (BHC80), mRNA.
chrX:76927912-76927925+0.9024.5631.190.3410.823NM_000489463 alpha thalassemia/mental retardation syndrome X-linked
chr8:41303964-41303977+0.9014.5511.080.3390.823NM_003012-17827 secreted frizzled-related protein 1 (SFRP1), mRNA.
chr18:43041065-43041078+0.9084.6141.040.3390.823NM_016097-84322 immediate early response 3 interacting protein 1
chr6:91422202-91422215-0.9054.5851.080.3390.823NM_145333-68574 mitogen-activated protein kinase kinase kinase 7
chr12:52725171-52725184+0.9044.5731.380.3380.823NM_153633-8657 homeo box C4 (HOXC4), transcript variant 2, mRNA.
chr7:98815873-98815886-0.9094.6161.220.3380.823NM_0057205708 actin related protein 2/3 complex, subunit 1B, 41kDa
chr3:66739047-66739060-0.9044.5801.050.3380.823NM_015541-105512 leucine-rich repeats and immunoglobulin-like domains 1
chr12:113334085-113334098-0.9094.6201.140.3360.823NM_080717-3455 T-box 5 (TBX5), transcript variant 3, mRNA.
chr1:235272056-235272069+0.9014.5551.040.3350.823NM_001035-169 ryanodine receptor 2 (cardiac) (RYR2), mRNA.
chrX:152948427-152948440-0.9014.5531.200.3350.823NM_001569-9891 interleukin-1 receptor-associated kinase 1 (IRAK1),
chr9:97617382-97617395-0.9044.5731.230.3350.823NM_001010895-60322-
chr18:54417988-54418001+0.9044.5801.150.3350.823NM_05294729181 heart alpha-kinase (HAK), mRNA.
chr1:17166464-17166477+0.9024.5631.020.3340.823NM_00240313262 microfibrillar-associated protein 2 (MFAP2),
chr3:114306574-114306587+0.9484.9461.730.8960.825NM_015412-85329 DKFZP434F2021 protein (DKFZP434F2021), mRNA.
chr19:35535473-35535486-0.9444.9102.230.8840.825NM_014717-19595-
chr6:137285731-137285744+0.9034.5721.600.4660.825NM_001008783736-
chr8:107292711-107292724+0.9014.5511.020.4660.825NM_181354-446459 oxidation resistance 1 (OXR1), mRNA.
chr5:36606011-36606024+0.9064.5931.540.4650.825NM_004172-36337 solute carrier family 1 (glial high affinity glutamate
chr3:50233542-50233555+0.9044.5801.220.4640.825NM_002070-15009 guanine nucleotide binding protein (G protein), alpha
chr1:7141609-7141622-0.9064.5971.120.4640.825NM_015215373738-
chr18:21155804-21155817+0.9084.6091.290.4640.825NM_01546130310 zinc finger protein 521 (ZNF521), mRNA.
chrX:48703549-48703562+0.9034.5651.320.4630.825NM_017602-3712 hypothetical protein DKFZp761A052 (DKFZp761A052),
chr9:128490022-128490035+0.9084.6061.470.4630.825NM_00231673503 LIM homeobox transcription factor 1, beta (LMX1B),
chr1:46719302-46719315-0.9084.6141.190.4620.825NM_147192-25853 diencephalon/mesencephalon homeobox 1 (DMBX1),
chr20:34123032-34123045-0.9044.5811.510.4620.825NM_177996-40630 erythrocyte membrane protein band 4.1-like 1
chr8:55528824-55528837-0.9084.6061.090.4620.825NM_022454-4124 SRY (sex determining region Y)-box 17 (SOX17), mRNA.
chr5:88010109-88010122+0.9084.6141.350.4610.825NM_002397204671 MADS box transcription enhancer factor 2, polypeptide
chr17:24502884-24502897+0.9034.5681.340.4600.825NM_07847128649 myosin XVIIIA (MYO18A), transcript variant 1, mRNA.
chr10:119742912-119742925-0.9014.5551.320.4600.825NM_01490453192 RAB11 family interacting protein 2 (class I)
chr17:28546295-28546308+0.9094.6201.060.4590.825NM_18337797824 amiloride-sensitive cation channel 1, neuronal
chr4:54782572-54782585-0.9084.6091.100.4580.825NM_006206-7532 platelet-derived growth factor receptor, alpha
chr2:25443203-25443216-0.9094.6161.210.4580.825NM_175630-24240 DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A),
chr20:40332338-40332351-0.9054.5851.510.4580.825NM_032221-651791 chromodomain helicase DNA binding protein 6 (CHD6),
chr1:148498802-148498815+0.9044.5801.120.4570.825NM_0121132060 carbonic anhydrase XIV (CA14), mRNA.
chr3:195586816-195586829+0.9094.6201.150.4570.825NM_00448814468 glycoprotein V (platelet) (GP5), mRNA.
chr15:68143807-68143820+0.9044.5731.390.4570.825NM_00507832405 transducin-like enhancer of split 3 (E(sp1) homolog,
chr2:60588846-60588859+0.9064.5941.270.4560.825NM_01801445291 B-cell CLL/lymphoma 11A (zinc finger protein)
chr12:106858605-106858618+0.9044.5731.280.4550.825NM_203436166413 achaete-scute complex-like 4 (Drosophila) (ASCL4),
chr11:130026813-130026826-0.9084.6141.010.4550.825NM_173580-21148 hypothetical protein FLJ39058 (FLJ39058), mRNA.
chr2:121812035-121812048-0.9084.6081.120.4540.825NM_014553-52790 transcription factor CP2-like 1 (TFCP2L1), mRNA.
chr7:54380145-54380158+0.9014.5551.440.4540.825NM_182546-197268 hypothetical protein MGC33530 (MGC33530), mRNA.
chr17:32031441-32031454-0.9034.5681.480.4530.825NM_024864-597 hypothetical protein FLJ22578 (FLJ22578), mRNA.
chr10:103531275-103531288+0.9094.6201.130.4500.825NM_0069931873 nucleophosmin/nucleoplasmin, 3 (NPM3), mRNA.
chr5:93150492-93150505-0.9044.5731.060.4500.825NM_153216-47427 hypothetical protein FLJ25680 (FLJ25680), mRNA.
chr20:61808413-61808426+0.9034.5651.050.4480.825NM_001083113-725-
chr1:110560697-110560710-0.9014.5551.090.4470.825NM_0049785209 potassium voltage-gated channel, Shaw-related
chr22:44844574-44844587-0.9084.6141.150.4460.825NM_018280-15886 hypothetical protein FLJ10945 (FLJ10945), mRNA.
chr11:11647559-11647572+0.9014.5551.110.4460.825NM_198516-47431 UDP-N-acetyl-alpha-D-galactosamine:polypeptide
chr11:108979419-108979432+0.9064.5901.070.4460.825NM_207645181434 similar to expressed sequence AI593442 (LOC399947),
chr1:203220225-203220238-0.9044.5731.000.4450.825NM_005076-58638 contactin 2 (axonal) (CNTN2), mRNA.
chr11:17532696-17532709-0.9094.6161.780.4440.825NM_153676-10157 Usher syndrome 1C (autosomal recessive, severe)
chr20:10228836-10228849-0.9044.5811.100.4430.825NM_13081181459 synaptosomal-associated protein, 25kDa (SNAP25),
chr9:91729679-91729692-0.9044.5811.120.4430.825NM_006705320031 growth arrest and DNA-damage-inducible, gamma
chr4:128261629-128261642+0.9014.5551.100.4430.825NM_015693-511841 PDZ domain containing 6 (PDZK6), mRNA.
chr14:22711159-22711172-0.9044.5801.560.4420.825NM_01224411530 solute carrier family 7 (cationic amino acid
chr5:169560862-169560875+0.9064.5971.280.4420.825NM_14476995467 forkhead box I1 (FOXI1), transcript variant 2, mRNA.
chr10:120445104-120445117+0.9084.6081.390.4420.825NM_15381059644 chromosome 10 open reading frame 46 (C10orf46), mRNA.
chr12:55312536-55312549+0.9094.6201.760.4420.825NM_0134493894 bromodomain adjacent to zinc finger domain, 2A
chr7:96298670-96298683+0.9094.6161.520.4420.825NM_006304-121531 split hand/foot malformation (ectrodactyly) type 1
chr13:72533768-72533781-0.9094.6161.390.4410.825NM_0017302725 Kruppel-like factor 5 (intestinal) (KLF5), mRNA.
chr4:24770752-24770765+0.9024.5601.110.4400.825NM_016955255 soluble liver antigen/liver pancreas antigen (SLA/LP),
chr20:42868641-42868654+0.9034.5651.270.4390.825NM_1829703685 regulating synaptic membrane exocytosis 4 (RIMS4),
chr2:72216931-72216944+0.9084.6141.300.4390.825NM_01988511540 cytochrome P450, family 26, subfamily B, polypeptide 1
chr1:38309778-38309791+0.9014.5551.420.4390.825NM_002699-24741 POU domain, class 3, transcription factor 1 (POU3F1),
chr11:77657401-77657414-0.9014.5551.120.4370.825NM_01229673173 GRB2-associated binding protein 2 (GAB2), transcript
chr22:28509941-28509954-0.9034.5711.060.4360.825NM_01338716683 ubiquinol-cytochrome c reductase complex (7.2 kD)
chr3:53040351-53040364+0.9094.6201.500.4360.825NM_00100515913970 Scm-like with four mbt domains 1 (SFMBT1), transcript
chr7:110617060-110617073+0.9044.5811.330.4360.825NM_01833498862 leucine rich repeat neuronal 3 (LRRN3), mRNA.
chr5:158568200-158568213+0.9044.5811.190.4340.825NM_144726-788 hypothetical protein FLJ31951 (FLJ31951), mRNA.
chr20:773171-773184-0.9054.5851.640.4340.825NM_031424-14 chromosome 20 open reading frame 55 (C20orf55),
chr1:145787447-145787460+0.9034.5721.430.4340.825NM_005267-54013 gap junction protein, alpha 8, 50kDa (connexin 50)
chr15:29453384-29453397-0.9104.6241.250.4340.825NM_01599547109 Kruppel-like factor 13 (KLF13), mRNA.
chr10:104226718-104226731+0.8964.5071.240.2660.825NM_02478915658 chromosome 10 open reading frame 77 (C10orf77), mRNA.
chr3:191152416-191152429+0.8994.5331.160.2660.825NM_018192168996 leprecan-like 1 (LEPREL1), mRNA.
chr9:19917625-19917638+0.8924.4791.090.2660.825NM_020344-140699 solute carrier family 24 (sodium/potassium/calcium
chr9:35610053-35610066-0.8954.5011.060.2650.825NM_001782-1645 CD72 antigen (CD72), mRNA.
chr12:3085614-3085627-0.8974.5231.090.2650.825NM_00667528896 transmembrane 4 superfamily member tetraspan NET-5
chr19:48707618-48707631+0.8924.4751.070.2630.825NM_198850-6691 pleckstrin homology-like domain, family B, member 3
chr6:1271086-1271099+0.8914.4671.100.2620.825NM_03326013511 forkhead box Q1 (FOXQ1), mRNA.
chr4:148277185-148277198+0.8954.5011.700.2620.825NM_031956-190701 NYD-SP14 protein (NYD-SP14), mRNA.
chr3:60938923-60938936-0.8964.5121.160.2620.825NM_002012273241 fragile histidine triad gene (FHIT), mRNA.
chr6:142933213-142933226-0.8954.5031.070.2610.825NM_198569268554 G protein-coupled receptor 126 (GPR126), mRNA.
chr17:11073010-11073023-0.8954.5011.070.2610.825NM_207386-12661 FLJ45455 protein (FLJ45455), mRNA.
chr6:51883626-51883639+0.8974.5231.000.2610.825NM_138694176756 polycystic kidney and hepatic disease 1 (autosomal
chr22:22439901-22439914+0.8984.5271.120.2590.825NM_213720240 chromosome 22 open reading frame 16 (C22orf16), mRNA.
chr2:29886430-29886443-0.8994.5391.100.2590.825NM_004304111506 anaplastic lymphoma kinase (Ki-1) (ALK), mRNA.
chr3:185394384-185394397-0.8974.5231.150.2580.825NM_0183587927 ATP-binding cassette, sub-family F (GCN20), member 3
chr16:63658434-63658447-0.8914.4671.200.2580.825NM_00179754986 cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11),
chr2:202540206-202540219-0.8934.4881.180.2570.825NM_003507-67249 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr17:44017283-44017296+0.8994.5351.510.2560.825NM_024015-6541 homeo box B4 (HOXB4), mRNA.
chr9:34580402-34580415+0.8994.5371.060.2560.825NM_147164-680 ciliary neurotrophic factor receptor (CNTFR),
chr6:5538911-5538924-0.8934.4891.270.2560.825NM_006567332428 phenylalanine-tRNA synthetase 1 (mitochondrial)
chr11:17630053-17630066-0.8954.5051.280.2550.825NM_002478-67533 myogenic factor 3 (MYOD1), mRNA.
chr5:167723686-167723699+0.8944.4971.190.2550.825NM_01523872116 KIBRA protein (KIBRA), mRNA.
chr9:34580401-34580414+0.8934.4851.060.2540.825NM_147164-679 ciliary neurotrophic factor receptor (CNTFR),
chr9:127872568-127872581-0.8944.4931.030.2540.825NM_001011703-256281-
chr5:88009955-88009968-0.9004.5451.080.2540.825NM_002397204825 MADS box transcription enhancer factor 2, polypeptide
chr7:129212390-129212403+0.8964.5121.020.2530.825NM_001040110155335-
chr1:241161576-241161589-0.8934.4881.140.2530.825NM_014812323755 KARP-1-binding protein (KAB), mRNA.
chr17:46062314-46062327-0.8964.5071.370.2520.825NM_003786-4813 ATP-binding cassette, sub-family C (CFTR/MRP), member
chr2:70849726-70849739+0.8974.5231.050.2510.825NM_017484-889 adducin 2 (beta) (ADD2), transcript variant beta-3b,
chr5:107223156-107223169+0.8954.5011.520.2500.825NM_001962-188661 ephrin-A5 (EFNA5), mRNA.
chr2:37405192-37405205-0.8924.4801.290.2490.825NM_005813-7466 protein kinase C, nu (PRKCN), mRNA.
chr12:5201710-5201723+0.8964.5071.050.2490.825NM_002234178464 potassium voltage-gated channel, shaker-related
chr6:152171597-152171610-0.8934.4851.330.2490.825NM_0001251318 estrogen receptor 1 (ESR1), mRNA.
chr5:77625843-77625856+0.8944.4921.100.2490.825NM_003664441 adaptor-related protein complex 3, beta 1 subunit
chr3:76566771-76566784+0.8964.5071.040.2490.825NM_002942-605113-
chr14:22824571-22824584-0.8934.4841.430.2480.825NM_020834502 KIAA1443 (KIAA1443), mRNA.
chr5:149107552-149107565-0.8984.5281.000.2480.825NM_13326317595 peroxisome proliferative activated receptor, gamma,
chr3:38757050-38757063-0.8914.4671.010.2460.825NM_00651453455 sodium channel, voltage-gated, type X, alpha (SCN10A),
chr5:153680225-153680238+0.8994.5351.050.2460.825NM_017540-83205 UDP-N-acetyl-alpha-D-galactosamine:polypeptide
chr2:46517198-46517211+0.8954.5031.100.2450.825NM_08065383402 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E
chr17:52002605-52002618-0.8914.4731.150.2450.825NM_005450-23569 noggin (NOG), mRNA.
chr3:62375599-62375612+0.8914.4671.190.2450.825NM_018008-41538 zinc finger protein 312 (ZNF312), mRNA.
chr5:155178659-155178672-0.8934.4891.050.2440.825NM_172244-507586 sarcoglycan, delta (35kDa dystrophin-associated
chr16:71638617-71638630+0.8994.5351.250.2440.825NM_0068851158 AT-binding transcription factor 1 (ATBF1), mRNA.
chr10:102404059-102404072+0.8964.5071.250.2430.825NM_003988-91299 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr11:112344672-112344685-0.8994.5371.090.2430.825NM_0006157567 neural cell adhesion molecule 1 (NCAM1), mRNA.
chr5:77884756-77884769+0.8924.4761.390.2420.825NM_00577995648 lipoma HMGIC fusion partner-like 2 (LHFPL2), mRNA.
chr18:51325980-51325993-0.8924.4751.030.2420.825NM_00319980878 transcription factor 4 (TCF4), mRNA.
chr1:61680177-61680190+0.8944.4931.170.2410.825NM_032027283506 beta-amyloid binding protein precursor (BBP), mRNA.
chr6:121335794-121335807+0.8954.5031.180.2410.825NM_152730361549 chromosome 6 open reading frame 170 (C6orf170), mRNA.
chr9:8812820-8812833+0.8954.4991.260.2410.825NM_033428-1023021-
chr1:109714991-109715004+0.8964.5121.840.2400.825NM_00295927095 sortilin 1 (SORT1), mRNA.
chr20:55403132-55403145-0.9004.5451.040.2390.825NM_1834253362 RNA-binding region (RNP1, RRM) containing 1 (RNPC1),
chr12:98250791-98250804-0.8934.4891.010.2390.825NM_181670-178188 E2a-Pbx1-associated protein (EB-1), transcript variant
chr7:43121462-43121475-0.8934.4841.190.2390.825NM_0150522839 NEDD4-like ubiquitin-protein ligase 1 (NEDL1), mRNA.
chr4:91890640-91890653-0.8994.5391.030.2390.825NM_18304988652 thymosin-like 3 (TMSL3), mRNA.
chr7:96478059-96478072+0.8954.5011.310.2380.825NM_0052224933-
chr1:61241103-61241116+0.8964.5111.110.2380.825NM_005595-79680 nuclear factor I/A (NFIA), mRNA.
chr10:70151246-70151259+0.8944.4931.680.2360.825NM_018237369 cell division cycle and apoptosis regulator 1 (CCAR1),
chr1:241724445-241724458+0.8984.5241.010.2360.825NM_006642238602 serologically defined colon cancer antigen 8
chr19:48830588-48830601-0.8924.4801.400.2350.825NM_1452965243 immunoglobulin superfamily, member 4C (IGSF4C), mRNA.
chr19:43558726-43558739-0.8974.5201.430.2340.825NM_0028121765 proteasome (prosome, macropain) 26S subunit,
chr6:88691247-88691260-0.8944.4951.130.2340.825NM_030960-122879 sperm acrosome associated 1 (SPACA1), mRNA.
chr5:82244282-82244295-0.8994.5371.010.2340.825NM_174909164653 hypothetical protein MGC23909 (MGC23909), mRNA.
chr10:126717342-126717355+0.9084.6141.340.4990.828NM_022802-10899 C-terminal binding protein 2 (CTBP2), transcript
chr21:35085863-35085876+0.9084.6121.120.4990.828NM_00100189096994 runt-related transcription factor 1 (acute myeloid
chr13:78073218-78073231+0.9094.6201.600.4990.828NM_0062372478 POU domain, class 4, transcription factor 1 (POU4F1),
chrX:101035711-101035724-0.9044.5811.300.4980.828NM_032441-3862-
chr6:20511990-20512003+0.9024.5631.100.4980.828NM_0019491713 E2F transcription factor 3 (E2F3), mRNA.
chr15:75967325-75967338+0.9024.5591.010.4980.828NM_015079189587 KIAA1055 protein (KIAA1055), mRNA.
chr9:33433100-33433113-0.9094.6221.340.4960.828NM_0049254490 aquaporin 3 (AQP3), mRNA.
chr13:105816578-105816591+0.9044.5731.150.4960.828NM_004093168760 ephrin-B2 (EFNB2), mRNA.
chr9:14303895-14303908-0.9034.5721.220.4950.828NM_00559650 nuclear factor I/B (NFIB), mRNA.
chr2:60601354-60601367+0.9044.5761.020.4950.828NM_01801432783 B-cell CLL/lymphoma 11A (zinc finger protein)
chr1:149481127-149481140-0.9044.5801.320.4920.828NM_002810-12594 proteasome (prosome, macropain) 26S subunit,
chr16:88083332-88083345+0.9014.5551.220.4920.828NM_0132751138 ankyrin repeat domain 11 (ANKRD11), mRNA.
chr9:91526372-91526385-0.9064.5971.500.4920.828NM_006705116724 growth arrest and DNA-damage-inducible, gamma
chr1:17871885-17871898-0.9044.5811.140.4910.828NM_030812-82446 actin like protein (LOC81569), mRNA.
chr8:25883942-25883955+0.9024.5601.750.4900.828NM_02265974367 early B-cell factor 2 (EBF2), mRNA.
chr3:68617171-68617184+0.9044.5731.320.4890.828NM_001005527447230-
chr2:210189694-210189707-0.9084.6141.550.4880.828NM_03184737146 microtubule-associated protein 2 (MAP2), transcript
chr19:47444274-47444287+0.9054.5851.480.4870.828NM_019884-5698 glycogen synthase kinase 3 alpha (GSK3A), mRNA.
chr20:61838214-61838227-0.9034.5651.080.4850.828NM_017806-125 hypothetical protein FLJ20406 (FLJ20406), mRNA.
chr6:84585357-84585370-0.9094.6161.470.4840.828NM_001009994-34247-
chr1:87679985-87679998-0.9094.6161.300.4840.828NM_006769113346 LIM domain only 4 (LMO4), mRNA.
chr3:185372166-185372179+0.9094.6201.170.4820.828NM_001025205-3062-
chr5:149845126-149845139-0.9044.5801.120.4820.828NM_001543-35397 N-deacetylase/N-sulfotransferase (heparan
chr19:13025102-13025115+0.9094.6201.070.4820.828NM_00558349579 lymphoblastic leukemia derived sequence 1 (LYL1),
chr5:62211139-62211152-0.9054.5851.060.4820.828NM_001080540-102213-
chr21:28743985-28743998-0.9064.5901.110.4820.828NM_013240435579 chromosome 21 open reading frame 127 (C21orf127),
chr20:10242964-10242977-0.9084.6081.640.4810.828NM_13081195587 synaptosomal-associated protein, 25kDa (SNAP25),
chr16:29592902-29592915-0.9064.5931.120.4800.828NM_014298-4940 quinolinate phosphoribosyltransferase
chr8:25930479-25930492+0.9024.5592.340.4800.828NM_02265927830 early B-cell factor 2 (EBF2), mRNA.
chr5:173405511-173405524+0.9044.5801.760.4790.828NM_015980281 HMP19 protein (HMP19), mRNA.
chr16:71439610-71439623-0.9014.5531.290.4780.828NM_006885200165 AT-binding transcription factor 1 (ATBF1), mRNA.
chr2:233092969-233092982+0.9074.6011.200.4760.828NM_000751-6097 cholinergic receptor, nicotinic, delta polypeptide
chr15:74143264-74143277-0.9064.5901.720.4760.828NM_1523354010 chromosome 15 open reading frame 27 (C15orf27), mRNA.
chr3:71342004-71342017+0.9094.6161.220.4760.828NM_032682373826 forkhead box P1 (FOXP1), mRNA.
chr9:99150908-99150921+0.9024.5601.440.4740.828NM_014290-63115 tudor domain containing 7 (TDRD7), mRNA.
chr6:85643527-85643540+0.9044.5731.380.4720.828NM_001080508-112909-
chr13:39665005-39665018-0.9054.5851.280.4700.828NM_002015473729 forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA.
chr1:57660978-57660991-0.9094.6201.120.4700.828NM_000066-456702 complement component 8, beta polypeptide (C8B), mRNA.
chr3:182901966-182901979-0.9054.5851.610.4700.828NM_003106-10350 SRY (sex determining region Y)-box 2 (SOX2), mRNA.
chr19:48671521-48671534-0.9064.5931.360.4680.828NM_014400-9850 GPI-anchored metastasis-associated protein homolog
chr15:86872396-86872409+0.9464.9241.900.7520.829NM_01799618492 de-etiolated 1 (DET1), mRNA.
chr4:169777798-169777811+0.9414.8811.530.7440.829NM_016081123106 palladin (KIAA0992), mRNA.
chr19:6163423-6163436+0.9044.5801.080.5330.830NM_00593467536 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr1:40198636-40198649+0.9044.5801.570.5320.830NM_0327935339 hypothetical protein FLJ14490 (FLJ14490), mRNA.
chr3:124962673-124962686+0.9064.5901.350.5320.830NM_053025123166 myosin, light polypeptide kinase (MYLK), transcript
chr10:93359240-93359253+0.9094.6201.450.5320.830NM_00539823598 protein phosphatase 1, regulatory (inhibitor) subunit
chr12:83830385-83830398+0.9064.5971.550.5320.830NM_182767320 solute carrier family 6 (neurotransmitter
chr2:156849417-156849430+0.9094.6201.320.5310.830NM_00618648029 nuclear receptor subfamily 4, group A, member 2
chr3:52031904-52031917-0.9014.5511.610.5290.830NM_000992-26906 ribosomal protein L29 (RPL29), mRNA.
chr14:20562847-20562860+0.9014.5551.390.5280.830NM_201538257 NDRG family member 2 (NDRG2), transcript variant 5,
chr11:112811264-112811277-0.9104.6242.000.5280.830NM_00079539827 dopamine receptor D2 (DRD2), transcript variant 1,
chr12:53101383-53101396+0.9084.6141.660.5260.830NM_002205-2066 integrin, alpha 5 (fibronectin receptor, alpha
chr4:112108019-112108032-0.9064.5941.050.5260.830NM_153427-330062 paired-like homeodomain transcription factor 2
chrX:119379642-119379655+0.9094.6201.420.5250.830NM_012069-253 ATPase, (Na+)/K+ transporting, beta 4 polypeptide
chr3:121991901-121991914-0.9024.5631.250.5240.830NM_00551347753 general transcription factor IIE, polypeptide 1 (alpha
chr20:48242750-48242763-0.9094.6201.320.5220.830NM_0051942067 CCAAT/enhancer binding protein (C/EBP), beta (CEBPB),
chr1:32573702-32573715+0.9044.5801.050.5210.830NM_023009708 MARCKS-like protein (MLP), mRNA.
chr1:151781408-151781421+0.9084.6141.110.5190.830NM_002962-543 S100 calcium binding protein A5 (S100A5), mRNA.
chr17:61328571-61328584-0.9104.6241.590.5170.830NM_001037325-75508-
chr3:41018776-41018789+0.9084.6082.040.5170.830NM_001098210-197070-
chr3:173038886-173038899+0.9074.6011.710.5160.830NM_002662-100320 phospholipase D1, phophatidylcholine-specific (PLD1),
chr3:148817763-148817776-0.9034.5651.330.5160.830NM_003412207992 Zic family member 1 (odd-paired homolog, Drosophila)
chrX:13736033-13736046+0.9044.5801.040.5140.830NM_0010019959202 glycoprotein M6B (GPM6B), transcript variant 1, mRNA.
chr18:55098149-55098162+0.9094.6201.430.5130.830NM_013435-6544 retina and anterior neural fold homeobox (RAX), mRNA.
chr13:31647624-31647637-0.9044.5801.670.5130.830NM_000059-139893 breast cancer 2, early onset (BRCA2), mRNA.
chr4:6250086-6250099+0.9044.5731.110.5130.830NM_0010994333133-
chr9:129911377-129911390-0.9014.5551.190.5120.830NM_00100664310820-
chr5:149549184-149549197+0.9064.5971.360.5120.830NM_014228-429 solute carrier family 6 (neurotransmitter transporter,
chr12:6820298-6820311+0.9084.6141.180.5110.830NM_002075762 guanine nucleotide binding protein (G protein), beta
chr2:60184245-60184258-0.9074.5982.140.5090.830NM_018014449892 B-cell CLL/lymphoma 11A (zinc finger protein)
chr5:148338437-148338450+0.9014.5551.030.5080.830NM_02457784493 KIAA1985 protein (KIAA1985), mRNA.
chr2:210543019-210543032-0.9074.6011.970.5070.830NM_006916-32478 ribulose-5-phosphate-3-epimerase (RPE), transcript
chr2:106496487-106496500+0.9094.6161.040.5070.830NM_025076-319260 UDP-glucuronate decarboxylase 1 (UXS1), mRNA.
chr15:94681139-94681152+0.9094.6201.950.5070.830NM_0210056289 nuclear receptor subfamily 2, group F, member 2
chr12:49875995-49876008+0.9104.6241.640.5060.830NM_00270221749-
chr17:31146801-31146814+0.9034.5721.560.5060.830NM_001032278-48-
chr7:129795370-129795383-0.9044.5801.470.5040.830NM_001868-12121 carboxypeptidase A1 (pancreatic) (CPA1), mRNA.
chr17:16928349-16928362-0.9024.5571.210.5030.830NM_20127441617 myosin phosphatase-Rho interacting protein (M-RIP),
chr15:73290874-73290887-0.9044.5801.070.5030.830NM_0154929700 DKFZP434H132 protein (DKFZP434H132), mRNA.
chr17:17816569-17816582+0.9034.5721.750.5030.830NM_001033551-60-
chr12:6672612-6672625+0.9044.5811.340.5020.830NM_001039920-3682-
chr1:38800295-38800308-0.9084.6081.450.5010.830NM_022157297632 Ras-related GTP binding C (RRAGC), mRNA.
chr3:45329126-45329139-0.9094.6201.050.5000.830NM_015340-75853 leucyl-tRNA synthetase 2, mitochondrial (LARS2),
chr5:153503402-153503415-0.9004.5451.080.3330.830NM_198321-46986 UDP-N-acetyl-alpha-D-galactosamine:polypeptide
chr20:45420782-45420795+0.9004.5431.140.3330.830NM_183048-1901 protein kinase C binding protein 1 (PRKCBP1),
chr8:49118753-49118766-0.8954.5011.000.3330.830NM_00335035305 ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2),
chr2:227355099-227355112-0.8924.4761.300.3330.830NM_00554417620 insulin receptor substrate 1 (IRS1), mRNA.
chr18:42545988-42546001-0.8934.4841.100.3320.830NM_01330545049 sialyltransferase 8E (alpha-2,
chr6:136794728-136794741-0.8984.5291.050.3320.830NM_003980118757 microtubule-associated protein 7 (MAP7), mRNA.
chr18:43041064-43041077+0.8914.4721.040.3320.830NM_016097-84321 immediate early response 3 interacting protein 1
chr12:88819949-88819962+0.8994.5331.000.3320.830NM_001682-245974 ATPase, Ca++ transporting, plasma membrane 1 (ATP2B1),
chrX:48699796-48699809+0.8934.4891.810.3310.830NM_01760241 hypothetical protein DKFZp761A052 (DKFZp761A052),
chr7:5538793-5538806+0.8994.5351.170.3310.830NM_001101-2046 actin, beta (ACTB), mRNA.
chr14:87673200-87673213-0.8934.4841.360.3310.830NM_003608132051 G protein-coupled receptor 65 (GPR65), mRNA.
chr4:85059635-85059648-0.8964.5121.260.3310.830NM_032717383058 hypothetical protein MGC11324 (MGC11324), mRNA.
chr5:123945869-123945882+0.8924.4771.110.3310.830NM_020747162835-
chr14:87478587-87478600+0.8984.5311.050.3300.830NM_00015351073 galactosylceramidase (Krabbe disease) (GALC), mRNA.
chr1:159396117-159396130-0.8944.4961.300.3290.830NM_012475339 ubiquitin specific protease 21 (USP21), transcript
chr1:196259196-196259209-0.8924.4761.360.3290.830NM_020204106156 LIM homeobox 9 (LHX9), mRNA.
chr11:121177273-121177286-0.8994.5351.070.3290.830NM_001001786314860 BRCC2 mRNA (BRCC2), mRNA.
chr17:52926782-52926795-0.8914.4671.410.3280.830NM_170721237509 musashi homolog 2 (Drosophila) (MSI2), transcript
chr20:45410804-45410817-0.8934.4841.000.3280.830NM_0124088077 protein kinase C binding protein 1 (PRKCBP1),
chr17:56828665-56828678+0.8994.5371.020.3280.830NM_005994-3274 T-box 2 (TBX2), mRNA.
chr2:218574872-218574885+0.8964.5071.090.3270.830NM_022648-57866 tensin (TNS), mRNA.
chr6:151301434-151301447-0.8924.4761.120.3270.830NM_01544073150 formyltetrahydrofolate synthetase domain containing 1
chr5:53917032-53917045-0.8994.5371.050.3270.830NM_05287067592 sorting nexin associated golgi protein 1 (SNAG1),
chr1:72523547-72523560-0.8934.4841.220.3270.830NM_173808-2682 neuronal growth regulator 1 (NEGR1), mRNA.
chr9:35783832-35783845-0.8914.4731.060.3260.830NM_0039951526 natriuretic peptide receptor B/guanylate cyclase B
chr16:48291510-48291523-0.8944.4971.380.3260.830NM_015069126909 zinc finger protein 423 (ZNF423), mRNA.
chr15:82297152-82297165-0.8994.5331.100.3260.830NM_207517183410 ADAMTS-like 3 (ADAMTSL3), mRNA.
chr12:120483539-120483552+0.8934.4881.280.3250.830NM_00100536619208-
chr18:5532987-5533000+0.8944.4931.000.3250.830NM_012307999 erythrocyte membrane protein band 4.1-like 3
chrX:39263181-39263194+0.8914.4721.040.3250.830NM_017745578419 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chrX:111976416-111976429+0.8984.5241.230.3240.830NM_133265-5717 angiomotin (AMOT), mRNA.
chr5:176851162-176851175+0.8964.5131.070.3230.830NM_0054516046 PDZ and LIM domain 7 (enigma) (PDLIM7), transcript
chr19:60749476-60749489+0.8934.4871.130.3230.830NM_15260034547 zinc finger protein 579 (ZNF579), mRNA.
chr18:28605734-28605747-0.8984.5251.130.3220.830NM_0208051238-
chr20:15588084-15588097+0.8944.4951.100.3220.830NM_001033087462680-
chr17:34136598-34136611+0.8954.5011.010.3210.830NM_00593721299 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr10:7609149-7609162+0.8924.4761.130.3210.830NM_03281792471 inter-alpha (globulin) inhibitor H5 (ITIH5),
chr16:28181047-28181060+0.8974.5231.100.3200.830NM_001024401-30194-
chr9:100180118-100180131+0.8944.4951.220.3200.830NM_018421-122382-
chr10:33631158-33631171+0.8974.5231.330.3200.830NM_00102462932298-
chr19:37424421-37424434+0.8934.4891.060.3200.830NM_014910-103872-
chr2:27047695-27047708-0.8964.5071.070.3190.830NM_012326766 microtubule-associated protein, RP/EB family, member 3
chr2:68880979-68880992+0.8964.5111.070.3190.830NM_01488225642-
chrX:53266964-53266977+0.9004.5431.420.3190.830NM_0041874365 Jumonji, AT rich interactive domain 1C (RBP2-like)
chr5:58143365-58143378+0.8974.5231.160.3190.830NM_138453228769 RAB3C, member RAS oncogene family (RAB3C), mRNA.
chr8:21576852-21576865-0.9004.5451.090.3190.830NM_001495125440 GDNF family receptor alpha 2 (GFRA2), mRNA.
chr19:11297054-11297067-0.8924.4801.170.3180.830NM_00428314267 RAB3D, member RAS oncogene family (RAB3D), mRNA.
chr16:20121384-20121397+0.8994.5331.150.3180.830NM_001007240124952-
chr8:75168952-75168965-0.8974.5231.100.3180.830NM_015364102908 lymphocyte antigen 96 (LY96), mRNA.
chr1:87679990-87680003-0.8994.5371.130.3180.830NM_006769113351 LIM domain only 4 (LMO4), mRNA.
chr17:38975893-38975906-0.8934.4841.950.3170.830NM_0019862938 ets variant gene 4 (E1A enhancer binding protein,
chr10:29226527-29226540-0.9004.5451.270.3170.830NM_012342220197 BMP and activin membrane-bound inhibitor homolog
chr4:149638046-149638059+0.8964.5111.660.3170.830NM_000901-55073 nuclear receptor subfamily 3, group C, member 2
chr1:35810601-35810614-0.8934.4841.000.3160.830NM_178548-857 adaptor-related protein complex 2, epsilon subunit
chr2:27338063-27338076+0.8924.4801.710.3140.830NM_0034591401 solute carrier family 30 (zinc transporter), member 3
chr1:119572329-119572342-0.8974.5231.250.3140.830NM_201263-87511 tryptophanyl tRNA synthetase 2 (mitochondrial)
chr16:80177229-80177242-0.8954.5051.010.3140.830NM_03062990874 c-Maf-inducing protein (CMIP), transcript variant
chr5:138748260-138748273+0.8964.5121.210.3130.830NM_152685-1360 solute carrier family 23 (nucleobase transporters),
chr11:62355353-62355366+0.8944.4921.430.3130.830NM_003164783 syntaxin 5A (STX5A), mRNA.
chr16:15858460-15858473-0.8974.5201.270.3130.830NM_001040113-72-
chr16:55965921-55965934-0.8924.4791.550.3110.830NM_0029962106 chemokine (C-X3-C motif) ligand 1 (CX3CL1), mRNA.
chr7:5561368-5561381+0.8994.5351.010.3110.830NM_001101-24621 actin, beta (ACTB), mRNA.
chr17:37502819-37502832+0.8914.4711.080.3110.830NM_02411915458 likely ortholog of mouse D11lgp2 (LGP2), mRNA.
chr11:27155457-27155470+0.9004.5431.250.3110.830NM_003986136472 butyrobetaine (gamma), 2-oxoglutarate dioxygenase
chr12:114792786-114792799-0.8984.5251.050.3110.830NM_015335406740 thyroid hormone receptor associated protein 2
chr16:56610675-56610688+0.8954.5011.100.3100.830NM_002428-6008 matrix metalloproteinase 15 (membrane-inserted)
chr11:60943880-60943893+0.8944.4921.310.3100.830NM_0248119969 pre-mRNA cleavage factor I, 59 kDa subunit (FLJ12529),
chr10:22758996-22759009-0.8974.5201.180.3090.830NM_17224284691 sperm associated antigen 6 (SPAG6), transcript variant
chr10:99327478-99327491-0.8994.5371.080.3080.830NM_0203495332 ankyrin repeat domain 2 (stretch responsive muscle)
chr1:26475485-26475498-0.8934.4841.070.3080.830NM_031286-3215 SH3 domain binding glutamic acid-rich protein like 3
chr1:26117334-26117347-0.8934.4881.220.3080.830NM_203399-11379 stathmin 1/oncoprotein 18 (STMN1), transcript variant
chr8:11584603-11584616+0.8954.5051.280.3080.830NM_002052-14459 GATA binding protein 4 (GATA4), mRNA.
chr3:48601025-48601038+0.8944.4971.320.3070.830NM_0000946664 collagen, type VII, alpha 1 (epidermolysis bullosa,
chr6:39303129-39303142+0.8934.4831.080.3060.830NM_0037402100 potassium channel, subfamily K, member 5 (KCNK5),
chr8:9261024-9261037+0.9004.5431.010.3060.830NM_003747-189731 tankyrase, TRF1-interacting ankyrin-related ADP-ribose
chr5:79268505-79268518+0.8934.4881.070.3060.830NM_00101089154339-
chr3:10918082-10918095+0.8944.4921.330.3050.830NM_01422985265 solute carrier family 6 (neurotransmitter transporter,
chr6:10522452-10522465+0.8964.5071.060.3040.830NM_0032201004 transcription factor AP-2 alpha (activating enhancer
chr6:132823445-132823458+0.8934.4851.040.3040.830NM_00356952414 syntaxin 7 (STX7), mRNA.
chr6:37259064-37259077-0.8934.4841.120.3040.830NM_00264813200 pim-1 oncogene (PIM1), mRNA.
chr11:110755779-110755792+0.8934.4881.040.3040.830NM_006235-152 POU domain, class 2, associating factor 1 (POU2AF1),
chr6:105197744-105197757+0.8924.4761.060.3040.830NM_020771216743 HECT domain and ankyrin repeat containing, E3
chr22:49330988-49331001+0.8984.5271.170.3030.830NM_138433-2240 hypothetical protein BC009980 (MGC16635), mRNA.
chr16:29739353-29739366+0.8924.4761.180.3030.830NM_017458164 major vault protein (MVP), transcript variant 1, mRNA.
chr6:38230699-38230712-0.8994.5371.040.3030.830NM_021943335188 testis expressed sequence 27 (TEX27), mRNA.
chr11:131287466-131287479-0.8954.4991.350.3020.830NM_0165221644 neurotrimin (HNT), mRNA.
chr1:26612038-26612051+0.8924.4801.150.3010.830NM_0246742282 lin-28 homolog (C. elegans) (LIN28), mRNA.
chr3:44935336-44935349-0.9004.5411.130.3010.830NM_00324144305 transglutaminase 4 (prostate) (TGM4), mRNA.
chr4:15548023-15548036-0.9004.5451.180.3010.830NM_0051301046 fibroblast growth factor binding protein 1 (FGFBP1),
chr4:183139793-183139806-0.8994.5361.260.3010.830NM_001080477-342238-
chr19:50563929-50563942+0.9004.5451.210.3000.830NM_0004001740 excision repair cross-complementing rodent repair
chr5:67522395-67522408+0.8934.4841.350.3000.830NM_181523-35723 phosphoinositide-3-kinase, regulatory subunit,
chr17:74536219-74536232-0.8924.4761.060.2330.830NM_1985944473 C1q and tumor necrosis factor related protein 1
chr11:133103117-133103130+0.9004.5411.230.2330.830NM_174927117485 spergen-1 (SPAS1), mRNA.
chr5:79105853-79105866-0.8924.4761.060.2330.830NM_15361084538 cardiomyopathy associated 5 (CMYA5), mRNA.
chr2:171976132-171976145-0.8974.5201.080.2320.830NM_02477022733 hypothetical protein FLJ13984 (FLJ13984), mRNA.
chr5:145993485-145993498-0.8914.4731.000.2310.830NM_194251-117616 G protein-coupled receptor 151 (GPR151), mRNA.
chr10:122270392-122270405-0.8974.5201.200.2310.830NM_00103005964036-
chr16:14303570-14303583-0.8924.4801.000.2300.830NM_014048230973 MKL/myocardin-like 2 (MKL2), mRNA.
chr1:119343607-119343620+0.9004.5451.030.2280.830NM_152380-9905-
chr12:19138739-19138752-0.8994.5331.230.2270.830NM_019012-35156 pleckstrin homology domain containing, family A member
chr3:73813217-73813230+0.9004.5411.070.2270.830NM_015009-56455-
chr12:56136993-56137006+0.8944.4951.210.2250.830NM_0314791730 inhibin, beta E (INHBE), mRNA.
chr17:43302109-43302122-0.8964.5071.000.2250.830NM_199262-13870 Sp6 transcription factor (SP6), mRNA.
chr19:39679412-39679425-0.8924.4801.180.2250.830NM_00108043614792-
chr1:10680679-10680692-0.9004.5451.090.2240.830NM_00107984398615-
chr12:120745630-120745643+0.8934.4881.180.2230.830NM_019034-29653 ras homolog gene family, member F (in filopodia)
chr6:44638836-44638849-0.8924.4761.060.2230.830NM_001253175656 CDC5 cell division cycle 5-like (S. pombe) (CDC5L),
chrX:19951848-19951861+0.8964.5111.750.2220.830NM_198279-53545 chromosome X open reading frame 23 (CXorf23), mRNA.
chr3:174601035-174601048+0.8994.5371.180.2220.830NM_0149322197 neuroligin 1 (NLGN1), mRNA.
chr6:150429021-150429034-0.9004.5411.020.2210.830NM_0245182874 UL16 binding protein 3 (ULBP3), mRNA.
chr6:136778327-136778340+0.8914.4721.100.2210.830NM_001077441-125645-
chr2:202611632-202611645+0.8934.4841.030.2210.830NM_0035074177 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chrX:68646170-68646183+0.8944.4951.250.2200.830NM_0156864467 transmembrane protein 28 (TMEM28), mRNA.
chr11:34029476-34029489+0.8934.4851.000.2200.830NM_005898-230 membrane component, chromosome 11, surface marker 1
chr22:36759565-36759578-0.8994.5371.130.2190.830NM_001039583-23543-
chr21:18317468-18317481-0.9004.5451.030.2190.830NM_017447-204955 chromosome 21 open reading frame 91 (C21orf91), mRNA.
chr9:109223890-109223903+0.8964.5071.090.2180.830NM_00423567686 Kruppel-like factor 4 (gut) (KLF4), mRNA.
chr14:72151994-72152007+0.8914.4671.200.2180.830NM_012074278568 D4, zinc and double PHD fingers, family 3 (DPF3),
chr22:36759566-36759579-0.8934.4841.130.2160.830NM_001039583-23542-
chr2:100086405-100086418-0.8924.4801.100.2160.830NM_0010251082072-
chr9:131526193-131526206+0.8944.4971.120.2140.830NM_00487828972 prostaglandin E synthase (PTGES), transcript variant
chr10:115795679-115795692-0.8924.4761.270.2140.830NM_0006841983 adrenergic, beta-1-, receptor (ADRB1), mRNA.
chr11:43472208-43472221+0.8914.4671.230.2140.830NM_018259135241 tetratricopeptide repeat domain 17 (TTC17), mRNA.
chr11:56765728-56765741+0.9004.5411.010.2130.830NM_005161-4239 angiotensin II receptor-like 1 (AGTRL1), mRNA.
chr14:60159401-60159414+0.8934.4841.360.2130.830NM_00598226532 sine oculis homeobox homolog 1 (Drosophila) (SIX1),
chr2:50156797-50156810-0.8914.4671.010.2120.830NM_138735271601 neurexin 1 (NRXN1), transcript variant beta, mRNA.
chr16:19032535-19032548-0.8944.4931.060.2110.830NM_001034841-148-
chr8:101541256-101541269-0.8974.5231.170.2110.830NM_19840199932 hypothetical protein LOC157567 (LOC157567), mRNA.
chr2:4581746-4581759-0.8964.5071.020.2110.830NM_018436898185 allantoicase (ALLC), transcript variant 1, mRNA.
chr3:71361960-71361973-0.8954.5011.040.2110.830NM_032682353870 forkhead box P1 (FOXP1), mRNA.
chr17:9027061-9027074-0.9004.5411.010.2100.830NM_004822161577 netrin 1 (NTN1), mRNA.
chr17:8889112-8889125-0.8954.4991.110.2100.830NM_00482223628 netrin 1 (NTN1), mRNA.
chr22:31523394-31523407-0.8944.4971.180.2060.830NM_000362-3308 tissue inhibitor of metalloproteinase 3 (Sorsby fundus
chr2:74519081-74519094+0.8934.4841.060.2050.830NM_0010150562137-
chr1:201539709-201539722-0.8924.4761.020.2050.830NM_006763-1478 BTG family, member 2 (BTG2), mRNA.
chr16:64321155-64321168+0.8954.5051.240.2050.830NM_001797-607735 cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11),
chr11:115307139-115307152+0.8934.4881.080.2050.830NM_014333-426688 immunoglobulin superfamily, member 4 (IGSF4), mRNA.
chr1:166469508-166469521-0.8934.4851.050.2030.830NM_1993447738 hypothetical protein LOC375035 (LOC375035), mRNA.
chr16:51671905-51671918+0.8954.5011.150.2030.830NM_02513425559 chromodomain helicase DNA binding protein 9 (CHD9),
chr20:22095001-22095014+0.8924.4751.230.2030.830NM_021784418100 forkhead box A2 (FOXA2), transcript variant 1, mRNA.
chr10:129962263-129962276+0.8994.5331.150.2020.830NM_002417-147618 antigen identified by monoclonal antibody Ki-67
chr1:63764550-63764563+0.8954.4991.070.1960.831NM_0324372794-
chr2:16511531-16511544+0.8924.4761.110.1960.831NM_030797199046 family with sequence similarity 49, member A (FAM49A),
chr11:46915077-46915090-0.8994.5371.370.1950.831NM_001003678350 MGC4707 protein (MGC4707), transcript variant 4, mRNA.
chrX:10411610-10411623+0.9004.5431.060.1940.831NM_000381137064 midline 1 (Opitz/BBB syndrome) (MID1), transcript
chr10:102969136-102969149+0.8944.4961.010.1900.831NM_0065629571 transcription factor similar to D. melanogaster
chr11:13277630-13277643-0.8944.4971.010.1900.831NM_00117821829 aryl hydrocarbon receptor nuclear translocator-like
chr1:18612692-18612705+0.8984.5271.190.1890.831NM_152375-67219 hypothetical protein FLJ38753 (FLJ38753), mRNA.
chr7:41535222-41535235+0.8954.5031.080.1890.831NM_002192174009 inhibin, beta A (activin A, activin AB alpha
chr3:141257123-141257136-0.8914.4671.020.1870.831NM_022131120326 calsyntenin 2 (CLSTN2), mRNA.
chr3:126240990-126241003+0.8964.5071.020.1850.831NM_02073316502-
chr5:55271291-55271304-0.8964.5121.000.1820.831NM_00218455229 interleukin 6 signal transducer (gp130, oncostatin M
chr15:62281477-62281490-0.8934.4841.120.1790.831NM_000942-39070 peptidylprolyl isomerase B (cyclophilin B) (PPIB),
chr20:53976319-53976332+0.8994.5331.060.1780.831NM_08061737100 cerebellin 4 precursor (CBLN4), mRNA.
chr20:10522983-10522996-0.8934.4881.090.1750.831NM_00021479607 jagged 1 (Alagille syndrome) (JAG1), mRNA.
chr5:60659787-60659800-0.8974.5231.180.1750.831NM_001048249-165728-
chr11:62163370-62163383+0.8954.5011.330.1740.831NM_1983357310 glucosidase, alpha; neutral AB (GANAB), mRNA.
chr6:144538802-144538815+0.8994.5371.000.1740.831NM_00376425540 syntaxin 11 (STX11), mRNA.
chr20:1921199-1921212+0.8914.4681.030.1730.831NM_0244111503 prodynorphin (PDYN), mRNA.
chr11:71578712-71578725-0.8974.5231.100.1700.831NM_016730-94 folate receptor 1 (adult) (FOLR1), transcript variant
chr19:55002008-55002021-0.8914.4721.090.1690.831NM_0251296272 hypothetical protein FLJ22688 (FLJ22688), mRNA.
chr1:10661060-10661073-0.9264.7591.710.9320.833NM_001079843118234-
chrX:19216269-19216282+0.9264.7591.620.9300.833NM_000284-55603 pyruvate dehydrogenase (lipoamide) alpha 1 (PDHA1),
chr19:50710389-50710402-0.9304.7901.490.9250.833NM_0033707961 vasodilator-stimulated phosphoprotein (VASP), mRNA.
chr7:40101771-40101784-0.9304.7902.190.9200.833NM_13870138970 chromosome 7 open reading frame 11 (C7orf11), mRNA.
chr3:183809494-183809507+0.9264.7591.830.9180.833NM_014616-184391-
chr16:9931234-9931247+0.9304.7911.820.9170.833NM_000833252878 glutamate receptor, ionotropic, N-methyl D-aspartate
chr17:35009260-35009273+0.9264.7592.050.9150.833NM_0061608441 neurogenic differentiation 2 (NEUROD2), mRNA.
chr17:1848071-1848084+0.9264.7591.700.9120.833NM_17856826857 reticulon 4 receptor-like 1 (RTN4RL1), mRNA.
chr15:80125329-80125342-0.9294.7821.610.9100.833NM_03224687 ring finger and KH domain containing 3 (RKHD3), mRNA.
chr2:79594368-79594381-0.9264.7591.300.9100.833NM_004389834 catenin (cadherin-associated protein), alpha 2
chr3:190860-190873-0.9294.7832.090.9060.833NM_006614-22690 cell adhesion molecule with homology to L1CAM (close
chr5:176806987-176807000-0.9264.7591.970.9050.833NM_030567685 hypothetical protein MGC10772 (MGC10772), mRNA.
chr1:155139016-155139029-0.8974.5191.460.4320.834NM_0010804718969-
chr6:33529240-33529253+0.8934.4881.370.4320.834NM_152735-994 zinc finger and BTB domain containing 9 (ZBTB9), mRNA.
chr8:96074285-96074298+0.8954.5031.480.4320.834NM_152416-32012 hypothetical protein MGC40214 (MGC40214), mRNA.
chr2:222800930-222800943-0.8924.4761.450.4320.834NM_153038-70080 hypothetical protein FLJ32447 (FLJ32447), mRNA.
chr20:22431783-22431796-0.9004.5411.480.4320.834NM_02178481318 forkhead box A2 (FOXA2), transcript variant 1, mRNA.
chr19:45430211-45430224+0.8984.5271.510.4310.834NM_024877-5807 hypothetical protein FLJ13265 (FLJ13265), mRNA.
chr7:30792204-30792217-0.8944.4931.670.4300.834NM_03222214746 hypothetical protein FLJ22374 (FLJ22374), mRNA.
chr15:29453385-29453398-0.8984.5271.150.4300.834NM_01599547110 Kruppel-like factor 13 (KLF13), mRNA.
chr6:124815771-124815784-0.8924.4761.410.4290.834NM_152553-530342 IBR domain containing 1 (IBRDC1), mRNA.
chr7:114353794-114353807+0.8924.4801.020.4290.834NM_1990724449 I-mfa domain-containing protein (HIC), mRNA.
chr1:38034234-38034247-0.8954.5031.240.4280.834NM_152496587 hypothetical protein FLJ31434 (FLJ31434), mRNA.
chr1:44199308-44199321-0.8954.5051.410.4280.834NM_001039589-8832-
chr12:109457383-109457396+0.8994.5351.450.4280.834NM_15244233000 RAD9 homolog B (S. cerevisiae) (RAD9B), mRNA.
chr4:153590287-153590300+0.9004.5441.270.4280.834NM_001013415-67173-
chr16:52103057-52103070+0.8974.5201.120.4270.834NM_022476-8386 fused toes homolog (mouse) (FTS), mRNA.
chrX:134306187-134306200+0.8974.5231.520.4260.834NM_152695-100 zinc finger protein 449 (ZNF449), mRNA.
chr19:50979855-50979868+0.8994.5361.040.4250.834NM_001081560-2200-
chr19:44354951-44354964-0.8954.5031.300.4240.834NM_001001414-24393 similar to F-box only protein 2 (LOC342897), mRNA.
chr3:115960852-115960865-0.8934.4871.660.4240.834NM_015642387965 zinc finger and BTB domain containing 20 (ZBTB20),
chr2:80463476-80463489-0.8924.4761.470.4240.834NM_178839-78478 leucine rich repeat transmembrane neuronal 1 (LRRTM1),
chr1:1848046-1848059-0.8944.4971.140.4230.834NM_0010038081182 hypothetical protein LOC339457 (LOC339457), mRNA.
chr16:65072281-65072294+0.9004.5411.620.4230.834NM_00461469535 thymidine kinase 2, mitochondrial (TK2), mRNA.
chr10:75199270-75199283-0.8994.5371.330.4220.834NM_173540-2685 fucosyltransferase 11 (alpha (1,3) fucosyltransferase)
chr8:72797394-72797407+0.8934.4851.020.4220.834NM_005098121891 musculin (activated B-cell factor-1) (MSC), mRNA.
chr17:1580280-1580293-0.9004.5451.220.4210.834NM_000934-12500 serine (or cysteine) proteinase inhibitor, clade F
chr3:14487111-14487124-0.9004.5411.400.4210.834NM_00304368101 solute carrier family 6 (neurotransmitter transporter,
chr7:112505814-112505827+0.8934.4891.210.4210.834NM_0189709255 G protein-coupled receptor 85 (GPR85), mRNA.
chr15:91388924-91388937-0.8954.5011.020.4210.834NM_02021144513 RGM domain family, member A (RGMA), mRNA.
chrX:17993439-17993452-0.8954.4991.480.4210.834NM_153346155485 chromosome X open reading frame 20 (CXorf20), mRNA.
chr12:109996854-109996867-0.8924.4771.610.4210.834NM_01526740742-
chr4:13514873-13514886-0.8964.5071.990.4210.834NM_148894-276447 family with sequence similarity 44, member A (FAM44A),
chrX:122923015-122923028-0.8994.5371.360.4200.834NM_001042751-122-
chr11:76576321-76576334-0.8934.4891.190.4190.834NM_00026059457 myosin VIIA (Usher syndrome 1B (autosomal recessive,
chr14:102263374-102263387+0.8984.5271.280.4190.834NM_003300-50095 TNF receptor-associated factor 3 (TRAF3), transcript
chr17:35114713-35114726-0.8964.5091.060.4180.834NM_0044485033 v-erb-b2 erythroblastic leukemia viral oncogene
chr6:155534744-155534757-0.8964.5111.020.4180.834NM_001010927-44945-
chrX:82651618-82651631-0.8994.5351.430.4180.834NM_0003071777 POU domain, class 3, transcription factor 4 (POU3F4),
chr1:48090372-48090385+0.8924.4801.330.4180.834NM_001011547-370519-
chr19:60863188-60863201-0.9004.5451.220.4170.834NM_0072796060 U2 (RNU2) small nuclear RNA auxiliary factor 2
chr3:48439646-48439659+0.9004.5451.050.4160.834NM_0026732100 plexin B1 (PLXNB1), mRNA.
chr14:73703509-73703522+0.8924.4761.900.4160.834NM_182894-72319 ceh-10 homeo domain containing homolog (C. elegans)
chr20:605173-605186-0.8924.4761.790.4160.834NM_033129-350 scratch homolog 2, zinc finger protein (Drosophila)
chr1:18936414-18936427+0.8914.4671.270.4160.834NM_013945106427 paired box gene 7 (PAX7), transcript variant 2, mRNA.
chr6:71874346-71874359+0.8924.4751.250.4160.834NM_080742-150837 beta-1,3-glucuronyltransferase 2
chr20:54588801-54588814-0.8934.4841.190.4150.834NM_00101364647192-
chr1:26818167-26818180+0.8994.5351.050.4150.834NM_00100666573337-
chr15:70399947-70399960-0.8924.4791.050.4130.834NM_052840-368 bruno-like 6, RNA binding protein (Drosophila)
chr1:41674186-41674199-0.8954.5031.020.4130.834NM_00195648698 endothelin 2 (EDN2), mRNA.
chr7:41875864-41875877-0.8944.4971.680.4130.834NM_002192-166633 inhibin, beta A (activin A, activin AB alpha
chrX:71094663-71094676-0.8954.5011.100.4120.834NM_001024455173813-
chr5:14199293-14199306-0.8964.5071.100.4120.834NM_0071182564 triple functional domain (PTPRF interacting) (TRIO),
chr7:138416001-138416014+0.8924.4761.140.4110.834NM_02011929004 zinc finger CCCH type, antiviral 1 (ZC3HAV1),
chrX:118695838-118695851+0.8964.5091.190.4110.834NM_14580015523 septin 6 (SEPT6), transcript variant III, mRNA.
chr9:78631756-78631769+0.8924.4801.270.4110.834NM_13881879067 chromosome 9 open reading frame 65 (C9orf65), mRNA.
chr6:32713117-32713130-0.8974.5161.210.4100.834NM_00212256 major histocompatibility complex, class II, DQ alpha 1
chr7:156500497-156500510+0.8934.4851.050.4100.834NM_005515-4389 homeo box HB9 (HLXB9), mRNA.
chr11:16748042-16748055+0.8934.4851.060.4100.834NM_01426731372 small acidic protein (SMAP), mRNA.
chr6:12136114-12136127-0.8954.4991.050.4100.834NM_00211415504 human immunodeficiency virus type I enhancer binding
chr22:26709291-26709304-0.8914.4722.090.4100.834NM_012399-64036 phosphatidylinositol transfer protein, beta (PITPNB),
chr2:176722347-176722360+0.8984.5291.850.4090.834NM_014621-1912 homeo box D4 (HOXD4), mRNA.
chr5:138746757-138746770+0.8984.5271.030.4090.834NM_005847143 solute carrier family 23 (nucleobase transporters),
chr4:39376608-39376621-0.9004.5451.180.4090.834NM_005339442 huntingtin interacting protein 2 (HIP2), mRNA.
chr11:20029532-20029545-0.8924.4751.490.4080.834NM_001029865108914-
chr16:2750048-2750061-0.8944.4971.410.4070.834NM_0163337817 serine/arginine repetitive matrix 2 (SRRM2), mRNA.
chr15:72704231-72704244-0.8934.4841.190.4070.834NM_00399216565 CDC-like kinase 3 (CLK3), transcript variant phclk3,
chr2:152634213-152634226+0.8914.4671.010.4070.834NM_00100574629252-
chr18:3382184-3382197-0.9004.5451.270.4070.834NM_174886-19788 TGFB-induced factor (TALE family homeobox) (TGIF),
chr3:41216559-41216572-0.8994.5351.190.4070.834NM_001098209713-
chr12:88612311-88612324+0.8924.4761.080.4070.834NM_001682-38336 ATPase, Ca++ transporting, plasma membrane 1 (ATP2B1),
chr17:43976857-43976870+0.8954.5011.250.4060.834NM_002145535 homeo box B2 (HOXB2), mRNA.
chr17:44642821-44642834-0.8994.5371.400.4060.834NM_016428333 ABI gene family, member 3 (ABI3), mRNA.
chr17:39313427-39313440+0.8964.5081.520.4060.834NM_00537427212 membrane protein, palmitoylated 2 (MAGUK p55 subfamily
chr3:195304745-195304758-0.8964.5071.140.4060.834NM_005524-31783 hairy and enhancer of split 1, (Drosophila) (HES1),
chr11:15285902-15285915-0.8974.5201.010.4060.834NM_001042536192942-
chr19:11455331-11455344-0.8994.5351.450.4050.834NM_032281-2528 ELAV (embryonic lethal, abnormal vision,
chr2:233030486-233030499+0.8934.4891.370.4050.834NM_0016311477 alkaline phosphatase, intestinal (ALPI), mRNA.
chr19:38997048-38997061-0.8964.5151.360.4050.834NM_02407617541 potassium channel tetramerisation domain containing 15
chrX:41680832-41680845-0.8994.5371.080.4050.834NM_003688-13620 calcium/calmodulin-dependent serine protein kinase
chr19:9800398-9800411-0.8924.4801.140.4040.834NM_024292930 ubiquitin-like 5 (UBL5), mRNA.
chr16:69064129-69064142-0.8974.5191.470.4040.834NM_14505918230 fucokinase (FUK), mRNA.
chr9:38049729-38049742+0.8934.4841.400.4040.834NM_0030289481 SHB (Src homology 2 domain containing) adaptor protein
chr11:14004294-14004307+0.8934.4841.110.4040.834NM_00610863904 spondin 1, extracellular matrix protein (SPON1), mRNA.
chr3:5233726-5233739-0.8974.5161.280.4040.834NM_01467429393 ER degradation enhancer, mannosidase alpha-like 1
chr2:220069017-220069030-0.8994.5321.080.4030.834NM_013335-2740 GDP-mannose pyrophosphorylase A (GMPPA), transcript
chr1:212269774-212269787-0.8934.4881.610.4030.834NM_00276341391 prospero-related homeobox 1 (PROX1), mRNA.
chr12:50872290-50872303-0.8934.4841.030.4020.834NM_182507-239 hypothetical protein LOC144501 (LOC144501), mRNA.
chr18:5285952-5285965-0.8994.5351.450.4020.834NM_003409-2639 zinc finger protein 161 homolog (mouse) (ZFP161),
chr9:123852169-123852182+0.8914.4671.320.4020.834NM_19425243537 chromosome 9 open reading frame 20 (C9orf20), mRNA.
chr5:11101366-11101379+0.8974.5161.520.4020.834NM_004394-286979 death-associated protein (DAP), mRNA.
chr2:60631566-60631579-0.8964.5072.100.4020.834NM_0180142571 B-cell CLL/lymphoma 11A (zinc finger protein)
chr11:71458644-71458657+0.8924.4761.470.4010.834NM_00618510577 nuclear mitotic apparatus protein 1 (NUMA1), mRNA.
chr21:32709898-32709911+0.8994.5321.070.4010.834NM_0581873375 chromosome 21 open reading frame 63 (C21orf63), mRNA.
chr7:108075597-108075610-0.8944.4951.420.4010.834NM_01232878105 DnaJ (Hsp40) homolog, subfamily B, member 9 (DNAJB9),
chr3:50189775-50189788-0.8924.4791.290.4000.834NM_000172-14172 guanine nucleotide binding protein (G protein), alpha
chr6:36831849-36831862+0.8984.5271.110.4000.834NM_07846777484 cyclin-dependent kinase inhibitor 1A (p21, Cip1)
chr22:20676481-20676494-0.8924.4801.330.4000.834NM_003935-9334 topoisomerase (DNA) III beta (TOP3B), mRNA.
chr17:7093299-7093312+0.8934.4831.220.2990.834NM_0153432684 dullard homolog (Xenopus laevis) (DULLARD), mRNA.
chr8:145032541-145032554-0.8994.5371.340.2990.834NM_031308-13119 epiplakin 1 (EPPK1), mRNA.
chr3:52845073-52845086-0.8964.5151.010.2990.834NM_205853-813 musculoskeletal, embryonic nuclear protein 1 (MUSTN1),
chr1:206056990-206057003-0.8914.4651.030.2990.834NM_17236165065 membrane cofactor protein (CD46,
chr11:113536205-113536218-0.8994.5371.280.2990.834NM_00101801199807-
chr11:46101141-46101154-0.8984.5271.150.2990.834NM_016621-1580 BRAF35/HDAC2 complex (80 kDa) (BHC80), mRNA.
chr8:61103129-61103142+0.8934.4851.160.2990.834NM_004056253379 carbonic anhydrase VIII (CA8), mRNA.
chr7:33509932-33509945-0.8954.5011.110.2980.834NM_198428374355 parathyroid hormone-responsive B1 gene (B1),
chr4:15548021-15548034-0.8924.4771.180.2970.834NM_0051301048 fibroblast growth factor binding protein 1 (FGFBP1),
chr11:19925510-19925523-0.8914.4711.200.2970.834NM_001029865212936-
chr8:117432465-117432478+0.8934.4881.370.2970.834NM_003756404778 eukaryotic translation initiation factor 3, subunit 3
chr13:79982588-79982601-0.8924.4761.400.2970.834NM_005842-169501 sprouty homolog 2 (Drosophila) (SPRY2), mRNA.
chr16:20854154-20854167+0.8964.5111.150.2960.834NM_02042434327 hypothetical protein A-211C6.1 (LOC57149), mRNA.
chr19:11297045-11297058-0.8954.5011.000.2950.834NM_00428314276 RAB3D, member RAS oncogene family (RAB3D), mRNA.
chr17:42388198-42388211+0.8914.4671.000.2950.834NM_20340023415 similar to candidate mediator of the p53-dependent G2
chr1:234702382-234702395-0.9004.5451.210.2950.834NM_201545-45706 lectin, galactoside-binding, soluble, 8 (galectin 8)
chr2:108932543-108932556-0.8924.4801.050.2950.834NM_02233639717 ectodysplasin A receptor (EDAR), mRNA.
chr9:140073298-140073311-0.8954.5051.030.2950.834NM_000718181336 calcium channel, voltage-dependent, L type, alpha 1B
chr19:14136087-14136100-0.8974.5211.000.2940.834NM_018154-27647 ASF1 anti-silencing function 1 homolog B (S.
chr6:32817102-32817115-0.8974.5161.170.2940.834NM_02005661 major histocompatibility complex, class II, DQ alpha 2
chr16:49151410-49151423-0.8914.4671.150.2940.834NM_03311911768 naked cuticle homolog 1 (Drosophila) (NKD1), mRNA.
chr12:120502646-120502659-0.8954.5011.150.2940.834NM_001005366101-
chr7:127398396-127398409+0.8944.4971.320.2930.834NM_014411-26302 nasopharyngeal carcinoma associated gene protein-8
chr10:29164816-29164829-0.8914.4671.090.2930.834NM_012342158486 BMP and activin membrane-bound inhibitor homolog
chr6:16913197-16913210+0.8964.5121.020.2930.834NM_000332-43497 ataxin 1 (ATXN1), mRNA.
chr2:173928637-173928650+0.8924.4801.000.2920.834NM_145810930 cell division cycle associated 7 (CDCA7), transcript
chr10:117823038-117823051-0.8974.5161.170.2920.834NM_145793198746 GDNF family receptor alpha 1 (GFRA1), transcript
chrX:128734690-128734703+0.8914.4681.290.2910.834NM_018990-6851 chromosome X open reading frame 9 (CXorf9), mRNA.
chr8:38909561-38909574-0.8974.5231.030.2910.834NM_02162331751-
chr1:22909032-22909045-0.8934.4881.320.2910.834NM_004442-786 EphB2 (EPHB2), transcript variant 2, mRNA.
chr3:43070347-43070360-0.8934.4871.140.2910.834NM_03280652222 hypothetical protein FLJ14566 (FLJ14566), mRNA.
chr10:115231328-115231341+0.8954.5001.130.2900.834NM_004132-71347 hyaluronan binding protein 2 (HABP2), mRNA.
chr11:74953037-74953050-0.8954.5011.020.2890.834NM_0012352319 serine (or cysteine) proteinase inhibitor, clade H
chr20:45420324-45420337+0.8984.5271.490.2890.834NM_183048-1443 protein kinase C binding protein 1 (PRKCBP1),
chr8:129288495-129288508-0.8944.4951.010.2890.834NM_002467471097 v-myc myelocytomatosis viral oncogene homolog (avian)
chr19:55046774-55046787-0.8924.4801.140.2870.834NM_017432646 prostate tumor overexpressed gene 1 (PTOV1), mRNA.
chr11:6389668-6389681+0.9004.5451.220.2870.834NM_0011647208 amyloid beta (A4) precursor protein-binding, family B,
chr20:34915784-34915797+0.9004.5451.040.2870.834NM_1991815906 FLJ44670 protein (FLJ44670), mRNA.
chr3:197643347-197643360-0.8914.4721.020.2870.834NM_015562395-
chr9:16859918-16859931+0.8994.5361.380.2870.834NM_017637868 basonuclin 2 (BNC2), mRNA.
chr19:568115-568128+0.8994.5371.100.2860.834NM_00503516453 polymerase (RNA) mitochondrial (DNA directed)
chr11:61469779-61469792-0.8954.5051.310.2850.834NM_004183-4529 vitelliform macular dystrophy (Best disease,
chr7:8155396-8155409+0.8914.4671.130.2850.834NM_022307112811 islet cell autoantigen 1, 69kDa (ICA1), transcript
chr14:23717044-23717057-0.8974.5171.290.2840.834NM_0051326070 REC8-like 1 (yeast) (REC8L1), mRNA.
chr10:75306191-75306204-0.8954.5011.320.2830.834NM_172170-1842 calcium/calmodulin-dependent protein kinase (CaM
chr5:77339750-77339763-0.8954.5011.190.2830.834NM_004607-231809 tubulin-specific chaperone a (TBCA), mRNA.
chrX:147884727-147884740-0.8984.5271.130.2830.834NM_002025494996 fragile X mental retardation 2 (FMR2), mRNA.
chr11:117390589-117390602+0.8934.4851.070.2820.834NM_00155828370 interleukin 10 receptor, alpha (IL10RA), mRNA.
chr6:32021612-32021625-0.8964.5071.030.2810.834NM_001710-40 B-factor, properdin (BF), mRNA.
chr1:9272713-9272726-0.8964.5071.320.2810.834NM_025106-2758 SPRY domain-containing SOCS box protein SSB-1 (SSB1),
chr12:3264693-3264706-0.8994.5371.060.2810.834NM_019854-205893 HMT1 hnRNP methyltransferase-like 4 (S. cerevisiae)
chr1:112579143-112579156+0.8914.4671.300.2810.834NM_018704-161140 hypothetical protein DKFZp547A023 (DKFZp547A023),
chrX:14824252-14824265+0.9004.5451.000.2810.834NM_15258122868 motile sperm domain containing 2 (MOSPD2), mRNA.
chr5:151301075-151301088-0.8944.4921.020.2810.834NM_000171-16479 glycine receptor, alpha 1 (startle
chr14:48623233-48623246+0.8934.4881.060.2810.834NM_001030001499611-
chrX:12957290-12957303-0.8964.5111.510.2800.834NM_17490115431 family with sequence similarity 9, member C (FAM9C),
chr20:638742-638755+0.8964.5091.130.2800.834NM_033129-33919 scratch homolog 2, zinc finger protein (Drosophila)
chr4:68212643-68212656+0.8994.5331.090.2800.834NM_01822736841 hypothetical protein FLJ10808 (FLJ10808), mRNA.
chr10:63341721-63341734+0.8934.4841.110.2800.834NM_03219910372-
chr11:65381042-65381055+0.8924.4801.070.2790.834NM_0055071338 cofilin 1 (non-muscle) (CFL1), mRNA.
chr6:33044652-33044665+0.8944.4931.050.2790.834NM_005104337 bromodomain containing 2 (BRD2), mRNA.
chr10:121107343-121107356-0.8954.5051.080.2790.834NM_005308150256 G protein-coupled receptor kinase 5 (GRK5), mRNA.
chr12:98164123-98164136+0.8964.5151.060.2790.834NM_181670-91520 E2a-Pbx1-associated protein (EB-1), transcript variant
chr2:201281476-201281489+0.8934.4831.160.2780.834NM_014670-103316 basic leucine zipper and W2 domains 1 (BZW1), mRNA.
chr15:89445441-89445454-0.8924.4751.240.2780.834NM_018668-78604 vacuolar protein sorting 33B (yeast) (VPS33B), mRNA.
chr8:22609010-22609023-0.8944.4931.190.2780.834NM_004430-2250 early growth response 3 (EGR3), mRNA.
chr7:137077522-137077535+0.8934.4851.270.2780.834NM_004717104627 diacylglycerol kinase, iota (DGKI), mRNA.
chr2:175241626-175241639+0.8994.5391.050.2770.834NM_00107726914247-
chr1:41560241-41560254+0.9004.5411.310.2770.834NM_012236-79866 sex comb on midleg homolog 1 (Drosophila) (SCMH1),
chr10:80608443-80608456+0.8984.5271.140.2770.834NM_02033816667 retinoic acid induced 17 (RAI17), mRNA.
chr16:27324513-27324526+0.8954.5051.200.2760.834NM_1810792689 interleukin 21 receptor (IL21R), transcript variant 3,
chr13:19665111-19665124+0.8944.4961.660.2760.834NM_0040043 gap junction protein, beta 2, 26kDa (connexin 26)
chr1:165890995-165891008+0.8964.5151.060.2760.834NM_05286225141 protein kinase substrate MK2S4 (MK2S4), mRNA.
chr10:98813647-98813660+0.8934.4891.310.2760.834NM_01565282716 chromosome 10 open reading frame 12 (C10orf12), mRNA.
chr15:37805192-37805205+0.8974.5161.140.2750.834NM_15259757139 fibrous sheath interacting protein 1 (FSIP1), mRNA.
chr2:231555290-231555303-0.8954.5011.140.2740.834NM_005683-57105 G protein-coupled receptor 55 (GPR55), mRNA.
chr5:94471537-94471550+0.8994.5391.140.2740.834NM_001002796-28595 multiple C2-domains with two transmembrane regions 1
chr17:45511364-45511377-0.8924.4791.280.2730.834NM_002611-16231 pyruvate dehydrogenase kinase, isoenzyme 2 (PDK2),
chr15:87205112-87205125-0.8914.4681.150.2730.834NM_17823234662 hyaluronan and proteoglycan link protein 3 (HAPLN3),
chr9:123500964-123500977-0.8994.5371.440.2730.834NM_138709-43821 DAB2 interacting protein (DAB2IP), mRNA.
chr5:106744647-106744660-0.8994.5351.050.2730.834NM_001962289848 ephrin-A5 (EFNA5), mRNA.
chr22:36776563-36776576-0.8934.4881.330.2720.834NM_001039583-6545-
chr11:72125347-72125360+0.8994.5371.160.2710.834NM_001040118-9526-
chr3:187377463-187377476-0.8934.4841.250.2710.834NM_004454-67892 ets variant gene 5 (ets-related molecule) (ETV5),
chr6:120214174-120214187+0.8934.4881.100.2710.834NM_005907-501549 mannosidase, alpha, class 1A, member 1 (MAN1A1), mRNA.
chr12:118672876-118672889+0.8924.4761.290.2700.834NM_00625382832 protein kinase, AMP-activated, beta 1 non-catalytic
chr4:24461569-24461582-0.8934.4841.170.2700.834NM_00310255486 superoxide dismutase 3, extracellular (SOD3), mRNA.
chr7:108075592-108075605-0.9004.5431.030.2700.834NM_01232878100 DnaJ (Hsp40) homolog, subfamily B, member 9 (DNAJB9),
chr9:3564838-3564851-0.9004.5411.110.2700.834NM_002919-48855 regulatory factor X, 3 (influences HLA class II
chr7:96450230-96450243-0.8964.5111.450.2690.834NM_005222-22896-
chr1:118666501-118666514+0.8914.4681.050.2690.834NM_206996-137144 projection protein PF6 (PF6), mRNA.
chr15:39018367-39018380+0.8924.4761.250.2680.834NM_0190749628 delta-like 4 (Drosophila) (DLL4), mRNA.
chr7:72957187-72957200+0.8934.4881.270.2680.834NM_18250443862 Williams-Beuren syndrome critical region 28 (WBSCR28),
chr9:112383862-112383875+0.8924.4761.400.2670.834NM_153366-1881-
chr17:32249907-32249920+0.8984.5271.070.2670.834NM_005568-118605 LIM homeobox 1 (LHX1), mRNA.
chr17:7288876-7288889+0.8924.4801.230.3660.835NM_000747-154 cholinergic receptor, nicotinic, beta polypeptide 1
chr4:75998737-75998750+0.8924.4761.120.3660.835NM_001729-59884 betacellulin (BTC), mRNA.
chr1:53480900-53480913-0.8924.4761.160.3660.835NM_002370-4105 mago-nashi homolog, proliferation-associated
chr2:152909801-152909814-0.8964.5111.540.3660.835NM_0529059904 formin-like 2 (FMNL2), transcript variant 2, mRNA.
chr7:98222981-98222994+0.8944.4951.130.3650.835NM_15291382592 hypothetical protein DKFZp761L1417 (DKFZp761L1417),
chr20:38708905-38708918+0.8914.4711.100.3650.835NM_00546142385 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr2:73176769-73176782+0.8934.4881.190.3640.835NM_01547016885 RAB11 family interacting protein 5 (class I)
chr8:19000846-19000859+0.8964.5121.780.3640.835NM_015310-85370 pleckstrin and Sec7 domain containing 3 (PSD3),
chr9:111588934-111588947-0.9004.5451.180.3640.835NM_0072036624 PALM2-AKAP2 protein (PALM2-AKAP2), transcript variant
chr16:50242767-50242780-0.8954.5051.030.3640.835NM_002968-500083 sal-like 1 (Drosophila) (SALL1), mRNA.
chr14:81226778-81226791-0.8924.4761.220.3640.835NM_005065-156892 sel-1 suppressor of lin-12-like (C. elegans) (SEL1L),
chr9:34333909-34333922+0.8954.5011.200.3630.835NM_14717314505 nudix (nucleoside diphosphate linked moiety X)-type
chr11:12510275-12510288+0.8934.4881.000.3630.835NM_021961-142170 TEA domain family member 1 (SV40 transcriptional
chr15:75500603-75500616-0.8954.5031.250.3630.835NM_018200405 high-mobility group 20A (HMG20A), mRNA.
chr12:28911240-28911253+0.8974.5231.190.3630.835NM_018099-356525 male sterility domain containing 1 (MLSTD1), mRNA.
chrX:119380168-119380181-0.8934.4841.240.3620.835NM_012069273 ATPase, (Na+)/K+ transporting, beta 4 polypeptide
chr1:23075359-23075372+0.9004.5451.310.3620.835NM_015013-143074 amine oxidase (flavin containing) domain 2 (AOF2),
chr16:66035861-66035874+0.8944.4931.030.3610.835NM_00019613424 hydroxysteroid (11-beta) dehydrogenase 2 (HSD11B2),
chr12:53099522-53099535-0.8924.4751.230.3610.835NM_002205-205 integrin, alpha 5 (fibronectin receptor, alpha
chr1:34404086-34404099-0.8944.4931.140.3600.835NM_052896-56 CUB and Sushi multiple domains 2 (CSMD2), mRNA.
chr5:174803457-174803470-0.8954.5011.260.3600.835NM_000794312 dopamine receptor D1 (DRD1), mRNA.
chr5:76953416-76953429+0.8994.5391.250.3590.835NM_03210916862 orthopedia homolog (Drosophila) (OTP), mRNA.
chr12:98889296-98889309+0.8934.4881.480.3590.835NM_15278813267 E2a-Pbx1-associated protein (EB-1), transcript variant
chr12:88016747-88016760+0.8934.4851.030.3590.835NM_001946253680 dual specificity phosphatase 6 (DUSP6), transcript
chr15:35180059-35180072-0.8944.4931.640.3580.835NM_170677-63 Meis1, myeloid ecotropic viral integration site 1
chr14:69379018-69379031+0.8924.4811.060.3580.835NM_001034852-36778-
chr2:27026488-27026501+0.8914.4671.490.3580.835NM_012326-20441 microtubule-associated protein, RP/EB family, member 3
chr5:76953417-76953430+0.8974.5201.250.3580.835NM_03210916861 orthopedia homolog (Drosophila) (OTP), mRNA.
chr12:115304211-115304224+0.8934.4841.030.3580.835NM_015335-104685 thyroid hormone receptor associated protein 2
chrX:69591044-69591057-0.8964.5111.290.3580.835NM_0207302258-
chrX:111954861-111954874+0.8994.5371.640.3570.835NM_13326515838 angiomotin (AMOT), mRNA.
chr12:102726997-102727010+0.8964.5121.220.3570.835NM_01657531917 TU12B1-TY protein (TU12B1-TY), mRNA.
chr2:220202482-220202495-0.8934.4841.030.3570.835NM_0050701634 solute carrier family 4, anion exchanger, member 3
chr14:98669872-98669885-0.8944.4931.110.3560.835NM_022898137703 B-cell CLL/lymphoma 11B (zinc finger protein)
chr12:29029554-29029567-0.8924.4761.210.3560.835NM_018099-238211 male sterility domain containing 1 (MLSTD1), mRNA.
chr13:65839267-65839280+0.8974.5161.220.3560.835NM_020403863197 protocadherin 9 (PCDH9), transcript variant 2, mRNA.
chrX:103416362-103416375+0.8944.4971.090.3550.835NM_153448-30118 extraembryonic, spermatogenesis, homeobox 1-like
chr3:189795163-189795176-0.8944.4971.050.3550.835NM_005578381848 LIM domain containing preferred translocation partner
chr12:48765715-48765728-0.8934.4841.090.3540.835NM_139071565 SWI/SNF related, matrix associated, actin dependent
chr15:39944722-39944735-0.8974.5171.240.3540.835NM_01664228845 spectrin, beta, non-erythrocytic 5 (SPTBN5), mRNA.
chr9:127508827-127508840+0.8964.5071.470.3540.835NM_001006617507-
chr12:5474991-5475004-0.8924.4761.480.3540.835NM_0025271564 neurotrophin 3 (NTF3), mRNA.
chr12:23143498-23143511-0.8974.5201.130.3540.835NM_018638474255 ethanolamine kinase 1 (ETNK1), mRNA.
chr2:177785863-177785876-0.8964.5091.270.3530.835NM_194247295 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr1:90009721-90009734+0.8924.4751.060.3530.835NM_018103-50280 leucine rich repeat containing 5 (LRRC5), mRNA.
chr3:43929097-43929110+0.8954.5031.140.3520.835NM_016006221818 abhydrolase domain containing 5 (ABHD5), mRNA.
chr11:4493290-4493303+0.8994.5321.110.3510.835NM_00100517126683 olfactory receptor, family 52, subfamily K, member 1
chr6:108990120-108990133-0.9004.5451.350.3500.835NM_0014551458 forkhead box O3A (FOXO3A), transcript variant 1, mRNA.
chr16:52767208-52767221+0.8994.5351.280.3500.835NM_024336110671 iroquois homeobox protein 3 (IRX3), mRNA.
chr4:110081870-110081883+0.8974.5231.300.3490.835NM_031279-178212 alanine-glyoxylate aminotransferase 2-like 1
chr2:99967578-99967591+0.8964.5091.290.3490.835NM_001025108120899-
chr5:139402015-139402028+0.8944.4931.360.3480.835NM_0048831048 neuregulin 2 (NRG2), transcript variant 1, mRNA.
chr11:65236911-65236924-0.8934.4841.210.3470.835NM_182710946 HIV-1 Tat interacting protein, 60kDa (HTATIP),
chr9:75911383-75911396-0.8924.4761.170.3470.835NM_006914-390589 RAR-related orphan receptor B (RORB), mRNA.
chr7:99605414-99605427+0.8984.5271.070.3460.835NM_024637-1105 galactose-3-O-sulfotransferase 4 (GAL3ST4), mRNA.
chr17:223101-223114+0.8934.4851.270.3460.835NM_006987-20525 rabphilin 3A-like (without C2 domains) (RPH3AL), mRNA.
chr20:31727575-31727588+0.8934.4871.430.3450.835NM_031232-1650 amyloid beta (A4) precursor protein-binding, family A,
chr12:25947608-25947621+0.8974.5231.030.3450.835NM_007211-55528 chromosome 12 open reading frame 2 (C12orf2), mRNA.
chr12:131706849-131706862-0.8984.5251.320.3440.835NM_1748731473 purinergic receptor P2X, ligand-gated ion channel, 2
chr5:133127279-133127292+0.8974.5201.230.3440.835NM_015082-151157-
chr2:8537305-8537318+0.8964.5151.110.3440.835NM_002166-202159 inhibitor of DNA binding 2, dominant negative
chr1:109834741-109834754-0.8924.4761.260.3430.835NM_182580-3404 cytochrome b-561 domain containing 1 (CYB561D1), mRNA.
chr14:76635056-76635069-0.8934.4841.050.3430.835NM_033426825 KIAA1737 (KIAA1737), mRNA.
chr16:66024047-66024060-0.8964.5071.100.3430.835NM_0001961610 hydroxysteroid (11-beta) dehydrogenase 2 (HSD11B2),
chr9:116836546-116836559+0.8974.5161.190.3430.835NM_00216083761 tenascin C (hexabrachion) (TNC), mRNA.
chr18:36486577-36486590-0.8924.4801.200.3430.835NM_002647-1302520 phosphoinositide-3-kinase, class 3 (PIK3C3), mRNA.
chr20:33608494-33608507-0.8944.4951.260.3420.835NM_19839815402 serologically defined breast cancer antigen 84
chr20:45431388-45431401+0.8934.4851.030.3420.835NM_183048-12507 protein kinase C binding protein 1 (PRKCBP1),
chr8:119272163-119272176+0.8974.5201.420.3420.835NM_000127-78924 exostoses (multiple) 1 (EXT1), mRNA.
chr10:105168044-105168057-0.8934.4881.180.3410.835NM_01497621742-
chr17:52761928-52761941-0.8924.4801.160.3410.835NM_17072172655 musashi homolog 2 (Drosophila) (MSI2), transcript
chr5:159654205-159654218+0.8934.4851.380.3400.835NM_02456517946 hypothetical protein FLJ14166 (FLJ14166), mRNA.
chr5:141150077-141150090-0.8974.5201.120.3400.835NM_03242088051 protocadherin 1 (cadherin-like 1) (PCDH1), transcript
chr3:38832928-38832941-0.8994.5351.470.3400.835NM_006514-22423 sodium channel, voltage-gated, type X, alpha (SCN10A),
chr12:90964131-90964144+0.8944.4971.290.3390.835NM_00173199620 B-cell translocation gene 1, anti-proliferative
chr17:2222018-2222031-0.8984.5291.220.3380.835NM_02031028990 MAX binding protein (MNT), mRNA.
chrX:49030995-49031008-0.8974.5201.330.3370.835NM_001098413-15974-
chr17:2222019-2222032-0.8974.5161.220.3370.835NM_02031028989 MAX binding protein (MNT), mRNA.
chr19:37600906-37600919+0.8934.4881.580.3370.835NM_20732512135 hypothetical protein LOC147991 (LOC147991), mRNA.
chr2:6697643-6697656+0.8914.4671.210.3370.835NM_207315225744 hypothetical protein LOC129607 (LOC129607), mRNA.
chr12:29488007-29488020+0.8944.4921.060.3360.835NM_18337853879 ovochymase 1 (OVCH1), mRNA.
chr6:129508469-129508482-0.8994.5371.200.3360.835NM_001079823262590-
chr22:26492011-26492024+0.9004.5471.040.3360.835NM_00243035475 meningioma (disrupted in balanced translocation) 1
chr11:6414827-6414840-0.8964.5151.010.3350.835NM_0006133942 hemopexin (HPX), mRNA.
chr6:143920291-143920304-0.8994.5371.240.3340.835NM_032020-45735 fucosidase, alpha-L- 2, plasma (FUCA2), mRNA.
chr14:74061057-74061070+0.8974.5171.050.3340.835NM_19427930936 HESB like domain containing 1 (HBLD1), mRNA.
chr17:32143578-32143591-0.8994.5361.170.3340.835NM_024864111540 hypothetical protein FLJ22578 (FLJ22578), mRNA.
chr13:33007889-33007902-0.8994.5331.370.3340.835NM_178006-250011 START domain containing 13 (STARD13), transcript
chr8:89459846-89459859-0.8914.4681.420.3340.835NM_022564-51013 matrix metalloproteinase 16 (membrane-inserted)
chr3:185628735-185628748-0.8674.2721.010.2660.835NM_00374148280 chordin (CHRD), transcript variant 1, mRNA.
chr12:6943026-6943039-0.8704.2961.090.2650.835NM_0072737126 repressor of estrogen receptor activity (REA), mRNA.
chr19:7321038-7321051-0.8674.2681.170.2650.835NM_015318-30728 rho/rac guanine nucleotide exchange factor (GEF) 18
chr15:29316244-29316257+0.8664.2651.080.2650.835NM_015995-90031 Kruppel-like factor 13 (KLF13), mRNA.
chr4:113655008-113655021+0.8684.2781.080.2650.835NM_0240191769 neurogenin 2 (NEUROG2), mRNA.
chr20:56781157-56781170-0.8694.2831.150.2640.835NM_016592-66933 GNAS complex locus (GNAS), transcript variant 4, mRNA.
chr7:92301929-92301942-0.8674.2681.010.2640.835NM_001259-781 cyclin-dependent kinase 6 (CDK6), mRNA.
chr20:39074006-39074019-0.8674.2721.020.2630.835NM_003286-16770 topoisomerase (DNA) I (TOP1), mRNA.
chr11:74953038-74953051-0.8674.2741.020.2610.835NM_0012352320 serine (or cysteine) proteinase inhibitor, clade H
chr18:33279376-33279389-0.8664.2651.030.2610.835NM_020180120565 bruno-like 4, RNA binding protein (Drosophila)
chr8:76827795-76827808-0.8694.2831.210.2590.835NM_004133213137 hepatocyte nuclear factor 4, gamma (HNF4G), mRNA.
chr11:397035-397048+0.8664.2651.250.2570.835NM_02180510362 single Ig IL-1R-related molecule (SIGIRR), mRNA.
chr3:135632131-135632144+0.8694.2871.040.2570.835NM_001042383-55034-
chr2:119328044-119328057+0.8684.2761.520.2560.835NM_001426-5815 engrailed homolog 1 (EN1), mRNA.
chr1:98582658-98582671+0.8694.2841.600.2560.835NM_015976-317043 sorting nexin 7 (SNX7), transcript variant 1, mRNA.
chr17:7074884-7074897+0.8684.2801.050.2550.835NM_0044223703 dishevelled, dsh homolog 2 (Drosophila) (DVL2), mRNA.
chr1:149564926-149564939+0.8704.2911.320.2550.835NM_002651422 phosphatidylinositol 4-kinase, catalytic, beta
chr12:119291635-119291648+0.8674.2741.020.2550.835NM_002442-294 musashi homolog 1 (Drosophila) (MSI1), mRNA.
chr11:2235073-2235086-0.8674.2741.010.2550.835NM_00517013685 achaete-scute complex-like 2 (Drosophila) (ASCL2),
chr9:17896535-17896548-0.8684.2781.090.2550.835NM_003026327441 SH3-domain GRB2-like 2 (SH3GL2), mRNA.
chr3:130849650-130849663-0.8694.2841.670.2540.835NM_01500840122 KIAA0779 protein (KIAA0779), mRNA.
chr5:60659783-60659796-0.8704.2911.180.2540.835NM_001048249-165724-
chr8:119161076-119161089+0.8674.2741.020.2540.835NM_00012732163 exostoses (multiple) 1 (EXT1), mRNA.
chr16:64918644-64918657-0.8674.2681.080.2540.835NM_001795-39320 cadherin 5, type 2, VE-cadherin (vascular epithelium)
chr1:154480229-154480242+0.8684.2781.000.2530.835NM_1991731700 bone gamma-carboxyglutamate (gla) protein
chr14:36095350-36095363-0.8674.2681.040.2530.835NM_01436026187 NK2 transcription factor related, locus 8 (Drosophila)
chr16:73842457-73842470+0.8674.2721.160.2520.835NM_014567547 breast cancer anti-estrogen resistance 1 (BCAR1),
chr8:117499887-117499900+0.8704.2911.180.2520.835NM_003756337356 eukaryotic translation initiation factor 3, subunit 3
chr12:112560470-112560483-0.8674.2681.000.2510.835NM_022363-166210 LIM homeobox 5 (LHX5), mRNA.
chr4:148277184-148277197+0.8674.2741.700.2510.835NM_031956-190700 NYD-SP14 protein (NYD-SP14), mRNA.
chrX:39611093-39611106+0.8674.2741.180.2510.835NM_017745230507 BCL6 co-repressor (BCOR), transcript variant 1, mRNA.
chrX:48929618-48929631+0.8674.2741.360.2500.835NM_006150102 LIM domain only 6 (LMO6), mRNA.
chr12:55809482-55809495-0.8674.2741.050.2500.835NM_0023321033 low density lipoprotein-related protein 1
chr11:133343157-133343170+0.8674.2721.070.2500.835NM_014987-11067-
chr2:206441350-206441363+0.8694.2871.050.2500.835NM_201279185981 neuropilin 2 (NRP2), transcript variant 3, mRNA.
chr20:45417985-45417998+0.8674.2681.340.2500.835NM_012408896 protein kinase C binding protein 1 (PRKCBP1),
chrX:136479050-136479063-0.8664.2651.080.2500.835NM_0034133138 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr1:148173794-148173807+0.8704.2921.210.2490.835NM_1818731073 cisplatin resistance associated (CRA), mRNA.
chr19:54778374-54778387-0.8704.2911.160.2490.835NM_000951194 proline rich Gla (G-carboxyglutamic acid) 2 (PRRG2),
chr17:34871768-34871781-0.8694.2831.550.2490.835NM_01650750 CDC2-related protein kinase 7 (CRK7), mRNA.
chr4:76270612-76270625+0.8674.2701.130.2490.835NM_015393193390 DKFZP564O0823 protein (DKFZP564O0823), mRNA.
chr1:4094045-4094058+0.8674.2741.090.2490.835NM_207356-287336 hypothetical protein LOC339448 (LOC339448), mRNA.
chr11:125720745-125720758-0.8694.2831.060.2480.835NM_006278-10461 sialyltransferase 4C (beta-galactoside
chr2:17585885-17585898-0.8694.2871.080.2480.835NM_003385697 visinin-like 1 (VSNL1), mRNA.
chr17:11073012-11073025-0.8674.2741.070.2480.835NM_207386-12659 FLJ45455 protein (FLJ45455), mRNA.
chr3:135687304-135687317-0.8694.2881.150.2450.835NM_001042384139-
chr10:50119087-50119100-0.8684.2791.180.2450.835NM_199459-58006 chromosome 10 open reading frame 71 (C10orf71), mRNA.
chr2:119582507-119582520-0.8694.2871.490.2450.835NM_18252850428 complement component 1, q subcomponent-like 2 (C1QL2),
chr1:56307744-56307757-0.8684.2801.130.2450.835NM_003713510101 phosphatidic acid phosphatase type 2B (PPAP2B),
chr12:48441663-48441676-0.8674.2721.050.2440.835NM_00109857619904-
chr2:183410049-183410062+0.8674.2741.020.2440.835NM_00146329694 frizzled-related protein (FRZB), mRNA.
chr17:32134932-32134945-0.8664.2661.320.2440.835NM_024864102894 hypothetical protein FLJ22578 (FLJ22578), mRNA.
chr9:127872569-127872582-0.8674.2741.030.2440.835NM_001011703-256280-
chr2:165479357-165479370-0.8694.2871.260.2430.835NM_17351240924 hypothetical protein FLJ39822 (FLJ39822), mRNA.
chrX:37396801-37396814-0.8674.2671.020.2430.835NM_021083-33151 Kell blood group precursor (McLeod phenotype) (XK),
chr5:167579786-167579799+0.8674.2701.030.2430.835NM_015238-71784 KIBRA protein (KIBRA), mRNA.
chr2:65513535-65513548-0.8674.2741.330.2430.835NM_181784-721 sprouty-related, EVH1 domain containing 2 (SPRED2),
chr3:56197500-56197513+0.8674.2741.020.2420.835NM_015576279931 CAZ-associated structural protein (CAST), mRNA.
chrX:15784823-15784836-0.8664.2651.120.2410.835NM_003916-1802 adaptor-related protein complex 1, sigma 2 subunit
chr2:43014745-43014758-0.8704.2911.120.2410.835NM_012205-141526 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), mRNA.
chr1:109946222-109946235-0.8704.2961.360.2400.835NM_00527211006 guanine nucleotide binding protein (G protein), alpha
chr1:58280175-58280188+0.8704.2911.110.2390.835NM_00109373214592-
chr17:23701465-23701478+0.8694.2841.010.2380.835NM_152464-7249 chromosome 17 open reading frame 32 (C17orf32), mRNA.
chr10:104426102-104426115+0.8674.2741.000.2380.835NM_03091231960 tripartite motif-containing 8 (TRIM8), mRNA.
chr10:104426101-104426114+0.8674.2741.000.2380.835NM_03091231959 tripartite motif-containing 8 (TRIM8), mRNA.
chr3:53245736-53245749+0.8704.2911.000.2380.835NM_00106419262 transketolase (Wernicke-Korsakoff syndrome) (TKT),
chr6:118440863-118440876+0.8664.2651.150.2380.835NM_001029858105581-
chr20:44290596-44290609-0.8674.2741.050.2370.835NM_02124823145 cadherin-like 22 (CDH22), mRNA.
chr12:51559859-51559872+0.8674.2741.090.2360.835NM_00227325268 keratin 8 (KRT8), mRNA.
chr1:39452469-39452482-0.8664.2651.020.2350.835NM_033044-116828 microtubule-actin crosslinking factor 1 (MACF1),
chr10:32675334-32675347+0.8664.2651.460.2350.835NM_025209785 enhancer of polycomb homolog 1 (Drosophila) (EPC1),
chr7:34151335-34151348-0.8664.2651.230.2350.835NM_133468240387 BMP-binding endothelial regulator precursor protein
chr2:187059436-187059449+0.8674.2721.330.2340.835NM_018471406 likely ortholog of mouse immediate early response,
chr1:209799072-209799085+0.8974.5231.020.1300.835NM_02119419650 solute carrier family 30 (zinc transporter), member 1
chr14:22097766-22097779+0.8974.5161.120.1280.835NM_00134430203 defender against cell death 1 (DAD1), mRNA.
chr4:184662742-184662755+0.8964.5091.260.1240.835NM_001564-372 inhibitor of growth family, member 1-like (ING1L),
chr12:124076000-124076013+0.8924.4761.140.1140.835NM_08062631953 BRI3 binding protein (BRI3BP), mRNA.
chr2:204826620-204826633+0.8954.5031.030.1040.835NM_152526-292041 amyotrophic lateral sclerosis 2 (juvenile) chromosome
chr2:104545360-104545373+0.8944.4971.020.1660.836NM_006236-292941 POU domain, class 3, transcription factor 3 (POU3F3),
chr12:3968521-3968534-0.8914.4671.230.1630.836NM_020367-115658 poly (ADP-ribose) polymerase family, member 11
chr5:136911204-136911217+0.8944.4951.070.1600.836NM_004598-48287 sparc/osteonectin, cwcv and kazal-like domains
chr12:6005235-6005248+0.9004.5451.030.1570.836NM_020373-79576 transmembrane protein 16B (TMEM16B), mRNA.
chr5:124110541-124110554-0.8994.5321.060.1530.836NM_020747-1837-
chr1:17638076-17638089+0.8914.4671.000.1510.836NM_018715731 RCC1-like (TD-60), mRNA.
chr6:44548649-44548662-0.8994.5351.050.1460.836NM_00125385469 CDC5 cell division cycle 5-like (S. pombe) (CDC5L),
chr11:34253264-34253277+0.8924.4761.060.0950.836NM_14580482114 ankyrin repeat and BTB (POZ) domain containing 2
chr12:52016504-52016517-0.9114.6341.840.5660.837NM_152860-700 Sp7 transcription factor (SP7), mRNA.
chr1:16290664-16290677-0.9194.6981.070.5660.837NM_182623-17982 hypothetical protein FLJ36766 (FLJ36766), mRNA.
chr1:6081880-6081893+0.9144.6601.060.5650.837NM_17213073013 potassium voltage-gated channel, shaker-related
chr12:55810963-55810976+0.9134.6561.580.5650.837NM_0023322514 low density lipoprotein-related protein 1
chrX:67978140-67978153+0.9144.6621.560.5650.837NM_00442912684 ephrin-B1 (EFNB1), mRNA.
chr16:30952509-30952522-0.9114.6381.580.5640.837NM_004604205 syntaxin 4A (placental) (STX4A), mRNA.
chr8:130359866-130359879-0.9174.6861.350.5640.837NM_031415508450 melanoma-derived leucine zipper, extra-nuclear factor
chr20:38701815-38701828+0.9134.6501.420.5630.837NM_00546149475 v-maf musculoaponeurotic fibrosarcoma oncogene homolog
chr4:158112011-158112024+0.9144.6621.070.5590.837NM_016205-15 platelet derived growth factor C (PDGFC), mRNA.
chr11:60869642-60869655-0.9194.6981.630.5580.837NM_001923-12400 damage-specific DNA binding protein 1, 127kDa (DDB1),
chr1:158298675-158298688-0.9174.6851.280.5570.837NM_0022417910 potassium inwardly-rectifying channel, subfamily J,
chr15:68354134-68354147+0.9144.6601.270.5570.837NM_005078-177922 transducin-like enhancer of split 3 (E(sp1) homolog,
chr6:14022933-14022946+0.9174.6881.920.5560.837NM_152737-10149 hypothetical protein MGC33993 (MGC33993), mRNA.
chr1:114487959-114487972+0.9194.6981.120.5560.837NM_20584810036 synaptotagmin VI (SYT6), mRNA.
chrX:68067364-68067377-0.9204.7131.090.5560.837NM_004429101908 ephrin-B1 (EFNB1), mRNA.
chr14:77844053-77844066+0.9134.6501.330.5540.837NM_004796-95693 neurexin 3 (NRXN3), transcript variant alpha, mRNA.
chr1:37955284-37955297+0.9184.6901.550.5530.837NM_01810124638 cell division cycle associated 8 (CDCA8), mRNA.
chr1:58443587-58443600+0.9154.6691.800.5500.837NM_02108045212 disabled homolog 1 (Drosophila) (DAB1), mRNA.
chr7:25604040-25604053+0.9154.6651.280.5500.837NM_022150-369410 chromosome 7 open reading frame 9 (C7orf9), mRNA.
chrX:117759818-117759831-0.9134.6521.110.5490.837NM_00156014331 interleukin 13 receptor, alpha 1 (IL13RA1), mRNA.
chr10:102399394-102399407-0.9184.6901.370.5490.837NM_003988-95964 paired box gene 2 (PAX2), transcript variant c, mRNA.
chr20:57308818-57308831+0.9204.7131.100.5490.837NM_20703424 endothelin 3 (EDN3), transcript variant 4, mRNA.
chr10:99538905-99538918-0.9204.7131.100.5480.837NM_003015-17145 secreted frizzled-related protein 5 (SFRP5), mRNA.
chr11:124437908-124437921-0.9134.6521.250.5480.837NM_198277-434 solute carrier family 37 (glycerol-3-phosphate
chr7:27119187-27119200+0.9134.6501.060.5470.837NM_153632954 homeo box A3 (HOXA3), transcript variant 3, mRNA.
chr17:36997978-36997991+0.9204.7131.590.5450.837NM_000526-1305 keratin 14 (epidermolysis bullosa simplex,
chr16:23624856-23624869-0.9174.6851.520.5450.837NM_0332667466 ER to nucleus signalling 2 (ERN2), mRNA.
chr1:17787322-17787335-0.9144.6601.210.5450.837NM_0010117227787-
chrX:127937392-127937405+0.9194.7051.580.5450.837NM_003069547730 SWI/SNF related, matrix associated, actin dependent
chr10:120957146-120957159-0.9144.6621.000.5440.837NM_00530859 G protein-coupled receptor kinase 5 (GRK5), mRNA.
chr12:113591342-113591355-0.9144.6621.430.5420.837NM_00599615010 T-box 3 (ulnar mammary syndrome) (TBX3), transcript
chr16:48272614-48272627-0.9114.6331.240.5420.837NM_015069145805 zinc finger protein 423 (ZNF423), mRNA.
chr10:73678602-73678615-0.9204.7131.480.5410.837NM_019058-24981 DNA-damage-inducible transcript 4 (DDIT4), mRNA.
chr6:44336396-44336409+0.9164.6741.420.5400.837NM_178148-3146 solute carrier family 35, member B2 (SLC35B2), mRNA.
chr17:69124325-69124338-0.9124.6441.020.5380.837NM_019064-178517 sidekick homolog 2 (chicken) (SDK2), mRNA.
chrX:109195477-109195490-0.9184.6901.250.5380.837NM_03222762559 hypothetical protein FLJ22679 (FLJ22679), mRNA.
chr6:46027598-46027611+0.9134.6561.310.5380.837NM_01692963955 chloride intracellular channel 5 (CLIC5), mRNA.
chr1:27756114-27756127+0.9204.7131.160.5370.837NM_00102988246616-
chrX:123535392-123535405-0.9134.6561.660.5370.837NM_002351227661 SH2 domain protein 1A, Duncan's disease
chr19:6163422-6163435+0.9144.6601.080.5360.837NM_00593467537 myeloid/lymphoid or mixed-lineage leukemia (trithorax
chr3:115518912-115518925+0.9114.6342.110.5360.837NM_17379923447 hypothetical protein FLJ39873 (FLJ39873), mRNA.
chr1:25744122-25744135-0.9144.6621.200.5340.837NM_0156271559 LDL receptor adaptor protein (ARH), mRNA.
chr17:67693771-67693784+0.9114.6371.310.5340.837NM_00034665115 SRY (sex determining region Y)-box 9 (campomelic
chr18:33370184-33370197-0.8674.2681.270.2330.837NM_02018029757 bruno-like 4, RNA binding protein (Drosophila)
chr10:33663634-33663647-0.8664.2651.010.2320.837NM_001024628-58-
chr2:177422146-177422159+0.8674.2681.240.2320.837NM_194247-363422 heterogeneous nuclear ribonucleoprotein A3 (HNRPA3),
chr2:104400584-104400597-0.8674.2701.320.2320.837NM_006236-437717 POU domain, class 3, transcription factor 3 (POU3F3),
chr14:74072137-74072150-0.8694.2831.250.2310.837NM_19427942016 HESB like domain containing 1 (HBLD1), mRNA.
chr1:61680176-61680189+0.8674.2741.170.2310.837NM_032027283507 beta-amyloid binding protein precursor (BBP), mRNA.
chr10:84201246-84201259-0.8704.2911.020.2310.837NM_001010848576269-
chr15:41715372-41715385-0.8664.2651.130.2300.837NM_05402012959 cation channel, sperm associated 2 (CATSPER2),
chr14:23680109-23680122-0.8674.2681.180.2290.837NM_016049528 chromosome 14 open reading frame 122 (C14orf122),
chr1:151638546-151638559-0.8664.2651.040.2290.837NM_002964-8373 S100 calcium binding protein A8 (calgranulin A)
chr22:49255423-49255436+0.8684.2761.070.2290.837NM_0029724897 SET binding factor 1 (SBF1), transcript variant 1,
chr4:146786296-146786309-0.8674.2681.130.2270.837NM_1722506719 methylmalonic aciduria (cobalamin deficiency) type A
chr6:43445299-43445312+0.8664.2661.190.2270.837NM_014345-140 zinc finger protein 318 (ZNF318), mRNA.
chr3:158955519-158955532+0.8694.2871.710.2270.837NM_001099777211759-
chr10:104156869-104156882+0.8664.2651.020.2260.837NM_00250211547 nuclear factor of kappa light polypeptide gene
chrX:118711259-118711272+0.8704.2951.170.2260.837NM_145800102 septin 6 (SEPT6), transcript variant III, mRNA.
chr7:43119443-43119456+0.8664.2651.030.2260.837NM_015052820 NEDD4-like ubiquitin-protein ligase 1 (NEDL1), mRNA.
chr1:18901715-18901728+0.8694.2871.020.2250.837NM_01394571728 paired box gene 7 (PAX7), transcript variant 2, mRNA.
chr20:34164910-34164923-0.8664.2651.280.2240.837NM_1779961248 erythrocyte membrane protein band 4.1-like 1
chr6:36307264-36307277-0.8694.2901.330.2230.837NM_173676-11559 patatin-like phospholipase domain containing 1
chr2:39605599-39605612-0.8664.2651.130.2210.837NM_003618-87876 mitogen-activated protein kinase kinase kinase kinase
chr12:3148656-3148669-0.8664.2651.190.2210.837NM_00667591938 transmembrane 4 superfamily member tetraspan NET-5
chr13:45101546-45101559-0.8704.2921.220.2190.837NM_152719-72801 testis-specific leucine zipper protein nurit (NURIT),
chr3:24846066-24846079-0.8664.2651.210.2190.837NM_000461-334749 thyroid hormone receptor, beta (erythroblastic
chr15:86031566-86031579-0.8704.2911.270.2190.837NM_001012338569099-
chr5:142046052-142046065+0.8684.2781.340.2170.837NM_033137-240 fibroblast growth factor 1 (acidic) (FGF1), transcript
chr2:45136720-45136733+0.8674.2741.200.2170.837NM_016932-46694 sine oculis homeobox homolog 2 (Drosophila) (SIX2),
chr2:229316265-229316278+0.8694.2831.070.2170.837NM_017933527960 hypothetical protein FLJ20701 (FLJ20701), mRNA.
chr1:152039824-152039837-0.8694.2831.100.2160.837NM_02433025532 solute carrier family 27 (fatty acid transporter),
chr17:39190809-39190822+0.8664.2661.020.2140.837NM_025237873 sclerosteosis (SOST), mRNA.
chr19:56563986-56563999+0.8664.2651.170.2130.837NM_15235383 hypothetical protein MGC33839 (MGC33839), mRNA.
chr7:137212806-137212819-0.8664.2651.050.2130.837NM_004717-30657 diacylglycerol kinase, iota (DGKI), mRNA.
chr22:36476287-36476300-0.8664.2651.030.2120.837NM_0070324200 Tara-like protein (HRIHFB2122), transcript variant 1,
chr1:35163290-35163303+0.8674.2741.280.2110.837NM_001080418-19719-
chr5:59416820-59416833-0.8674.2701.080.2110.837NM_006203-498788 phosphodiesterase 4D, cAMP-specific (phosphodiesterase
chr1:149411352-149411365+0.8704.2911.010.2100.837NM_0133533698 tropomodulin 4 (muscle) (TMOD4), mRNA.
chr11:19555835-19555848-0.8694.2831.210.2100.837NM_145117-135553 neuron navigator 2 (NAV2), transcript variant 2, mRNA.
chr1:18977827-18977840-0.8664.2651.010.2090.837NM_15223280915 taste receptor, type 1, member 2 (TAS1R2), mRNA.
chr1:196337626-196337639-0.8664.2651.020.2090.837NM_133494-130579 NIMA (never in mitosis gene a)-related kinase 7
chr6:22634924-22634937+0.8684.2801.550.2090.837NM_138574-42633 PWWP domain containing 1 (PWWP1), mRNA.
chr18:53251919-53251932-0.8674.2741.090.2070.837NM_004852-1896 one cut domain, family member 2 (ONECUT2), mRNA.
chr17:63253011-63253024+0.8684.2791.180.2070.837NM_182641869 fetal Alzheimer antigen (FALZ), transcript variant 1,
chr5:139401975-139401988+0.8664.2651.010.2060.837NM_0048831088 neuregulin 2 (NRG2), transcript variant 1, mRNA.
chr2:174069896-174069909+0.8674.2741.120.2060.837NM_145810142189 cell division cycle associated 7 (CDCA7), transcript
chr8:91126436-91126449-0.8704.2911.080.2050.837NM_00492937847 calbindin 1, 28kDa (CALB1), mRNA.
chr18:44114202-44114215+0.8694.2881.020.2050.837NM_014772-205123 KIAA0427 (KIAA0427), mRNA.
chr11:57122232-57122245-0.8674.2681.270.2040.837NM_00103229551-
chrX:132542162-132542175-0.8664.2651.080.2030.837NM_001448-165291 glypican 4 (GPC4), mRNA.
chr17:32320299-32320312+0.8694.2831.350.2020.837NM_005568-48213 LIM homeobox 1 (LHX1), mRNA.
chr2:106492466-106492479-0.8674.2711.070.2020.837NM_025076-315239 UDP-glucuronate decarboxylase 1 (UXS1), mRNA.
chr1:153548551-153548564-0.8694.2831.300.2000.837NM_0020042450 farnesyl diphosphate synthase (farnesyl pyrophosphate
chr3:49852119-49852132+0.8694.2831.100.2000.837NM_00587916877 TRAF interacting protein (TRIP), mRNA.
chr1:163833436-163833449+0.8674.2701.040.2000.837NM_004528-33538 microsomal glutathione S-transferase 3 (MGST3), mRNA.
chr12:112397733-112397746-0.8664.2651.030.2000.837NM_022363-3473 LIM homeobox 5 (LHX5), mRNA.
chr6:41788552-41788565+0.8824.3951.110.2660.838NM_00716222224 transcription factor EB (TFEB), mRNA.
chr1:19107432-19107445-0.8834.4021.290.2660.838NM_170726-5773 aldehyde dehydrogenase 4 family, member A1 (ALDH4A1),
chr6:120214173-120214186+0.8834.4061.100.2660.838NM_005907-501548 mannosidase, alpha, class 1A, member 1 (MAN1A1), mRNA.
chrX:128731287-128731300-0.8854.4231.140.2650.838NM_018990-10254 chromosome X open reading frame 9 (CXorf9), mRNA.
chr1:32969335-32969348-0.8864.4311.150.2650.838NM_020888-10664-
chr17:21223695-21223708-0.8884.4481.220.2650.838NM_0210123503 potassium inwardly-rectifying channel, subfamily J,
chr1:243797452-243797465+0.8874.4361.010.2650.838NM_018012412642-
chr7:27225722-27225735-0.8874.4401.160.2640.838NM_000522-19472 homeo box A13 (HOXA13), mRNA.
chr3:172556377-172556390+0.8824.3981.170.2640.838NM_015028104169-
chr2:206301607-206301620-0.8894.4531.020.2640.838NM_20127946238 neuropilin 2 (NRP2), transcript variant 3, mRNA.
chr14:26137656-26137669-0.8864.4311.140.2640.838NM_006491-856 neuro-oncological ventral antigen 1 (NOVA1),
chr9:130950082-130950095-0.8874.4391.150.2630.838NM_20343430279 immediate early response 5-like (IER5L), mRNA.
chr12:13758350-13758363+0.8834.4061.700.2630.838NM_000834265969 glutamate receptor, ionotropic, N-methyl D-aspartate
chr3:65556523-65556536-0.8824.3981.020.2630.838NM_001033057443026-
chr2:176748779-176748792-0.8854.4231.270.2620.838NM_00689811828 homeo box D3 (HOXD3), mRNA.
chr15:40076265-40076278-0.8814.3871.170.2620.838NM_00108049013472-
chr13:77377332-77377345-0.8864.4251.050.2620.838NM_00399113603 endothelin receptor type B (EDNRB), transcript variant
chr7:69717395-69717408-0.8814.3871.200.2620.838NM_022479-518230 Williams-Beuren syndrome chromosome region 17
chr8:60194948-60194961+0.8844.4081.150.2620.838NM_014729-627 thymus high mobility group box protein TOX (TOX),
chr10:93090641-93090654-0.8874.4361.110.2610.838NM_173497-69340 HECT domain containing 2 (HECTD2), transcript variant
chr1:114479576-114479589+0.8844.4081.090.2610.838NM_20584818419 synaptotagmin VI (SYT6), mRNA.
chr17:61328565-61328578-0.8844.4141.350.2610.838NM_001037325-75502-
chr2:200044326-200044339+0.8864.4271.030.2610.838NM_015265-10880 SATB family member 2 (SATB2), mRNA.
chr7:27126860-27126873-0.8874.4361.230.2600.838NM_030661-1121 homeo box A3 (HOXA3), transcript variant 1, mRNA.
chr14:23727363-23727376+0.8884.4481.120.2600.838NM_024658601 importin 4 (IPO4), mRNA.
chr9:35610054-35610067-0.8834.4061.060.2600.838NM_001782-1646 CD72 antigen (CD72), mRNA.
chr10:89567591-89567604+0.8864.4241.030.2600.838NM_032810306 ATPase family, AAA domain containing 1 (ATAD1), mRNA.
chr11:31771278-31771291+0.8864.4311.140.2600.838NM_00028018156 paired box gene 6 (aniridia, keratitis) (PAX6), mRNA.
chr1:158090813-158090826+0.8824.3941.280.2590.838NM_0010136618258-
chr22:37566669-37566682-0.8874.4331.020.2590.838NM_0142933294 neuronal pentraxin receptor (NPTXR), transcript
chr9:569194-569207+0.8834.4021.060.2590.838NM_01515874591 ankyrin repeat domain 15 (ANKRD15), transcript variant
chr1:64814101-64814114+0.8874.4391.140.2590.838NM_020925105137 KIAA1573 protein (KIAA1573), mRNA.
chr11:119296462-119296475-0.8854.4231.570.2590.838NM_002855-191817 poliovirus receptor-related 1 (herpesvirus entry
chr10:95060150-95060163+0.8834.4061.000.2590.838NM_013451171879 fer-1-like 3, myoferlin (C. elegans) (FER1L3),
chr6:14539910-14539923-0.8864.4311.170.2590.838NM_004233314166 CD83 antigen (activated B lymphocytes, immunoglobulin
chr14:23060915-23060928-0.8814.3881.520.2580.838NM_024328-34056-
chr12:75501790-75501803-0.8844.4111.170.2580.838NM_020841-24070 oxysterol binding protein-like 8 (OSBPL8), transcript
chr7:29292584-29292597-0.8864.4311.230.2580.838NM_00406792038 chimerin (chimaerin) 2 (CHN2), mRNA.
chr11:31789868-31789881+0.8864.4311.190.2580.838NM_001604-413 paired box gene 6 (aniridia, keratitis) (PAX6), mRNA.
chr3:68142963-68142976-0.8894.4491.150.2580.838NM_2136096919 TAFA1 protein (TAFA1), mRNA.
chr16:10169854-10169867+0.8854.4161.050.2580.838NM_00083314258 glutamate receptor, ionotropic, N-methyl D-aspartate
chr20:35588763-35588776+0.8844.4111.050.2570.838NM_006698954 bladder cancer associated protein (BLCAP), mRNA.
chr19:47451619-47451632+0.8904.4591.190.2570.838NM_006494-506 Ets2 repressor factor (ERF), mRNA.
chr5:149930362-149930375-0.8874.4401.060.2570.838NM_00154349839 N-deacetylase/N-sulfotransferase (heparan
chr2:28419041-28419054+0.8824.3961.060.2570.838NM_005253-50142 FOS-like antigen 2 (FOSL2), mRNA.
chr14:49028094-49028107+0.8814.3871.080.2570.838NM_00103000194750-
chr17:43486963-43486976-0.8824.3951.970.2560.838NM_0032046318 nuclear factor (erythroid-derived 2)-like 1 (NFE2L1),
chr3:190535310-190535323+0.8834.4071.230.2560.838NM_198485162953 FLJ41238 protein (FLJ41238), mRNA.
chr10:114567595-114567608-0.8874.4321.000.2560.838NM_030756-132506 transcription factor 7-like 2 (T-cell specific,
chrX:136456697-136456710+0.8844.4081.080.2560.838NM_003413-19215 Zic family member 3 heterotaxy 1 (odd-paired homolog,
chr20:12656944-12656957+0.8814.3881.010.2560.838NM_018327-280583 chromosome 20 open reading frame 38 (C20orf38), mRNA.
chr1:200127940-200127953-0.8874.4391.010.2550.838NM_1981493385 chromosome 1 open reading frame 40 (C1orf40), mRNA.
chr2:64708061-64708074+0.8854.4201.450.2550.838NM_01475526489-
chr12:67748948-67748961+0.8844.4081.310.2550.838NM_001874-105661 carboxypeptidase M (CPM), transcript variant 1, mRNA.
chr9:109268352-109268365+0.8874.4321.080.2550.838NM_00423523224 Kruppel-like factor 4 (gut) (KLF4), mRNA.
chr7:86432397-86432410+0.8874.4321.140.2550.838NM_15274875070 hypothetical protein FLJ31340 (FLJ31340), mRNA.
chr17:24918294-24918307+0.8834.4041.080.2540.838NM_198147-120 hypothetical protein LOC116236 (LOC116236), mRNA.
chr1:154177393-154177406+0.8844.4121.130.2540.838NM_181885-611 G protein-coupled receptor 100 (GPR100), mRNA.
chr11:64200011-64200024+0.8834.4021.180.2540.838NM_138734-32648 neurexin 2 (NRXN2), transcript variant beta, mRNA.
chr22:16230250-16230263-0.8884.4481.030.2540.838NM_031413-106278-
chr16:54658520-54658533+0.8864.4311.060.2540.838NM_138736-125029 guanine nucleotide binding protein (G protein), alpha
chr22:26516666-26516679-0.8814.3871.120.2540.838NM_00243010820 meningioma (disrupted in balanced translocation) 1
chr2:202540207-202540220-0.8834.4061.180.2530.838NM_003507-67248 frizzled homolog 7 (Drosophila) (FZD7), mRNA.
chr15:77362115-77362128+0.8824.3981.640.2530.838NM_007364-28331 chromosome 15 open reading frame 22 (C15orf22), mRNA.
chr20:3670629-3670642-0.8854.4231.180.2520.838NM_0529709373 heat shock 70kD protein 12B (HSPA12B), mRNA.
chr5:61134194-61134207-0.8884.4481.030.2520.838NM_173667164901 hypothetical protein FLJ37543 (FLJ37543), mRNA.
chr2:85894186-85894199+0.8864.4271.030.2510.838NM_00104243754118-
chr2:172151098-172151111+0.8864.4311.060.2510.838NM_02484363965 cytochrome b reductase 1 (CYBRD1), mRNA.
chr6:111911143-111911156-0.8904.4591.280.2510.838NM_002912-36 REV3-like, catalytic subunit of DNA polymerase zeta
chr3:181149178-181149191+0.8874.4401.030.2510.838NM_01655988033 peroxisomal biogenesis factor 5-like (PEX5L), mRNA.
chr18:71729745-71729758-0.8834.4061.040.2510.838NM_001037331-461168-
chr15:51827580-51827593-0.8824.3961.240.2510.838NM_18275811571 hypothetical protein FLJ38736 (FLJ38736), mRNA.
chr1:148498801-148498814+0.8834.4061.250.2500.838NM_0121132059 carbonic anhydrase XIV (CA14), mRNA.
chr2:218595934-218595947+0.8904.4591.400.2500.838NM_198483-50251 FLJ46536 protein (FLJ46536), mRNA.
chr1:158645094-158645107-0.8834.4041.240.2500.838NM_0203358203-
chr5:81432916-81432929-0.8834.4071.050.2500.838NM_031482129386 APG10 autophagy 10-like (S. cerevisiae) (APG10L),
chr8:126877352-126877365+0.8844.4081.030.2500.838NM_025195365707 tribbles homolog 1 (Drosophila) (TRIB1), mRNA.
chr19:51491944-51491957-0.8874.4401.210.2490.838NM_152795-101 hypoxia inducible factor 3, alpha subunit (HIF3A),
chr2:208598300-208598313+0.8864.4311.560.2490.838NM_001080475-23663-
chr21:33409927-33409940-0.8904.4591.340.2490.838NM_13898345584 oligodendrocyte transcription factor 1 (OLIG1), mRNA.
chr1:109845588-109845601+0.8824.3941.210.2480.838NM_1825807443 cytochrome b-561 domain containing 1 (CYB561D1), mRNA.
chr12:56209473-56209486+0.8894.4491.690.2480.838NM_0528976647 methyl-CpG binding domain protein 6 (MBD6), mRNA.
chr5:145278974-145278987+0.8834.4061.370.2480.838NM_152550-17261 SH3 domain containing ring finger 2 (SH3RF2), mRNA.
chr22:23165864-23165877-0.8834.4071.050.2480.838NM_0006756872 adenosine A2a receptor (ADORA2A), mRNA.
chr2:70807932-70807945+0.8844.4081.030.2480.838NM_00161740905 adducin 2 (beta) (ADD2), transcript variant beta-1,
chr1:71720460-71720473+0.8824.3981.080.2480.838NM_203350-401127 zinc finger protein 265 (ZNF265), transcript variant
chr12:47498760-47498773-0.8894.4531.110.2470.838NM_00072581 calcium channel, voltage-dependent, beta 3 subunit
chr9:130344270-130344283-0.8854.4161.160.2470.838NM_003127-10337 spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)
chr2:231504925-231504938+0.8874.4391.240.2470.838NM_005683-6740 G protein-coupled receptor 55 (GPR55), mRNA.
chr18:30699166-30699179+0.8854.4201.230.2470.838NM_03298046936 dystrobrevin, alpha (DTNA), transcript variant 6,
chr10:72827516-72827529-0.8864.4311.260.2470.838NM_022124919 cadherin-like 23 (CDH23), transcript variant 1, mRNA.
chr5:37913809-37913822-0.8874.4332.210.2470.838NM_000514-38270 glial cell derived neurotrophic factor (GDNF),
chr12:58645249-58645262-0.8874.4321.080.2470.838NM_004731275956 solute carrier family 16 (monocarboxylic acid
chr6:28601581-28601594-0.8904.4591.130.2460.838NM_001509-87 glutathione peroxidase 5 (epididymal androgen-related
chr11:10693043-10693056-0.8864.4311.180.2460.838NM_001100163-20932-
chr12:53101285-53101298-0.8874.4401.030.2460.838NM_002205-1968 integrin, alpha 5 (fibronectin receptor, alpha
chr17:13988933-13988946-0.8874.4361.240.2460.838NM_00130375589 COX10 homolog, cytochrome c oxidase assembly protein,
chr20:44290595-44290608-0.8854.4231.050.2460.838NM_02124823146 cadherin-like 22 (CDH22), mRNA.
chr4:24291776-24291789-0.8814.3841.170.2460.838NM_001358-96494 DEAH (Asp-Glu-Ala-His) box polypeptide 15 (DHX15),
chr15:86736130-86736143-0.8844.4081.050.2460.838NM_176805-75458 mitochondrial ribosomal protein S11 (MRPS11), nuclear
chr22:30653027-30653040+0.8884.4441.570.2460.838NM_003405-17352 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
chr17:820379-820392-0.8874.4361.880.2460.838NM_0224639381 nucleoredoxin (NXN), mRNA.
chr17:61328564-61328577-0.8844.4141.350.2460.838NM_001037325-75501-
chr2:43008415-43008428-0.8824.3951.210.2460.838NM_012205-135196 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), mRNA.
chr7:7571374-7571387-0.8814.3831.070.2450.838NM_019005-1667 hypothetical protein FLJ20323 (FLJ20323), mRNA.
chr6:69998945-69998958+0.8824.3961.150.2450.838NM_018368564664 chromosome 6 open reading frame 209 (C6orf209), mRNA.
chr16:8091463-8091476+0.8834.4021.000.2450.838NM_024109-531465 hypothetical protein MGC2654 (MGC2654), mRNA.
chr8:122724269-122724282+0.8844.4141.010.2450.838NM_005328-1458 hyaluronan synthase 2 (HAS2), mRNA.
chr6:35292983-35292996-0.8844.4141.150.2440.838NM_1527532915 signal peptide, CUB domain, EGF-like 3 (SCUBE3), mRNA.
chrX:151572910-151572923-0.8884.4441.120.2440.838NM_01855815717 gamma-aminobutyric acid (GABA) receptor, theta
chr1:202887354-202887367+0.8834.4021.090.2440.838NM_00633833750 leucine rich repeat neuronal 5 (LRRN5), transcript
chr4:164473289-164473302+0.8904.4591.120.2440.838NM_000909-91 neuropeptide Y receptor Y1 (NPY1R), mRNA.
chr1:66794910-66794923+0.8854.4231.190.2440.838NM_03229122597 hypothetical protein DKFZp761D221 (DKFZp761D221),
chr11:40165268-40165281-0.8894.4491.100.2440.838NM_020929106972 netrin-G1 ligand (NGL-1), mRNA.
chr11:116165221-116165234-0.8844.4141.040.2430.838NM_003904-1272 zinc finger protein 259 (ZNF259), mRNA.